data_1dk2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dk2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.16 6.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.98 -55.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.853 -0.792 . . . . 0.0 109.021 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -51.49 -31.5 23.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 110.345 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.91 -29.36 70.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.587 -0.696 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.7 mmt -88.87 -20.09 25.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 0.0 109.869 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 mp -89.28 -33.54 16.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.5 t -75.06 -34.33 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -59.44 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 0.0 109.308 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.455 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 4.0 pp -61.56 -30.66 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.41 -40.2 71.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 109.139 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.82 -35.84 82.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.14 -24.61 67.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.847 -0.533 . . . . 0.0 109.646 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -74.42 -61.21 1.94 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.543 -0.723 . . . . 0.0 109.292 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.9 tmtm? -63.47 -41.98 98.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.698 -0.626 . . . . 0.0 109.601 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.8 -23.88 54.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.1 t -89.83 164.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.7 t -75.4 -70.21 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.982 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -89.64 68.18 7.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.46 -0.775 . . . . 0.0 110.702 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.92 44.16 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.617 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.44 -26.77 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 109.453 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.462 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.46 -49.69 52.54 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.5 -19.87 62.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.755 . . . . 0.0 109.271 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.4 t80 -57.67 -60.13 4.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 -28.05 63.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.552 -0.717 . . . . 0.0 109.591 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -49.76 -63.09 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.612 -0.68 . . . . 0.0 110.492 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.455 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 58.6 m-85 -80.41 -23.21 40.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.781 -0.574 . . . . 0.0 110.488 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -45.37 94.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.687 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -78.9 -46.73 17.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.871 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.16 -29.68 70.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.542 -0.724 . . . . 0.0 109.789 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.14 -30.03 54.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 t -79.03 -42.81 25.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.926 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.18 -44.35 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.021 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.0 mt -73.23 -26.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 109.953 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.42 -20.24 37.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.68 26.54 8.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.872 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.444 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.5 t80 -80.75 140.97 51.13 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.516 -0.74 . . . . 0.0 109.037 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.4 Cg_endo -85.28 7.31 5.2 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.039 2.493 . . . . 0.0 111.172 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.0 179.59 7.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.893 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -109.71 169.03 8.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 109.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 pt -131.3 156.04 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -140.1 28.76 2.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -170.17 155.25 5.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 109.398 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.21 -30.3 77.1 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.3 93.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.971 . . . . 0.0 109.472 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -61.37 -21.99 64.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.973 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.17 -26.6 20.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.33 -0.857 . . . . 0.0 109.772 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -74.61 -37.87 62.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 109.687 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -59.7 -26.77 65.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.52 -0.737 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 82.7 mt -60.4 146.09 85.22 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.56 -0.712 . . . . 0.0 109.599 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.5 109.81 2.54 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.7 -28.47 4.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.82 138.34 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -1.01 . . . . 0.0 109.381 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.29 -141.71 10.14 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 p -96.11 -30.6 13.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.537 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -65.35 -62.14 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.63 -44.94 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.732 . . . . 0.0 109.722 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.54 69.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.759 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.91 -41.01 97.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.725 . . . . 0.0 109.405 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -65.49 -31.27 72.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.1 mm -63.47 -44.52 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -56.61 -40.35 75.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 109.605 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.06 -26.99 69.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 109.122 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -51.36 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.688 . . . . 0.0 109.462 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.39 -29.15 62.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.938 -0.476 . . . . 0.0 110.021 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.421 -0.8 . . . . 0.0 109.461 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.9 -37.57 6.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.78 -43.07 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.811 -0.817 . . . . 0.0 109.102 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -57.63 -34.13 68.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.7 . . . . 0.0 109.942 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -31.77 73.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.6 mmm -89.44 -22.16 22.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 109.915 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -37.08 23.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.1 t -75.08 -29.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.49 -64.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.456 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -64.26 -30.47 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.5 -46.14 66.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.547 -0.72 . . . . 0.0 109.524 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -36.97 84.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.48 -20.35 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.0 109.926 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.92 -57.78 3.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.336 -0.852 . . . . 0.0 109.038 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -68.71 -38.53 80.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.74 -26.77 64.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.752 . . . . 0.0 109.646 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.4 164.17 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -70.0 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 111.022 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 60.87 6.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.04 66.62 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.83 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.16 -32.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 108.88 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.404 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -61.61 -48.61 80.13 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.273 -0.892 . . . . 0.0 108.735 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.54 -20.58 62.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 40' ' ' ARG . 23.8 t80 -57.54 -69.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.27 -0.894 . . . . 0.0 109.607 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -52.94 -25.32 11.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.342 -0.849 . . . . 0.0 109.99 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.98 -55.43 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.482 -0.762 . . . . 0.0 109.859 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 44.7 m-85 -90.02 -29.72 18.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 110.116 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -63.05 -44.62 95.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -75.93 -41.83 50.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.588 -0.695 . . . . 0.0 109.594 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.72 -48.84 77.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.489 -0.757 . . . . 0.0 109.586 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.11 -27.05 68.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.486 -0.759 . . . . 0.0 109.887 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -75.97 -50.61 14.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.46 -0.775 . . . . 0.0 110.045 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.95 -44.16 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.496 -0.752 . . . . 0.0 110.001 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.3 mt -68.18 -53.9 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.464 -0.772 . . . . 0.0 109.78 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.28 60.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.42 28.32 8.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.452 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.6 t80 -87.01 139.53 32.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.582 -0.698 . . . . 0.0 109.155 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.99 10.14 3.79 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.067 2.511 . . . . 0.0 111.253 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.3 m-70 -147.09 175.09 10.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 0.0 109.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -91.52 177.95 6.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.687 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.1 mt -121.83 118.44 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -75.08 -43.24 54.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.512 -0.743 . . . . 0.0 109.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 -179.5 7.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.692 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.46 -26.84 60.06 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.98 70.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.465 -1.02 . . . . 0.0 109.367 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -73.24 -20.88 60.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.72 -0.612 . . . . 0.0 109.889 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.53 -26.52 24.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.89 . . . . 0.0 109.798 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -41.78 61.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -59.74 -24.49 64.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 110.02 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.452 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 82.5 mt -60.42 142.35 90.75 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.488 -0.758 . . . . 0.0 109.52 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.95 109.07 2.33 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.035 2.49 . . . . 0.0 110.253 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.77 5.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.53 137.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.435 -1.039 . . . . 0.0 109.39 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.07 -149.06 22.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -98.11 -29.9 12.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.591 -0.947 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -71.06 -44.49 65.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.622 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mm -70.34 -44.96 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 0.0 109.811 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.12 87.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.0 109.739 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.47 -37.6 84.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.528 -0.732 . . . . 0.0 109.601 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -63.01 -32.47 73.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 109.392 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.78 -43.05 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -55.93 -41.1 74.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.735 . . . . 0.0 109.674 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.69 -29.37 70.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -52.53 22.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.697 . . . . 0.0 109.393 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.47 61.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.906 -0.496 . . . . 0.0 110.062 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -79.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.95 -37.96 5.89 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.88 -49.4 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.947 -0.737 . . . . 0.0 109.756 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -58.15 -33.81 69.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.24 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 mtp -84.19 -16.23 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.1 -38.68 26.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.94 -28.96 31.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -64.52 -66.6 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.603 -0.686 . . . . 0.0 110.015 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 39' ' ' TYR . 1.9 pt? -63.76 -33.83 76.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.549 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.36 -41.63 60.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.558 -0.714 . . . . 0.0 109.82 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.14 -38.38 85.42 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -63.73 -26.09 68.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.745 -0.597 . . . . 0.0 109.655 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -75.97 -57.83 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.507 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 20.1 tttp -65.81 -42.22 90.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 0.0 109.507 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.44 -24.64 56.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.5 t -89.5 164.82 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -77.31 -70.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 111.072 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -83.53 63.12 7.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.696 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.84 38.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.43 -23.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -0.78 . . . . 0.0 109.523 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -73.87 -51.84 14.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.54 -19.88 63.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 109.164 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 18.9 t80 -59.35 -56.15 25.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 0.0 108.915 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -58.97 -26.72 64.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.747 . . . . 0.0 109.494 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 69' ' ' ILE . . . -57.75 -67.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.459 -0.776 . . . . 0.0 109.822 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.433 ' CE1' HD13 ' A' ' 22' ' ' LEU . 20.6 m-85 -75.35 -28.67 59.66 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.579 -0.7 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 23.5 tpt180 -63.5 -52.63 60.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.499 -0.751 . . . . 0.0 109.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -62.28 -39.49 93.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.35 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.5 93.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.563 -0.711 . . . . 0.0 109.106 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.2 65.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.449 -0.782 . . . . 0.0 109.704 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 m -82.96 -53.43 5.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.62 -42.5 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.491 -0.756 . . . . 0.0 109.815 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 46' ' ' ILE . 48.3 mm -68.9 -36.85 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.777 . . . . 0.0 109.404 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.64 36.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.494 -0.754 . . . . 0.0 110.31 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -101.02 15.8 27.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.487 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 4.2 t80 -96.8 133.63 24.17 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -86.57 14.94 2.31 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.198 2.599 . . . . 0.0 111.784 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.8 m-70 -148.11 175.02 11.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 109.893 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 159.84 14.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.695 . . . . 0.0 109.536 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mt -98.15 137.22 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -86.0 -47.9 9.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.704 . . . . 0.0 109.649 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 p -136.53 179.58 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.661 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.17 78.46 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.11 71.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.983 . . . . 0.0 109.413 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.21 -21.58 63.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.619 -0.676 . . . . 0.0 109.884 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 -32.73 35.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -74.43 -38.85 62.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.555 -0.716 . . . . 0.0 110.114 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -59.98 -26.69 66.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 8.2 mt -71.29 148.44 93.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.363 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.28 106.21 2.11 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.05 2.5 . . . . 0.0 110.351 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.04 2.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.8 t -89.73 139.66 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.993 . . . . 0.0 109.385 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.41 -147.21 21.98 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -30.59 11.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.601 -0.94 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -82.51 -41.7 19.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.658 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 38' ' ' ALA . 42.8 mm -72.18 -39.89 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.469 -0.769 . . . . 0.0 109.742 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.27 -51.91 67.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.494 -0.754 . . . . 0.0 109.778 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.35 -32.13 68.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.441 -0.787 . . . . 0.0 109.471 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -63.15 -34.51 77.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 73' ' ' ILE . 46.7 mm -64.33 -38.7 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.37 -40.17 74.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.48 -0.763 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.19 -30.57 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -52.47 36.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.282 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.28 -25.2 60.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.903 -0.498 . . . . 0.0 110.165 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.99 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.291 -0.881 . . . . 0.0 109.769 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.74 -43.52 4.48 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -68.11 -44.36 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.943 -0.74 . . . . 0.0 109.406 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -58.32 -34.14 70.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.6 -0.687 . . . . 0.0 109.948 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.08 -34.44 77.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.27 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.0 mtt -89.9 -15.55 31.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.694 -0.629 . . . . 0.0 110.157 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.19 -35.7 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 108.485 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.94 -31.4 14.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -70.45 -59.33 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.887 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.457 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 2.3 pp -63.92 -34.71 78.57 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.273 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.93 -42.22 62.63 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.593 -0.692 . . . . 0.0 109.71 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -63.68 -38.07 89.73 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -61.96 -23.76 66.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.818 -0.551 . . . . 0.0 109.82 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.88 -57.75 3.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.443 -0.786 . . . . 0.0 109.148 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 14.5 tttm -67.69 -41.12 84.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.537 -0.727 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -57.45 -25.41 59.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.383 -0.823 . . . . 0.0 109.733 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.8 t -89.27 164.23 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.62 -70.09 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.463 -0.773 . . . . 0.0 110.905 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -82.79 59.92 5.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.465 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.72 63.57 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.7 -29.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 108.957 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.417 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -64.11 -49.08 73.63 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.01 -25.45 63.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.629 -0.669 . . . . 0.0 109.421 179.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 40' ' ' ARG . 28.0 t80 -52.59 -64.12 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.246 -0.909 . . . . 0.0 109.799 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -57.42 -26.07 60.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.506 -0.746 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.16 -65.78 0.54 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 72.0 m-85 -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.636 -0.665 . . . . 0.0 110.039 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 9.1 mmm180 -67.16 -39.68 86.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.527 -0.733 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -72.69 -45.41 58.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.99 98.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.65 -24.76 66.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.548 -0.72 . . . . 0.0 109.883 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -78.13 -36.27 48.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.976 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 p -90.01 -44.95 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.402 -0.811 . . . . 0.0 110.008 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.8 mt -66.56 -56.03 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.41 -20.26 59.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.6 -0.687 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 26.7 9.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.2 t80 -88.52 138.14 30.19 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.183 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.419 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.39 12.06 3.12 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.104 2.536 . . . . 0.0 111.342 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 68.2 m-70 -147.69 169.74 19.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -0.971 . . . . 0.0 109.743 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -105.46 141.18 37.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 0.0 109.664 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.4 pt -97.51 154.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -114.88 -29.96 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.595 -0.691 . . . . 0.0 109.807 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.43 165.35 23.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 109.625 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.83 -26.03 64.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.35 85.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -1.068 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -63.69 -19.08 64.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.71 -0.619 . . . . 0.0 109.937 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.26 -26.4 21.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 109.831 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -38.52 63.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.763 . . . . 0.0 109.656 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -60.48 -26.45 66.81 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 51.9 mt -60.3 141.37 91.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.718 . . . . 0.0 109.563 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -80.02 112.65 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.931 2.421 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.06 -22.68 6.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.36 137.15 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -1.068 . . . . 0.0 109.373 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.07 -146.55 21.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 t -100.22 -30.32 11.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.635 -0.92 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -69.41 -45.33 69.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.552 -0.717 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.4 mm -72.85 -42.04 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.738 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.35 88.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -61.38 -36.35 80.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.563 -0.71 . . . . 0.0 109.448 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -64.45 -31.43 72.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.662 -0.649 . . . . 0.0 109.412 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.53 -45.64 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -55.81 -39.72 71.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -64.47 -30.36 71.39 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -51.62 45.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.609 -0.682 . . . . 0.0 109.219 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.73 -25.24 60.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.896 -0.503 . . . . 0.0 110.057 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.403 -0.81 . . . . 0.0 109.54 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -36.29 6.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.07 -47.9 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.886 -0.773 . . . . 0.0 109.135 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -60.3 -29.6 68.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.768 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.3 -32.79 74.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -90.0 -14.08 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.632 -0.667 . . . . 0.0 110.139 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.8 -35.11 16.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.67 -31.8 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -70.11 -59.19 3.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.622 -0.674 . . . . 0.0 109.656 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.0 pp -63.02 -34.96 78.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 109.195 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.88 -42.16 62.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.541 -0.724 . . . . 0.0 109.76 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.2 -35.18 80.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -64.16 -27.16 68.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.846 -0.534 . . . . 0.0 109.582 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -78.58 -55.51 5.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.279 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.9 ttmt -63.8 -43.59 95.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.502 -0.749 . . . . 0.0 109.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.25 -24.52 59.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.34 165.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 t -76.81 -70.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.471 -0.768 . . . . 0.0 111.241 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -85.43 65.02 8.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.394 -0.816 . . . . 0.0 110.789 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.82 43.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.348 -0.845 . . . . 0.0 109.667 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.54 -23.39 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.777 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.426 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 p-80 -70.86 -51.69 24.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.375 -0.828 . . . . 0.0 108.808 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.32 -25.41 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 29.0 t80 -53.21 -53.97 42.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.47 -27.43 69.28 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.02 -63.71 1.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.507 -0.746 . . . . 0.0 110.435 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 74.5 m-85 -71.59 -23.96 61.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.793 -0.567 . . . . 0.0 110.49 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.19 -55.63 23.46 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -62.72 -43.02 99.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 109.811 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.65 -27.73 67.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.577 -0.702 . . . . 0.0 109.801 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.2 -24.47 61.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 110.077 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.5 p -90.08 -49.91 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.284 -0.885 . . . . 0.0 110.025 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.87 -33.28 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.554 -0.717 . . . . 0.0 109.901 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 46' ' ' ILE . 63.7 mt -87.02 -30.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.442 -0.787 . . . . 0.0 109.976 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.21 -18.22 30.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 0.0 110.311 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -112.97 25.88 11.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.0 t80 -89.91 140.03 27.63 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.419 -0.801 . . . . 0.0 109.125 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.76 12.0 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.113 2.542 . . . . 0.0 111.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.431 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.1 m-70 -146.38 170.86 15.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.92 . . . . 0.0 109.734 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -94.42 147.42 23.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.738 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 mt -97.0 134.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -100.77 -57.94 2.0 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 109.587 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -105.22 159.94 15.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.25 -31.26 80.12 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.03 71.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.944 . . . . 0.0 109.377 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -67.8 -22.35 65.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.644 -0.66 . . . . 0.0 109.806 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.17 -29.47 24.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.677 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -75.63 -38.13 59.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.845 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -59.85 -24.25 64.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 110.219 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 49' ' ' TYR . 44.0 mt -69.07 151.09 97.34 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.521 -0.737 . . . . 0.0 109.458 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.34 99.94 1.28 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.029 2.486 . . . . 0.0 110.154 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.55 -27.54 1.94 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.68 138.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -1.009 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.93 -146.89 21.19 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -100.1 -28.27 13.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.968 . . . . 0.0 109.726 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.21 -61.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 109.761 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 39' ' ' TYR . 46.4 mm -65.13 -33.29 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.514 -0.741 . . . . 0.0 109.75 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.51 -57.49 9.78 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 110.22 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.15 -31.4 67.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 109.329 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.04 70.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.429 HD13 HG23 ' A' ' 73' ' ' ILE . 44.6 mm -71.03 -43.87 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 108.978 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -52.36 -50.54 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.62 -30.26 70.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.42 -0.8 . . . . 0.0 109.142 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -42.47 93.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.79 -22.74 31.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.184 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.34 -0.85 . . . . 0.0 109.645 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.86 -35.93 6.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.82 -48.11 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.88 -0.776 . . . . 0.0 109.117 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -56.77 -28.09 60.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.605 -0.684 . . . . 0.0 109.899 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.54 -27.01 64.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 mmt -89.95 -19.45 24.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 109.966 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 mp -86.52 -33.65 20.23 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.23 -36.02 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -58.99 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.616 -0.678 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 4.2 pp -63.06 -31.03 72.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.214 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.42 61.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -0.772 . . . . 0.0 109.592 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.32 -40.33 81.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -63.32 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG3' ' CD ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -76.24 -56.85 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.228 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 24.4 ttpt -61.8 -46.92 87.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -0.788 . . . . 0.0 109.742 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -56.79 -22.46 36.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.367 -0.833 . . . . 0.0 109.93 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.86 165.29 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.6 t -76.98 -70.56 0.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 111.402 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -81.23 62.4 5.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.404 -0.81 . . . . 0.0 110.737 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.0 27.55 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -30.82 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.448 -0.783 . . . . 0.0 108.921 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -69.66 -44.68 70.01 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' CD ' ' HG3' ' A' ' 26' ' ' GLU . 1.6 ptpm? -75.75 -20.45 58.29 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 8.5 t80 -58.41 -58.23 9.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.312 -0.867 . . . . 0.0 108.794 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -57.56 -28.8 63.88 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.561 -0.712 . . . . 0.0 109.328 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.42 -59.8 3.63 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.45 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 44.1 m-85 -82.09 -26.68 33.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.69 . . . . 0.0 110.143 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -40.55 96.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.366 -0.834 . . . . 0.0 109.698 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -79.0 -49.98 11.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.879 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.6 -35.41 77.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 109.858 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.96 67.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.5 -0.75 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -80.02 -45.65 17.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.66 -43.05 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.57 -0.706 . . . . 0.0 109.942 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.12 -33.56 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.439 -0.788 . . . . 0.0 109.911 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.18 -22.7 60.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.835 . . . . 0.0 110.114 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -120.52 26.56 9.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 0.0 109.73 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.6 t80 -81.78 141.45 47.91 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -86.03 9.11 4.18 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.044 2.496 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.428 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.1 m-70 -146.53 175.28 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.244 -0.91 . . . . 0.0 109.632 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -94.61 178.67 5.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.679 . . . . 0.0 109.688 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.3 mt -135.14 104.43 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.58 -0.7 . . . . 0.0 109.337 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -90.18 -52.46 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.674 -0.641 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.8 p -96.15 150.5 20.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.03 -25.8 64.78 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.97 72.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -1.053 . . . . 0.0 109.624 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 -20.05 66.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.698 . . . . 0.0 109.769 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.79 -28.73 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -75.71 -38.47 58.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -59.94 -24.66 64.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.555 -0.716 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 85.9 mt -59.8 143.81 86.64 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.47 -0.769 . . . . 0.0 109.738 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.48 111.91 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.981 2.454 . . . . 0.0 110.143 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.78 -29.42 5.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -89.98 137.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.966 . . . . 0.0 109.251 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.23 -139.27 10.01 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -98.21 -28.4 13.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.952 . . . . 0.0 109.604 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -62.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 0.0 109.588 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.0 mm -62.2 -44.39 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.698 . . . . 0.0 109.735 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.11 83.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.735 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.84 -40.29 88.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.745 . . . . 0.0 109.568 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -63.49 -29.74 70.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.613 -0.68 . . . . 0.0 109.442 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.5 -46.32 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.725 . . . . 0.0 109.164 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.81 -41.41 74.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.466 -0.771 . . . . 0.0 109.77 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.97 -27.2 69.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 109.206 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -51.62 19.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.9 -27.3 61.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.576 -0.449 . . . . 0.0 109.981 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.421 -0.799 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.406 -0.809 . . . . 0.0 109.323 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.535 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -50.0 5.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mt -67.51 -46.25 83.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.0 m -59.25 -29.12 67.31 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.626 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.05 -37.74 88.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.0 mtt -82.57 -17.94 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.22 -36.62 20.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.16 -31.65 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.64 -61.81 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.554 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.6 pp -64.31 -32.23 73.74 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.094 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.33 -43.35 67.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.582 -0.699 . . . . 0.0 109.54 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -63.72 -37.31 86.88 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -62.38 -23.45 66.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.543 . . . . 0.0 109.792 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -57.74 3.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -67.12 -40.5 86.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.617 -0.677 . . . . 0.0 109.675 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.5 -25.22 62.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.46 -0.775 . . . . 0.0 109.739 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.4 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.3 t -76.32 -70.45 0.45 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.518 -0.738 . . . . 0.0 110.974 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -85.92 63.48 8.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.49 -0.756 . . . . 0.0 110.586 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.85 49.0 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 109.741 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.3 -28.94 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.418 -0.801 . . . . 0.0 109.332 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.2 -48.89 71.8 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.26 -23.62 63.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.685 -0.634 . . . . 0.0 109.438 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.414 ' CZ ' ' HD3' ' A' ' 40' ' ' ARG . 28.3 t80 -54.87 -62.95 1.33 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.291 -0.88 . . . . 0.0 109.75 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.5 -59.48 4.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 0.0 110.076 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.458 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 35.4 m-85 -88.92 -29.61 19.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.815 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HD3' ' CZ ' ' A' ' 36' ' ' TYR . 9.1 tpt180 -62.19 -43.21 99.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.53 -0.731 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -79.19 -38.03 36.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 109.695 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.97 84.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.83 -29.93 66.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.531 -0.731 . . . . 0.0 109.509 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -67.75 -55.51 12.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.098 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.35 -43.79 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.001 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.4 mt -71.0 -38.16 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.775 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.2 -26.26 68.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.02 27.46 8.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.792 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.447 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 3.2 t80 -84.17 137.05 40.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.73 . . . . 0.0 109.256 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.3 Cg_endo -87.23 14.49 2.4 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 123.195 2.597 . . . . 0.0 111.392 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.4 m-70 -147.87 173.26 13.01 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.218 -0.926 . . . . 0.0 109.762 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -97.85 139.23 34.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 109.827 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.9 pt -103.88 67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.291 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -69.59 -15.1 63.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.9 m -116.19 139.52 50.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.24 -31.17 65.39 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.76 78.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.634 -0.921 . . . . 0.0 109.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -63.37 -23.02 67.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.673 -0.642 . . . . 0.0 109.831 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.06 25.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -74.42 -42.23 59.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.79 . . . . 0.0 109.615 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -59.28 -23.75 62.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.54 -0.725 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 83.5 mt -59.56 138.82 89.46 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.728 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.98 101.37 1.14 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.046 2.497 . . . . 0.0 110.007 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.86 -19.11 3.75 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.3 t -89.31 138.42 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.329 -1.1 . . . . 0.0 109.302 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.44 -155.89 25.67 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -96.96 -27.02 14.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.967 . . . . 0.0 109.777 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -83.06 -38.09 22.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.496 -0.753 . . . . 0.0 109.667 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.1 mm -72.65 -42.22 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.434 -0.791 . . . . 0.0 109.868 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.84 76.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.781 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.12 -32.39 68.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -33.45 75.61 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 73' ' ' ILE . 47.5 mm -63.47 -42.18 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -56.94 -36.84 70.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.629 -0.67 . . . . 0.0 109.588 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.93 -32.38 73.89 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -50.18 65.09 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.59 0.71 . . . . 0.0 109.159 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -74.01 -24.59 59.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.872 -0.517 . . . . 0.0 110.153 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.18 -34.15 7.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mt -75.04 -49.34 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.856 -0.791 . . . . 0.0 109.353 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -58.9 -34.69 71.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.664 -0.648 . . . . 0.0 109.898 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -35.24 79.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 109.268 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttm -86.06 -22.95 26.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.626 -0.671 . . . . 0.0 109.779 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.07 -37.75 38.09 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.2 t -72.0 -28.82 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.21 -66.41 0.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.003 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.456 ' CD1' ' CE2' ' A' ' 39' ' ' TYR . 2.2 pt? -64.73 -31.72 73.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.82 -40.7 56.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.555 -0.716 . . . . 0.0 110.111 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.64 69.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -64.61 -27.21 68.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.36 -56.18 4.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.624 -0.673 . . . . 0.0 109.394 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 14.2 tttp -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -57.15 -25.59 59.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.465 -0.772 . . . . 0.0 109.471 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.6 t -89.52 165.32 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.14 -67.48 0.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 111.211 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -78.85 57.87 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.901 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.03 28.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.27 -33.01 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -67.82 -44.69 76.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -76.51 -16.98 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 4.7 t80 -61.89 -63.29 1.3 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -55.51 -26.13 41.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -0.751 . . . . 0.0 109.632 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -58.1 9.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.478 -0.763 . . . . 0.0 109.654 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CE2' ' CD1' ' A' ' 22' ' ' LEU . 27.9 m-85 -84.61 -27.99 26.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 109.674 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -53.98 44.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 109.546 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -67.57 -43.16 81.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.549 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.36 -29.7 70.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.544 -0.723 . . . . 0.0 109.552 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.32 -26.22 60.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.558 -0.713 . . . . 0.0 109.796 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -87.88 -48.5 7.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 109.993 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.68 -33.54 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.1 mt -85.8 -25.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.533 -0.729 . . . . 0.0 109.705 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.46 -20.98 24.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -108.89 23.45 14.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 1.8 t80 -94.59 139.64 22.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 108.935 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.51 12.24 3.06 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.105 2.537 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -146.02 153.58 40.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 0.0 109.795 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -77.23 145.77 37.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 109.772 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.05 81.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -69.66 -27.78 65.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 p -121.52 145.86 47.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.452 -0.78 . . . . 0.0 109.376 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.0 79.23 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -31.41 72.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.542 -0.975 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.31 -22.27 66.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.635 -0.666 . . . . 0.0 109.775 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.75 -32.23 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -76.31 -37.75 57.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.523 -0.735 . . . . 0.0 109.724 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -60.02 -23.31 63.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.185 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.433 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 24.7 mt -63.89 151.1 90.12 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.421 -0.799 . . . . 0.0 109.543 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -81.29 104.14 1.48 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.117 2.545 . . . . 0.0 110.054 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.16 -22.68 4.73 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -89.3 139.84 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.387 -1.066 . . . . 0.0 109.282 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.73 -153.48 28.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.0 p -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.489 -1.007 . . . . 0.0 109.624 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -66.57 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 39' ' ' TYR . 50.1 mm -64.08 -35.09 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 109.775 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.01 96.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.507 -0.745 . . . . 0.0 109.377 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -59.59 -33.73 71.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.598 -0.689 . . . . 0.0 109.428 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -65.87 -30.72 71.37 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.6 mm -63.15 -46.22 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -56.62 -37.5 70.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.475 -0.766 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.57 -31.28 72.43 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -50.49 62.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.562 0.696 . . . . 0.0 109.206 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -74.45 -25.58 59.51 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.027 -0.42 . . . . 0.0 110.143 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.59 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.387 -0.821 . . . . 0.0 109.742 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.436 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.08 -37.01 6.43 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.7 mt -69.16 -60.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.892 -0.769 . . . . 0.0 109.184 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -52.99 -25.9 13.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.811 -0.556 . . . . 0.0 110.525 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.29 -30.38 68.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.69 -21.8 21.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.952 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mp -86.94 -35.29 18.98 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.7 t -77.22 -31.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -65.35 -61.84 1.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.442 ' CD2' ' CE2' ' A' ' 39' ' ' TYR . 3.1 pp -63.06 -33.34 75.23 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.06 -36.23 38.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.681 -0.637 . . . . 0.0 109.809 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.92 74.86 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -60.83 -21.11 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.299 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -58.5 3.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.248 -0.907 . . . . 0.0 109.151 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 10.0 tttp -68.78 -38.05 79.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.52 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.65 -27.26 64.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.406 -0.808 . . . . 0.0 109.592 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.34 164.03 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -77.72 -70.22 0.49 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 0.0 110.853 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -81.37 59.15 3.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.77 65.64 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -30.8 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.419 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -62.59 -48.96 77.15 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.338 -0.851 . . . . 0.0 108.829 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -71.15 -20.85 62.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.69 . . . . 0.0 109.641 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 23.8 t80 -57.32 -68.76 0.2 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.866 . . . . 0.0 109.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -55.72 -23.03 26.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.384 -0.822 . . . . 0.0 110.054 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.14 -63.53 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.368 -0.832 . . . . 0.0 109.916 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.442 ' CE2' ' CD2' ' A' ' 22' ' ' LEU . 86.9 m-85 -74.61 -27.34 60.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.713 -0.617 . . . . 0.0 110.086 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -61.57 -37.21 83.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.441 -0.787 . . . . 0.0 109.683 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -81.95 -49.74 9.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -63.84 -27.91 69.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 -37.08 62.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.774 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.3 m -71.6 -47.42 54.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.01 -35.46 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.554 -0.716 . . . . 0.0 109.767 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.6 mt -84.17 -28.27 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.752 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.06 -21.15 24.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.47 -0.769 . . . . 0.0 110.039 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.26 22.44 15.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.922 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.436 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.1 t80 -96.02 140.67 22.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 108.998 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.05 8.13 4.66 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.979 2.453 . . . . 0.0 111.226 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.42 -176.28 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.678 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -104.17 160.49 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.532 -0.73 . . . . 0.0 109.57 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.4 mt -97.05 143.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.68 . . . . 0.0 109.383 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -91.48 -65.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.732 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 m -119.88 -179.95 4.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.729 . . . . 0.0 109.537 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.35 -33.8 87.3 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.2 71.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.997 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.19 -24.24 62.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.686 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.59 -31.96 22.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 0.0 109.662 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -75.33 -36.28 61.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.571 -0.705 . . . . 0.0 110.042 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.57 -27.28 67.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD21 ' CE1' ' A' ' 49' ' ' TYR . 6.4 mt -71.18 146.95 93.05 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 0.0 109.401 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.8 102.45 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.959 2.439 . . . . 0.0 110.272 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.9 -25.84 2.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.72 139.16 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.46 -1.023 . . . . 0.0 109.587 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.2 -151.53 23.94 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -99.05 -29.47 12.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.958 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -72.07 -64.09 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.498 -0.751 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 39' ' ' TYR . 47.3 mm -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.76 78.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.45 -38.62 87.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -62.11 -31.14 71.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.6 mm -63.34 -42.47 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.08 -41.04 74.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.413 -0.804 . . . . 0.0 109.548 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -62.89 -28.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -52.13 18.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.395 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.54 -26.79 61.88 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.87 -0.519 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.837 . . . . 0.0 109.525 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 109.237 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.9 -36.63 6.32 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.5 -43.8 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.845 -0.797 . . . . 0.0 109.74 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -59.44 -26.03 64.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.09 -46.33 57.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.47 -0.769 . . . . 0.0 109.423 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -85.24 -8.58 58.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.712 . . . . 0.0 110.456 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.48 -42.1 17.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.09 -30.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.28 -65.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.602 -0.686 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 39' ' ' TYR . 1.6 pt? -63.14 -35.07 79.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.94 -48.95 64.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.62 -0.675 . . . . 0.0 110.114 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -62.81 -33.85 76.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -65.41 -22.55 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.739 -0.601 . . . . 0.0 109.876 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.94 -56.95 4.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.452 -0.78 . . . . 0.0 109.18 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 17.8 tttm -66.37 -39.87 89.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.376 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.15 -26.42 64.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.453 -0.779 . . . . 0.0 109.447 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -89.48 164.46 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.15 -68.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.435 -0.79 . . . . 0.0 110.939 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -86.18 60.68 6.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.448 -0.782 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.74 57.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 109.542 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.93 -37.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.01 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.409 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.8 p-80 -55.73 -46.3 77.81 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.011 -1.056 . . . . 0.0 109.259 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -73.03 -20.41 61.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -57.74 -70.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -53.42 -24.85 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.425 -0.797 . . . . 0.0 109.938 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.62 -66.34 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.501 -0.749 . . . . 0.0 109.784 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CE2' ' CD1' ' A' ' 22' ' ' LEU . 41.2 m-85 -77.94 -30.36 50.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 110.07 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -42.7 99.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.392 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -69.24 -44.84 71.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.747 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.38 92.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.41 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.48 -22.94 64.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 0.0 109.901 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -79.61 -54.67 5.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.59 -44.39 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.541 -0.724 . . . . 0.0 110.104 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 46' ' ' ILE . 78.4 mt -62.87 -58.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.475 -0.765 . . . . 0.0 109.597 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.69 -20.98 62.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.533 -0.729 . . . . 0.0 110.187 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -112.21 28.83 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.452 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.1 t80 -94.07 140.47 22.9 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.2 Cg_endo -85.35 8.78 4.41 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.072 2.515 . . . . 0.0 111.284 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 171.18 15.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -94.48 145.08 25.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.613 -0.679 . . . . 0.0 109.543 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.6 mt -78.24 115.56 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.351 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -74.01 -31.11 62.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 0.0 109.562 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -164.84 -179.79 6.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.578 -0.701 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -28.0 63.54 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.99 95.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.574 -0.956 . . . . 0.0 109.451 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -69.93 -23.28 63.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.71 . . . . 0.0 109.77 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.5 -27.06 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 109.733 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -74.93 -40.99 60.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -59.95 -23.73 63.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.565 -0.709 . . . . 0.0 110.029 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.452 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 80.7 mt -59.99 136.83 90.75 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.55 106.03 1.94 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.865 2.377 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.49 -26.39 3.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.63 138.06 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -1.036 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.75 -146.17 14.09 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -99.14 -37.87 9.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.948 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -64.63 -44.01 91.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.745 . . . . 0.0 109.812 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.9 mm -71.2 -44.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.883 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.04 81.44 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 109.768 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -61.02 -39.42 89.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.51 -0.744 . . . . 0.0 109.544 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -63.26 -30.94 71.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.06 -44.98 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -55.36 -40.95 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -64.26 -28.46 69.74 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.28 -52.57 18.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.608 -0.683 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.941 -0.474 . . . . 0.0 110.028 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.373 -0.83 . . . . 0.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.802 . . . . 0.0 109.47 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.05 -33.57 8.12 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.13 -51.3 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.871 -0.782 . . . . 0.0 109.286 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -57.17 -28.54 62.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.68 -27.02 63.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 0.0 109.552 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.5 mmt -90.3 -19.44 24.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.992 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -33.9 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.88 -31.74 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.19 -58.82 3.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.655 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.428 HD13 ' CG ' ' A' ' 39' ' ' TYR . 3.2 pp -62.67 -34.98 78.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.15 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.95 -43.12 63.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.504 -0.748 . . . . 0.0 109.572 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.74 -34.31 78.03 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -66.2 -26.64 67.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.768 -0.583 . . . . 0.0 109.789 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -80.44 -52.37 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.41 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 53.7 tttt -66.07 -42.85 88.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.409 -0.807 . . . . 0.0 109.145 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -58.62 -26.15 63.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.247 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.34 165.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.6 t -79.39 -70.32 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.446 -0.784 . . . . 0.0 111.238 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -79.13 59.21 2.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.434 -0.791 . . . . 0.0 110.95 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.97 48.69 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.71 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.13 -21.9 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.419 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -71.97 -51.78 20.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.322 -0.861 . . . . 0.0 108.825 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.03 -23.62 63.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.557 -0.715 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 21.9 t80 -56.72 -51.94 66.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.41 -0.806 . . . . 0.0 109.255 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -62.39 -29.9 70.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.192 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 69' ' ' ILE . . . -54.96 -65.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.772 . . . . 0.0 109.989 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.428 ' CG ' HD13 ' A' ' 22' ' ' LEU . 81.7 m-85 -72.59 -16.01 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -72.1 -55.23 7.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -65.66 -43.54 89.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.526 -0.733 . . . . 0.0 110.078 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -64.95 -46.48 81.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.0 64.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.629 -0.669 . . . . 0.0 110.082 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -81.2 -52.67 7.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.13 -43.71 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.834 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.96 -54.88 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.49 -20.88 58.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.503 -0.748 . . . . 0.0 110.371 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -117.43 25.96 10.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.8 t80 -86.08 140.19 34.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.0 109.198 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.19 9.87 3.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.981 2.454 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.428 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 178.68 8.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.291 -0.881 . . . . 0.0 109.645 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -99.41 157.68 16.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.654 -0.654 . . . . 0.0 109.81 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.9 mt -102.53 108.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -69.93 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.584 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -111.85 -179.85 3.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.688 -0.632 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.52 64.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.34 70.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -1.068 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -70.55 -25.21 63.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.714 . . . . 0.0 109.695 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.02 -28.24 22.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 109.631 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -75.26 -40.11 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -59.79 -24.21 63.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.605 -0.685 . . . . 0.0 110.04 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 82.8 mt -60.23 142.65 89.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.456 -0.778 . . . . 0.0 109.636 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.29 105.62 1.78 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.032 2.488 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.45 -26.16 4.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.53 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.461 -1.023 . . . . 0.0 109.468 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.63 -140.59 10.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.49 -27.48 14.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.912 . . . . 0.0 109.778 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -66.14 -67.68 0.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.475 -0.766 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.407 ' CD1' ' CB ' ' A' ' 38' ' ' ALA . 50.8 mm -60.03 -44.87 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.29 -35.46 71.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.45 -38.02 82.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 109.443 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -69.8 -25.25 63.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.645 -0.66 . . . . 0.0 109.653 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.5 mm -72.81 -48.28 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 109.386 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.36 -47.95 68.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.46 -28.95 70.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.475 -0.766 . . . . 0.0 109.054 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -44.15 79.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.69 . . . . 0.0 109.167 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.66 -23.93 36.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.86 -0.525 . . . . 0.0 110.129 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -78.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.498 -0.752 . . . . 0.0 109.433 179.925 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.0 -35.27 7.2 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 19' ' ' LEU . 3.9 mt -70.94 -57.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.78 -0.836 . . . . 0.0 109.17 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -53.48 -30.96 43.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.776 -0.578 . . . . 0.0 110.668 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.97 -29.48 68.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 110.014 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.4 mmt -90.13 -23.71 21.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 110.058 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' CD1' ' CG2' ' A' ' 15' ' ' ILE . 1.8 mp -88.37 -34.27 17.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 108.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.48 -32.92 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -68.6 -61.56 1.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.438 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 4.2 pp -61.69 -32.32 72.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.48 -44.35 65.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 109.63 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -35.62 79.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.13 -22.83 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.859 -0.526 . . . . 0.0 109.678 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -78.23 -57.88 3.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.99 -40.69 95.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.287 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -58.98 -25.4 63.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.582 -0.698 . . . . 0.0 109.498 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -89.59 164.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 t -76.76 -70.19 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.49 -0.756 . . . . 0.0 111.096 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.46 65.97 9.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.386 -0.821 . . . . 0.0 110.884 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.76 36.89 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.86 -26.11 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.316 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.427 ' NE2' ' HE3' ' A' ' 35' ' ' LYS . 6.4 p-80 -71.36 -50.76 28.98 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 10.8 ptpt -66.7 -23.75 66.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.6 t80 -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.475 -0.766 . . . . 0.0 109.648 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -56.71 -24.79 51.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.14 -59.24 5.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.388 -0.82 . . . . 0.0 109.89 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.438 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 48.0 m-85 -85.12 -27.61 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.949 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 28.9 tpt85 -64.41 -42.84 95.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.469 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -78.33 -46.62 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.26 96.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.551 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.73 70.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -66.91 -50.19 63.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.96 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.34 -45.07 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.466 -0.771 . . . . 0.0 110.112 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.3 mt -64.22 -51.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 109.556 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.01 -21.36 66.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 110.076 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.07 27.93 8.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.448 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.4 t80 -90.45 139.38 26.68 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.728 . . . . 0.0 109.129 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.14 10.87 3.49 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.081 2.521 . . . . 0.0 111.263 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.432 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.6 m-70 -147.3 171.68 15.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.273 -0.892 . . . . 0.0 109.642 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.98 138.6 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.696 . . . . 0.0 109.665 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.5 mt -73.12 125.78 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.239 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -81.67 -56.95 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 p -132.21 -179.82 5.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.544 -0.723 . . . . 0.0 109.509 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.8 -29.37 67.31 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.86 72.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.22 -21.33 65.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.718 -0.614 . . . . 0.0 109.9 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.99 -27.63 24.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.788 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -73.38 -40.72 64.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.767 . . . . 0.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -60.27 -26.62 66.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.568 -0.708 . . . . 0.0 110.039 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.448 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 46.5 mt -63.41 136.65 96.8 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.719 . . . . 0.0 109.297 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.55 108.39 2.12 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.937 2.425 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.05 -19.85 4.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.27 139.31 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -1.101 . . . . 0.0 109.285 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.38 -149.92 23.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -98.64 -35.56 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.952 . . . . 0.0 109.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -71.86 -39.93 69.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.0 109.74 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.0 mm -72.83 -40.56 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.764 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.6 -50.65 73.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.543 -0.723 . . . . 0.0 110.126 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.97 -34.01 69.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.789 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -62.27 -37.93 87.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.556 -0.715 . . . . 0.0 109.182 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 73' ' ' ILE . 47.2 mm -63.74 -38.31 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.77 -40.3 72.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.525 -0.735 . . . . 0.0 109.617 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.8 -32.98 74.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -53.12 50.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.39 -22.79 61.08 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.962 -0.461 . . . . 0.0 110.168 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.79 -80.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.617 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.42 -34.81 7.76 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.37 -59.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.861 -0.788 . . . . 0.0 109.146 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -53.17 -31.54 43.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.819 -0.551 . . . . 0.0 110.333 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.9 -29.38 69.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 mmt -90.4 -21.74 21.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.821 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mp -88.78 -34.01 17.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.44 -33.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.77 -60.38 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 109.42 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 39' ' ' TYR . 3.8 pp -61.51 -34.5 75.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.136 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.25 -41.44 60.36 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.556 -0.715 . . . . 0.0 109.669 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -64.25 -37.09 86.26 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -64.38 -23.49 67.31 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -76.1 -56.61 4.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.382 -0.823 . . . . 0.0 109.125 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -69.51 -40.48 76.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 109.728 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -57.5 -25.07 59.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.6 t -89.28 164.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -76.72 -70.43 0.46 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.765 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -85.05 64.56 8.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.459 -0.775 . . . . 0.0 110.412 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.77 48.98 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.683 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 -22.57 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.512 -0.742 . . . . 0.0 109.626 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.8 p-80 -71.5 -51.65 22.54 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 108.677 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -68.1 -23.27 64.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 109.309 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.5 -55.1 39.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -60.94 -27.44 68.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 0.0 109.565 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.99 -63.56 1.14 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.436 -0.79 . . . . 0.0 110.067 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.443 ' CE1' HD11 ' A' ' 22' ' ' LEU . 63.4 m-85 -78.37 -27.4 46.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.722 -0.611 . . . . 0.0 110.149 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -66.83 -33.87 76.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.66 -49.64 10.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.506 -0.746 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -50.85 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.53 -0.731 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -27.76 68.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.506 -0.746 . . . . 0.0 109.626 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -73.74 -32.29 63.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.861 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -90.1 -35.28 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 46' ' ' ILE . 73.2 mt -77.09 -48.62 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.515 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.24 -20.06 62.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 0.0 110.23 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -121.66 26.17 8.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 109.724 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.455 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 1.9 t80 -83.72 145.58 47.68 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.057 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -85.29 -0.01 8.85 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.05 2.5 . . . . 0.0 110.989 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.4 m-70 -142.32 177.75 8.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.325 -0.86 . . . . 0.0 109.634 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -103.79 141.51 35.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.591 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.2 mt -81.83 130.43 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -94.6 -50.5 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.747 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.4 m -125.77 177.93 5.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.33 -29.46 73.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.97 72.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -73.34 -25.78 60.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.46 -28.38 19.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.644 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -77.04 -35.63 56.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.735 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -60.25 -23.27 63.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.588 -0.695 . . . . 0.0 110.031 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 78.9 mt -60.76 143.54 90.86 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.13 107.45 2.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.972 2.448 . . . . 0.0 110.251 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.49 -29.05 3.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.1 t -89.82 138.8 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.984 . . . . 0.0 109.479 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.11 -136.67 7.98 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -98.81 -28.35 13.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.976 . . . . 0.0 109.657 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -66.13 -66.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.568 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.3 mm -61.43 -45.11 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.598 -0.689 . . . . 0.0 109.731 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.64 -34.31 71.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.54 -41.41 97.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.575 -0.703 . . . . 0.0 109.451 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -62.45 -29.64 70.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.681 -0.637 . . . . 0.0 109.366 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.6 -46.87 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.719 . . . . 0.0 109.061 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.41 -32.37 66.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.518 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -67.33 -29.85 69.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -73.18 -50.53 22.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.569 0.7 . . . . 0.0 109.428 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.95 -27.62 61.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 122.043 -0.41 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -79.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.763 . . . . 0.0 109.531 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -42.31 5.03 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.3 mt -66.5 -58.19 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.96 -0.73 . . . . 0.0 109.079 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -52.6 -31.04 34.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.731 -0.606 . . . . 0.0 110.384 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -63.83 -30.38 71.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.496 -0.752 . . . . 0.0 109.529 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 ttm -90.31 -21.39 22.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.888 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.29 -33.95 19.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.8 -35.78 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -65.46 -60.99 2.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.375 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.46 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.7 pp -61.53 -33.66 74.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 109.151 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.88 -41.65 62.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 109.507 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.05 -36.96 85.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -63.87 -23.2 67.26 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -77.01 -57.12 4.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 46.7 tttm -68.27 -40.29 81.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.488 -0.757 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -25.53 61.29 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.481 -0.762 . . . . 0.0 109.696 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.31 164.29 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.14 -70.08 0.49 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.955 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -84.77 62.19 7.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.445 -0.785 . . . . 0.0 110.458 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.77 53.91 0.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.862 . . . . 0.0 109.684 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.27 -29.71 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.785 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.73 -48.37 74.86 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.37 -22.77 62.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.591 -0.693 . . . . 0.0 109.411 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 25.7 t80 -55.64 -67.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.271 -0.893 . . . . 0.0 109.741 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -55.82 -23.13 28.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.479 -0.763 . . . . 0.0 110.038 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.47 -63.62 1.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.286 -0.884 . . . . 0.0 109.88 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.46 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 64.3 m-85 -79.17 -26.8 42.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.024 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -37.86 88.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.319 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -48.28 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.721 -0.612 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -62.56 -27.65 69.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.604 -0.685 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.04 57.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.494 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -72.45 -44.11 62.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 109.861 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.03 -36.66 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.455 -0.778 . . . . 0.0 109.766 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.08 -26.51 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.73 -26.25 21.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -97.9 20.35 12.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.445 -0.785 . . . . 0.0 109.856 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.448 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 6.3 t80 -95.14 137.67 22.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.38 12.4 3.02 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.113 2.542 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.427 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.3 m-70 -148.28 -171.58 3.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.527 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -124.96 149.91 47.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.585 -0.697 . . . . 0.0 109.52 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 pt -101.42 158.02 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.53 -0.731 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -114.01 -32.23 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.712 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -118.46 167.61 11.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.86 -30.58 70.23 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.59 70.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -68.16 -24.46 64.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.672 -0.642 . . . . 0.0 109.716 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.86 -31.13 35.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -73.98 -40.68 62.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.738 . . . . 0.0 110.122 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -59.26 -27.24 65.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.533 -0.729 . . . . 0.0 110.142 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 9.9 mt -72.0 149.12 92.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.22 118.54 4.71 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.092 2.528 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.91 -25.69 5.77 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.8 139.71 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -1.018 . . . . 0.0 109.509 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.16 -150.72 18.6 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -99.55 -29.22 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.612 -0.934 . . . . 0.0 109.612 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -77.26 -59.34 2.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.592 -0.692 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.404 ' CG2' ' CB ' ' A' ' 42' ' ' ALA . 46.2 mm -62.04 -32.54 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.69 . . . . 0.0 109.457 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.19 -38.64 87.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 109.126 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -61.41 -38.93 88.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -62.37 -30.69 71.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.53 -44.5 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.76 -40.59 72.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.55 -0.719 . . . . 0.0 109.797 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.38 -51.95 45.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.513 0.673 . . . . 0.0 109.278 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.23 -24.08 60.44 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.952 -0.467 . . . . 0.0 110.058 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.63 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 109.731 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.0 109.619 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.59 -41.47 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.72 -57.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.902 -0.763 . . . . 0.0 109.166 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -52.93 -33.93 52.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.739 -0.601 . . . . 0.0 110.472 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.98 -32.41 72.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.2 tpt -86.74 -20.55 27.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.21 -37.64 18.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.58 -39.59 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.99 -60.18 3.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.742 . . . . 0.0 109.638 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.464 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 2.0 pp -62.31 -34.07 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 109.239 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.45 -42.32 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.535 -0.728 . . . . 0.0 109.739 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -63.66 -43.81 95.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -49.0 -30.81 6.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.745 -0.597 . . . . 0.0 110.709 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 35' ' ' LYS . 3.5 mp0 -79.91 -44.23 20.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.066 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -70.26 -49.89 45.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.937 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -14.91 49.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.0 110.239 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.1 t -87.74 164.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -70.54 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.0 111.531 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -90.63 66.98 6.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 0.0 111.183 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.71 56.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.96 -22.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.131 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.469 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.6 p-80 -76.16 -47.14 25.33 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -72.89 -24.67 60.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.533 -0.729 . . . . 0.0 109.044 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -58.02 -49.17 77.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.44 -0.787 . . . . 0.0 109.053 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.57 -25.26 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.605 -0.684 . . . . 0.0 109.48 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.48 -62.92 1.36 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.327 -0.858 . . . . 0.0 110.268 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 80.6 m-85 -76.71 -25.21 53.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 110.847 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -74.27 -37.03 63.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.309 -0.869 . . . . 0.0 109.012 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -76.8 -31.65 57.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.372 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -85.49 -26.66 26.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -27.93 61.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.617 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -81.56 -45.78 15.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 109.937 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 65' ' ' VAL . 7.2 p -63.88 -34.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.464 -0.772 . . . . 0.0 109.756 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.6 mt -85.11 -28.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.5 -21.84 23.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.429 -0.794 . . . . 0.0 109.952 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -104.35 22.14 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 109.743 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.448 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.4 t80 -94.65 142.9 25.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 109.004 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.5 9.21 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.077 2.518 . . . . 0.0 110.991 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.428 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.8 m-70 -146.66 178.69 8.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.216 -0.927 . . . . 0.0 109.56 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -98.52 174.42 6.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.537 -0.727 . . . . 0.0 109.705 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 53' ' ' ILE . 60.8 mt -132.75 106.33 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.664 -0.648 . . . . 0.0 109.42 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.83 34.26 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -165.99 139.81 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 109.402 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.87 -40.37 95.45 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.88 -30.42 71.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.97 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.786 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.92 -30.53 31.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -74.72 -38.67 62.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.582 -0.698 . . . . 0.0 110.012 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -59.84 -25.89 65.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.143 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 11.1 mt -71.01 152.23 94.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 109.447 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.53 105.99 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 123.073 2.516 . . . . 0.0 110.289 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 -30.82 2.31 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.401 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 33.9 t -90.13 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.87 -147.67 12.5 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -98.55 -29.73 12.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 109.61 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.16 -58.63 3.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 42' ' ' ALA . 45.9 mm -61.82 -34.79 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.738 . . . . 0.0 109.626 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.35 91.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -60.55 -37.03 79.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.649 -0.657 . . . . 0.0 109.46 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.94 -31.4 72.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.367 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.8 mm -63.8 -46.16 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.89 -39.61 68.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.448 -0.782 . . . . 0.0 109.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.98 -31.85 73.19 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -52.56 37.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.573 0.702 . . . . 0.0 109.326 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.77 -23.15 60.77 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.87 -0.519 . . . . 0.0 110.11 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -0.807 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 109.374 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.76 -34.85 7.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.94 -47.09 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.023 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -56.57 -31.43 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 109.862 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -65.0 -28.41 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.542 -0.724 . . . . 0.0 109.486 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mmt -89.9 -20.98 22.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.67 -33.89 21.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.33 -33.05 22.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.21 -61.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.436 HD13 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -62.54 -32.06 72.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.23 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.61 -45.85 66.74 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.485 -0.759 . . . . 0.0 109.68 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -63.79 -35.76 81.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -61.19 -26.04 67.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.758 -0.589 . . . . 0.0 109.935 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.88 -55.39 5.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.0 109.153 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 109.423 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.73 -25.1 64.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.416 -0.803 . . . . 0.0 109.455 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.0 t -89.07 164.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -69.32 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.466 -0.771 . . . . 0.0 111.297 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -85.29 62.13 7.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.95 55.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.58 -29.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.405 -0.809 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.36 -48.81 71.66 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.59 -23.01 62.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 109.462 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 24.7 t80 -55.25 -66.5 0.4 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 109.557 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.69 -24.27 21.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.451 -0.78 . . . . 0.0 109.923 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.19 -55.14 34.57 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.422 -0.799 . . . . 0.0 109.874 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.436 ' CG ' HD13 ' A' ' 22' ' ' LEU . 62.5 m-85 -89.97 -26.4 20.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.594 -0.691 . . . . 0.0 110.11 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -39.29 93.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.793 . . . . 0.0 109.109 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -85.83 -41.89 14.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.04 69.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.537 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.49 31.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.681 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -68.23 -48.95 63.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 109.898 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.8 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.0 109.822 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.2 mt -77.19 -27.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.469 -0.769 . . . . 0.0 109.937 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.473 -0.767 . . . . 0.0 110.072 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -120.26 27.05 8.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.447 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.7 t80 -82.49 139.92 44.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.88 10.64 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.096 2.531 . . . . 0.0 111.317 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.43 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.9 m-70 -146.61 169.0 19.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.681 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -96.44 148.57 22.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.2 mt -97.86 104.39 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -87.57 -40.87 13.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.656 -0.652 . . . . 0.0 109.565 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -112.38 155.37 24.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.734 . . . . 0.0 109.597 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.53 -27.57 66.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.91 71.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.431 -1.04 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -25.59 68.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.723 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.35 -26.63 26.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 109.846 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.97 -40.93 62.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.504 -0.748 . . . . 0.0 109.674 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -25.13 66.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 110.002 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 91.4 mt -58.46 137.72 85.57 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 109.928 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -80.85 109.74 2.26 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.055 2.503 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.78 -24.47 5.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.5 137.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.41 -1.053 . . . . 0.0 109.372 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.5 -147.97 23.47 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.9 p -98.98 -28.96 13.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.923 . . . . 0.0 109.696 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -65.41 -65.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.08 -39.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.747 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.99 86.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.25 -35.15 76.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.566 -0.709 . . . . 0.0 109.395 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -65.69 -31.09 71.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 109.258 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.3 mm -62.83 -44.76 99.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -57.47 -38.56 74.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.464 -0.772 . . . . 0.0 109.518 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.21 -27.14 69.15 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -49.61 31.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.84 -42.46 60.8 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.899 -0.501 . . . . 0.0 110.17 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -80.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.432 -0.793 . . . . 0.0 109.795 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.55 -48.6 3.18 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.87 -52.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.858 -0.79 . . . . 0.0 109.675 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -57.91 -28.37 64.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 110.037 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.14 -38.26 88.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.73 . . . . 0.0 109.273 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.3 mmt -87.33 -10.18 52.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 110.184 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mt -87.86 -35.88 17.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.1 t -78.33 -31.09 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -69.55 -60.24 2.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.599 -0.688 . . . . 0.0 109.719 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 2.2 pp -63.15 -34.8 78.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.21 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.79 -40.78 60.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.569 -0.707 . . . . 0.0 109.647 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -63.86 -38.91 92.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.11 -22.31 65.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.47 -59.07 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.823 . . . . 0.0 109.038 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -67.48 -40.09 85.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.89 -24.7 58.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.35 -0.844 . . . . 0.0 109.688 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -89.4 164.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -70.15 0.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -88.06 67.61 8.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 0.0 110.296 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.71 40.27 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.667 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.33 -27.21 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.474 -0.766 . . . . 0.0 109.359 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -68.47 -50.89 49.06 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -25.89 66.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.51 -0.744 . . . . 0.0 109.242 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -53.31 -64.29 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.24 -0.912 . . . . 0.0 109.615 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -55.12 -25.46 31.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.75 -65.9 0.56 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.382 -0.824 . . . . 0.0 109.79 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.459 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 74.4 m-85 -72.34 -27.38 62.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.747 -0.596 . . . . 0.0 110.119 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -63.49 -46.1 87.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.447 -0.783 . . . . 0.0 109.393 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -65.85 -46.21 79.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.485 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.34 77.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.422 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.29 20.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -77.13 -59.84 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.47 -44.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.47 -0.769 . . . . 0.0 109.791 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.3 mm -63.18 -28.41 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.369 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.02 -18.7 25.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -116.31 26.8 9.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 3.3 t80 -88.55 135.66 32.25 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.511 -0.743 . . . . 0.0 109.023 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HG2' ' CD2' ' A' ' 51' ' ' HIS . 42.4 Cg_endo -85.55 10.41 3.72 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 123.148 2.565 . . . . 0.0 111.58 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.426 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.5 m-70 -148.82 -174.95 4.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.083 -1.011 . . . . 0.0 109.721 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 176.33 5.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.597 -0.689 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.7 pt -136.85 141.46 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.632 -0.668 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -121.83 25.99 8.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.654 -0.654 . . . . 0.0 109.646 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -170.41 150.59 3.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.788 . . . . 0.0 109.356 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -28.94 68.16 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.4 85.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -64.51 -20.39 66.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.63 -0.669 . . . . 0.0 109.918 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.0 -25.14 23.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.348 -0.845 . . . . 0.0 109.883 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -73.38 -41.0 63.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 109.735 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.23 -26.42 66.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.461 -0.775 . . . . 0.0 109.939 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 93.4 mt -55.95 134.65 73.54 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.71 102.55 1.4 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.931 2.42 . . . . 0.0 109.986 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.43 -26.26 2.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.38 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -1.052 . . . . 0.0 109.218 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.79 -156.54 25.35 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -87.96 -7.37 57.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.667 -0.902 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -90.21 -63.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.452 ' CD1' ' CE2' ' A' ' 39' ' ' TYR . 46.9 mm -67.26 -34.57 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.775 . . . . 0.0 110.445 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.76 -55.8 29.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.309 -0.869 . . . . 0.0 109.917 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -59.84 -31.49 69.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 109.512 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -59.96 -43.86 94.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 0.0 109.418 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 73' ' ' ILE . 65.1 mt -64.1 -29.91 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -56.04 -43.79 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.224 -0.922 . . . . 0.0 108.964 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -31.01 71.74 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -43.08 96.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.45 -24.89 31.63 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.086 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.428 -0.795 . . . . 0.0 109.786 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.07 -39.0 5.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.91 -50.7 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.88 -0.776 . . . . 0.0 108.952 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -59.36 -29.52 67.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.748 -0.595 . . . . 0.0 109.798 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.69 -34.58 77.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.629 -0.669 . . . . 0.0 109.22 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.8 mmm -89.61 -17.17 28.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.127 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.86 -35.63 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 108.489 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.58 -30.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.08 -60.52 2.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.724 . . . . 0.0 109.76 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.456 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 2.7 pp -62.87 -34.15 76.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.22 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.29 -44.15 61.8 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.626 -0.671 . . . . 0.0 109.917 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.34 -36.65 84.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 29' ' ' VAL . 34.9 t80 -63.72 -23.07 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.895 -0.503 . . . . 0.0 109.682 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.31 -57.74 3.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.346 -0.847 . . . . 0.0 109.106 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -67.01 -40.41 87.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.537 -0.727 . . . . 0.0 109.553 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.12 -25.59 61.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.433 -0.792 . . . . 0.0 109.659 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 25' ' ' PHE . 54.6 t -89.47 164.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.25 -69.77 0.51 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.485 -0.759 . . . . 0.0 110.937 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -85.32 62.15 7.31 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.84 47.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.34 -28.6 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.0 109.378 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.3 p-80 -64.59 -48.55 74.54 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.49 -25.78 64.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.616 -0.678 . . . . 0.0 109.347 179.274 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.0 t80 -52.48 -60.72 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.304 -0.872 . . . . 0.0 109.796 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.83 -26.88 64.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.91 -65.22 0.65 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.411 -0.806 . . . . 0.0 109.77 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 62.4 m-85 -76.38 -26.15 55.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.675 -0.641 . . . . 0.0 110.082 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -63.72 -52.11 61.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.466 -0.771 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.68 -45.69 81.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.403 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -62.98 -37.04 85.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.44 -25.52 68.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.918 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.26 -50.79 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 110.016 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 65' ' ' VAL . 7.7 p -62.79 -34.05 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 46' ' ' ILE . 74.4 mt -83.34 -41.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.23 -17.59 54.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.328 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.21 23.37 14.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.789 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.6 t80 -94.66 144.9 28.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.9 Cg_endo -86.43 4.82 6.2 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 123.128 2.552 . . . . 0.0 110.846 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.6 m-70 -146.61 -175.38 4.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -105.38 160.56 15.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.564 -0.71 . . . . 0.0 109.67 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.7 mt -101.71 131.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -77.89 -65.3 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.729 . . . . 0.0 109.719 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 p -114.26 174.97 5.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.43 83.73 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -34.28 76.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.946 . . . . 0.0 109.308 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.13 -23.28 65.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.677 . . . . 0.0 109.716 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.76 -28.69 26.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.428 -0.795 . . . . 0.0 109.666 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -74.49 -38.64 62.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -59.59 -26.44 65.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.755 . . . . 0.0 110.075 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 49' ' ' TYR . 53.7 mt -71.65 150.2 93.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.74 106.31 2.17 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.024 2.483 . . . . 0.0 110.313 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.35 -29.44 2.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 36.0 t -89.72 146.0 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -1.004 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.72 -145.77 15.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.4 p -100.15 -39.79 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.895 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -73.43 -44.66 57.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.635 -0.666 . . . . 0.0 109.725 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.403 ' CG2' ' CB ' ' A' ' 42' ' ' ALA . 43.8 mm -69.62 -38.6 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.64 -41.66 91.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 109.656 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.64 -38.54 85.13 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.481 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -62.28 -30.22 70.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.604 -0.685 . . . . 0.0 109.368 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.0 mm -64.32 -45.51 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -54.84 -40.65 69.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.49 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -53.16 36.68 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.509 0.671 . . . . 0.0 109.308 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.56 -22.3 61.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.948 -0.47 . . . . 0.0 110.14 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.08 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.406 -0.809 . . . . 0.0 109.623 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.71 -32.76 8.93 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.6 mt -74.89 -59.08 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.764 -0.845 . . . . 0.0 109.334 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 t -51.8 -32.41 31.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.756 -0.59 . . . . 0.0 110.553 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.46 -26.21 64.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.8 mtp -90.02 -21.32 22.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.956 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.65 -33.89 17.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.25 -34.75 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -68.34 -60.2 2.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.656 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 39' ' ' TYR . 3.8 pp -60.82 -35.2 75.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 109.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.68 -42.1 56.48 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.666 -0.646 . . . . 0.0 109.739 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.16 -36.12 83.02 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -65.69 -24.77 67.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.888 -0.507 . . . . 0.0 109.676 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.8 -57.79 3.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.388 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -66.14 -41.94 89.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.0 109.58 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -57.3 -24.7 56.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.4 -0.813 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -89.66 164.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.6 t -77.19 -70.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 110.876 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -85.05 66.75 9.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.471 -0.768 . . . . 0.0 110.734 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.63 29.18 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.89 -21.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.59 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.42 ' CD2' ' HE2' ' A' ' 35' ' ' LYS . 6.4 p-80 -76.09 -49.85 16.28 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -67.62 -26.46 66.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.57 -51.62 67.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.03 -28.13 68.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 0.0 109.532 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.46 -62.32 1.8 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 22' ' ' LEU . 66.0 m-85 -78.5 -1.42 33.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.912 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 -87.14 -36.27 18.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -81.1 -46.62 14.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.78 98.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.589 -0.695 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.86 -26.06 64.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.639 -0.663 . . . . 0.0 109.762 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -80.57 -28.93 37.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.783 . . . . 0.0 109.906 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 p -90.0 -44.71 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.417 -0.802 . . . . 0.0 109.924 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.71 -52.27 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 109.587 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.65 -21.08 62.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -118.1 28.74 8.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.452 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.0 t80 -89.56 145.68 34.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.0 Cg_endo -85.97 2.11 7.64 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.101 2.534 . . . . 0.0 110.979 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.2 m-70 -144.06 -179.35 6.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -105.93 139.68 40.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.0 mt -77.12 106.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.605 -0.684 . . . . 0.0 109.356 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.8 mttt -72.36 -69.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.55 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -102.53 174.65 5.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.556 -0.715 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.36 -28.96 71.87 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.86 -30.38 70.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -1.008 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.28 -27.61 67.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.651 -0.655 . . . . 0.0 109.628 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.92 -28.85 22.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -75.57 -39.04 58.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.475 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -60.51 -24.16 65.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.502 -0.749 . . . . 0.0 110.039 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 81.7 mt -60.84 140.92 93.32 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.426 -0.796 . . . . 0.0 109.545 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.29 107.18 1.99 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.983 2.456 . . . . 0.0 110.14 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.87 -25.38 4.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.8 t -89.55 138.52 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.978 . . . . 0.0 109.432 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.26 -139.65 9.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.39 -29.49 12.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.94 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -67.42 -64.6 0.82 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -61.42 -41.97 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 0.0 109.789 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.64 -35.35 74.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.543 -0.723 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.72 -41.59 95.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.511 -0.743 . . . . 0.0 109.516 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -62.04 -30.4 70.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.615 -0.678 . . . . 0.0 109.31 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -63.16 -47.23 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.11 -31.54 65.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 109.606 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.7 -30.67 70.23 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -74.2 -50.79 17.69 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.582 0.705 . . . . 0.0 109.592 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.33 -27.42 62.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.908 -0.495 . . . . 0.0 109.95 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.44 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.81 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.3 -41.49 5.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mt -66.11 -50.56 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.893 -0.769 . . . . 0.0 109.072 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -58.08 -31.17 66.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.698 -0.626 . . . . 0.0 109.963 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.15 -36.03 76.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 109.381 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtt -87.54 -14.55 39.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.609 -0.682 . . . . 0.0 110.135 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.2 -42.55 13.72 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.12 -31.62 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.21 -64.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.1 pp -62.07 -33.73 74.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.11 -42.5 63.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.86 -36.51 84.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -63.73 -22.76 67.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -77.48 -57.63 3.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.099 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 71.6 tttt -67.79 -39.48 84.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.51 -0.743 . . . . 0.0 109.622 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.79 -25.7 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.403 -0.811 . . . . 0.0 109.605 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.36 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -70.09 0.48 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 0.0 110.98 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -85.12 62.11 7.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 110.407 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.81 53.64 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -0.822 . . . . 0.0 109.68 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.18 -30.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.795 . . . . 0.0 109.105 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.451 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.05 -48.43 76.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.451 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.66 -23.78 63.51 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 26.7 t80 -54.6 -67.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.22 -0.925 . . . . 0.0 109.694 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -54.74 -24.59 23.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 109.88 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.14 -65.36 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.459 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 58.2 m-85 -79.12 -29.31 43.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.587 -0.695 . . . . 0.0 109.851 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -65.36 -46.34 80.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.486 -0.759 . . . . 0.0 109.456 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -70.59 -40.57 73.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.499 -0.751 . . . . 0.0 109.661 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.88 -39.56 79.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.602 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.01 -28.17 69.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -70.84 -51.29 27.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.67 -44.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 46' ' ' ILE . 73.2 mt -67.17 -29.45 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.448 -0.783 . . . . 0.0 109.971 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.05 -13.85 35.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.429 -0.795 . . . . 0.0 110.538 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -123.26 27.99 7.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.2 t80 -85.24 143.69 39.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.196 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.24 3.87 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.052 2.502 . . . . 0.0 111.066 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -145.01 -177.72 5.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.645 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 160.8 17.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.7 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 pt -123.41 153.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 109.318 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -137.73 28.58 2.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.511 -0.743 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 t -170.3 151.52 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.02 -28.1 69.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.92 72.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.464 -1.021 . . . . 0.0 109.695 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.66 -14.43 61.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.614 -0.679 . . . . 0.0 110.355 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.11 -29.72 18.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -29.52 55.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.555 -0.716 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 80.9 mt -61.77 146.17 91.13 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.21 113.13 3.14 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.0 2.466 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.36 -28.54 5.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 t -89.9 138.48 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -1.023 . . . . 0.0 109.392 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -139.75 9.23 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 t -98.87 -28.59 13.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.958 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -67.9 -65.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.47 -0.769 . . . . 0.0 109.503 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.5 mm -61.34 -41.67 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.828 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.05 73.66 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.582 -0.699 . . . . 0.0 109.736 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -61.86 -40.38 95.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.48 -0.762 . . . . 0.0 109.526 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -62.79 -32.68 73.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.0 109.285 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.469 HG23 HD13 ' A' ' 73' ' ' ILE . 47.7 mm -64.14 -42.43 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.79 -40.83 73.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.487 -0.758 . . . . 0.0 109.732 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.5 -29.62 70.86 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.43 -52.7 24.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.538 0.685 . . . . 0.0 109.37 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.23 -24.9 61.45 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.926 -0.484 . . . . 0.0 110.054 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.474 179.958 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.538 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.85 -33.82 8.1 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.42 -42.1 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.879 -0.777 . . . . 0.0 109.245 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -60.73 -30.89 70.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.66 -0.65 . . . . 0.0 109.761 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -39.23 93.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.711 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.6 mtm -83.04 -19.31 37.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.648 -0.658 . . . . 0.0 109.87 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -80.35 -37.54 32.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.416 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.67 -28.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -66.57 -68.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.12 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.427 HD11 ' CE1' ' A' ' 39' ' ' TYR . 2.3 pt? -57.55 -31.0 65.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.939 -1.1 . . . . 0.0 109.491 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.42 68.74 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -62.1 -25.47 67.73 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.5 -57.66 3.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.557 -0.714 . . . . 0.0 109.665 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -67.22 -41.61 85.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.556 -0.715 . . . . 0.0 109.524 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.07 -25.18 58.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -89.53 164.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.1 t -78.02 -70.13 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.485 -0.759 . . . . 0.0 111.009 -178.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -82.93 61.63 6.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.77 45.34 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 179.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -27.76 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.463 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 6.1 p-80 -70.21 -49.86 45.85 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.463 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.79 -18.82 62.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.344 -0.848 . . . . 0.0 109.393 178.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 16.7 t80 -59.45 -63.9 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 108.933 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -55.08 -24.11 23.83 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.722 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.96 -65.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' CE1' HD11 ' A' ' 22' ' ' LEU . 34.5 m-85 -80.59 -31.07 36.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.854 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -48.79 78.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.819 . . . . 0.0 109.814 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -72.8 -35.84 67.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 0.0 109.855 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.08 -49.91 63.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.472 -0.767 . . . . 0.0 109.781 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.44 -26.47 66.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.47 -0.769 . . . . 0.0 109.855 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -71.67 -58.88 3.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.54 -43.44 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -68.17 -27.67 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.37 -25.46 29.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.825 . . . . 0.0 109.806 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -107.05 28.13 8.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 3.6 t80 -93.35 139.48 22.96 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.23 11.54 3.28 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.104 2.536 . . . . 0.0 111.354 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.22 176.77 9.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -102.13 144.26 30.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.547 -0.72 . . . . 0.0 109.636 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.7 mt -82.67 122.1 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.622 -0.674 . . . . 0.0 109.223 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -81.02 -60.8 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -126.24 -179.96 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.19 -27.4 65.1 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.08 95.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -1.081 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.7 -20.88 63.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.588 -0.695 . . . . 0.0 109.971 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.24 -24.86 25.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 109.895 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -70.34 -43.72 69.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.724 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -60.81 -28.72 68.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.773 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 97.4 mt -56.8 130.47 78.3 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.552 -0.717 . . . . 0.0 109.978 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.69 102.15 1.52 Allowed 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.833 2.356 . . . . 0.0 110.11 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.15 -27.74 1.85 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 t -89.57 138.3 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.545 -0.973 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.56 -143.76 13.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.0 t -98.64 -27.18 14.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.94 . . . . 0.0 109.694 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -82.26 -41.47 20.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.551 -0.718 . . . . 0.0 109.7 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.9 mm -72.37 -41.82 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.738 . . . . 0.0 109.884 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.94 71.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -0.811 . . . . 0.0 110.057 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.33 -32.62 68.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -64.73 -33.13 75.25 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.58 -42.8 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.54 -35.53 72.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.695 . . . . 0.0 109.372 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.64 -30.79 71.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -48.99 64.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.514 0.673 . . . . 0.0 109.2 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.7 mm? -74.33 -26.42 60.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.061 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -80.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 0.0 109.698 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 109.472 179.959 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -35.33 7.25 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.71 -57.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.858 -0.789 . . . . 0.0 108.957 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -56.19 -30.85 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.962 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -32.72 74.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.9 mmm -88.74 -17.67 29.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.741 -0.6 . . . . 0.0 109.944 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.34 -35.37 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.59 -30.82 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -69.97 -59.73 2.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.661 -0.649 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 3.3 pp -63.24 -33.73 76.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.16 -41.51 62.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.484 -0.76 . . . . 0.0 109.537 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -64.87 -37.53 87.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -63.49 -24.05 67.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' CG ' ' CG ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -74.12 -62.99 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.669 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 21.9 tttt -62.1 -41.95 98.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.876 -0.515 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -57.76 -23.94 54.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.772 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.81 165.11 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.4 t -76.01 -70.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.459 -0.776 . . . . 0.0 111.107 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -88.69 67.73 8.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.815 . . . . 0.0 110.675 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.1 38.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 109.666 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.69 -25.59 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.718 . . . . 0.0 109.589 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.472 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.99 -51.82 29.32 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.02 -19.34 63.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.739 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.2 t80 -57.15 -57.67 11.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.216 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.44 -26.77 66.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.655 -0.653 . . . . 0.0 109.469 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.98 -64.79 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.378 -0.826 . . . . 0.0 110.215 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 70.5 m-85 -74.01 -25.44 59.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 110.13 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -63.4 -47.73 80.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.357 -0.839 . . . . 0.0 109.316 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.42 -49.94 50.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.595 -0.691 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.95 -27.35 68.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 109.808 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.69 -28.22 62.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.938 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 p -84.81 -46.56 11.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 65' ' ' VAL . 8.1 p -64.2 -35.57 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 110.109 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 46' ' ' ILE . 66.8 mt -84.22 -37.05 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.951 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.61 -19.99 37.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.402 -0.811 . . . . 0.0 110.218 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -104.72 21.52 16.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.301 -0.875 . . . . 0.0 110.014 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.452 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.9 t80 -94.07 140.81 23.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -86.32 9.96 3.83 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.015 2.476 . . . . 0.0 111.071 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.429 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.18 -176.61 5.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.76 162.64 12.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.714 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.7 mt -107.52 144.76 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.616 -0.677 . . . . 0.0 109.195 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -91.6 -63.72 1.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 109.673 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.8 p -124.42 -179.86 4.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.502 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.24 -29.87 72.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -30.36 70.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.991 . . . . 0.0 109.491 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.13 -25.74 36.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.581 -0.699 . . . . 0.0 109.724 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.89 -33.62 24.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.477 -0.765 . . . . 0.0 109.562 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.526 -0.734 . . . . 0.0 109.974 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -59.68 -25.62 64.9 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.427 -0.796 . . . . 0.0 110.208 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 10.9 mt -70.8 152.01 95.16 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.491 -0.756 . . . . 0.0 109.464 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -77.94 103.02 1.64 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.106 2.538 . . . . 0.0 110.297 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.13 -30.4 2.02 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 38.2 t -89.98 140.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.588 -0.948 . . . . 0.0 109.44 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.06 -146.64 15.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -99.47 -36.16 9.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.968 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.05 -60.2 2.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.8 mm -61.74 -36.54 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.535 -0.728 . . . . 0.0 109.728 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.59 78.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -61.72 -39.6 92.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.093 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -62.58 -30.23 71.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.621 -0.674 . . . . 0.0 109.312 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.84 -45.13 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.63 -41.79 74.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.42 -28.75 70.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.13 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -52.47 18.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.378 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.75 61.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.972 -0.455 . . . . 0.0 110.086 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.23 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 109.543 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 109.487 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.476 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.09 -39.6 5.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.77 -41.87 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.874 -0.78 . . . . 0.0 109.202 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -59.65 -31.08 69.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.613 -0.679 . . . . 0.0 109.643 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -65.0 -33.53 76.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.1 mmt -90.13 -15.22 32.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.667 -0.646 . . . . 0.0 110.113 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -35.18 16.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 108.519 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.07 -31.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.3 -57.34 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.449 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 2.5 pp -63.27 -34.65 78.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.7 -44.78 63.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.55 -0.719 . . . . 0.0 109.791 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.91 -35.07 79.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -63.56 -24.66 67.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.854 -0.529 . . . . 0.0 109.898 179.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.25 -56.63 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.851 . . . . 0.0 109.31 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.0 ttpt -64.99 -41.37 95.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.497 -0.752 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -58.51 -26.69 63.74 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.823 . . . . 0.0 109.412 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.9 t -89.55 164.77 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.2 t -78.63 -70.16 0.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.454 -0.779 . . . . 0.0 111.093 -178.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -81.01 57.85 3.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.511 -0.743 . . . . 0.0 110.905 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.88 62.01 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.56 -28.87 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.195 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -63.35 -49.1 75.24 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.8 -25.99 63.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.594 -0.691 . . . . 0.0 109.312 179.375 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -51.35 -59.01 4.69 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.291 -0.88 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -61.37 -27.84 68.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.531 -0.731 . . . . 0.0 109.318 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.68 -65.96 0.52 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.461 -0.774 . . . . 0.0 109.953 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 81.1 m-85 -71.27 -8.79 56.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 110.798 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -83.88 -54.41 4.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.119 -0.988 . . . . 0.0 109.3 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -61.07 -29.11 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.516 -0.74 . . . . 0.0 109.83 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.82 -47.17 15.61 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.529 -0.732 . . . . 0.0 109.575 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.24 67.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.879 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 -45.36 27.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.966 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 p -75.51 -44.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -0.777 . . . . 0.0 110.086 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.6 -55.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.53 -20.01 62.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -116.02 28.11 8.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 109.575 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.449 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.4 t80 -89.7 141.77 28.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -85.7 8.41 4.56 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.002 2.468 . . . . 0.0 110.998 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.429 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.7 m-70 -146.55 175.25 10.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 139.83 36.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.631 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 53' ' ' ILE . 60.5 mt -78.08 108.36 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.428 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -69.75 -40.34 76.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.821 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.3 m -148.55 -179.88 7.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.532 -0.73 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.33 -26.36 61.59 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.82 96.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.479 -1.012 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.58 -24.99 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.719 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.62 -27.67 27.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.415 -0.803 . . . . 0.0 109.733 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -75.9 -40.52 54.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -59.92 -22.4 62.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.446 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 86.5 mt -59.3 139.04 88.58 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 109.717 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.45 112.36 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.957 2.438 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.27 -28.52 5.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.78 138.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.932 . . . . 0.0 109.361 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.09 -139.52 10.17 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -99.22 -27.82 13.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.964 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -65.51 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.402 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.5 mm -61.94 -42.13 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 109.717 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.74 82.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.534 -0.729 . . . . 0.0 109.673 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.7 -35.75 77.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.514 -0.741 . . . . 0.0 109.53 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -68.9 -28.94 67.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.619 -0.676 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.17 -49.44 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 109.144 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.22 -40.61 74.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.454 -0.779 . . . . 0.0 109.694 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.01 -28.77 70.33 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.43 -51.65 27.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.64 -0.662 . . . . 0.0 109.294 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.65 -25.68 61.37 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.907 -0.496 . . . . 0.0 110.039 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.405 -0.809 . . . . 0.0 109.587 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 109.407 179.867 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -39.52 5.79 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 ' HA ' ' CE1' ' A' ' 76' ' ' PHE . 3.3 mt -68.21 -52.25 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.826 -0.808 . . . . 0.0 109.086 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -55.88 -33.98 65.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.737 -0.602 . . . . 0.0 110.175 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.36 -33.49 73.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.552 -0.718 . . . . 0.0 109.45 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt -86.88 -13.74 43.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.693 -0.629 . . . . 0.0 110.258 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.44 -35.71 21.09 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.54 -31.68 20.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.747 -0.595 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.6 pp -63.28 -33.05 74.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.08 -41.95 65.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -63.54 -37.77 88.58 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -62.69 -23.58 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.92 -0.487 . . . . 0.0 109.707 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -77.34 -57.58 3.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.067 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 13.6 tttt -66.47 -41.35 89.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -58.12 -25.27 61.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.732 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -89.43 164.35 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 t -77.01 -70.25 0.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 110.925 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -84.54 61.7 6.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 110.638 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.79 52.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.759 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.98 -28.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.372 -0.83 . . . . 0.0 109.061 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.9 p-80 -65.27 -49.26 70.26 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -69.15 -22.06 63.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.675 . . . . 0.0 109.569 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 26.8 t80 -56.9 -64.59 0.83 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -55.96 -25.02 41.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 109.772 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.71 -64.87 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.441 -0.787 . . . . 0.0 110.053 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 45.7 m-85 -81.7 -25.76 35.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.667 . . . . 0.0 110.282 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 tpt85 -62.11 -44.47 96.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.8 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -78.0 -42.58 32.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.796 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.97 -29.74 71.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 109.662 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.64 -31.71 57.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -75.49 -41.31 55.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.88 -44.25 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.478 -0.764 . . . . 0.0 110.032 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 46' ' ' ILE . 69.9 mt -73.41 -27.95 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.471 -0.768 . . . . 0.0 109.853 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.41 -23.3 43.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -116.64 28.14 8.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.455 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.1 t80 -88.1 142.48 31.95 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -85.63 6.78 5.41 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.063 2.509 . . . . 0.0 111.177 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.426 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -145.67 170.77 15.81 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -98.26 135.95 39.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.551 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -73.06 120.66 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.572 -0.705 . . . . 0.0 109.271 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -82.16 -49.64 9.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.543 -0.723 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.48 -179.81 5.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.607 -0.683 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.42 -27.72 71.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.01 96.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.589 -0.948 . . . . 0.0 109.681 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -20.79 63.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.836 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.87 -26.4 22.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.397 -0.815 . . . . 0.0 109.644 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -74.01 -39.92 63.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.504 -0.747 . . . . 0.0 109.71 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.19 -25.86 65.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.55 -0.719 . . . . 0.0 110.01 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.446 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 84.3 mt -59.21 144.64 82.89 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.503 -0.748 . . . . 0.0 109.714 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -79.1 112.61 3.09 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.021 2.481 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.13 -28.57 6.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.7 139.6 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 109.343 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.43 -137.61 7.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 p -99.1 -29.34 12.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.601 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -65.92 -65.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.482 -0.761 . . . . 0.0 109.587 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.7 mm -61.78 -42.78 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.818 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.89 70.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.7 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.43 -43.22 99.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -62.22 -28.45 69.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.315 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.48 -44.52 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.41 -41.3 76.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.474 -0.766 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.07 -27.54 69.47 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -71.46 -52.09 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 0.0 109.409 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.22 -26.68 63.03 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.949 -179.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 109.527 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.416 -0.803 . . . . 0.0 109.272 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.25 -38.43 5.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.08 -49.52 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.836 -0.802 . . . . 0.0 109.155 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -57.48 -35.01 69.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.055 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -59.74 -35.53 74.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.458 -0.776 . . . . 0.0 109.471 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 tpp -90.35 -11.88 39.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.163 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.48 -32.62 19.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.702 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.3 t -85.57 -36.54 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HA ' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -67.04 -47.24 71.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.463 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 1.9 pp -73.82 -34.97 64.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 108.437 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.82 -49.9 67.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.675 . . . . 0.0 109.81 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -62.4 -33.02 73.94 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -64.52 -21.33 66.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.714 -0.616 . . . . 0.0 109.609 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 -57.81 3.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.366 -0.834 . . . . 0.0 108.85 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.1 tmtt? -66.81 -39.79 87.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 109.426 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -58.7 -26.4 63.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.791 . . . . 0.0 109.603 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.1 t -89.44 164.41 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -70.01 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.768 . . . . 0.0 111.012 -178.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -84.64 60.34 6.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 110.687 -178.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.91 63.96 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.12 -31.02 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.812 . . . . 0.0 109.008 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.402 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -60.88 -48.8 80.15 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.426 -0.796 . . . . 0.0 108.904 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.92 -26.02 63.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.645 -0.659 . . . . 0.0 109.544 179.339 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.3 t80 -51.54 -65.56 0.54 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -57.61 -25.06 59.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.42 -67.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 74.8 m-85 -72.32 -24.65 61.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.64 -0.663 . . . . 0.0 110.268 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 -62.54 -42.3 99.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -75.12 -44.53 46.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.504 -0.747 . . . . 0.0 109.801 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.26 98.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 109.652 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -29.45 70.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.793 . . . . 0.0 109.524 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -70.78 -34.67 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.72 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.14 -45.35 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 110.121 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 46' ' ' ILE . 69.7 mt -66.74 -55.64 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.0 109.723 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.25 -19.92 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -118.05 28.08 8.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.763 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.449 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 1.6 t80 -91.05 139.84 25.85 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -85.09 6.95 5.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.034 2.489 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.423 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.7 m-70 -147.14 172.52 13.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.168 -0.957 . . . . 0.0 109.536 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -98.61 144.05 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.553 -0.717 . . . . 0.0 109.512 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -75.28 108.85 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 109.36 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -71.18 -46.57 61.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.657 -0.652 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.9 173.43 11.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.08 -28.43 68.91 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.44 71.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.654 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.36 -24.18 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.556 -0.715 . . . . 0.0 109.848 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.38 -29.31 24.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.41 -0.806 . . . . 0.0 109.587 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -76.22 -38.82 55.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.543 -0.723 . . . . 0.0 109.629 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -60.32 -23.67 64.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 0.0 110.06 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 57.9 mt -60.94 141.29 93.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.515 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.54 107.91 2.22 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.939 2.426 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.9 -28.78 3.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 t -89.79 138.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -1.02 . . . . 0.0 109.379 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.7 -137.38 8.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -98.91 -26.69 14.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.598 -0.943 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -69.93 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.42 -45.08 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.733 . . . . 0.0 109.804 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.11 68.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.469 -0.77 . . . . 0.0 109.831 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.95 -43.55 98.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.732 . . . . 0.0 109.312 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -63.43 -29.65 70.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.673 . . . . 0.0 109.266 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.17 -46.42 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.67 -40.72 72.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.531 -0.731 . . . . 0.0 109.647 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.58 -28.72 70.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -52.31 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.56 -0.712 . . . . 0.0 109.36 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.68 -25.67 61.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.932 -0.48 . . . . 0.0 110.005 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.93 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.451 -0.781 . . . . 0.0 109.435 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt 60.03 85.06 0.11 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.468 -0.77 . . . . 0.0 109.692 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.09 -70.91 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.673 . . . . 0.0 109.465 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm 60.34 83.61 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.8 176.15 2.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 109.463 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -86.28 157.68 9.65 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.402 2.735 . . . . 0.0 110.477 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -71.33 127.9 34.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.515 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -152.41 162.13 41.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 p -102.65 83.78 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 tp -110.06 -69.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.545 -0.722 . . . . 0.0 109.457 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -131.89 37.24 3.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.0 109.289 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.64 0.52 86.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.16 6.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.98 -55.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.853 -0.792 . . . . 0.0 109.021 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -51.49 -31.5 23.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 110.345 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.91 -29.36 70.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.587 -0.696 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.7 mmt -88.87 -20.09 25.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 0.0 109.869 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 mp -89.28 -33.54 16.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.5 t -75.06 -34.33 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -59.44 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 0.0 109.308 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.455 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 4.0 pp -61.56 -30.66 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.41 -40.2 71.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 109.139 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.82 -35.84 82.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.14 -24.61 67.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.847 -0.533 . . . . 0.0 109.646 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -74.42 -61.21 1.94 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.543 -0.723 . . . . 0.0 109.292 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.9 tmtm? -63.47 -41.98 98.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.698 -0.626 . . . . 0.0 109.601 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.8 -23.88 54.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.1 t -89.83 164.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.7 t -75.4 -70.21 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.982 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -89.64 68.18 7.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.46 -0.775 . . . . 0.0 110.702 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.92 44.16 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.617 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.44 -26.77 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 109.453 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.462 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.46 -49.69 52.54 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.5 -19.87 62.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.755 . . . . 0.0 109.271 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.4 t80 -57.67 -60.13 4.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 -28.05 63.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.552 -0.717 . . . . 0.0 109.591 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -49.76 -63.09 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.612 -0.68 . . . . 0.0 110.492 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.455 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 58.6 m-85 -80.41 -23.21 40.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.781 -0.574 . . . . 0.0 110.488 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -45.37 94.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.687 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -78.9 -46.73 17.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.871 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.16 -29.68 70.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.542 -0.724 . . . . 0.0 109.789 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.14 -30.03 54.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 t -79.03 -42.81 25.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.926 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.18 -44.35 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.021 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.0 mt -73.23 -26.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 109.953 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.42 -20.24 37.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.68 26.54 8.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.872 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.444 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.5 t80 -80.75 140.97 51.13 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.516 -0.74 . . . . 0.0 109.037 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.4 Cg_endo -85.28 7.31 5.2 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.039 2.493 . . . . 0.0 111.172 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.0 179.59 7.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.893 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -109.71 169.03 8.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 109.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 pt -131.3 156.04 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -140.1 28.76 2.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -170.17 155.25 5.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 109.398 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.21 -30.3 77.1 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.3 93.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.971 . . . . 0.0 109.472 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -61.37 -21.99 64.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.973 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.17 -26.6 20.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.33 -0.857 . . . . 0.0 109.772 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -74.61 -37.87 62.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 109.687 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -59.7 -26.77 65.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.52 -0.737 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 82.7 mt -60.4 146.09 85.22 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.56 -0.712 . . . . 0.0 109.599 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.5 109.81 2.54 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.7 -28.47 4.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.82 138.34 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -1.01 . . . . 0.0 109.381 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.29 -141.71 10.14 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 p -96.11 -30.6 13.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.537 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -65.35 -62.14 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.63 -44.94 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.732 . . . . 0.0 109.722 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.54 69.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.759 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.91 -41.01 97.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.725 . . . . 0.0 109.405 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -65.49 -31.27 72.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.1 mm -63.47 -44.52 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -56.61 -40.35 75.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 109.605 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.06 -26.99 69.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 109.122 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -51.36 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.688 . . . . 0.0 109.462 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.39 -29.15 62.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.938 -0.476 . . . . 0.0 110.021 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -123.17 -68.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.421 -0.8 . . . . 0.0 109.461 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.05 -46.08 0.81 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.51 153.86 29.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.609 -0.936 . . . . 0.0 109.462 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.34 146.1 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -100.05 -54.84 2.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.552 -0.718 . . . . 0.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -114.87 174.46 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.705 . . . . 0.0 109.414 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -98.72 171.92 7.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.581 -0.699 . . . . 0.0 109.463 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.16 162.88 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.442 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -175.54 130.37 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.497 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -81.07 -59.16 2.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -120.74 135.87 55.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.598 -0.689 . . . . 0.0 109.465 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.64 176.28 3.77 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.46 139.53 6.89 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.364 2.709 . . . . 0.0 110.512 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -63.26 -39.55 94.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -161.03 147.27 14.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 t -82.21 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.2 mt -110.06 -69.4 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.544 -0.723 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -132.91 48.58 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 109.267 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.47 -4.91 72.92 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.9 -37.57 6.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.78 -43.07 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.811 -0.817 . . . . 0.0 109.102 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -57.63 -34.13 68.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.7 . . . . 0.0 109.942 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -31.77 73.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.6 mmm -89.44 -22.16 22.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 109.915 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -37.08 23.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.1 t -75.08 -29.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.49 -64.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -64.26 -30.47 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.5 -46.14 66.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.547 -0.72 . . . . 0.0 109.524 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -36.97 84.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.48 -20.35 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.0 109.926 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.92 -57.78 3.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.336 -0.852 . . . . 0.0 109.038 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -68.71 -38.53 80.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.74 -26.77 64.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.752 . . . . 0.0 109.646 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.4 164.17 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -70.0 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 111.022 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 60.87 6.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.04 66.62 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.83 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.16 -32.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 108.88 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.404 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -61.61 -48.61 80.13 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.273 -0.892 . . . . 0.0 108.735 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.54 -20.58 62.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 40' ' ' ARG . 23.8 t80 -57.54 -69.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.27 -0.894 . . . . 0.0 109.607 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -52.94 -25.32 11.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.342 -0.849 . . . . 0.0 109.99 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.98 -55.43 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.482 -0.762 . . . . 0.0 109.859 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 44.7 m-85 -90.02 -29.72 18.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 110.116 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -63.05 -44.62 95.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -75.93 -41.83 50.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.588 -0.695 . . . . 0.0 109.594 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.72 -48.84 77.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.489 -0.757 . . . . 0.0 109.586 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.11 -27.05 68.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.486 -0.759 . . . . 0.0 109.887 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -75.97 -50.61 14.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.46 -0.775 . . . . 0.0 110.045 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.95 -44.16 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.496 -0.752 . . . . 0.0 110.001 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.3 mt -68.18 -53.9 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.464 -0.772 . . . . 0.0 109.78 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.28 60.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.42 28.32 8.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.452 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.6 t80 -87.01 139.53 32.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.582 -0.698 . . . . 0.0 109.155 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.99 10.14 3.79 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.067 2.511 . . . . 0.0 111.253 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.3 m-70 -147.09 175.09 10.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 0.0 109.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -91.52 177.95 6.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.687 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.1 mt -121.83 118.44 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -75.08 -43.24 54.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.512 -0.743 . . . . 0.0 109.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 -179.5 7.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.692 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.46 -26.84 60.06 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.98 70.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.465 -1.02 . . . . 0.0 109.367 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -73.24 -20.88 60.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.72 -0.612 . . . . 0.0 109.889 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.53 -26.52 24.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.89 . . . . 0.0 109.798 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -41.78 61.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -59.74 -24.49 64.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 110.02 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.452 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 82.5 mt -60.42 142.35 90.75 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.488 -0.758 . . . . 0.0 109.52 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.95 109.07 2.33 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.035 2.49 . . . . 0.0 110.253 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.77 5.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.53 137.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.435 -1.039 . . . . 0.0 109.39 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.07 -149.06 22.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -98.11 -29.9 12.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.591 -0.947 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -71.06 -44.49 65.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.622 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mm -70.34 -44.96 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 0.0 109.811 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.12 87.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.0 109.739 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.47 -37.6 84.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.528 -0.732 . . . . 0.0 109.601 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -63.01 -32.47 73.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 109.392 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.78 -43.05 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -55.93 -41.1 74.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.735 . . . . 0.0 109.674 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.69 -29.37 70.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -52.53 22.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.697 . . . . 0.0 109.393 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.47 61.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.906 -0.496 . . . . 0.0 110.062 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -79.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -61.09 1.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 109.47 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.07 58.87 3.08 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -139.43 140.29 37.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.964 . . . . 0.0 109.532 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.85 51.37 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.559 -0.713 . . . . 0.0 109.411 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -73.81 -72.05 0.29 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -110.51 -41.4 4.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.06 135.15 48.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.488 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -94.27 -46.3 7.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.479 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.064 0.459 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 69.41 -67.53 0.22 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.578 -0.701 . . . . 0.0 109.795 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 mtt-85 59.18 91.57 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.391 -0.818 . . . . 0.0 109.826 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -88.5 -48.76 7.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.82 169.15 19.97 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.67 . . . . 0.0 109.533 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.46 158.6 9.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.386 2.724 . . . . 0.0 110.489 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -67.28 144.33 55.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -154.84 170.91 20.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.745 . . . . 0.0 109.547 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 t -109.31 81.96 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 0.0 109.472 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.92 -70.02 0.75 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.501 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -94.46 46.78 1.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.2 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.97 -3.84 72.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.893 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.95 -37.96 5.89 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.88 -49.4 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.947 -0.737 . . . . 0.0 109.756 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -58.15 -33.81 69.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.24 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 mtp -84.19 -16.23 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.1 -38.68 26.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.94 -28.96 31.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -64.52 -66.6 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.603 -0.686 . . . . 0.0 110.015 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 39' ' ' TYR . 1.9 pt? -63.76 -33.83 76.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.549 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.36 -41.63 60.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.558 -0.714 . . . . 0.0 109.82 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.14 -38.38 85.42 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -63.73 -26.09 68.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.745 -0.597 . . . . 0.0 109.655 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -75.97 -57.83 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.507 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 20.1 tttp -65.81 -42.22 90.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 0.0 109.507 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.44 -24.64 56.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.5 t -89.5 164.82 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -77.31 -70.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 111.072 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -83.53 63.12 7.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.696 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.84 38.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.43 -23.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -0.78 . . . . 0.0 109.523 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -73.87 -51.84 14.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.54 -19.88 63.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 109.164 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 18.9 t80 -59.35 -56.15 25.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 0.0 108.915 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -58.97 -26.72 64.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.747 . . . . 0.0 109.494 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 69' ' ' ILE . . . -57.75 -67.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.459 -0.776 . . . . 0.0 109.822 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.433 ' CE1' HD13 ' A' ' 22' ' ' LEU . 20.6 m-85 -75.35 -28.67 59.66 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.579 -0.7 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 23.5 tpt180 -63.5 -52.63 60.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.499 -0.751 . . . . 0.0 109.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -62.28 -39.49 93.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.35 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.5 93.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.563 -0.711 . . . . 0.0 109.106 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.2 65.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.449 -0.782 . . . . 0.0 109.704 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 m -82.96 -53.43 5.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.62 -42.5 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.491 -0.756 . . . . 0.0 109.815 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 46' ' ' ILE . 48.3 mm -68.9 -36.85 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.777 . . . . 0.0 109.404 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.64 36.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.494 -0.754 . . . . 0.0 110.31 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -101.02 15.8 27.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.487 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 4.2 t80 -96.8 133.63 24.17 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -86.57 14.94 2.31 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.198 2.599 . . . . 0.0 111.784 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.8 m-70 -148.11 175.02 11.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 109.893 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 159.84 14.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.695 . . . . 0.0 109.536 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mt -98.15 137.22 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -86.0 -47.9 9.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.704 . . . . 0.0 109.649 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 p -136.53 179.58 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.661 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.17 78.46 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.11 71.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.983 . . . . 0.0 109.413 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.21 -21.58 63.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.619 -0.676 . . . . 0.0 109.884 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 -32.73 35.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -74.43 -38.85 62.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.555 -0.716 . . . . 0.0 110.114 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -59.98 -26.69 66.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 8.2 mt -71.29 148.44 93.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.363 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.28 106.21 2.11 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.05 2.5 . . . . 0.0 110.351 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.04 2.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.8 t -89.73 139.66 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.993 . . . . 0.0 109.385 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.41 -147.21 21.98 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -30.59 11.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.601 -0.94 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -82.51 -41.7 19.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.658 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 38' ' ' ALA . 42.8 mm -72.18 -39.89 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.469 -0.769 . . . . 0.0 109.742 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.27 -51.91 67.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.494 -0.754 . . . . 0.0 109.778 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.35 -32.13 68.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.441 -0.787 . . . . 0.0 109.471 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -63.15 -34.51 77.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 73' ' ' ILE . 46.7 mm -64.33 -38.7 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.37 -40.17 74.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.48 -0.763 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.19 -30.57 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -52.47 36.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.282 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.28 -25.2 60.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.903 -0.498 . . . . 0.0 110.165 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.99 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.291 -0.881 . . . . 0.0 109.769 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.0 m -122.64 -61.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.27 -32.5 1.97 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -106.74 169.03 8.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.615 -0.932 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mt -112.58 131.39 55.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.725 . . . . 0.0 109.455 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -89.36 149.69 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -87.4 164.61 16.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.577 -0.702 . . . . 0.0 109.511 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.76 38.43 1.65 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.522 -0.736 . . . . 0.0 109.459 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.64 159.28 42.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.496 -0.752 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.5 tttm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.479 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -63.28 -29.98 71.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.577 -0.702 . . . . 0.0 109.65 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -149.49 -44.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.508 -0.745 . . . . 0.0 109.809 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? 61.1 38.79 16.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.387 -0.821 . . . . 0.0 109.568 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.85 111.77 5.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.523 -0.735 . . . . 0.0 109.502 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.02 81.72 1.3 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.132 2.554 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.63 -171.05 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.372 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -83.21 100.44 10.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -62.78 112.99 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.7 . . . . 0.0 109.585 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -105.45 -73.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 109.515 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -92.02 53.57 2.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.579 -0.7 . . . . 0.0 109.142 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -7.0 68.4 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.74 -43.52 4.48 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -68.11 -44.36 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.943 -0.74 . . . . 0.0 109.406 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -58.32 -34.14 70.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.6 -0.687 . . . . 0.0 109.948 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.08 -34.44 77.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.27 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.0 mtt -89.9 -15.55 31.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.694 -0.629 . . . . 0.0 110.157 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.19 -35.7 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 108.485 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.94 -31.4 14.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -70.45 -59.33 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.887 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.457 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 2.3 pp -63.92 -34.71 78.57 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.273 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.93 -42.22 62.63 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.593 -0.692 . . . . 0.0 109.71 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -63.68 -38.07 89.73 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -61.96 -23.76 66.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.818 -0.551 . . . . 0.0 109.82 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.88 -57.75 3.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.443 -0.786 . . . . 0.0 109.148 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 14.5 tttm -67.69 -41.12 84.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.537 -0.727 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -57.45 -25.41 59.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.383 -0.823 . . . . 0.0 109.733 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.8 t -89.27 164.23 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.62 -70.09 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.463 -0.773 . . . . 0.0 110.905 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -82.79 59.92 5.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.465 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.72 63.57 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.7 -29.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 108.957 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.417 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -64.11 -49.08 73.63 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.01 -25.45 63.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.629 -0.669 . . . . 0.0 109.421 179.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 40' ' ' ARG . 28.0 t80 -52.59 -64.12 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.246 -0.909 . . . . 0.0 109.799 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -57.42 -26.07 60.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.506 -0.746 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.16 -65.78 0.54 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 72.0 m-85 -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.636 -0.665 . . . . 0.0 110.039 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 9.1 mmm180 -67.16 -39.68 86.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.527 -0.733 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -72.69 -45.41 58.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.99 98.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.65 -24.76 66.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.548 -0.72 . . . . 0.0 109.883 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -78.13 -36.27 48.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.976 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 p -90.01 -44.95 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.402 -0.811 . . . . 0.0 110.008 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.8 mt -66.56 -56.03 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.41 -20.26 59.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.6 -0.687 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 26.7 9.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.2 t80 -88.52 138.14 30.19 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.183 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.419 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.39 12.06 3.12 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.104 2.536 . . . . 0.0 111.342 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 68.2 m-70 -147.69 169.74 19.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -0.971 . . . . 0.0 109.743 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -105.46 141.18 37.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 0.0 109.664 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.4 pt -97.51 154.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -114.88 -29.96 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.595 -0.691 . . . . 0.0 109.807 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.43 165.35 23.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 109.625 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.83 -26.03 64.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.35 85.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -1.068 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -63.69 -19.08 64.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.71 -0.619 . . . . 0.0 109.937 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.26 -26.4 21.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 109.831 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -38.52 63.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.763 . . . . 0.0 109.656 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -60.48 -26.45 66.81 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 51.9 mt -60.3 141.37 91.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.718 . . . . 0.0 109.563 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -80.02 112.65 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.931 2.421 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.06 -22.68 6.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.36 137.15 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -1.068 . . . . 0.0 109.373 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.07 -146.55 21.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 t -100.22 -30.32 11.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.635 -0.92 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -69.41 -45.33 69.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.552 -0.717 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.4 mm -72.85 -42.04 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.738 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.35 88.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -61.38 -36.35 80.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.563 -0.71 . . . . 0.0 109.448 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -64.45 -31.43 72.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.662 -0.649 . . . . 0.0 109.412 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.53 -45.64 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -55.81 -39.72 71.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -64.47 -30.36 71.39 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -51.62 45.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.609 -0.682 . . . . 0.0 109.219 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.73 -25.24 60.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.896 -0.503 . . . . 0.0 110.057 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.7 p -123.27 -51.07 1.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.403 -0.81 . . . . 0.0 109.54 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.09 -58.51 0.45 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -132.03 134.57 45.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.962 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -145.01 137.84 26.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.557 -0.715 . . . . 0.0 109.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -66.23 89.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.59 -0.694 . . . . 0.0 109.494 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -139.41 115.79 10.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.536 -0.728 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.6 mt -136.69 123.65 21.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -122.4 145.42 48.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.451 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 tttm 60.1 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 109.688 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 -64.04 147.67 51.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.612 -0.68 . . . . 0.0 109.571 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.14 85.53 0.11 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.558 -0.713 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 161.49 37.95 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.64 -0.663 . . . . 0.0 109.457 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.51 50.5 2.35 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.399 2.733 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -89.69 158.56 17.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -99.46 172.36 7.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.622 -0.674 . . . . 0.0 109.56 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -118.12 -11.17 10.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 110.468 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.21 -69.68 0.1 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.981 -1.075 . . . . 0.0 110.706 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -109.59 36.1 3.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -4.39 71.71 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -36.29 6.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.07 -47.9 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.886 -0.773 . . . . 0.0 109.135 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -60.3 -29.6 68.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.768 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.3 -32.79 74.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -90.0 -14.08 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.632 -0.667 . . . . 0.0 110.139 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.8 -35.11 16.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.67 -31.8 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -70.11 -59.19 3.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.622 -0.674 . . . . 0.0 109.656 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.0 pp -63.02 -34.96 78.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 109.195 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.88 -42.16 62.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.541 -0.724 . . . . 0.0 109.76 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.2 -35.18 80.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -64.16 -27.16 68.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.846 -0.534 . . . . 0.0 109.582 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -78.58 -55.51 5.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.279 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.9 ttmt -63.8 -43.59 95.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.502 -0.749 . . . . 0.0 109.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.25 -24.52 59.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.34 165.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 t -76.81 -70.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.471 -0.768 . . . . 0.0 111.241 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -85.43 65.02 8.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.394 -0.816 . . . . 0.0 110.789 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.82 43.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.348 -0.845 . . . . 0.0 109.667 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.54 -23.39 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.777 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.426 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 p-80 -70.86 -51.69 24.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.375 -0.828 . . . . 0.0 108.808 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.32 -25.41 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 29.0 t80 -53.21 -53.97 42.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.47 -27.43 69.28 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.02 -63.71 1.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.507 -0.746 . . . . 0.0 110.435 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 74.5 m-85 -71.59 -23.96 61.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.793 -0.567 . . . . 0.0 110.49 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.19 -55.63 23.46 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -62.72 -43.02 99.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 109.811 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.65 -27.73 67.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.577 -0.702 . . . . 0.0 109.801 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.2 -24.47 61.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 110.077 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.5 p -90.08 -49.91 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.284 -0.885 . . . . 0.0 110.025 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.87 -33.28 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.554 -0.717 . . . . 0.0 109.901 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 46' ' ' ILE . 63.7 mt -87.02 -30.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.442 -0.787 . . . . 0.0 109.976 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.21 -18.22 30.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 0.0 110.311 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -112.97 25.88 11.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.0 t80 -89.91 140.03 27.63 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.419 -0.801 . . . . 0.0 109.125 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.76 12.0 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.113 2.542 . . . . 0.0 111.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.431 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.1 m-70 -146.38 170.86 15.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.92 . . . . 0.0 109.734 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -94.42 147.42 23.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.738 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 mt -97.0 134.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -100.77 -57.94 2.0 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 109.587 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -105.22 159.94 15.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.25 -31.26 80.12 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.03 71.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.944 . . . . 0.0 109.377 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -67.8 -22.35 65.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.644 -0.66 . . . . 0.0 109.806 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.17 -29.47 24.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.677 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -75.63 -38.13 59.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.845 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -59.85 -24.25 64.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 110.219 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 49' ' ' TYR . 44.0 mt -69.07 151.09 97.34 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.521 -0.737 . . . . 0.0 109.458 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.34 99.94 1.28 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.029 2.486 . . . . 0.0 110.154 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.55 -27.54 1.94 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.68 138.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -1.009 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.93 -146.89 21.19 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -100.1 -28.27 13.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.968 . . . . 0.0 109.726 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.21 -61.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 109.761 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 39' ' ' TYR . 46.4 mm -65.13 -33.29 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.514 -0.741 . . . . 0.0 109.75 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.51 -57.49 9.78 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 110.22 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.15 -31.4 67.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 109.329 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.04 70.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.429 HD13 HG23 ' A' ' 73' ' ' ILE . 44.6 mm -71.03 -43.87 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 108.978 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -52.36 -50.54 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.62 -30.26 70.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.42 -0.8 . . . . 0.0 109.142 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -42.47 93.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.79 -22.74 31.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.184 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.34 -0.85 . . . . 0.0 109.645 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.7 t -127.41 -42.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.1 60.08 1.7 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -138.51 168.01 20.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.576 -0.955 . . . . 0.0 109.486 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.3 mm? -90.43 95.03 9.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -62.87 140.38 58.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -107.05 -62.35 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.46 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.6 mt -82.78 155.79 24.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.06 -31.05 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 tptt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.5 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 149.66 47.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.614 -0.679 . . . . 0.0 109.59 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.54 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.565 -0.709 . . . . 0.0 109.493 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 59.91 168.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.499 -0.751 . . . . 0.0 109.677 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.8 159.09 81.89 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.532 -0.73 . . . . 0.0 109.514 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -86.76 -165.13 0.24 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.475 2.784 . . . . 0.0 110.408 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.55 -173.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -155.53 111.53 3.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.566 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.6 p -117.86 -42.39 2.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.627 -0.671 . . . . 0.0 109.385 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -163.12 0.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.535 -0.728 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -90.59 51.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.414 -0.804 . . . . 0.0 109.425 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.48 62.95 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.86 -35.93 6.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.82 -48.11 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.88 -0.776 . . . . 0.0 109.117 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -56.77 -28.09 60.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.605 -0.684 . . . . 0.0 109.899 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.54 -27.01 64.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 mmt -89.95 -19.45 24.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 109.966 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 mp -86.52 -33.65 20.23 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.23 -36.02 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -58.99 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.616 -0.678 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 4.2 pp -63.06 -31.03 72.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.214 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.42 61.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -0.772 . . . . 0.0 109.592 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.32 -40.33 81.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -63.32 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG3' ' CD ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -76.24 -56.85 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.228 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 24.4 ttpt -61.8 -46.92 87.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -0.788 . . . . 0.0 109.742 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -56.79 -22.46 36.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.367 -0.833 . . . . 0.0 109.93 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.86 165.29 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.6 t -76.98 -70.56 0.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 111.402 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -81.23 62.4 5.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.404 -0.81 . . . . 0.0 110.737 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.0 27.55 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -30.82 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.448 -0.783 . . . . 0.0 108.921 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -69.66 -44.68 70.01 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' CD ' ' HG3' ' A' ' 26' ' ' GLU . 1.6 ptpm? -75.75 -20.45 58.29 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 8.5 t80 -58.41 -58.23 9.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.312 -0.867 . . . . 0.0 108.794 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -57.56 -28.8 63.88 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.561 -0.712 . . . . 0.0 109.328 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.42 -59.8 3.63 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.45 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 44.1 m-85 -82.09 -26.68 33.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.69 . . . . 0.0 110.143 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -40.55 96.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.366 -0.834 . . . . 0.0 109.698 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -79.0 -49.98 11.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.879 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.6 -35.41 77.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 109.858 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.96 67.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.5 -0.75 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -80.02 -45.65 17.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.66 -43.05 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.57 -0.706 . . . . 0.0 109.942 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.12 -33.56 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.439 -0.788 . . . . 0.0 109.911 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.18 -22.7 60.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.835 . . . . 0.0 110.114 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -120.52 26.56 9.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 0.0 109.73 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.451 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.6 t80 -81.78 141.45 47.91 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -86.03 9.11 4.18 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.044 2.496 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.428 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.1 m-70 -146.53 175.28 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.244 -0.91 . . . . 0.0 109.632 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -94.61 178.67 5.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.679 . . . . 0.0 109.688 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.3 mt -135.14 104.43 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.58 -0.7 . . . . 0.0 109.337 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -90.18 -52.46 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.674 -0.641 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.8 p -96.15 150.5 20.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.03 -25.8 64.78 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.97 72.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -1.053 . . . . 0.0 109.624 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 -20.05 66.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.698 . . . . 0.0 109.769 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.79 -28.73 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -75.71 -38.47 58.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -59.94 -24.66 64.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.555 -0.716 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 85.9 mt -59.8 143.81 86.64 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.47 -0.769 . . . . 0.0 109.738 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.48 111.91 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.981 2.454 . . . . 0.0 110.143 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.78 -29.42 5.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -89.98 137.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.966 . . . . 0.0 109.251 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.23 -139.27 10.01 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -98.21 -28.4 13.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.952 . . . . 0.0 109.604 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -62.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 0.0 109.588 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.0 mm -62.2 -44.39 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.698 . . . . 0.0 109.735 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.11 83.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.735 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.84 -40.29 88.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.745 . . . . 0.0 109.568 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -63.49 -29.74 70.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.613 -0.68 . . . . 0.0 109.442 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.5 -46.32 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.725 . . . . 0.0 109.164 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.81 -41.41 74.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.466 -0.771 . . . . 0.0 109.77 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.97 -27.2 69.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 109.206 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -51.62 19.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.9 -27.3 61.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.576 -0.449 . . . . 0.0 109.981 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.421 -0.799 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.5 p -129.96 -56.49 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.406 -0.809 . . . . 0.0 109.323 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.64 58.67 10.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -149.27 -169.34 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.973 . . . . 0.0 109.452 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.2 mm? -88.5 85.4 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.653 -0.655 . . . . 0.0 109.449 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -85.97 -28.96 23.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -170.08 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -96.45 100.64 12.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.34 -167.44 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.707 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.442 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -72.67 66.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -66.33 -60.24 2.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.522 -0.736 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 60.08 78.96 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.566 -0.709 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.05 165.12 25.44 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.727 . . . . 0.0 109.474 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.61 51.08 2.45 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.41 2.74 . . . . 0.0 110.519 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -77.79 -176.47 4.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.16 75.4 1.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.609 -0.682 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.2 p -130.11 168.16 17.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.479 -0.763 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.98 -172.3 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m120 66.76 -62.37 0.29 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.792 -0.567 . . . . 0.0 110.753 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.49 -16.97 17.7 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -50.0 5.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mt -67.51 -46.25 83.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.0 m -59.25 -29.12 67.31 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.626 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.05 -37.74 88.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.0 mtt -82.57 -17.94 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.22 -36.62 20.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.16 -31.65 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.64 -61.81 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.554 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.6 pp -64.31 -32.23 73.74 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.094 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.33 -43.35 67.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.582 -0.699 . . . . 0.0 109.54 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -63.72 -37.31 86.88 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -62.38 -23.45 66.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.543 . . . . 0.0 109.792 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -57.74 3.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -67.12 -40.5 86.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.617 -0.677 . . . . 0.0 109.675 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.5 -25.22 62.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.46 -0.775 . . . . 0.0 109.739 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.4 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.3 t -76.32 -70.45 0.45 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.518 -0.738 . . . . 0.0 110.974 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -85.92 63.48 8.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.49 -0.756 . . . . 0.0 110.586 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.85 49.0 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 109.741 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.3 -28.94 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.418 -0.801 . . . . 0.0 109.332 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.2 -48.89 71.8 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.26 -23.62 63.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.685 -0.634 . . . . 0.0 109.438 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.414 ' CZ ' ' HD3' ' A' ' 40' ' ' ARG . 28.3 t80 -54.87 -62.95 1.33 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.291 -0.88 . . . . 0.0 109.75 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.5 -59.48 4.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 0.0 110.076 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.458 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 35.4 m-85 -88.92 -29.61 19.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.815 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HD3' ' CZ ' ' A' ' 36' ' ' TYR . 9.1 tpt180 -62.19 -43.21 99.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.53 -0.731 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -79.19 -38.03 36.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 109.695 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.97 84.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.83 -29.93 66.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.531 -0.731 . . . . 0.0 109.509 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -67.75 -55.51 12.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.098 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.35 -43.79 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.001 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.4 mt -71.0 -38.16 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.775 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.2 -26.26 68.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.02 27.46 8.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.792 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 3.2 t80 -84.17 137.05 40.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.73 . . . . 0.0 109.256 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.3 Cg_endo -87.23 14.49 2.4 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 123.195 2.597 . . . . 0.0 111.392 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.4 m-70 -147.87 173.26 13.01 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.218 -0.926 . . . . 0.0 109.762 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -97.85 139.23 34.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 109.827 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.9 pt -103.88 67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.291 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -69.59 -15.1 63.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.9 m -116.19 139.52 50.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.24 -31.17 65.39 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.76 78.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.634 -0.921 . . . . 0.0 109.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -63.37 -23.02 67.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.673 -0.642 . . . . 0.0 109.831 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.06 25.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -74.42 -42.23 59.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.79 . . . . 0.0 109.615 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -59.28 -23.75 62.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.54 -0.725 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 83.5 mt -59.56 138.82 89.46 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.728 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.98 101.37 1.14 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.046 2.497 . . . . 0.0 110.007 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.86 -19.11 3.75 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.3 t -89.31 138.42 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.329 -1.1 . . . . 0.0 109.302 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.44 -155.89 25.67 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -96.96 -27.02 14.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.967 . . . . 0.0 109.777 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -83.06 -38.09 22.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.496 -0.753 . . . . 0.0 109.667 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.1 mm -72.65 -42.22 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.434 -0.791 . . . . 0.0 109.868 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.84 76.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.781 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.12 -32.39 68.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -33.45 75.61 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 73' ' ' ILE . 47.5 mm -63.47 -42.18 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -56.94 -36.84 70.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.629 -0.67 . . . . 0.0 109.588 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.93 -32.38 73.89 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -50.18 65.09 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.59 0.71 . . . . 0.0 109.159 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -74.01 -24.59 59.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.872 -0.517 . . . . 0.0 110.153 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.2 m -113.93 -50.38 2.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 60.01 2.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -157.49 146.19 19.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.998 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.9 tp -108.28 108.25 19.19 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -84.0 153.19 24.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -113.05 -175.43 2.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.671 -0.643 . . . . 0.0 109.386 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.88 163.43 27.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -95.01 146.26 24.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.6 -0.688 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.517 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -114.19 -61.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 109.451 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -31.25 72.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.33 169.39 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 109.778 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.4 172.3 9.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.54 147.25 8.52 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.506 2.804 . . . . 0.0 110.42 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -89.94 -74.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.35 30.95 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 109.398 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -110.36 143.34 40.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.628 -0.67 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.61 -170.11 1.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.473 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 59.61 30.71 20.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.674 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.54 82.83 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.18 -34.15 7.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mt -75.04 -49.34 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.856 -0.791 . . . . 0.0 109.353 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -58.9 -34.69 71.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.664 -0.648 . . . . 0.0 109.898 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -35.24 79.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 109.268 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttm -86.06 -22.95 26.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.626 -0.671 . . . . 0.0 109.779 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.07 -37.75 38.09 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.2 t -72.0 -28.82 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.21 -66.41 0.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.003 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' CD1' ' CE2' ' A' ' 39' ' ' TYR . 2.2 pt? -64.73 -31.72 73.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.82 -40.7 56.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.555 -0.716 . . . . 0.0 110.111 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.64 69.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -64.61 -27.21 68.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.36 -56.18 4.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.624 -0.673 . . . . 0.0 109.394 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 14.2 tttp -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -57.15 -25.59 59.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.465 -0.772 . . . . 0.0 109.471 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.6 t -89.52 165.32 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.14 -67.48 0.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 111.211 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -78.85 57.87 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.901 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.03 28.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.27 -33.01 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -67.82 -44.69 76.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -76.51 -16.98 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 4.7 t80 -61.89 -63.29 1.3 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -55.51 -26.13 41.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -0.751 . . . . 0.0 109.632 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -58.1 9.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.478 -0.763 . . . . 0.0 109.654 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CE2' ' CD1' ' A' ' 22' ' ' LEU . 27.9 m-85 -84.61 -27.99 26.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 109.674 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -53.98 44.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 109.546 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -67.57 -43.16 81.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.549 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.36 -29.7 70.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.544 -0.723 . . . . 0.0 109.552 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.32 -26.22 60.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.558 -0.713 . . . . 0.0 109.796 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -87.88 -48.5 7.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 109.993 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.68 -33.54 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.1 mt -85.8 -25.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.533 -0.729 . . . . 0.0 109.705 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.46 -20.98 24.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -108.89 23.45 14.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 1.8 t80 -94.59 139.64 22.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 108.935 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.51 12.24 3.06 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.105 2.537 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -146.02 153.58 40.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 0.0 109.795 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -77.23 145.77 37.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 109.772 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.05 81.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -69.66 -27.78 65.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 p -121.52 145.86 47.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.452 -0.78 . . . . 0.0 109.376 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.0 79.23 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -31.41 72.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.542 -0.975 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.31 -22.27 66.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.635 -0.666 . . . . 0.0 109.775 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.75 -32.23 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -76.31 -37.75 57.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.523 -0.735 . . . . 0.0 109.724 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -60.02 -23.31 63.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.185 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.433 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 24.7 mt -63.89 151.1 90.12 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.421 -0.799 . . . . 0.0 109.543 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -81.29 104.14 1.48 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.117 2.545 . . . . 0.0 110.054 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.16 -22.68 4.73 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -89.3 139.84 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.387 -1.066 . . . . 0.0 109.282 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.73 -153.48 28.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.0 p -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.489 -1.007 . . . . 0.0 109.624 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -66.57 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 39' ' ' TYR . 50.1 mm -64.08 -35.09 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 109.775 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.01 96.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.507 -0.745 . . . . 0.0 109.377 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -59.59 -33.73 71.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.598 -0.689 . . . . 0.0 109.428 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -65.87 -30.72 71.37 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.6 mm -63.15 -46.22 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -56.62 -37.5 70.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.475 -0.766 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.57 -31.28 72.43 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -50.49 62.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.562 0.696 . . . . 0.0 109.206 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -74.45 -25.58 59.51 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.027 -0.42 . . . . 0.0 110.143 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.59 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.387 -0.821 . . . . 0.0 109.742 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -129.72 -58.13 1.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.37 -34.05 2.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -113.02 178.11 4.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.476 -1.014 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mt -111.35 143.81 41.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.545 -0.722 . . . . 0.0 109.411 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -100.07 90.52 4.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.651 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -127.78 83.91 2.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.479 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -78.37 152.4 32.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.475 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -106.49 -69.93 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.559 -0.713 . . . . 0.0 109.472 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.436 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -62.22 178.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.566 -0.709 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -63.4 -173.63 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.646 -0.659 . . . . 0.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.29 -58.83 1.85 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.488 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.56 160.11 37.17 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.82 -76.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.385 2.723 . . . . 0.0 110.73 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -90.19 -75.91 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.526 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.99 161.27 8.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 109.452 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 t -130.01 158.99 38.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.636 -0.665 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.86 -170.11 1.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.432 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 58.14 41.25 24.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 109.777 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.91 -3.29 83.27 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.08 -37.01 6.43 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.7 mt -69.16 -60.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.892 -0.769 . . . . 0.0 109.184 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -52.99 -25.9 13.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.811 -0.556 . . . . 0.0 110.525 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.29 -30.38 68.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.69 -21.8 21.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.952 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mp -86.94 -35.29 18.98 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.7 t -77.22 -31.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -65.35 -61.84 1.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' CD2' ' CE2' ' A' ' 39' ' ' TYR . 3.1 pp -63.06 -33.34 75.23 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.06 -36.23 38.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.681 -0.637 . . . . 0.0 109.809 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.92 74.86 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -60.83 -21.11 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.299 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -58.5 3.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.248 -0.907 . . . . 0.0 109.151 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 10.0 tttp -68.78 -38.05 79.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.52 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.65 -27.26 64.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.406 -0.808 . . . . 0.0 109.592 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.34 164.03 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -77.72 -70.22 0.49 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 0.0 110.853 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -81.37 59.15 3.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.77 65.64 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -30.8 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.419 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -62.59 -48.96 77.15 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.338 -0.851 . . . . 0.0 108.829 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -71.15 -20.85 62.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.69 . . . . 0.0 109.641 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 23.8 t80 -57.32 -68.76 0.2 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.866 . . . . 0.0 109.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -55.72 -23.03 26.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.384 -0.822 . . . . 0.0 110.054 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.14 -63.53 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.368 -0.832 . . . . 0.0 109.916 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.442 ' CE2' ' CD2' ' A' ' 22' ' ' LEU . 86.9 m-85 -74.61 -27.34 60.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.713 -0.617 . . . . 0.0 110.086 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -61.57 -37.21 83.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.441 -0.787 . . . . 0.0 109.683 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -81.95 -49.74 9.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -63.84 -27.91 69.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 -37.08 62.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.774 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.3 m -71.6 -47.42 54.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.01 -35.46 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.554 -0.716 . . . . 0.0 109.767 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.6 mt -84.17 -28.27 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.752 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.06 -21.15 24.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.47 -0.769 . . . . 0.0 110.039 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.26 22.44 15.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.922 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.436 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.1 t80 -96.02 140.67 22.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 108.998 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.05 8.13 4.66 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.979 2.453 . . . . 0.0 111.226 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.42 -176.28 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.678 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -104.17 160.49 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.532 -0.73 . . . . 0.0 109.57 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.4 mt -97.05 143.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.68 . . . . 0.0 109.383 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -91.48 -65.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.732 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 m -119.88 -179.95 4.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.729 . . . . 0.0 109.537 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.35 -33.8 87.3 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.2 71.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.997 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.19 -24.24 62.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.686 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.59 -31.96 22.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 0.0 109.662 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -75.33 -36.28 61.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.571 -0.705 . . . . 0.0 110.042 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.57 -27.28 67.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD21 ' CE1' ' A' ' 49' ' ' TYR . 6.4 mt -71.18 146.95 93.05 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 0.0 109.401 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.8 102.45 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.959 2.439 . . . . 0.0 110.272 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.9 -25.84 2.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.72 139.16 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.46 -1.023 . . . . 0.0 109.587 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.2 -151.53 23.94 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -99.05 -29.47 12.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.958 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -72.07 -64.09 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.498 -0.751 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 39' ' ' TYR . 47.3 mm -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.76 78.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.45 -38.62 87.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -62.11 -31.14 71.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.6 mm -63.34 -42.47 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.08 -41.04 74.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.413 -0.804 . . . . 0.0 109.548 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -62.89 -28.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -52.13 18.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.395 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.54 -26.79 61.88 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.87 -0.519 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.837 . . . . 0.0 109.525 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m -95.82 -56.35 2.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 109.237 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.47 -48.38 0.97 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -111.46 161.16 16.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.955 . . . . 0.0 109.584 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -150.17 178.14 9.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.606 -0.684 . . . . 0.0 109.637 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.9 mtp85 -100.06 135.16 41.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.651 -0.656 . . . . 0.0 109.45 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 mtpp -130.55 -173.45 3.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.66 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 85' ' ' LEU . 4.3 mm? -80.57 118.88 22.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.687 . . . . 0.0 109.434 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -143.19 145.12 32.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 tttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.434 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -98.63 -32.29 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -124.4 143.87 50.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -64.56 110.54 2.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.48 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.33 158.25 83.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.659 . . . . 0.0 109.438 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.84 -175.79 1.98 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.401 2.734 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -64.14 -64.25 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -152.94 150.87 29.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -126.62 135.49 51.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mt -85.23 -170.14 2.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 0.0 109.295 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 m120 59.51 32.02 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.712 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.29 -9.72 64.87 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.376 -0.916 . . . . 0.0 110.823 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.9 -36.63 6.32 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.5 -43.8 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.845 -0.797 . . . . 0.0 109.74 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -59.44 -26.03 64.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.09 -46.33 57.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.47 -0.769 . . . . 0.0 109.423 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -85.24 -8.58 58.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.712 . . . . 0.0 110.456 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.48 -42.1 17.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.09 -30.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.28 -65.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.602 -0.686 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 39' ' ' TYR . 1.6 pt? -63.14 -35.07 79.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.94 -48.95 64.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.62 -0.675 . . . . 0.0 110.114 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -62.81 -33.85 76.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -65.41 -22.55 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.739 -0.601 . . . . 0.0 109.876 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.94 -56.95 4.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.452 -0.78 . . . . 0.0 109.18 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 17.8 tttm -66.37 -39.87 89.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.376 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.15 -26.42 64.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.453 -0.779 . . . . 0.0 109.447 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -89.48 164.46 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.15 -68.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.435 -0.79 . . . . 0.0 110.939 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -86.18 60.68 6.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.448 -0.782 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.74 57.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 109.542 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.93 -37.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.01 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.8 p-80 -55.73 -46.3 77.81 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.011 -1.056 . . . . 0.0 109.259 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -73.03 -20.41 61.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -57.74 -70.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -53.42 -24.85 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.425 -0.797 . . . . 0.0 109.938 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.62 -66.34 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.501 -0.749 . . . . 0.0 109.784 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CE2' ' CD1' ' A' ' 22' ' ' LEU . 41.2 m-85 -77.94 -30.36 50.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 110.07 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -42.7 99.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.392 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -69.24 -44.84 71.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.747 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.38 92.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.41 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.48 -22.94 64.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 0.0 109.901 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -79.61 -54.67 5.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.59 -44.39 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.541 -0.724 . . . . 0.0 110.104 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 46' ' ' ILE . 78.4 mt -62.87 -58.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.475 -0.765 . . . . 0.0 109.597 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.69 -20.98 62.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.533 -0.729 . . . . 0.0 110.187 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -112.21 28.83 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.452 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.1 t80 -94.07 140.47 22.9 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.2 Cg_endo -85.35 8.78 4.41 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.072 2.515 . . . . 0.0 111.284 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 171.18 15.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -94.48 145.08 25.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.613 -0.679 . . . . 0.0 109.543 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.6 mt -78.24 115.56 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.351 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -74.01 -31.11 62.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 0.0 109.562 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -164.84 -179.79 6.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.578 -0.701 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -28.0 63.54 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.99 95.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.574 -0.956 . . . . 0.0 109.451 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -69.93 -23.28 63.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.71 . . . . 0.0 109.77 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.5 -27.06 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 109.733 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -74.93 -40.99 60.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -59.95 -23.73 63.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.565 -0.709 . . . . 0.0 110.029 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.452 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 80.7 mt -59.99 136.83 90.75 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.55 106.03 1.94 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.865 2.377 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.49 -26.39 3.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.63 138.06 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -1.036 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.75 -146.17 14.09 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -99.14 -37.87 9.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.948 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -64.63 -44.01 91.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.745 . . . . 0.0 109.812 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.9 mm -71.2 -44.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.883 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.04 81.44 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 109.768 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -61.02 -39.42 89.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.51 -0.744 . . . . 0.0 109.544 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -63.26 -30.94 71.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.06 -44.98 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -55.36 -40.95 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -64.26 -28.46 69.74 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.28 -52.57 18.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.608 -0.683 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.941 -0.474 . . . . 0.0 110.028 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.373 -0.83 . . . . 0.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p -101.55 -57.66 2.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.802 . . . . 0.0 109.47 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.38 55.12 3.31 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -145.96 177.04 9.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.647 -0.913 . . . . 0.0 109.437 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.3 mm? -83.97 75.79 10.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 109.229 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -76.35 99.06 4.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.499 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -111.9 30.79 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.01 100.88 10.01 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -91.26 -63.68 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.514 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -64.4 -165.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 60.24 165.24 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -91.35 105.29 17.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.88 171.37 8.77 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.4 151.18 9.13 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 123.405 2.737 . . . . 0.0 110.538 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.07 142.9 57.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -119.71 179.12 4.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.576 -0.702 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 p -74.42 -31.05 62.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.53 -169.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.494 -0.754 . . . . 0.0 109.392 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -98.3 53.67 1.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.535 -0.728 . . . . 0.0 109.341 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.7 55.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.05 -33.57 8.12 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.13 -51.3 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.871 -0.782 . . . . 0.0 109.286 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -57.17 -28.54 62.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.68 -27.02 63.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 0.0 109.552 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.5 mmt -90.3 -19.44 24.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.992 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -33.9 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.88 -31.74 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.19 -58.82 3.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.655 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.428 HD13 ' CG ' ' A' ' 39' ' ' TYR . 3.2 pp -62.67 -34.98 78.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.15 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.95 -43.12 63.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.504 -0.748 . . . . 0.0 109.572 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.74 -34.31 78.03 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -66.2 -26.64 67.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.768 -0.583 . . . . 0.0 109.789 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -80.44 -52.37 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.41 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 53.7 tttt -66.07 -42.85 88.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.409 -0.807 . . . . 0.0 109.145 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -58.62 -26.15 63.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.247 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.34 165.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.6 t -79.39 -70.32 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.446 -0.784 . . . . 0.0 111.238 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -79.13 59.21 2.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.434 -0.791 . . . . 0.0 110.95 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.97 48.69 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.71 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.13 -21.9 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.419 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -71.97 -51.78 20.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.322 -0.861 . . . . 0.0 108.825 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.03 -23.62 63.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.557 -0.715 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 21.9 t80 -56.72 -51.94 66.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.41 -0.806 . . . . 0.0 109.255 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -62.39 -29.9 70.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.192 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 69' ' ' ILE . . . -54.96 -65.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.772 . . . . 0.0 109.989 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.428 ' CG ' HD13 ' A' ' 22' ' ' LEU . 81.7 m-85 -72.59 -16.01 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -72.1 -55.23 7.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -65.66 -43.54 89.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.526 -0.733 . . . . 0.0 110.078 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -64.95 -46.48 81.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.0 64.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.629 -0.669 . . . . 0.0 110.082 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -81.2 -52.67 7.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.13 -43.71 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.834 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.96 -54.88 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.49 -20.88 58.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.503 -0.748 . . . . 0.0 110.371 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -117.43 25.96 10.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.8 t80 -86.08 140.19 34.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.0 109.198 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.19 9.87 3.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.981 2.454 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.428 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 178.68 8.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.291 -0.881 . . . . 0.0 109.645 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -99.41 157.68 16.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.654 -0.654 . . . . 0.0 109.81 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.9 mt -102.53 108.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -69.93 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.584 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -111.85 -179.85 3.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.688 -0.632 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.52 64.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.34 70.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -1.068 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -70.55 -25.21 63.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.714 . . . . 0.0 109.695 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.02 -28.24 22.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 109.631 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -75.26 -40.11 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -59.79 -24.21 63.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.605 -0.685 . . . . 0.0 110.04 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 82.8 mt -60.23 142.65 89.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.456 -0.778 . . . . 0.0 109.636 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.29 105.62 1.78 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.032 2.488 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.45 -26.16 4.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.53 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.461 -1.023 . . . . 0.0 109.468 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.63 -140.59 10.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.49 -27.48 14.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.912 . . . . 0.0 109.778 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -66.14 -67.68 0.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.475 -0.766 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.407 ' CD1' ' CB ' ' A' ' 38' ' ' ALA . 50.8 mm -60.03 -44.87 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.29 -35.46 71.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.45 -38.02 82.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 109.443 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -69.8 -25.25 63.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.645 -0.66 . . . . 0.0 109.653 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.5 mm -72.81 -48.28 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 109.386 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.36 -47.95 68.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.46 -28.95 70.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.475 -0.766 . . . . 0.0 109.054 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -44.15 79.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.69 . . . . 0.0 109.167 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.66 -23.93 36.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.86 -0.525 . . . . 0.0 110.129 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -78.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 p -118.61 -59.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.498 -0.752 . . . . 0.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.4 59.99 1.01 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -157.15 40.68 0.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.551 -0.97 . . . . 0.0 109.464 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mt -129.66 92.57 3.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.673 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -168.49 88.39 0.22 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 mp -136.57 154.37 50.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.579 -0.701 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.88 -36.37 67.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.634 -0.667 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.509 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttt 43.35 -164.8 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.032 0.444 . . . . 0.0 111.315 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 59.61 38.66 22.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.678 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 tttm 60.28 166.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.573 -0.705 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.4 111.47 4.36 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.665 -0.647 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.33 173.99 5.34 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.204 2.603 . . . . 0.0 110.504 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -90.01 157.59 17.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -112.49 119.16 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -105.25 176.81 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mt -74.6 -72.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -87.88 57.71 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.604 -0.685 . . . . 0.0 109.212 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -15.56 57.31 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.0 -35.27 7.2 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 19' ' ' LEU . 3.9 mt -70.94 -57.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.78 -0.836 . . . . 0.0 109.17 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -53.48 -30.96 43.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.776 -0.578 . . . . 0.0 110.668 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.97 -29.48 68.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 110.014 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.4 mmt -90.13 -23.71 21.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 110.058 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' CD1' ' CG2' ' A' ' 15' ' ' ILE . 1.8 mp -88.37 -34.27 17.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 108.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.48 -32.92 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -68.6 -61.56 1.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.438 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 4.2 pp -61.69 -32.32 72.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.48 -44.35 65.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 109.63 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -35.62 79.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.13 -22.83 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.859 -0.526 . . . . 0.0 109.678 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -78.23 -57.88 3.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.99 -40.69 95.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.287 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -58.98 -25.4 63.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.582 -0.698 . . . . 0.0 109.498 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -89.59 164.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 t -76.76 -70.19 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.49 -0.756 . . . . 0.0 111.096 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.46 65.97 9.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.386 -0.821 . . . . 0.0 110.884 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.76 36.89 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.86 -26.11 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.316 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.427 ' NE2' ' HE3' ' A' ' 35' ' ' LYS . 6.4 p-80 -71.36 -50.76 28.98 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 10.8 ptpt -66.7 -23.75 66.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.6 t80 -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.475 -0.766 . . . . 0.0 109.648 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -56.71 -24.79 51.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.14 -59.24 5.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.388 -0.82 . . . . 0.0 109.89 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.438 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 48.0 m-85 -85.12 -27.61 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.949 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 28.9 tpt85 -64.41 -42.84 95.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.469 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -78.33 -46.62 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.26 96.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.551 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.73 70.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -66.91 -50.19 63.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.96 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.34 -45.07 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.466 -0.771 . . . . 0.0 110.112 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.3 mt -64.22 -51.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 109.556 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.01 -21.36 66.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 110.076 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.07 27.93 8.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.448 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.4 t80 -90.45 139.38 26.68 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.728 . . . . 0.0 109.129 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.14 10.87 3.49 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.081 2.521 . . . . 0.0 111.263 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.432 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.6 m-70 -147.3 171.68 15.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.273 -0.892 . . . . 0.0 109.642 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.98 138.6 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.696 . . . . 0.0 109.665 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.5 mt -73.12 125.78 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.239 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -81.67 -56.95 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 p -132.21 -179.82 5.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.544 -0.723 . . . . 0.0 109.509 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.8 -29.37 67.31 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.86 72.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.22 -21.33 65.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.718 -0.614 . . . . 0.0 109.9 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.99 -27.63 24.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.788 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -73.38 -40.72 64.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.767 . . . . 0.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -60.27 -26.62 66.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.568 -0.708 . . . . 0.0 110.039 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.448 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 46.5 mt -63.41 136.65 96.8 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.719 . . . . 0.0 109.297 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.55 108.39 2.12 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.937 2.425 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.05 -19.85 4.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.27 139.31 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -1.101 . . . . 0.0 109.285 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.38 -149.92 23.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -98.64 -35.56 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.952 . . . . 0.0 109.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -71.86 -39.93 69.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.0 109.74 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.0 mm -72.83 -40.56 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.764 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.6 -50.65 73.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.543 -0.723 . . . . 0.0 110.126 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.97 -34.01 69.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.789 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -62.27 -37.93 87.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.556 -0.715 . . . . 0.0 109.182 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 73' ' ' ILE . 47.2 mm -63.74 -38.31 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.77 -40.3 72.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.525 -0.735 . . . . 0.0 109.617 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.8 -32.98 74.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -53.12 50.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.39 -22.79 61.08 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.962 -0.461 . . . . 0.0 110.168 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.79 -80.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t -130.03 -43.58 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.617 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.45 49.19 71.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -117.2 -37.63 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.34 90.39 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.521 -0.737 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -60.76 175.53 0.47 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.606 -0.684 . . . . 0.0 109.807 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -84.16 104.53 14.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.754 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.24 82.89 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.456 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -170.02 158.22 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.44 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.121 0.486 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -85.21 131.19 34.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 109.412 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 59.39 -174.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 109.744 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -86.56 -33.65 20.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.66 156.06 47.81 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.57 -0.706 . . . . 0.0 109.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.97 143.52 8.1 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 123.379 2.72 . . . . 0.0 110.504 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -90.03 130.54 36.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.73 . . . . 0.0 109.471 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -124.57 106.48 10.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.509 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.3 p -130.06 135.23 48.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.576 -0.703 . . . . 0.0 109.422 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mt -110.06 -73.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -101.71 67.55 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.618 -0.676 . . . . 0.0 109.298 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 1.32 79.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.42 -34.81 7.76 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.37 -59.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.861 -0.788 . . . . 0.0 109.146 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -53.17 -31.54 43.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.819 -0.551 . . . . 0.0 110.333 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.9 -29.38 69.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 mmt -90.4 -21.74 21.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.821 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mp -88.78 -34.01 17.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.44 -33.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.77 -60.38 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 109.42 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 39' ' ' TYR . 3.8 pp -61.51 -34.5 75.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.136 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.25 -41.44 60.36 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.556 -0.715 . . . . 0.0 109.669 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -64.25 -37.09 86.26 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -64.38 -23.49 67.31 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -76.1 -56.61 4.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.382 -0.823 . . . . 0.0 109.125 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -69.51 -40.48 76.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 109.728 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -57.5 -25.07 59.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.6 t -89.28 164.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -76.72 -70.43 0.46 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.765 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -85.05 64.56 8.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.459 -0.775 . . . . 0.0 110.412 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.77 48.98 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.683 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 -22.57 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.512 -0.742 . . . . 0.0 109.626 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.8 p-80 -71.5 -51.65 22.54 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 108.677 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -68.1 -23.27 64.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 109.309 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.5 -55.1 39.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -60.94 -27.44 68.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 0.0 109.565 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.99 -63.56 1.14 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.436 -0.79 . . . . 0.0 110.067 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.443 ' CE1' HD11 ' A' ' 22' ' ' LEU . 63.4 m-85 -78.37 -27.4 46.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.722 -0.611 . . . . 0.0 110.149 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -66.83 -33.87 76.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.66 -49.64 10.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.506 -0.746 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -50.85 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.53 -0.731 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -27.76 68.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.506 -0.746 . . . . 0.0 109.626 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -73.74 -32.29 63.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.861 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -90.1 -35.28 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 46' ' ' ILE . 73.2 mt -77.09 -48.62 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.515 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.24 -20.06 62.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 0.0 110.23 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -121.66 26.17 8.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 109.724 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.455 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 1.9 t80 -83.72 145.58 47.68 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.057 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -85.29 -0.01 8.85 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.05 2.5 . . . . 0.0 110.989 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.4 m-70 -142.32 177.75 8.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.325 -0.86 . . . . 0.0 109.634 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -103.79 141.51 35.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.591 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.2 mt -81.83 130.43 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -94.6 -50.5 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.747 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.4 m -125.77 177.93 5.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.33 -29.46 73.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.97 72.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -73.34 -25.78 60.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.46 -28.38 19.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.644 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -77.04 -35.63 56.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.735 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -60.25 -23.27 63.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.588 -0.695 . . . . 0.0 110.031 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 78.9 mt -60.76 143.54 90.86 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.13 107.45 2.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.972 2.448 . . . . 0.0 110.251 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.49 -29.05 3.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.1 t -89.82 138.8 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.984 . . . . 0.0 109.479 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.11 -136.67 7.98 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -98.81 -28.35 13.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.976 . . . . 0.0 109.657 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -66.13 -66.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.568 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.3 mm -61.43 -45.11 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.598 -0.689 . . . . 0.0 109.731 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.64 -34.31 71.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.54 -41.41 97.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.575 -0.703 . . . . 0.0 109.451 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -62.45 -29.64 70.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.681 -0.637 . . . . 0.0 109.366 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.6 -46.87 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.719 . . . . 0.0 109.061 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.41 -32.37 66.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.518 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -67.33 -29.85 69.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -73.18 -50.53 22.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.569 0.7 . . . . 0.0 109.428 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.95 -27.62 61.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 122.043 -0.41 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -79.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.763 . . . . 0.0 109.531 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m -130.06 -65.09 0.84 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.81 59.96 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -126.75 94.72 4.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.973 . . . . 0.0 109.53 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.3 mm? -86.69 79.34 8.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -87.4 -73.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 109.548 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -169.98 146.44 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.497 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.9 mt -143.37 119.48 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.568 -0.708 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -41.15 12.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.462 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -145.43 139.76 27.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.13 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.559 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.66 161.22 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.455 -0.778 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.24 170.48 16.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.04 80.88 1.72 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.407 2.738 . . . . 0.0 110.427 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -86.39 85.13 7.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.23 128.89 40.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.8 p -111.31 65.4 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.508 -0.745 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -110.1 -71.34 0.77 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.516 -0.74 . . . . 0.0 109.472 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -107.27 41.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.602 -0.686 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.04 0.13 84.11 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -42.31 5.03 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.3 mt -66.5 -58.19 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.96 -0.73 . . . . 0.0 109.079 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -52.6 -31.04 34.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.731 -0.606 . . . . 0.0 110.384 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -63.83 -30.38 71.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.496 -0.752 . . . . 0.0 109.529 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 ttm -90.31 -21.39 22.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.888 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.29 -33.95 19.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.8 -35.78 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -65.46 -60.99 2.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.375 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.7 pp -61.53 -33.66 74.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 109.151 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.88 -41.65 62.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 109.507 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.05 -36.96 85.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -63.87 -23.2 67.26 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -77.01 -57.12 4.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 46.7 tttm -68.27 -40.29 81.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.488 -0.757 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -25.53 61.29 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.481 -0.762 . . . . 0.0 109.696 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.31 164.29 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.14 -70.08 0.49 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.955 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -84.77 62.19 7.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.445 -0.785 . . . . 0.0 110.458 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.77 53.91 0.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.862 . . . . 0.0 109.684 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.27 -29.71 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.785 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.73 -48.37 74.86 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.37 -22.77 62.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.591 -0.693 . . . . 0.0 109.411 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 25.7 t80 -55.64 -67.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.271 -0.893 . . . . 0.0 109.741 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -55.82 -23.13 28.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.479 -0.763 . . . . 0.0 110.038 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.47 -63.62 1.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.286 -0.884 . . . . 0.0 109.88 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.46 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 64.3 m-85 -79.17 -26.8 42.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.024 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -37.86 88.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.319 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -48.28 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.721 -0.612 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -62.56 -27.65 69.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.604 -0.685 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.04 57.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.494 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -72.45 -44.11 62.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 109.861 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.03 -36.66 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.455 -0.778 . . . . 0.0 109.766 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.08 -26.51 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.73 -26.25 21.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -97.9 20.35 12.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.445 -0.785 . . . . 0.0 109.856 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.448 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 6.3 t80 -95.14 137.67 22.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.38 12.4 3.02 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.113 2.542 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.427 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.3 m-70 -148.28 -171.58 3.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.527 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -124.96 149.91 47.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.585 -0.697 . . . . 0.0 109.52 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 pt -101.42 158.02 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.53 -0.731 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -114.01 -32.23 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.712 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -118.46 167.61 11.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.86 -30.58 70.23 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.59 70.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -68.16 -24.46 64.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.672 -0.642 . . . . 0.0 109.716 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.86 -31.13 35.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -73.98 -40.68 62.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.738 . . . . 0.0 110.122 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -59.26 -27.24 65.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.533 -0.729 . . . . 0.0 110.142 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 9.9 mt -72.0 149.12 92.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.22 118.54 4.71 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.092 2.528 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.91 -25.69 5.77 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.8 139.71 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -1.018 . . . . 0.0 109.509 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.16 -150.72 18.6 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -99.55 -29.22 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.612 -0.934 . . . . 0.0 109.612 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -77.26 -59.34 2.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.592 -0.692 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.404 ' CG2' ' CB ' ' A' ' 42' ' ' ALA . 46.2 mm -62.04 -32.54 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.69 . . . . 0.0 109.457 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.19 -38.64 87.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 109.126 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -61.41 -38.93 88.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -62.37 -30.69 71.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.53 -44.5 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.76 -40.59 72.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.55 -0.719 . . . . 0.0 109.797 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.38 -51.95 45.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.513 0.673 . . . . 0.0 109.278 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.23 -24.08 60.44 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.952 -0.467 . . . . 0.0 110.058 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.63 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 109.731 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t -130.21 -43.73 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.0 109.619 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.14 35.37 1.65 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -100.99 128.73 46.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.907 . . . . 0.0 109.407 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.13 60.62 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.682 . . . . 0.0 109.424 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -99.97 141.52 32.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.466 -0.771 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -163.98 156.73 17.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.492 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.16 127.38 33.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.417 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.77 -49.83 6.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.455 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? 59.8 83.29 0.14 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 109.746 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 63.22 -82.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.715 -0.616 . . . . 0.0 109.682 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -116.16 134.84 54.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 109.45 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.01 167.42 36.88 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.3 67.72 4.87 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.451 2.768 . . . . 0.0 110.457 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -67.68 -48.14 67.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -119.9 94.0 4.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 p -129.97 -57.91 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.715 . . . . 0.0 109.498 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.89 -74.41 0.65 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.504 -0.747 . . . . 0.0 109.443 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -112.42 58.66 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.735 . . . . 0.0 109.31 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.04 -0.09 78.13 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.59 -41.47 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.72 -57.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.902 -0.763 . . . . 0.0 109.166 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -52.93 -33.93 52.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.739 -0.601 . . . . 0.0 110.472 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.98 -32.41 72.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.2 tpt -86.74 -20.55 27.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.21 -37.64 18.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.58 -39.59 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.99 -60.18 3.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.742 . . . . 0.0 109.638 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.464 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 2.0 pp -62.31 -34.07 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 109.239 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.45 -42.32 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.535 -0.728 . . . . 0.0 109.739 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -63.66 -43.81 95.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -49.0 -30.81 6.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.745 -0.597 . . . . 0.0 110.709 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 35' ' ' LYS . 3.5 mp0 -79.91 -44.23 20.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.066 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -70.26 -49.89 45.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.937 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -14.91 49.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.0 110.239 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.1 t -87.74 164.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -70.54 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.0 111.531 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -90.63 66.98 6.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 0.0 111.183 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.71 56.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.96 -22.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.131 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.6 p-80 -76.16 -47.14 25.33 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -72.89 -24.67 60.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.533 -0.729 . . . . 0.0 109.044 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -58.02 -49.17 77.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.44 -0.787 . . . . 0.0 109.053 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.57 -25.26 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.605 -0.684 . . . . 0.0 109.48 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.48 -62.92 1.36 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.327 -0.858 . . . . 0.0 110.268 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 80.6 m-85 -76.71 -25.21 53.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 110.847 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -74.27 -37.03 63.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.309 -0.869 . . . . 0.0 109.012 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -76.8 -31.65 57.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.372 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -85.49 -26.66 26.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -27.93 61.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.617 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -81.56 -45.78 15.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 109.937 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 65' ' ' VAL . 7.2 p -63.88 -34.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.464 -0.772 . . . . 0.0 109.756 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.6 mt -85.11 -28.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.5 -21.84 23.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.429 -0.794 . . . . 0.0 109.952 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -104.35 22.14 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 109.743 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.448 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.4 t80 -94.65 142.9 25.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 109.004 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.5 9.21 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.077 2.518 . . . . 0.0 110.991 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.428 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.8 m-70 -146.66 178.69 8.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.216 -0.927 . . . . 0.0 109.56 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -98.52 174.42 6.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.537 -0.727 . . . . 0.0 109.705 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 53' ' ' ILE . 60.8 mt -132.75 106.33 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.664 -0.648 . . . . 0.0 109.42 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.83 34.26 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -165.99 139.81 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 109.402 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.87 -40.37 95.45 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.88 -30.42 71.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.97 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.786 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.92 -30.53 31.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -74.72 -38.67 62.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.582 -0.698 . . . . 0.0 110.012 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -59.84 -25.89 65.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.143 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 11.1 mt -71.01 152.23 94.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 109.447 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.53 105.99 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 123.073 2.516 . . . . 0.0 110.289 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 -30.82 2.31 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.401 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 33.9 t -90.13 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.87 -147.67 12.5 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -98.55 -29.73 12.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 109.61 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.16 -58.63 3.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 42' ' ' ALA . 45.9 mm -61.82 -34.79 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.738 . . . . 0.0 109.626 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.35 91.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -60.55 -37.03 79.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.649 -0.657 . . . . 0.0 109.46 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.94 -31.4 72.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.367 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.8 mm -63.8 -46.16 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.89 -39.61 68.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.448 -0.782 . . . . 0.0 109.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.98 -31.85 73.19 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -52.56 37.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.573 0.702 . . . . 0.0 109.326 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.77 -23.15 60.77 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.87 -0.519 . . . . 0.0 110.11 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -0.807 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.29 -46.78 3.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 109.374 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.9 -53.6 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -170.04 -173.3 1.51 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.673 -0.898 . . . . 0.0 109.405 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.8 -179.91 4.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 109.572 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -95.75 164.77 12.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.503 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -115.76 -174.77 2.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.677 . . . . 0.0 109.378 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.56 75.29 5.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.55 -28.0 63.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.726 . . . . 0.0 109.664 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.476 179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -101.61 135.03 43.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.517 -0.739 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -64.14 151.56 42.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.539 -0.726 . . . . 0.0 109.479 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -128.08 -177.82 4.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 109.453 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.51 167.2 30.11 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.534 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.476 2.784 . . . . 0.0 110.554 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -87.72 82.1 7.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.554 -0.716 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -105.08 82.04 1.8 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.426 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -130.08 -44.17 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.708 . . . . 0.0 109.585 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.6 mt -84.31 -70.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 109.588 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -151.25 35.5 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.522 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.15 0.04 83.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.76 -34.85 7.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.94 -47.09 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.023 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -56.57 -31.43 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 109.862 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -65.0 -28.41 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.542 -0.724 . . . . 0.0 109.486 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mmt -89.9 -20.98 22.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.67 -33.89 21.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.33 -33.05 22.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.21 -61.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 HD13 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -62.54 -32.06 72.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.23 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.61 -45.85 66.74 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.485 -0.759 . . . . 0.0 109.68 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -63.79 -35.76 81.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -61.19 -26.04 67.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.758 -0.589 . . . . 0.0 109.935 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.88 -55.39 5.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.0 109.153 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 109.423 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.73 -25.1 64.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.416 -0.803 . . . . 0.0 109.455 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.0 t -89.07 164.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -69.32 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.466 -0.771 . . . . 0.0 111.297 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -85.29 62.13 7.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.95 55.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.58 -29.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.405 -0.809 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.36 -48.81 71.66 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.59 -23.01 62.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 109.462 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 24.7 t80 -55.25 -66.5 0.4 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 109.557 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.69 -24.27 21.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.451 -0.78 . . . . 0.0 109.923 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.19 -55.14 34.57 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.422 -0.799 . . . . 0.0 109.874 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.436 ' CG ' HD13 ' A' ' 22' ' ' LEU . 62.5 m-85 -89.97 -26.4 20.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.594 -0.691 . . . . 0.0 110.11 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -39.29 93.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.793 . . . . 0.0 109.109 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -85.83 -41.89 14.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.04 69.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.537 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.49 31.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.681 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -68.23 -48.95 63.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 109.898 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.8 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.0 109.822 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.2 mt -77.19 -27.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.469 -0.769 . . . . 0.0 109.937 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.473 -0.767 . . . . 0.0 110.072 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -120.26 27.05 8.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.7 t80 -82.49 139.92 44.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.88 10.64 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.096 2.531 . . . . 0.0 111.317 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.43 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.9 m-70 -146.61 169.0 19.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.681 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -96.44 148.57 22.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.2 mt -97.86 104.39 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -87.57 -40.87 13.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.656 -0.652 . . . . 0.0 109.565 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -112.38 155.37 24.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.734 . . . . 0.0 109.597 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.53 -27.57 66.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.91 71.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.431 -1.04 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -25.59 68.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.723 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.35 -26.63 26.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 109.846 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.97 -40.93 62.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.504 -0.748 . . . . 0.0 109.674 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -25.13 66.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 110.002 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 91.4 mt -58.46 137.72 85.57 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 109.928 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -80.85 109.74 2.26 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.055 2.503 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.78 -24.47 5.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.5 137.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.41 -1.053 . . . . 0.0 109.372 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.5 -147.97 23.47 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.9 p -98.98 -28.96 13.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.923 . . . . 0.0 109.696 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -65.41 -65.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.08 -39.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.747 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.99 86.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.25 -35.15 76.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.566 -0.709 . . . . 0.0 109.395 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -65.69 -31.09 71.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 109.258 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.3 mm -62.83 -44.76 99.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -57.47 -38.56 74.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.464 -0.772 . . . . 0.0 109.518 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.21 -27.14 69.15 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -49.61 31.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -73.84 -42.46 60.8 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.899 -0.501 . . . . 0.0 110.17 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -80.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.432 -0.793 . . . . 0.0 109.795 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.22 -70.14 0.67 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.0 53.3 0.7 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.98 87.97 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.999 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.4 tp -111.58 94.15 4.82 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -99.99 -67.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.717 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -146.52 82.68 1.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.374 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.1 mp -137.72 125.81 22.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.61 -0.681 . . . . 0.0 109.47 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -91.35 -49.98 6.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 pttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.496 179.97 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -104.73 -44.12 4.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -146.5 81.11 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mttt 59.64 83.04 0.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.488 -0.757 . . . . 0.0 109.763 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 111.74 4.87 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.71 -25.83 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.095 2.53 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -63.37 136.0 57.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.734 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.4 -169.51 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 t -123.3 31.58 5.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.682 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -75.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -100.06 65.25 1.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.21 0.94 79.17 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.55 -48.6 3.18 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.87 -52.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.858 -0.79 . . . . 0.0 109.675 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -57.91 -28.37 64.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 110.037 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.14 -38.26 88.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.73 . . . . 0.0 109.273 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.3 mmt -87.33 -10.18 52.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 110.184 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mt -87.86 -35.88 17.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.1 t -78.33 -31.09 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -69.55 -60.24 2.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.599 -0.688 . . . . 0.0 109.719 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 2.2 pp -63.15 -34.8 78.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.21 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.79 -40.78 60.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.569 -0.707 . . . . 0.0 109.647 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -63.86 -38.91 92.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.11 -22.31 65.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.47 -59.07 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.823 . . . . 0.0 109.038 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -67.48 -40.09 85.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.89 -24.7 58.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.35 -0.844 . . . . 0.0 109.688 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -89.4 164.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -70.15 0.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -88.06 67.61 8.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 0.0 110.296 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.71 40.27 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.667 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.33 -27.21 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.474 -0.766 . . . . 0.0 109.359 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -68.47 -50.89 49.06 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -25.89 66.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.51 -0.744 . . . . 0.0 109.242 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -53.31 -64.29 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.24 -0.912 . . . . 0.0 109.615 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -55.12 -25.46 31.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.75 -65.9 0.56 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.382 -0.824 . . . . 0.0 109.79 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.459 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 74.4 m-85 -72.34 -27.38 62.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.747 -0.596 . . . . 0.0 110.119 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -63.49 -46.1 87.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.447 -0.783 . . . . 0.0 109.393 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -65.85 -46.21 79.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.485 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.34 77.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.422 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.29 20.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -77.13 -59.84 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.47 -44.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.47 -0.769 . . . . 0.0 109.791 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.3 mm -63.18 -28.41 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.369 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.02 -18.7 25.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -116.31 26.8 9.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 3.3 t80 -88.55 135.66 32.25 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.511 -0.743 . . . . 0.0 109.023 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HG2' ' CD2' ' A' ' 51' ' ' HIS . 42.4 Cg_endo -85.55 10.41 3.72 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 123.148 2.565 . . . . 0.0 111.58 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.426 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.5 m-70 -148.82 -174.95 4.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.083 -1.011 . . . . 0.0 109.721 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 176.33 5.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.597 -0.689 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.7 pt -136.85 141.46 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.632 -0.668 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -121.83 25.99 8.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.654 -0.654 . . . . 0.0 109.646 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -170.41 150.59 3.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.788 . . . . 0.0 109.356 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -28.94 68.16 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.4 85.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -64.51 -20.39 66.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.63 -0.669 . . . . 0.0 109.918 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.0 -25.14 23.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.348 -0.845 . . . . 0.0 109.883 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -73.38 -41.0 63.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 109.735 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.23 -26.42 66.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.461 -0.775 . . . . 0.0 109.939 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 93.4 mt -55.95 134.65 73.54 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.71 102.55 1.4 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.931 2.42 . . . . 0.0 109.986 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.43 -26.26 2.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.38 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -1.052 . . . . 0.0 109.218 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.79 -156.54 25.35 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -87.96 -7.37 57.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.667 -0.902 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -90.21 -63.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.452 ' CD1' ' CE2' ' A' ' 39' ' ' TYR . 46.9 mm -67.26 -34.57 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.775 . . . . 0.0 110.445 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.76 -55.8 29.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.309 -0.869 . . . . 0.0 109.917 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -59.84 -31.49 69.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 109.512 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -59.96 -43.86 94.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 0.0 109.418 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 73' ' ' ILE . 65.1 mt -64.1 -29.91 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -56.04 -43.79 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.224 -0.922 . . . . 0.0 108.964 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -31.01 71.74 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -43.08 96.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.45 -24.89 31.63 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.086 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.428 -0.795 . . . . 0.0 109.786 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.6 m -110.71 -58.48 2.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.77 -49.68 0.92 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -158.68 -59.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.665 -0.903 . . . . 0.0 109.508 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.8 -173.79 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.438 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -77.34 97.31 4.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.566 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -134.86 160.7 37.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.488 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.45 124.53 13.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -72.06 162.5 29.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.711 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mttm . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.465 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -71.24 153.1 42.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 60.16 87.47 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.716 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -125.57 -43.63 1.88 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.484 -0.76 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.19 165.61 25.55 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 109.478 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.466 2.777 . . . . 0.0 110.511 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -88.55 -173.5 4.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.96 38.57 1.9 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.593 -0.692 . . . . 0.0 109.492 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.2 p -97.43 178.04 5.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.57 -0.706 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.74 -170.0 1.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.705 . . . . 0.0 109.497 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 m120 60.51 40.2 17.27 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.461 -0.774 . . . . 0.0 109.568 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.01 -10.37 64.64 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.07 -39.0 5.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.91 -50.7 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.88 -0.776 . . . . 0.0 108.952 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -59.36 -29.52 67.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.748 -0.595 . . . . 0.0 109.798 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.69 -34.58 77.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.629 -0.669 . . . . 0.0 109.22 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.8 mmm -89.61 -17.17 28.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.127 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.86 -35.63 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 108.489 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.58 -30.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.08 -60.52 2.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.724 . . . . 0.0 109.76 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 2.7 pp -62.87 -34.15 76.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.22 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.29 -44.15 61.8 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.626 -0.671 . . . . 0.0 109.917 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.34 -36.65 84.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 29' ' ' VAL . 34.9 t80 -63.72 -23.07 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.895 -0.503 . . . . 0.0 109.682 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.31 -57.74 3.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.346 -0.847 . . . . 0.0 109.106 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -67.01 -40.41 87.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.537 -0.727 . . . . 0.0 109.553 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.12 -25.59 61.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.433 -0.792 . . . . 0.0 109.659 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 25' ' ' PHE . 54.6 t -89.47 164.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.25 -69.77 0.51 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.485 -0.759 . . . . 0.0 110.937 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -85.32 62.15 7.31 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.84 47.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.34 -28.6 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.0 109.378 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.3 p-80 -64.59 -48.55 74.54 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.49 -25.78 64.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.616 -0.678 . . . . 0.0 109.347 179.274 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.0 t80 -52.48 -60.72 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.304 -0.872 . . . . 0.0 109.796 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.83 -26.88 64.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.91 -65.22 0.65 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.411 -0.806 . . . . 0.0 109.77 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 62.4 m-85 -76.38 -26.15 55.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.675 -0.641 . . . . 0.0 110.082 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -63.72 -52.11 61.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.466 -0.771 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.68 -45.69 81.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' CB ' ' CG2' ' A' ' 69' ' ' ILE . . . -62.98 -37.04 85.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.44 -25.52 68.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.918 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.26 -50.79 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 110.016 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 65' ' ' VAL . 7.7 p -62.79 -34.05 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 46' ' ' ILE . 74.4 mt -83.34 -41.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.23 -17.59 54.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.328 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.21 23.37 14.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.789 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.6 t80 -94.66 144.9 28.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.9 Cg_endo -86.43 4.82 6.2 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 123.128 2.552 . . . . 0.0 110.846 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.6 m-70 -146.61 -175.38 4.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -105.38 160.56 15.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.564 -0.71 . . . . 0.0 109.67 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.7 mt -101.71 131.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -77.89 -65.3 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.729 . . . . 0.0 109.719 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 p -114.26 174.97 5.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.43 83.73 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -34.28 76.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.946 . . . . 0.0 109.308 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.13 -23.28 65.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.677 . . . . 0.0 109.716 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.76 -28.69 26.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.428 -0.795 . . . . 0.0 109.666 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -74.49 -38.64 62.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -59.59 -26.44 65.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.755 . . . . 0.0 110.075 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 49' ' ' TYR . 53.7 mt -71.65 150.2 93.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.74 106.31 2.17 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.024 2.483 . . . . 0.0 110.313 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.35 -29.44 2.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 36.0 t -89.72 146.0 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -1.004 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.72 -145.77 15.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.4 p -100.15 -39.79 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.895 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -73.43 -44.66 57.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.635 -0.666 . . . . 0.0 109.725 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.403 ' CG2' ' CB ' ' A' ' 42' ' ' ALA . 43.8 mm -69.62 -38.6 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.64 -41.66 91.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 109.656 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.64 -38.54 85.13 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.481 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -62.28 -30.22 70.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.604 -0.685 . . . . 0.0 109.368 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.0 mm -64.32 -45.51 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -54.84 -40.65 69.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.49 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -53.16 36.68 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.509 0.671 . . . . 0.0 109.308 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.56 -22.3 61.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.948 -0.47 . . . . 0.0 110.14 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.08 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 t -126.48 -42.32 1.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.406 -0.809 . . . . 0.0 109.623 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.29 -46.48 0.84 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.4 tttt -132.33 79.3 1.85 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 109.554 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.6 tp -113.05 93.95 4.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -74.92 138.62 42.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -165.07 97.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.705 . . . . 0.0 109.396 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.27 -73.99 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.422 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -109.54 158.83 17.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 pttp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.471 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -159.48 94.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.685 . . . . 0.0 109.436 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -158.26 30.84 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.568 -0.708 . . . . 0.0 109.435 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -79.68 147.24 32.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.591 -0.693 . . . . 0.0 109.506 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.75 168.42 8.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.723 . . . . 0.0 109.455 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.55 123.75 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.498 2.799 . . . . 0.0 110.483 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -166.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -79.07 155.81 28.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.606 -0.683 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.3 p -99.87 -175.83 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.595 -0.691 . . . . 0.0 109.455 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.25 -69.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -76.0 73.74 2.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.643 -0.661 . . . . 0.0 109.525 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.19 0.96 79.26 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.71 -32.76 8.93 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.6 mt -74.89 -59.08 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.764 -0.845 . . . . 0.0 109.334 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 t -51.8 -32.41 31.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.756 -0.59 . . . . 0.0 110.553 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.46 -26.21 64.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.8 mtp -90.02 -21.32 22.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.956 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.65 -33.89 17.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.25 -34.75 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -68.34 -60.2 2.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.656 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 39' ' ' TYR . 3.8 pp -60.82 -35.2 75.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 109.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.68 -42.1 56.48 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.666 -0.646 . . . . 0.0 109.739 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.16 -36.12 83.02 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -65.69 -24.77 67.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.888 -0.507 . . . . 0.0 109.676 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.8 -57.79 3.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.388 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -66.14 -41.94 89.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.0 109.58 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -57.3 -24.7 56.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.4 -0.813 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -89.66 164.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.6 t -77.19 -70.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 110.876 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -85.05 66.75 9.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.471 -0.768 . . . . 0.0 110.734 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.63 29.18 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.89 -21.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.59 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.42 ' CD2' ' HE2' ' A' ' 35' ' ' LYS . 6.4 p-80 -76.09 -49.85 16.28 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -67.62 -26.46 66.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.57 -51.62 67.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.03 -28.13 68.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 0.0 109.532 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.46 -62.32 1.8 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 22' ' ' LEU . 66.0 m-85 -78.5 -1.42 33.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.912 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 -87.14 -36.27 18.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -81.1 -46.62 14.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.78 98.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.589 -0.695 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.86 -26.06 64.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.639 -0.663 . . . . 0.0 109.762 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -80.57 -28.93 37.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.783 . . . . 0.0 109.906 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 p -90.0 -44.71 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.417 -0.802 . . . . 0.0 109.924 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.71 -52.27 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 109.587 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.65 -21.08 62.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -118.1 28.74 8.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.452 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.0 t80 -89.56 145.68 34.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.0 Cg_endo -85.97 2.11 7.64 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.101 2.534 . . . . 0.0 110.979 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.2 m-70 -144.06 -179.35 6.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -105.93 139.68 40.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.0 mt -77.12 106.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.605 -0.684 . . . . 0.0 109.356 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.8 mttt -72.36 -69.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.55 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -102.53 174.65 5.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.556 -0.715 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.36 -28.96 71.87 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.86 -30.38 70.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -1.008 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.28 -27.61 67.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.651 -0.655 . . . . 0.0 109.628 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.92 -28.85 22.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -75.57 -39.04 58.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.475 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -60.51 -24.16 65.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.502 -0.749 . . . . 0.0 110.039 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 81.7 mt -60.84 140.92 93.32 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.426 -0.796 . . . . 0.0 109.545 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.29 107.18 1.99 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.983 2.456 . . . . 0.0 110.14 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.87 -25.38 4.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.8 t -89.55 138.52 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.978 . . . . 0.0 109.432 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.26 -139.65 9.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.39 -29.49 12.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.94 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -67.42 -64.6 0.82 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -61.42 -41.97 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 0.0 109.789 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.64 -35.35 74.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.543 -0.723 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.72 -41.59 95.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.511 -0.743 . . . . 0.0 109.516 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -62.04 -30.4 70.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.615 -0.678 . . . . 0.0 109.31 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -63.16 -47.23 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.11 -31.54 65.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 109.606 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.7 -30.67 70.23 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -74.2 -50.79 17.69 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.582 0.705 . . . . 0.0 109.592 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.33 -27.42 62.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.908 -0.495 . . . . 0.0 109.95 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.44 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.81 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -104.83 -62.05 1.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.45 -48.27 0.86 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -146.92 -172.98 4.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.941 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 pp -158.49 45.47 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.567 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -62.89 148.41 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.575 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -105.82 -173.71 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.718 . . . . 0.0 109.424 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 mt -113.6 -59.92 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.545 -0.722 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.0 -179.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.553 -0.717 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 118.058 -0.973 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 118.56 27.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.659 -0.651 . . . . 0.0 109.469 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -130.1 89.57 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -172.9 36.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.06 167.07 40.0 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.541 -0.724 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.38 145.55 8.29 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.511 2.807 . . . . 0.0 110.494 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -89.28 116.83 27.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.642 -0.661 . . . . 0.0 109.415 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.5 151.89 28.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -129.95 33.15 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.519 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.69 -74.05 0.66 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 109.366 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -131.06 41.53 3.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.66 -2.17 90.61 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.3 -41.49 5.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mt -66.11 -50.56 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.893 -0.769 . . . . 0.0 109.072 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -58.08 -31.17 66.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.698 -0.626 . . . . 0.0 109.963 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.15 -36.03 76.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 109.381 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtt -87.54 -14.55 39.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.609 -0.682 . . . . 0.0 110.135 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.2 -42.55 13.72 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.12 -31.62 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.21 -64.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.1 pp -62.07 -33.73 74.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.11 -42.5 63.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.86 -36.51 84.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -63.73 -22.76 67.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -77.48 -57.63 3.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.099 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 71.6 tttt -67.79 -39.48 84.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.51 -0.743 . . . . 0.0 109.622 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.79 -25.7 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.403 -0.811 . . . . 0.0 109.605 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.36 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -70.09 0.48 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 0.0 110.98 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -85.12 62.11 7.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 110.407 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.81 53.64 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -0.822 . . . . 0.0 109.68 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.18 -30.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.795 . . . . 0.0 109.105 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.451 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.05 -48.43 76.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.451 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.66 -23.78 63.51 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 26.7 t80 -54.6 -67.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.22 -0.925 . . . . 0.0 109.694 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -54.74 -24.59 23.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 109.88 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.14 -65.36 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.459 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 58.2 m-85 -79.12 -29.31 43.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.587 -0.695 . . . . 0.0 109.851 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -65.36 -46.34 80.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.486 -0.759 . . . . 0.0 109.456 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -70.59 -40.57 73.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.499 -0.751 . . . . 0.0 109.661 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.88 -39.56 79.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.602 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.01 -28.17 69.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -70.84 -51.29 27.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.67 -44.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 46' ' ' ILE . 73.2 mt -67.17 -29.45 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.448 -0.783 . . . . 0.0 109.971 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.05 -13.85 35.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.429 -0.795 . . . . 0.0 110.538 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -123.26 27.99 7.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 2.2 t80 -85.24 143.69 39.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.196 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.24 3.87 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.052 2.502 . . . . 0.0 111.066 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -145.01 -177.72 5.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.645 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 160.8 17.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.7 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 pt -123.41 153.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 109.318 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -137.73 28.58 2.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.511 -0.743 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 t -170.3 151.52 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.02 -28.1 69.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.92 72.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.464 -1.021 . . . . 0.0 109.695 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.66 -14.43 61.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.614 -0.679 . . . . 0.0 110.355 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.11 -29.72 18.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -29.52 55.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.555 -0.716 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 80.9 mt -61.77 146.17 91.13 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.21 113.13 3.14 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.0 2.466 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.36 -28.54 5.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 t -89.9 138.48 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -1.023 . . . . 0.0 109.392 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -139.75 9.23 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 t -98.87 -28.59 13.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.958 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -67.9 -65.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.47 -0.769 . . . . 0.0 109.503 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.5 mm -61.34 -41.67 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.828 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.05 73.66 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.582 -0.699 . . . . 0.0 109.736 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -61.86 -40.38 95.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.48 -0.762 . . . . 0.0 109.526 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -62.79 -32.68 73.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.0 109.285 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.469 HG23 HD13 ' A' ' 73' ' ' ILE . 47.7 mm -64.14 -42.43 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.79 -40.83 73.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.487 -0.758 . . . . 0.0 109.732 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.5 -29.62 70.86 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.43 -52.7 24.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.538 0.685 . . . . 0.0 109.37 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.23 -24.9 61.45 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.926 -0.484 . . . . 0.0 110.054 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -113.95 -53.0 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.71 -55.31 0.76 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -102.29 137.34 40.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.983 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 mt -92.84 80.42 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.513 -0.742 . . . . 0.0 109.449 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -100.14 -62.51 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.616 -0.677 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -132.75 47.56 2.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.517 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.08 133.7 47.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.53 -0.731 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -153.32 -176.77 5.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.603 -0.685 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.514 -179.922 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mttp 59.76 95.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -0.754 . . . . 0.0 109.763 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 59.55 -175.64 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.715 . . . . 0.0 109.726 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -132.58 150.02 52.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.96 172.83 6.32 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.685 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.5 -165.53 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.424 2.749 . . . . 0.0 110.521 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.06 161.99 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.502 -0.749 . . . . 0.0 109.477 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -138.15 40.04 2.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.7 p -110.62 37.45 2.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.518 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -66.86 -69.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -98.18 39.88 1.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.342 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.55 84.46 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.85 -33.82 8.1 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.42 -42.1 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.879 -0.777 . . . . 0.0 109.245 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -60.73 -30.89 70.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.66 -0.65 . . . . 0.0 109.761 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -39.23 93.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.711 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.6 mtm -83.04 -19.31 37.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.648 -0.658 . . . . 0.0 109.87 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -80.35 -37.54 32.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.416 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.67 -28.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -66.57 -68.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.12 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.427 HD11 ' CE1' ' A' ' 39' ' ' TYR . 2.3 pt? -57.55 -31.0 65.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.939 -1.1 . . . . 0.0 109.491 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.42 68.74 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -62.1 -25.47 67.73 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.5 -57.66 3.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.557 -0.714 . . . . 0.0 109.665 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -67.22 -41.61 85.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.556 -0.715 . . . . 0.0 109.524 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.07 -25.18 58.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -89.53 164.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.1 t -78.02 -70.13 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.485 -0.759 . . . . 0.0 111.009 -178.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -82.93 61.63 6.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.77 45.34 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 179.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -27.76 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.463 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 6.1 p-80 -70.21 -49.86 45.85 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.463 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.79 -18.82 62.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.344 -0.848 . . . . 0.0 109.393 178.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 16.7 t80 -59.45 -63.9 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 108.933 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -55.08 -24.11 23.83 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.722 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.96 -65.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.427 ' CE1' HD11 ' A' ' 22' ' ' LEU . 34.5 m-85 -80.59 -31.07 36.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.854 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -48.79 78.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.819 . . . . 0.0 109.814 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -72.8 -35.84 67.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 0.0 109.855 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.08 -49.91 63.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.472 -0.767 . . . . 0.0 109.781 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.44 -26.47 66.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.47 -0.769 . . . . 0.0 109.855 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -71.67 -58.88 3.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.54 -43.44 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -68.17 -27.67 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.37 -25.46 29.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.825 . . . . 0.0 109.806 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -107.05 28.13 8.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 3.6 t80 -93.35 139.48 22.96 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.23 11.54 3.28 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.104 2.536 . . . . 0.0 111.354 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.22 176.77 9.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -102.13 144.26 30.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.547 -0.72 . . . . 0.0 109.636 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.7 mt -82.67 122.1 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.622 -0.674 . . . . 0.0 109.223 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -81.02 -60.8 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -126.24 -179.96 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.19 -27.4 65.1 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.08 95.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -1.081 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.7 -20.88 63.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.588 -0.695 . . . . 0.0 109.971 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.24 -24.86 25.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 109.895 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -70.34 -43.72 69.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.724 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -60.81 -28.72 68.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.773 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 97.4 mt -56.8 130.47 78.3 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.552 -0.717 . . . . 0.0 109.978 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.69 102.15 1.52 Allowed 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.833 2.356 . . . . 0.0 110.11 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.15 -27.74 1.85 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 t -89.57 138.3 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.545 -0.973 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.56 -143.76 13.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.0 t -98.64 -27.18 14.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.94 . . . . 0.0 109.694 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -82.26 -41.47 20.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.551 -0.718 . . . . 0.0 109.7 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.9 mm -72.37 -41.82 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.738 . . . . 0.0 109.884 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.94 71.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -0.811 . . . . 0.0 110.057 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.33 -32.62 68.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -64.73 -33.13 75.25 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.58 -42.8 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.54 -35.53 72.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.695 . . . . 0.0 109.372 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.64 -30.79 71.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -48.99 64.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.514 0.673 . . . . 0.0 109.2 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.7 mm? -74.33 -26.42 60.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.061 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -80.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 0.0 109.698 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 p -127.11 -62.32 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.67 60.14 0.24 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -136.92 165.14 26.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.511 -0.993 . . . . 0.0 109.524 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt -141.67 97.86 3.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.537 -0.727 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -100.09 89.25 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.6 pttt -170.07 137.96 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.6 30.73 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.482 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -138.46 151.36 47.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.569 -0.707 . . . . 0.0 109.464 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 169.41 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.597 -0.689 . . . . 0.0 109.479 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 68.88 -69.59 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.524 -0.735 . . . . 0.0 109.683 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -110.29 128.8 55.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.762 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 160.39 44.45 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.48 52.47 2.79 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.397 2.731 . . . . 0.0 110.557 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -91.06 20.09 5.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.582 -0.699 . . . . 0.0 110.454 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -158.57 152.63 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 t -112.63 36.13 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.11 -168.74 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.601 -0.687 . . . . 0.0 109.284 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -70.06 77.12 0.5 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.703 . . . . 0.0 109.476 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.25 1.06 79.25 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -35.33 7.25 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.71 -57.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.858 -0.789 . . . . 0.0 108.957 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -56.19 -30.85 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.962 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -32.72 74.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.9 mmm -88.74 -17.67 29.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.741 -0.6 . . . . 0.0 109.944 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.34 -35.37 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.59 -30.82 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -69.97 -59.73 2.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.661 -0.649 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 3.3 pp -63.24 -33.73 76.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.16 -41.51 62.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.484 -0.76 . . . . 0.0 109.537 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -64.87 -37.53 87.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -63.49 -24.05 67.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' CG ' ' CG ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -74.12 -62.99 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.669 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 21.9 tttt -62.1 -41.95 98.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.876 -0.515 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -57.76 -23.94 54.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.772 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.81 165.11 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.4 t -76.01 -70.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.459 -0.776 . . . . 0.0 111.107 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -88.69 67.73 8.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.815 . . . . 0.0 110.675 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.1 38.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 109.666 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.69 -25.59 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.718 . . . . 0.0 109.589 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.472 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.99 -51.82 29.32 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.02 -19.34 63.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.739 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.2 t80 -57.15 -57.67 11.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.216 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.44 -26.77 66.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.655 -0.653 . . . . 0.0 109.469 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.98 -64.79 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.378 -0.826 . . . . 0.0 110.215 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 70.5 m-85 -74.01 -25.44 59.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 110.13 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -63.4 -47.73 80.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.357 -0.839 . . . . 0.0 109.316 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.42 -49.94 50.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.595 -0.691 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.95 -27.35 68.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 109.808 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.69 -28.22 62.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.938 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 p -84.81 -46.56 11.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 65' ' ' VAL . 8.1 p -64.2 -35.57 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 110.109 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 46' ' ' ILE . 66.8 mt -84.22 -37.05 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.951 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.61 -19.99 37.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.402 -0.811 . . . . 0.0 110.218 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -104.72 21.52 16.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.301 -0.875 . . . . 0.0 110.014 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.452 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.9 t80 -94.07 140.81 23.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -86.32 9.96 3.83 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.015 2.476 . . . . 0.0 111.071 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.429 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.18 -176.61 5.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.76 162.64 12.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.714 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.7 mt -107.52 144.76 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.616 -0.677 . . . . 0.0 109.195 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -91.6 -63.72 1.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 109.673 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.8 p -124.42 -179.86 4.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.502 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.24 -29.87 72.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -30.36 70.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.991 . . . . 0.0 109.491 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.13 -25.74 36.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.581 -0.699 . . . . 0.0 109.724 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.89 -33.62 24.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.477 -0.765 . . . . 0.0 109.562 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.526 -0.734 . . . . 0.0 109.974 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -59.68 -25.62 64.9 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.427 -0.796 . . . . 0.0 110.208 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 10.9 mt -70.8 152.01 95.16 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.491 -0.756 . . . . 0.0 109.464 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -77.94 103.02 1.64 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.106 2.538 . . . . 0.0 110.297 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.13 -30.4 2.02 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 38.2 t -89.98 140.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.588 -0.948 . . . . 0.0 109.44 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.06 -146.64 15.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -99.47 -36.16 9.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.968 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.05 -60.2 2.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.8 mm -61.74 -36.54 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.535 -0.728 . . . . 0.0 109.728 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.59 78.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -61.72 -39.6 92.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.093 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -62.58 -30.23 71.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.621 -0.674 . . . . 0.0 109.312 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.84 -45.13 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.63 -41.79 74.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.42 -28.75 70.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.13 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -52.47 18.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.378 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.75 61.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.972 -0.455 . . . . 0.0 110.086 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.23 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 109.543 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.9 m -107.55 -60.78 1.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.74 56.6 4.1 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -144.12 35.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.547 -0.972 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.73 104.93 8.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.499 -0.751 . . . . 0.0 109.459 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.3 mtm-85 -99.32 -41.75 7.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -73.32 151.87 41.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 mt -105.52 168.14 9.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -111.0 141.24 44.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.663 . . . . 0.0 109.53 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.489 -179.973 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt 60.12 36.27 21.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.559 -0.713 . . . . 0.0 109.734 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -108.86 -30.96 7.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.82 -81.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.731 -0.606 . . . . 0.0 109.721 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.24 148.06 98.18 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 0.0 109.441 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.03 -26.84 1.35 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.203 2.602 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -62.52 164.12 7.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.41 -0.806 . . . . 0.0 109.645 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.77 -166.21 0.64 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.697 -0.627 . . . . 0.0 109.319 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.699 . . . . 0.0 109.407 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.25 -164.55 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.437 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -88.66 53.3 2.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 0.39 78.12 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.09 -39.6 5.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.77 -41.87 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.874 -0.78 . . . . 0.0 109.202 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -59.65 -31.08 69.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.613 -0.679 . . . . 0.0 109.643 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -65.0 -33.53 76.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.1 mmt -90.13 -15.22 32.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.667 -0.646 . . . . 0.0 110.113 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -35.18 16.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 108.519 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.07 -31.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.3 -57.34 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.449 ' CD1' ' CG ' ' A' ' 39' ' ' TYR . 2.5 pp -63.27 -34.65 78.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.7 -44.78 63.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.55 -0.719 . . . . 0.0 109.791 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.91 -35.07 79.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -63.56 -24.66 67.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.854 -0.529 . . . . 0.0 109.898 179.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.25 -56.63 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.851 . . . . 0.0 109.31 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.0 ttpt -64.99 -41.37 95.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.497 -0.752 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -58.51 -26.69 63.74 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.823 . . . . 0.0 109.412 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.9 t -89.55 164.77 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.2 t -78.63 -70.16 0.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.454 -0.779 . . . . 0.0 111.093 -178.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -81.01 57.85 3.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.511 -0.743 . . . . 0.0 110.905 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.88 62.01 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.56 -28.87 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.195 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -63.35 -49.1 75.24 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -70.8 -25.99 63.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.594 -0.691 . . . . 0.0 109.312 179.375 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -51.35 -59.01 4.69 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.291 -0.88 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -61.37 -27.84 68.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.531 -0.731 . . . . 0.0 109.318 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.68 -65.96 0.52 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.461 -0.774 . . . . 0.0 109.953 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CG ' ' CD1' ' A' ' 22' ' ' LEU . 81.1 m-85 -71.27 -8.79 56.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 110.798 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -83.88 -54.41 4.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.119 -0.988 . . . . 0.0 109.3 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -61.07 -29.11 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.516 -0.74 . . . . 0.0 109.83 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.82 -47.17 15.61 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.529 -0.732 . . . . 0.0 109.575 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.24 67.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.879 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 -45.36 27.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.966 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 p -75.51 -44.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -0.777 . . . . 0.0 110.086 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.6 -55.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.53 -20.01 62.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -116.02 28.11 8.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 109.575 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.449 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.4 t80 -89.7 141.77 28.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -85.7 8.41 4.56 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.002 2.468 . . . . 0.0 110.998 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.429 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.7 m-70 -146.55 175.25 10.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 139.83 36.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.631 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 53' ' ' ILE . 60.5 mt -78.08 108.36 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.428 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -69.75 -40.34 76.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.821 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.3 m -148.55 -179.88 7.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.532 -0.73 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.33 -26.36 61.59 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.82 96.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.479 -1.012 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.58 -24.99 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.719 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.62 -27.67 27.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.415 -0.803 . . . . 0.0 109.733 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -75.9 -40.52 54.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -59.92 -22.4 62.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.446 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 86.5 mt -59.3 139.04 88.58 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 109.717 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.45 112.36 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.957 2.438 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.27 -28.52 5.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.78 138.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.932 . . . . 0.0 109.361 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.09 -139.52 10.17 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -99.22 -27.82 13.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.964 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -65.51 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.402 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.5 mm -61.94 -42.13 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 109.717 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.74 82.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.534 -0.729 . . . . 0.0 109.673 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.7 -35.75 77.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.514 -0.741 . . . . 0.0 109.53 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -68.9 -28.94 67.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.619 -0.676 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.17 -49.44 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 109.144 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.22 -40.61 74.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.454 -0.779 . . . . 0.0 109.694 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.01 -28.77 70.33 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.43 -51.65 27.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.64 -0.662 . . . . 0.0 109.294 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.65 -25.68 61.37 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.907 -0.496 . . . . 0.0 110.039 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.405 -0.809 . . . . 0.0 109.587 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -106.44 -54.75 2.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 109.407 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.56 3.19 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -170.17 155.01 5.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -1.016 . . . . 0.0 109.539 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 mt -103.91 99.27 9.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.552 -0.717 . . . . 0.0 109.359 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -66.82 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.701 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 144.58 25.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.59 -0.694 . . . . 0.0 109.541 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -99.99 123.57 44.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.48 166.43 10.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.423 -179.95 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -85.14 155.26 21.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.622 -0.674 . . . . 0.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 59.92 92.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -85.59 -51.64 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.73 163.46 15.68 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.619 -0.676 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.54 177.68 4.21 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.34 2.693 . . . . 0.0 110.505 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -89.13 81.74 6.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.589 -0.695 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.95 105.07 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.738 . . . . 0.0 109.359 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -91.94 85.56 5.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.538 -0.727 . . . . 0.0 109.58 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mt -68.37 -69.74 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 109.286 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -83.8 57.83 4.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.609 -0.682 . . . . 0.0 109.496 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.29 0.51 78.28 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -39.52 5.79 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' HA ' ' CE1' ' A' ' 76' ' ' PHE . 3.3 mt -68.21 -52.25 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.826 -0.808 . . . . 0.0 109.086 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -55.88 -33.98 65.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.737 -0.602 . . . . 0.0 110.175 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.36 -33.49 73.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.552 -0.718 . . . . 0.0 109.45 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt -86.88 -13.74 43.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.693 -0.629 . . . . 0.0 110.258 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.44 -35.71 21.09 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.54 -31.68 20.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.747 -0.595 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 3.6 pp -63.28 -33.05 74.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.08 -41.95 65.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -63.54 -37.77 88.58 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -62.69 -23.58 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.92 -0.487 . . . . 0.0 109.707 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -77.34 -57.58 3.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.067 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 13.6 tttt -66.47 -41.35 89.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -58.12 -25.27 61.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.732 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -89.43 164.35 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 t -77.01 -70.25 0.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 110.925 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -84.54 61.7 6.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 110.638 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.79 52.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.759 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.98 -28.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.372 -0.83 . . . . 0.0 109.061 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.9 p-80 -65.27 -49.26 70.26 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -69.15 -22.06 63.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.675 . . . . 0.0 109.569 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 26.8 t80 -56.9 -64.59 0.83 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -55.96 -25.02 41.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 109.772 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.71 -64.87 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.441 -0.787 . . . . 0.0 110.053 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 45.7 m-85 -81.7 -25.76 35.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.667 . . . . 0.0 110.282 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 tpt85 -62.11 -44.47 96.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.8 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -78.0 -42.58 32.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.796 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.97 -29.74 71.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 109.662 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.64 -31.71 57.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -75.49 -41.31 55.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.88 -44.25 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.478 -0.764 . . . . 0.0 110.032 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 46' ' ' ILE . 69.9 mt -73.41 -27.95 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.471 -0.768 . . . . 0.0 109.853 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.41 -23.3 43.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -116.64 28.14 8.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.455 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.1 t80 -88.1 142.48 31.95 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -85.63 6.78 5.41 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.063 2.509 . . . . 0.0 111.177 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.426 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -145.67 170.77 15.81 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -98.26 135.95 39.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.551 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -73.06 120.66 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.572 -0.705 . . . . 0.0 109.271 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -82.16 -49.64 9.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.543 -0.723 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.48 -179.81 5.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.607 -0.683 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.42 -27.72 71.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.01 96.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.589 -0.948 . . . . 0.0 109.681 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -20.79 63.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.836 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.87 -26.4 22.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.397 -0.815 . . . . 0.0 109.644 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -74.01 -39.92 63.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.504 -0.747 . . . . 0.0 109.71 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.19 -25.86 65.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.55 -0.719 . . . . 0.0 110.01 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.446 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 84.3 mt -59.21 144.64 82.89 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.503 -0.748 . . . . 0.0 109.714 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -79.1 112.61 3.09 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.021 2.481 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.13 -28.57 6.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.7 139.6 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 109.343 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.43 -137.61 7.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 p -99.1 -29.34 12.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.601 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -65.92 -65.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.482 -0.761 . . . . 0.0 109.587 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.7 mm -61.78 -42.78 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.818 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.89 70.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.7 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.43 -43.22 99.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -62.22 -28.45 69.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.315 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.48 -44.52 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.41 -41.3 76.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.474 -0.766 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.07 -27.54 69.47 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -71.46 -52.09 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 0.0 109.409 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.22 -26.68 63.03 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.949 -179.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 109.527 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 -66.63 1.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.416 -0.803 . . . . 0.0 109.272 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.25 41.91 98.49 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.19 -52.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.692 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -108.6 123.51 49.05 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -65.84 143.24 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.676 . . . . 0.0 109.455 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.74 19.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 109.491 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.14 -176.41 1.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.98 80.24 1.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.6 -0.687 . . . . 0.0 109.49 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.6 tptp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.386 -179.906 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -78.29 -35.45 47.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.12 -82.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -145.53 143.23 29.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.85 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.89 159.72 84.53 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.451 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.5 -168.94 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.412 2.741 . . . . 0.0 110.575 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -84.87 99.48 10.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.632 -0.668 . . . . 0.0 109.48 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -149.78 30.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.602 -0.686 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 p -86.15 145.25 27.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.685 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mt -83.15 -170.31 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.725 . . . . 0.0 109.415 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.3 m120 58.37 29.84 18.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.493 -0.754 . . . . 0.0 109.921 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 -17.22 54.09 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.25 -38.43 5.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.08 -49.52 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.836 -0.802 . . . . 0.0 109.155 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -57.48 -35.01 69.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.055 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -59.74 -35.53 74.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.458 -0.776 . . . . 0.0 109.471 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 tpp -90.35 -11.88 39.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.163 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.48 -32.62 19.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.702 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.3 t -85.57 -36.54 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HA ' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -67.04 -47.24 71.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.463 ' CD1' ' CD1' ' A' ' 39' ' ' TYR . 1.9 pp -73.82 -34.97 64.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 108.437 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.82 -49.9 67.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.675 . . . . 0.0 109.81 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -62.4 -33.02 73.94 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -64.52 -21.33 66.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.714 -0.616 . . . . 0.0 109.609 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 -57.81 3.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.366 -0.834 . . . . 0.0 108.85 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.1 tmtt? -66.81 -39.79 87.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 109.426 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -58.7 -26.4 63.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.791 . . . . 0.0 109.603 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.1 t -89.44 164.41 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -70.01 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.768 . . . . 0.0 111.012 -178.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -84.64 60.34 6.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 110.687 -178.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.91 63.96 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.12 -31.02 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.812 . . . . 0.0 109.008 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.402 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -60.88 -48.8 80.15 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.426 -0.796 . . . . 0.0 108.904 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -69.92 -26.02 63.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.645 -0.659 . . . . 0.0 109.544 179.339 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.3 t80 -51.54 -65.56 0.54 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -57.61 -25.06 59.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.42 -67.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 74.8 m-85 -72.32 -24.65 61.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.64 -0.663 . . . . 0.0 110.268 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 -62.54 -42.3 99.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -75.12 -44.53 46.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.504 -0.747 . . . . 0.0 109.801 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.26 98.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 109.652 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -29.45 70.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.793 . . . . 0.0 109.524 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -70.78 -34.67 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.72 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.14 -45.35 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 110.121 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 46' ' ' ILE . 69.7 mt -66.74 -55.64 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.0 109.723 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.25 -19.92 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -118.05 28.08 8.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.763 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.449 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 1.6 t80 -91.05 139.84 25.85 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -85.09 6.95 5.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.034 2.489 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.423 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.7 m-70 -147.14 172.52 13.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.168 -0.957 . . . . 0.0 109.536 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -98.61 144.05 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.553 -0.717 . . . . 0.0 109.512 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -75.28 108.85 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 109.36 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -71.18 -46.57 61.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.657 -0.652 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.9 173.43 11.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.08 -28.43 68.91 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.44 71.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.654 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.36 -24.18 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.556 -0.715 . . . . 0.0 109.848 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.38 -29.31 24.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.41 -0.806 . . . . 0.0 109.587 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -76.22 -38.82 55.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.543 -0.723 . . . . 0.0 109.629 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -60.32 -23.67 64.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 0.0 110.06 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 49' ' ' TYR . 57.9 mt -60.94 141.29 93.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.515 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.54 107.91 2.22 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.939 2.426 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.9 -28.78 3.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 t -89.79 138.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -1.02 . . . . 0.0 109.379 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.7 -137.38 8.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -98.91 -26.69 14.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.598 -0.943 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -69.93 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.42 -45.08 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.733 . . . . 0.0 109.804 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.11 68.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.469 -0.77 . . . . 0.0 109.831 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.95 -43.55 98.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.732 . . . . 0.0 109.312 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -63.43 -29.65 70.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.673 . . . . 0.0 109.266 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.17 -46.42 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.67 -40.72 72.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.531 -0.731 . . . . 0.0 109.647 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.58 -28.72 70.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -52.31 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.56 -0.712 . . . . 0.0 109.36 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -72.68 -25.67 61.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.932 -0.48 . . . . 0.0 110.005 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.93 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -58.19 1.93 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.451 -0.781 . . . . 0.0 109.435 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.66 37.32 4.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -170.07 179.24 3.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.541 -0.976 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 mt -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 0.0 109.461 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.05 100.65 11.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.735 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -139.21 76.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.87 161.47 30.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.422 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.54 35.73 2.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.517 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 tttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.442 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.16 6.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.844 HG22 ' CD1' ' A' ' 19' ' ' LEU . 4.1 mt -65.98 -55.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.853 -0.792 . . . . 0.0 109.021 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -51.49 -31.5 23.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 110.345 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.91 -29.36 70.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.587 -0.696 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.56 ' O ' HD23 ' A' ' 22' ' ' LEU . 14.7 mmt -88.87 -20.09 25.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 0.0 109.869 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.844 ' CD1' HG22 ' A' ' 15' ' ' ILE . 2.5 mp -89.28 -33.54 16.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' THR . 51.5 t -75.06 -34.33 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -59.44 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 0.0 109.308 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.995 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.0 pp -61.56 -30.66 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -55.41 -40.2 71.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 109.139 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.82 -35.84 82.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.3 t80 -64.14 -24.61 67.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.847 -0.533 . . . . 0.0 109.646 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.576 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -74.42 -61.21 1.94 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.543 -0.723 . . . . 0.0 109.292 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.9 tmtm? -63.47 -41.98 98.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.698 -0.626 . . . . 0.0 109.601 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.8 -23.88 54.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' PHE . 50.1 t -89.83 164.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.7 t -75.4 -70.21 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.982 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -89.64 68.18 7.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.46 -0.775 . . . . 0.0 110.702 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.92 44.16 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.617 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -92.44 -26.77 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.46 -49.69 52.54 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.5 -19.87 62.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.755 . . . . 0.0 109.271 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.4 t80 -57.67 -60.13 4.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 34' ' ' HIS . 12.1 p30 -57.96 -28.05 63.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.552 -0.717 . . . . 0.0 109.591 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.03 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -49.76 -63.09 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.612 -0.68 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.995 ' CG ' HD11 ' A' ' 22' ' ' LEU . 58.6 m-85 -80.41 -23.21 40.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.781 -0.574 . . . . 0.0 110.488 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -45.37 94.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.687 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -78.9 -46.73 17.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.871 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.826 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.16 -29.68 70.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.542 -0.724 . . . . 0.0 109.789 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.14 -30.03 54.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 t -79.03 -42.81 25.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.926 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 62' ' ' LEU . 10.6 p -69.18 -44.35 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.021 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.556 HG13 HG13 ' A' ' 45' ' ' VAL . 71.0 mt -73.23 -26.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 109.953 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.42 -20.24 37.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.68 26.54 8.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.872 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.504 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.5 t80 -80.75 140.97 51.13 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.516 -0.74 . . . . 0.0 109.037 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.4 Cg_endo -85.28 7.31 5.2 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.039 2.493 . . . . 0.0 111.172 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.0 179.59 7.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.893 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -109.71 169.03 8.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 109.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 58' ' ' GLU . 11.9 pt -131.3 156.04 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -140.1 28.76 2.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -170.17 155.25 5.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 109.398 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.21 -30.3 77.1 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.3 93.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.971 . . . . 0.0 109.472 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.482 ' HB3' HG22 ' A' ' 53' ' ' ILE . 5.3 mt-10 -61.37 -21.99 64.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.973 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -90.17 -26.6 20.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.33 -0.857 . . . . 0.0 109.772 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -74.61 -37.87 62.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 109.687 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -59.7 -26.77 65.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.52 -0.737 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.845 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.7 mt -60.4 146.09 85.22 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.56 -0.712 . . . . 0.0 109.599 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.5 109.81 2.54 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.7 -28.47 4.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 42' ' ' ALA . 26.1 t -89.82 138.34 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -1.01 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.29 -141.71 10.14 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 p -96.11 -30.6 13.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.537 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -65.35 -62.14 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.03 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.9 mm -61.63 -44.94 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.732 . . . . 0.0 109.722 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.54 69.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.759 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.91 -41.01 97.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.725 . . . . 0.0 109.405 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -65.49 -31.27 72.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.666 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.1 mm -63.47 -44.52 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -56.61 -40.35 75.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 109.605 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.06 -26.99 69.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 109.122 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -51.36 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.688 . . . . 0.0 109.462 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.39 -29.15 62.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.938 -0.476 . . . . 0.0 110.021 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.421 -0.8 . . . . 0.0 109.461 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.9 -37.57 6.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.759 HG22 HD12 ' A' ' 19' ' ' LEU . 1.6 mp -65.78 -43.07 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.811 -0.817 . . . . 0.0 109.102 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.684 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.2 t -57.63 -34.13 68.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.7 . . . . 0.0 109.942 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -31.77 73.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.6 mmm -89.44 -22.16 22.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 109.915 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.768 HD23 ' CD2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -83.43 -37.08 23.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 16' ' ' THR . 50.1 t -75.08 -29.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.49 -64.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -64.26 -30.47 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.5 -46.14 66.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.547 -0.72 . . . . 0.0 109.524 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -36.97 84.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 29' ' ' VAL . 27.0 t80 -62.48 -20.35 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.0 109.926 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -78.92 -57.78 3.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.336 -0.852 . . . . 0.0 109.038 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -68.71 -38.53 80.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.74 -26.77 64.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.752 . . . . 0.0 109.646 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 25' ' ' PHE . 79.1 t -89.4 164.17 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.97 -70.0 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 111.022 -178.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.0 60.87 6.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.04 66.62 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.83 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.16 -32.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 108.88 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.426 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -61.61 -48.61 80.13 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.273 -0.892 . . . . 0.0 108.735 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.54 -20.58 62.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CZ ' ' HG3' ' A' ' 40' ' ' ARG . 23.8 t80 -57.54 -69.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.27 -0.894 . . . . 0.0 109.607 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -52.94 -25.32 11.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.342 -0.849 . . . . 0.0 109.99 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.032 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.98 -55.43 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.482 -0.762 . . . . 0.0 109.859 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.01 ' CG ' HD11 ' A' ' 22' ' ' LEU . 44.7 m-85 -90.02 -29.72 18.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 110.116 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -63.05 -44.62 95.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -75.93 -41.83 50.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.588 -0.695 . . . . 0.0 109.594 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.803 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -62.72 -48.84 77.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.489 -0.757 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -62.11 -27.05 68.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.486 -0.759 . . . . 0.0 109.887 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -75.97 -50.61 14.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.46 -0.775 . . . . 0.0 110.045 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.0 p -66.95 -44.16 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.496 -0.752 . . . . 0.0 110.001 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.485 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.3 mt -68.18 -53.9 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.464 -0.772 . . . . 0.0 109.78 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.28 60.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.42 28.32 8.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.486 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.6 t80 -87.01 139.53 32.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.582 -0.698 . . . . 0.0 109.155 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.99 10.14 3.79 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.067 2.511 . . . . 0.0 111.253 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.3 m-70 -147.09 175.09 10.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 0.0 109.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -91.52 177.95 6.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.687 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.662 HG23 ' CB ' ' A' ' 58' ' ' GLU . 48.1 mt -121.83 118.44 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -75.08 -43.24 54.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.512 -0.743 . . . . 0.0 109.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 -179.5 7.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.692 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.46 -26.84 60.06 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.98 70.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.465 -1.02 . . . . 0.0 109.367 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.662 ' CB ' HG23 ' A' ' 53' ' ' ILE . 4.1 mp0 -73.24 -20.88 60.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.72 -0.612 . . . . 0.0 109.889 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.53 -26.52 24.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.89 . . . . 0.0 109.798 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -41.78 61.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -59.74 -24.49 64.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 110.02 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.83 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.5 mt -60.42 142.35 90.75 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.488 -0.758 . . . . 0.0 109.52 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.95 109.07 2.33 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.035 2.49 . . . . 0.0 110.253 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.77 5.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.563 HG22 ' HA ' ' A' ' 42' ' ' ALA . 22.0 t -89.53 137.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.435 -1.039 . . . . 0.0 109.39 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.07 -149.06 22.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -98.11 -29.9 12.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.591 -0.947 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -71.06 -44.49 65.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.622 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.032 HD11 ' HB1' ' A' ' 38' ' ' ALA . 40.6 mm -70.34 -44.96 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 0.0 109.811 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.12 87.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.0 109.739 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.47 -37.6 84.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.528 -0.732 . . . . 0.0 109.601 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -63.01 -32.47 73.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 109.392 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.78 -43.05 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -55.93 -41.1 74.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.735 . . . . 0.0 109.674 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.69 -29.37 70.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -52.53 22.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.697 . . . . 0.0 109.393 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.47 61.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.906 -0.496 . . . . 0.0 110.062 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -79.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.95 -37.96 5.89 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 73' ' ' ILE . 3.0 mp -78.88 -49.4 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.947 -0.737 . . . . 0.0 109.756 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.3 t -58.15 -33.81 69.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.24 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.402 ' O ' HD22 ' A' ' 22' ' ' LEU . 6.2 mtp -84.19 -16.23 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -81.1 -38.68 26.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 16' ' ' THR . 48.8 t -71.94 -28.96 31.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -64.52 -66.6 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.603 -0.686 . . . . 0.0 110.015 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.678 HD11 ' CE1' ' A' ' 39' ' ' TYR . 1.9 pt? -63.76 -33.83 76.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.549 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.36 -41.63 60.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.558 -0.714 . . . . 0.0 109.82 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.14 -38.38 85.42 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 29' ' ' VAL . 66.9 t80 -63.73 -26.09 68.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.745 -0.597 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.663 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.2 mp0 -75.97 -57.83 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 20.1 tttp -65.81 -42.22 90.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 0.0 109.507 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.44 -24.64 56.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.5 t -89.5 164.82 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 47.4 t -77.31 -70.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 111.072 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -83.53 63.12 7.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.696 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.84 38.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.43 -23.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -0.78 . . . . 0.0 109.523 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -73.87 -51.84 14.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.54 -19.88 63.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 109.164 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 18.9 t80 -59.35 -56.15 25.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 0.0 108.915 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -58.97 -26.72 64.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.747 . . . . 0.0 109.494 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.059 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -57.75 -67.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.459 -0.776 . . . . 0.0 109.822 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.678 ' CE1' HD11 ' A' ' 22' ' ' LEU . 20.6 m-85 -75.35 -28.67 59.66 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.579 -0.7 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 23.5 tpt180 -63.5 -52.63 60.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.499 -0.751 . . . . 0.0 109.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -62.28 -39.49 93.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.35 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.903 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -65.02 -39.5 93.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.563 -0.711 . . . . 0.0 109.106 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.2 65.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.449 -0.782 . . . . 0.0 109.704 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 m -82.96 -53.43 5.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.711 HG11 HG23 ' A' ' 65' ' ' VAL . 7.9 p -63.62 -42.5 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.491 -0.756 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.462 ' N ' HG13 ' A' ' 45' ' ' VAL . 48.3 mm -68.9 -36.85 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.777 . . . . 0.0 109.404 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.64 36.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.494 -0.754 . . . . 0.0 110.31 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -101.02 15.8 27.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.487 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.456 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 4.2 t80 -96.8 133.63 24.17 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -86.57 14.94 2.31 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.198 2.599 . . . . 0.0 111.784 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.414 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.8 m-70 -148.11 175.02 11.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 109.893 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 159.84 14.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.695 . . . . 0.0 109.536 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 58' ' ' GLU . 9.1 mt -98.15 137.22 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -86.0 -47.9 9.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.704 . . . . 0.0 109.649 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 p -136.53 179.58 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.661 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.17 78.46 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.11 71.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.983 . . . . 0.0 109.413 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.695 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.6 mt-10 -70.21 -21.58 63.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.619 -0.676 . . . . 0.0 109.884 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.714 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -80.71 -32.73 35.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 18.0 ttpp -74.43 -38.85 62.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.555 -0.716 . . . . 0.0 110.114 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -59.98 -26.69 66.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' A' ' 59' ' ' ALA . 8.2 mt -71.29 148.44 93.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.363 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.28 106.21 2.11 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.05 2.5 . . . . 0.0 110.351 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.04 2.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.711 HG23 HG11 ' A' ' 45' ' ' VAL . 28.8 t -89.73 139.66 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.993 . . . . 0.0 109.385 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.41 -147.21 21.98 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -30.59 11.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.601 -0.94 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -82.51 -41.7 19.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.658 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.059 HD11 ' HB1' ' A' ' 38' ' ' ALA . 42.8 mm -72.18 -39.89 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.469 -0.769 . . . . 0.0 109.742 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.27 -51.91 67.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.494 -0.754 . . . . 0.0 109.778 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.35 -32.13 68.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.441 -0.787 . . . . 0.0 109.471 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -63.15 -34.51 77.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 15' ' ' ILE . 46.7 mm -64.33 -38.7 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.37 -40.17 74.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.48 -0.763 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.19 -30.57 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -52.47 36.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.282 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.28 -25.2 60.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.903 -0.498 . . . . 0.0 110.165 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.99 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.291 -0.881 . . . . 0.0 109.769 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.74 -43.52 4.48 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.806 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.9 mt -68.11 -44.36 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.943 -0.74 . . . . 0.0 109.406 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.726 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 5.0 t -58.32 -34.14 70.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.6 -0.687 . . . . 0.0 109.948 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.08 -34.44 77.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.27 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.511 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.0 mtt -89.9 -15.55 31.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.694 -0.629 . . . . 0.0 110.157 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.806 ' CD1' HG22 ' A' ' 15' ' ' ILE . 2.2 mt -88.19 -35.7 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 108.485 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 16' ' ' THR . 44.7 t -78.94 -31.4 14.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -70.45 -59.33 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.887 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.002 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.3 pp -63.92 -34.71 78.57 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.273 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.93 -42.22 62.63 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.593 -0.692 . . . . 0.0 109.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -63.68 -38.07 89.73 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.1 t80 -61.96 -23.76 66.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.818 -0.551 . . . . 0.0 109.82 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.6 mm-40 -76.88 -57.75 3.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.443 -0.786 . . . . 0.0 109.148 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 14.5 tttm -67.69 -41.12 84.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.537 -0.727 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -57.45 -25.41 59.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.383 -0.823 . . . . 0.0 109.733 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 63.8 t -89.27 164.23 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.62 -70.09 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.463 -0.773 . . . . 0.0 110.905 -178.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -82.79 59.92 5.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.465 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.72 63.57 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -109.7 -29.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 108.957 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -64.11 -49.08 73.63 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.01 -25.45 63.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.629 -0.669 . . . . 0.0 109.421 179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 40' ' ' ARG . 28.0 t80 -52.59 -64.12 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.246 -0.909 . . . . 0.0 109.799 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -57.42 -26.07 60.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.506 -0.746 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.057 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.16 -65.78 0.54 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.002 ' CG ' HD11 ' A' ' 22' ' ' LEU . 72.0 m-85 -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.636 -0.665 . . . . 0.0 110.039 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' HG2' ' HB1' ' A' ' 23' ' ' ALA . 9.1 mmm180 -67.16 -39.68 86.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.527 -0.733 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -72.69 -45.41 58.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -63.37 -40.99 98.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -66.65 -24.76 66.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.548 -0.72 . . . . 0.0 109.883 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -78.13 -36.27 48.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.976 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.812 HG21 ' HB3' ' A' ' 62' ' ' LEU . 13.5 p -90.01 -44.95 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.402 -0.811 . . . . 0.0 110.008 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.481 ' N ' HG13 ' A' ' 45' ' ' VAL . 69.8 mt -66.56 -56.03 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.726 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -60.41 -20.26 59.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.6 -0.687 . . . . 0.0 110.3 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 26.7 9.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.523 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.2 t80 -88.52 138.14 30.19 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.183 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.39 12.06 3.12 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.104 2.536 . . . . 0.0 111.342 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.411 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 68.2 m-70 -147.69 169.74 19.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -0.971 . . . . 0.0 109.743 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -105.46 141.18 37.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 0.0 109.664 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.662 HG22 ' HB3' ' A' ' 58' ' ' GLU . 17.4 pt -97.51 154.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -114.88 -29.96 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.595 -0.691 . . . . 0.0 109.807 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.43 165.35 23.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 109.625 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.83 -26.03 64.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.35 85.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -1.068 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.662 ' HB3' HG22 ' A' ' 53' ' ' ILE . 7.7 mt-10 -63.69 -19.08 64.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.71 -0.619 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -89.26 -26.4 21.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -38.52 63.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.763 . . . . 0.0 109.656 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -60.48 -26.45 66.81 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.812 ' HB3' HG21 ' A' ' 45' ' ' VAL . 51.9 mt -60.3 141.37 91.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.718 . . . . 0.0 109.563 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -80.02 112.65 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.931 2.421 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.06 -22.68 6.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.36 137.15 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -1.068 . . . . 0.0 109.373 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.07 -146.55 21.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 t -100.22 -30.32 11.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.635 -0.92 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -69.41 -45.33 69.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.552 -0.717 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.057 HD11 ' HB1' ' A' ' 38' ' ' ALA . 43.4 mm -72.85 -42.04 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.35 88.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -61.38 -36.35 80.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.563 -0.71 . . . . 0.0 109.448 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -64.45 -31.43 72.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.662 -0.649 . . . . 0.0 109.412 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.2 mm -63.53 -45.64 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -55.81 -39.72 71.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -64.47 -30.36 71.39 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -51.62 45.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.609 -0.682 . . . . 0.0 109.219 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.73 -25.24 60.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.896 -0.503 . . . . 0.0 110.057 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.403 -0.81 . . . . 0.0 109.54 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -36.29 6.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.8 mp -68.07 -47.9 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.886 -0.773 . . . . 0.0 109.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -60.3 -29.6 68.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.3 -32.79 74.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.593 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -90.0 -14.08 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.632 -0.667 . . . . 0.0 110.139 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 1.5 mt -88.8 -35.11 16.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 16' ' ' THR . 42.9 t -79.67 -31.8 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -70.11 -59.19 3.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.622 -0.674 . . . . 0.0 109.656 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.983 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.0 pp -63.02 -34.96 78.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 109.195 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.88 -42.16 62.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.541 -0.724 . . . . 0.0 109.76 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.2 -35.18 80.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.9 t80 -64.16 -27.16 68.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.846 -0.534 . . . . 0.0 109.582 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.651 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 38.3 mm-40 -78.58 -55.51 5.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.9 ttmt -63.8 -43.59 95.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.502 -0.749 . . . . 0.0 109.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.25 -24.52 59.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' PHE . 46.5 t -89.34 165.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 29' ' ' VAL . 42.5 t -76.81 -70.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.471 -0.768 . . . . 0.0 111.241 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -85.43 65.02 8.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.394 -0.816 . . . . 0.0 110.789 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.82 43.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.348 -0.845 . . . . 0.0 109.667 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -94.54 -23.39 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.777 . . . . 0.0 109.479 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.445 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 p-80 -70.86 -51.69 24.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.375 -0.828 . . . . 0.0 108.808 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.32 -25.41 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 29.0 t80 -53.21 -53.97 42.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.47 -27.43 69.28 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -56.02 -63.71 1.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.507 -0.746 . . . . 0.0 110.435 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.983 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.5 m-85 -71.59 -23.96 61.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.793 -0.567 . . . . 0.0 110.49 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.19 -55.63 23.46 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -62.72 -43.02 99.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 109.811 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.825 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -67.65 -27.73 67.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.577 -0.702 . . . . 0.0 109.801 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -72.2 -24.47 61.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 110.077 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.5 p -90.08 -49.91 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.284 -0.885 . . . . 0.0 110.025 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.778 HG11 HG23 ' A' ' 65' ' ' VAL . 7.4 p -60.87 -33.28 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.554 -0.717 . . . . 0.0 109.901 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.606 HG13 HG13 ' A' ' 45' ' ' VAL . 63.7 mt -87.02 -30.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.442 -0.787 . . . . 0.0 109.976 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -87.21 -18.22 30.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 0.0 110.311 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -112.97 25.88 11.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.579 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.0 t80 -89.91 140.03 27.63 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.419 -0.801 . . . . 0.0 109.125 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.76 12.0 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.113 2.542 . . . . 0.0 111.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.1 m-70 -146.38 170.86 15.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.92 . . . . 0.0 109.734 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -94.42 147.42 23.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.738 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 58' ' ' GLU . 11.0 mt -97.0 134.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -100.77 -57.94 2.0 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 109.587 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -105.22 159.94 15.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.25 -31.26 80.12 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.03 71.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.944 . . . . 0.0 109.377 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' A' ' 53' ' ' ILE . 18.4 tt0 -67.8 -22.35 65.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.644 -0.66 . . . . 0.0 109.806 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.619 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.17 -29.47 24.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.677 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 10.8 ttpp -75.63 -38.13 59.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.845 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -59.85 -24.25 64.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 110.219 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 49' ' ' TYR . 44.0 mt -69.07 151.09 97.34 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.521 -0.737 . . . . 0.0 109.458 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.34 99.94 1.28 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.029 2.486 . . . . 0.0 110.154 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.55 -27.54 1.94 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.778 HG23 HG11 ' A' ' 45' ' ' VAL . 38.5 t -89.68 138.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -1.009 . . . . 0.0 109.538 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -98.93 -146.89 21.19 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -100.1 -28.27 13.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.968 . . . . 0.0 109.726 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.21 -61.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 109.761 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.825 HG21 ' CB ' ' A' ' 42' ' ' ALA . 46.4 mm -65.13 -33.29 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.514 -0.741 . . . . 0.0 109.75 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -52.51 -57.49 9.78 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 110.22 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.15 -31.4 67.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 109.329 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.04 70.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 59' ' ' ALA . 44.6 mm -71.03 -43.87 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 108.978 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -52.36 -50.54 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.62 -30.26 70.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.42 -0.8 . . . . 0.0 109.142 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -42.47 93.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 77' ' ' LEU . 4.1 mm? -83.79 -22.74 31.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.184 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.34 -0.85 . . . . 0.0 109.645 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.86 -35.93 6.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.845 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.7 mp -67.82 -48.11 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.88 -0.776 . . . . 0.0 109.117 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -56.77 -28.09 60.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.605 -0.684 . . . . 0.0 109.899 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.54 -27.01 64.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.497 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.5 mmt -89.95 -19.45 24.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 109.966 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.3 mp -86.52 -33.65 20.23 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 16' ' ' THR . 48.7 t -76.23 -36.02 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -58.99 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.616 -0.678 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.97 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -63.06 -31.03 72.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.214 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.71 -41.42 61.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -0.772 . . . . 0.0 109.592 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -40.33 81.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.7 t80 -63.32 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.771 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -76.24 -56.85 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.228 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 24.4 ttpt -61.8 -46.92 87.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -0.788 . . . . 0.0 109.742 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -56.79 -22.46 36.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.367 -0.833 . . . . 0.0 109.93 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 25' ' ' PHE . 40.1 t -88.86 165.29 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 29' ' ' VAL . 42.6 t -76.98 -70.56 0.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 111.402 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -81.23 62.4 5.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.404 -0.81 . . . . 0.0 110.737 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.0 27.55 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -82.18 -30.82 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.448 -0.783 . . . . 0.0 108.921 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 8.2 p-80 -69.66 -44.68 70.01 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 1.6 ptpm? -75.75 -20.45 58.29 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 8.5 t80 -58.41 -58.23 9.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.312 -0.867 . . . . 0.0 108.794 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 34' ' ' HIS . 11.6 p30 -57.56 -28.8 63.88 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.561 -0.712 . . . . 0.0 109.328 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.086 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -50.42 -59.8 3.63 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.97 ' CG ' HD11 ' A' ' 22' ' ' LEU . 44.1 m-85 -82.09 -26.68 33.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.69 . . . . 0.0 110.143 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -40.55 96.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.366 -0.834 . . . . 0.0 109.698 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.5 mtpp -79.0 -49.98 11.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.879 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.764 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -61.6 -35.41 77.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 109.858 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.96 67.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.5 -0.75 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -80.02 -45.65 17.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.857 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.2 p -65.66 -43.05 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.57 -0.706 . . . . 0.0 109.942 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.553 HG13 HG13 ' A' ' 45' ' ' VAL . 75.7 mt -74.12 -33.56 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.439 -0.788 . . . . 0.0 109.911 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.18 -22.7 60.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.835 . . . . 0.0 110.114 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -120.52 26.56 9.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 0.0 109.73 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.503 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.6 t80 -81.78 141.45 47.91 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -86.03 9.11 4.18 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.044 2.496 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.1 m-70 -146.53 175.28 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.244 -0.91 . . . . 0.0 109.632 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -94.61 178.67 5.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.679 . . . . 0.0 109.688 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 58' ' ' GLU . 61.3 mt -135.14 104.43 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.58 -0.7 . . . . 0.0 109.337 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -90.18 -52.46 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.674 -0.641 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.8 p -96.15 150.5 20.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.03 -25.8 64.78 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.97 72.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -1.053 . . . . 0.0 109.624 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -64.89 -20.05 66.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.698 . . . . 0.0 109.769 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.79 -28.73 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -75.71 -38.47 58.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -59.94 -24.66 64.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.555 -0.716 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.857 ' HB3' HG21 ' A' ' 45' ' ' VAL . 85.9 mt -59.8 143.81 86.64 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.47 -0.769 . . . . 0.0 109.738 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.48 111.91 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.981 2.454 . . . . 0.0 110.143 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.78 -29.42 5.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -89.98 137.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.966 . . . . 0.0 109.251 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.23 -139.27 10.01 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -98.21 -28.4 13.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.952 . . . . 0.0 109.604 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -62.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 0.0 109.588 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.086 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.0 mm -62.2 -44.39 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.698 . . . . 0.0 109.735 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.11 83.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.735 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.84 -40.29 88.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.745 . . . . 0.0 109.568 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -63.49 -29.74 70.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.613 -0.68 . . . . 0.0 109.442 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.5 mm -63.5 -46.32 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.725 . . . . 0.0 109.164 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.81 -41.41 74.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.466 -0.771 . . . . 0.0 109.77 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.97 -27.2 69.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 109.206 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -51.62 19.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.9 -27.3 61.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.576 -0.449 . . . . 0.0 109.981 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.421 -0.799 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.406 -0.809 . . . . 0.0 109.323 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.535 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -50.0 5.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.8 mt -67.51 -46.25 83.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 47' ' ' ALA . 96.0 m -59.25 -29.12 67.31 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.626 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.05 -37.74 88.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.0 mtt -82.57 -17.94 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.22 -36.62 20.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 16' ' ' THR . 48.6 t -76.16 -31.65 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.64 -61.81 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.554 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.998 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.6 pp -64.31 -32.23 73.74 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.094 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.33 -43.35 67.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.582 -0.699 . . . . 0.0 109.54 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -63.72 -37.31 86.88 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.6 t80 -62.38 -23.45 66.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.543 . . . . 0.0 109.792 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.9 -57.74 3.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HD2' HD11 ' A' ' 33' ' ' ILE . 13.0 tptt -67.12 -40.5 86.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.617 -0.677 . . . . 0.0 109.675 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.5 -25.22 62.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.46 -0.775 . . . . 0.0 109.739 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 25' ' ' PHE . 57.8 t -89.4 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 29' ' ' VAL . 35.3 t -76.32 -70.45 0.45 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.518 -0.738 . . . . 0.0 110.974 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -85.92 63.48 8.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.49 -0.756 . . . . 0.0 110.586 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.85 49.0 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 109.741 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.58 HD11 ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -96.3 -28.94 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.418 -0.801 . . . . 0.0 109.332 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.42 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.2 -48.89 71.8 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.633 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.26 -23.62 63.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.685 -0.634 . . . . 0.0 109.438 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CZ ' ' HD3' ' A' ' 40' ' ' ARG . 28.3 t80 -54.87 -62.95 1.33 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.291 -0.88 . . . . 0.0 109.75 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.084 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.5 -59.48 4.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 0.0 110.076 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.998 ' CG ' HD11 ' A' ' 22' ' ' LEU . 35.4 m-85 -88.92 -29.61 19.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.815 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 36' ' ' TYR . 9.1 tpt180 -62.19 -43.21 99.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.53 -0.731 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -79.19 -38.03 36.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 109.695 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.694 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -67.33 -37.97 84.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.688 ' HB1' HG23 ' A' ' 16' ' ' THR . . . -70.83 -29.93 66.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.531 -0.731 . . . . 0.0 109.509 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -67.75 -55.51 12.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.098 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.827 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.3 p -60.35 -43.79 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.502 HG13 HG13 ' A' ' 45' ' ' VAL . 73.4 mt -71.0 -38.16 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.775 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.764 ' HB2' HG21 ' A' ' 16' ' ' THR . . . -64.2 -26.26 68.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.02 27.46 8.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.792 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.531 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 3.2 t80 -84.17 137.05 40.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.73 . . . . 0.0 109.256 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.3 Cg_endo -87.23 14.49 2.4 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 123.195 2.597 . . . . 0.0 111.392 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.4 m-70 -147.87 173.26 13.01 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.218 -0.926 . . . . 0.0 109.762 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -97.85 139.23 34.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 109.827 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.865 HD12 HG21 ' A' ' 73' ' ' ILE . 17.9 pt -103.88 67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.291 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -69.59 -15.1 63.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.9 m -116.19 139.52 50.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.24 -31.17 65.39 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.76 78.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.634 -0.921 . . . . 0.0 109.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' HB3' HG22 ' A' ' 53' ' ' ILE . 13.6 mt-10 -63.37 -23.02 67.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.673 -0.642 . . . . 0.0 109.831 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.06 25.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -74.42 -42.23 59.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.79 . . . . 0.0 109.615 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -59.28 -23.75 62.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.54 -0.725 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.827 ' HB3' HG21 ' A' ' 45' ' ' VAL . 83.5 mt -59.56 138.82 89.46 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.728 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.98 101.37 1.14 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.046 2.497 . . . . 0.0 110.007 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.86 -19.11 3.75 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 42' ' ' ALA . 33.3 t -89.31 138.42 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.329 -1.1 . . . . 0.0 109.302 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.44 -155.89 25.67 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -96.96 -27.02 14.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.967 . . . . 0.0 109.777 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -83.06 -38.09 22.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.496 -0.753 . . . . 0.0 109.667 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.084 HD11 ' HB1' ' A' ' 38' ' ' ALA . 38.1 mm -72.65 -42.22 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.434 -0.791 . . . . 0.0 109.868 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.84 76.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.781 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.12 -32.39 68.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -33.45 75.61 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.865 HG21 HD12 ' A' ' 53' ' ' ILE . 47.5 mm -63.47 -42.18 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -56.94 -36.84 70.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.629 -0.67 . . . . 0.0 109.588 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.93 -32.38 73.89 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -50.18 65.09 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.59 0.71 . . . . 0.0 109.159 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -74.01 -24.59 59.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.872 -0.517 . . . . 0.0 110.153 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.18 -34.15 7.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.7 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.6 mt -75.04 -49.34 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.856 -0.791 . . . . 0.0 109.353 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -58.9 -34.69 71.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.664 -0.648 . . . . 0.0 109.898 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -35.24 79.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 109.268 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttm -86.06 -22.95 26.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.626 -0.671 . . . . 0.0 109.779 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.7 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -79.07 -37.75 38.09 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' THR . 58.2 t -72.0 -28.82 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.21 -66.41 0.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.003 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' CZ ' ' A' ' 39' ' ' TYR . 2.2 pt? -64.73 -31.72 73.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -50.82 -40.7 56.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.555 -0.716 . . . . 0.0 110.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.64 69.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 29' ' ' VAL . 30.1 t80 -64.61 -27.21 68.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.729 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -78.36 -56.18 4.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.624 -0.673 . . . . 0.0 109.394 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 14.2 tttp -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -57.15 -25.59 59.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.465 -0.772 . . . . 0.0 109.471 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 25' ' ' PHE . 51.6 t -89.52 165.32 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -80.14 -67.48 0.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 111.211 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -78.85 57.87 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.901 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.03 28.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.27 -33.01 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -67.82 -44.69 76.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 16.3 ptpt -76.51 -16.98 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 4.7 t80 -61.89 -63.29 1.3 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -55.51 -26.13 41.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -0.751 . . . . 0.0 109.632 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.756 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.43 -58.1 9.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.478 -0.763 . . . . 0.0 109.654 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.55 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 27.9 m-85 -84.61 -27.99 26.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 109.674 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -63.15 -53.98 44.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 109.546 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.472 ' O ' HG12 ' A' ' 45' ' ' VAL . 6.6 mttm -67.57 -43.16 81.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.711 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.36 -29.7 70.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.544 -0.723 . . . . 0.0 109.552 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -74.32 -26.22 60.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.558 -0.713 . . . . 0.0 109.796 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -87.88 -48.5 7.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 109.993 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.915 HG22 HD13 ' A' ' 62' ' ' LEU . 7.9 p -61.68 -33.54 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.592 HG13 HG13 ' A' ' 45' ' ' VAL . 72.1 mt -85.8 -25.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.533 -0.729 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.46 -20.98 24.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -108.89 23.45 14.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.606 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.8 t80 -94.59 139.64 22.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 108.935 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.51 12.24 3.06 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.105 2.537 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -146.02 153.58 40.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 0.0 109.795 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -77.23 145.77 37.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 109.772 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.05 81.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -69.66 -27.78 65.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 p -121.52 145.86 47.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.452 -0.78 . . . . 0.0 109.376 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.0 79.23 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -31.41 72.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.542 -0.975 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.31 -22.27 66.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.635 -0.666 . . . . 0.0 109.775 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.75 -32.23 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -76.31 -37.75 57.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.523 -0.735 . . . . 0.0 109.724 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -60.02 -23.31 63.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.185 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.915 HD13 HG22 ' A' ' 45' ' ' VAL . 24.7 mt -63.89 151.1 90.12 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.421 -0.799 . . . . 0.0 109.543 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -81.29 104.14 1.48 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.117 2.545 . . . . 0.0 110.054 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.16 -22.68 4.73 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.792 ' CG2' HG11 ' A' ' 45' ' ' VAL . 40.5 t -89.3 139.84 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.387 -1.066 . . . . 0.0 109.282 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -98.73 -153.48 28.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.0 p -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.489 -1.007 . . . . 0.0 109.624 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -66.57 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.756 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.1 mm -64.08 -35.09 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 109.775 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -60.97 -45.01 96.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.507 -0.745 . . . . 0.0 109.377 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -59.59 -33.73 71.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.598 -0.689 . . . . 0.0 109.428 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -65.87 -30.72 71.37 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.6 mm -63.15 -46.22 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -56.62 -37.5 70.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.475 -0.766 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.57 -31.28 72.43 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -50.49 62.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.562 0.696 . . . . 0.0 109.206 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -74.45 -25.58 59.51 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.027 -0.42 . . . . 0.0 110.143 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.59 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.387 -0.821 . . . . 0.0 109.742 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.436 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.08 -37.01 6.43 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.852 HG22 ' CD1' ' A' ' 19' ' ' LEU . 4.7 mt -69.16 -60.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.892 -0.769 . . . . 0.0 109.184 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.4 t -52.99 -25.9 13.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.811 -0.556 . . . . 0.0 110.525 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.29 -30.38 68.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.69 -21.8 21.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.952 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.852 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.7 mp -86.94 -35.29 18.98 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 16' ' ' THR . 67.7 t -77.22 -31.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -65.35 -61.84 1.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.883 HD21 ' CE2' ' A' ' 39' ' ' TYR . 3.1 pp -63.06 -33.34 75.23 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.06 -36.23 38.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.681 -0.637 . . . . 0.0 109.809 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.92 74.86 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 28.8 t80 -60.83 -21.11 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -77.89 -58.5 3.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.248 -0.907 . . . . 0.0 109.151 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 10.0 tttp -68.78 -38.05 79.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.52 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.65 -27.26 64.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.406 -0.808 . . . . 0.0 109.592 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' PHE . 72.8 t -89.34 164.03 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 29' ' ' VAL . 43.6 t -77.72 -70.22 0.49 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 0.0 110.853 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -81.37 59.15 3.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 65.64 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -30.8 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -62.59 -48.96 77.15 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.338 -0.851 . . . . 0.0 108.829 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -71.15 -20.85 62.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.69 . . . . 0.0 109.641 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 23.8 t80 -57.32 -68.76 0.2 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.866 . . . . 0.0 109.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -55.72 -23.03 26.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.384 -0.822 . . . . 0.0 110.054 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -56.14 -63.53 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.368 -0.832 . . . . 0.0 109.916 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.883 ' CE2' HD21 ' A' ' 22' ' ' LEU . 86.9 m-85 -74.61 -27.34 60.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.713 -0.617 . . . . 0.0 110.086 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -61.57 -37.21 83.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.441 -0.787 . . . . 0.0 109.683 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -81.95 -49.74 9.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.747 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.84 -27.91 69.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 -37.08 62.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.774 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.3 m -71.6 -47.42 54.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.769 HG11 ' CG2' ' A' ' 65' ' ' VAL . 7.4 p -64.01 -35.46 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.554 -0.716 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.633 HG13 HG13 ' A' ' 45' ' ' VAL . 65.6 mt -84.17 -28.27 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.06 -21.15 24.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.47 -0.769 . . . . 0.0 110.039 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.26 22.44 15.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.922 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.47 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.1 t80 -96.02 140.67 22.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 108.998 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.05 8.13 4.66 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.979 2.453 . . . . 0.0 111.226 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.42 -176.28 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.678 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -104.17 160.49 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.532 -0.73 . . . . 0.0 109.57 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 58' ' ' GLU . 50.4 mt -97.05 143.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.68 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -91.48 -65.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.732 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 m -119.88 -179.95 4.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.729 . . . . 0.0 109.537 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.35 -33.8 87.3 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.2 71.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.997 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.747 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.5 mt-10 -71.19 -24.24 62.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.688 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -85.59 -31.96 22.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 0.0 109.662 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.582 ' CG ' ' HB1' ' A' ' 70' ' ' ALA . 5.9 mtpm? -75.33 -36.28 61.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.571 -0.705 . . . . 0.0 110.042 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.57 -27.28 67.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 59' ' ' ALA . 6.4 mt -71.18 146.95 93.05 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 0.0 109.401 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.8 102.45 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.959 2.439 . . . . 0.0 110.272 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.9 -25.84 2.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.769 ' CG2' HG11 ' A' ' 45' ' ' VAL . 36.8 t -89.72 139.16 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.46 -1.023 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -102.2 -151.53 23.94 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -99.05 -29.47 12.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.958 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -72.07 -64.09 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.498 -0.751 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.747 HG21 ' CB ' ' A' ' 42' ' ' ALA . 47.3 mm -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -56.98 -41.76 78.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.45 -38.62 87.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -62.11 -31.14 71.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.6 mm -63.34 -42.47 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.08 -41.04 74.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.413 -0.804 . . . . 0.0 109.548 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -62.89 -28.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -52.13 18.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.395 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.54 -26.79 61.88 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.87 -0.519 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.837 . . . . 0.0 109.525 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 109.237 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.9 -36.63 6.32 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.873 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.2 mp -78.5 -43.8 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.845 -0.797 . . . . 0.0 109.74 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.718 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 4.6 t -59.44 -26.03 64.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.09 -46.33 57.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.47 -0.769 . . . . 0.0 109.423 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.541 ' O ' HD22 ' A' ' 22' ' ' LEU . 4.7 ppp? -85.24 -8.58 58.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.712 . . . . 0.0 110.456 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.873 ' CD1' HG22 ' A' ' 15' ' ' ILE . 4.9 mt -83.48 -42.1 17.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 16' ' ' THR . 46.9 t -72.09 -30.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.28 -65.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.602 -0.686 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD11 ' CZ ' ' A' ' 39' ' ' TYR . 1.6 pt? -63.14 -35.07 79.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.94 -48.95 64.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.62 -0.675 . . . . 0.0 110.114 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -62.81 -33.85 76.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 29' ' ' VAL . 50.1 t80 -65.41 -22.55 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.739 -0.601 . . . . 0.0 109.876 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.0 mm-40 -78.94 -56.95 4.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.452 -0.78 . . . . 0.0 109.18 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 17.8 tttm -66.37 -39.87 89.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.376 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.15 -26.42 64.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.453 -0.779 . . . . 0.0 109.447 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 25' ' ' PHE . 57.5 t -89.48 164.46 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -78.15 -68.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.435 -0.79 . . . . 0.0 110.939 -178.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -86.18 60.68 6.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.448 -0.782 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.74 57.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 109.542 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.93 -37.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.01 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.8 p-80 -55.73 -46.3 77.81 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.011 -1.056 . . . . 0.0 109.259 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -73.03 -20.41 61.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -57.74 -70.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -53.42 -24.85 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.425 -0.797 . . . . 0.0 109.938 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.043 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.62 -66.34 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.501 -0.749 . . . . 0.0 109.784 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 41.2 m-85 -77.94 -30.36 50.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 110.07 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -42.7 99.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.392 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -69.24 -44.84 71.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.747 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.747 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -63.12 -45.38 92.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.41 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -60.48 -22.94 64.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 0.0 109.901 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -79.61 -54.67 5.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.6 p -72.59 -44.39 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.541 -0.724 . . . . 0.0 110.104 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.497 ' CD1' ' HB1' ' A' ' 42' ' ' ALA . 78.4 mt -62.87 -58.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.475 -0.765 . . . . 0.0 109.597 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.718 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -60.69 -20.98 62.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.533 -0.729 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -112.21 28.83 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.545 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.1 t80 -94.07 140.47 22.9 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.2 Cg_endo -85.35 8.78 4.41 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.072 2.515 . . . . 0.0 111.284 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 171.18 15.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -94.48 145.08 25.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.613 -0.679 . . . . 0.0 109.543 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.518 HG21 HG21 ' A' ' 73' ' ' ILE . 52.6 mt -78.24 115.56 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -74.01 -31.11 62.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 0.0 109.562 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -164.84 -179.79 6.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.578 -0.701 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -28.0 63.54 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.99 95.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.574 -0.956 . . . . 0.0 109.451 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -69.93 -23.28 63.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.71 . . . . 0.0 109.77 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.5 -27.06 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 109.733 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -74.93 -40.99 60.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -59.95 -23.73 63.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.565 -0.709 . . . . 0.0 110.029 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.745 ' HB3' HG21 ' A' ' 45' ' ' VAL . 80.7 mt -59.99 136.83 90.75 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.55 106.03 1.94 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.865 2.377 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.49 -26.39 3.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 42' ' ' ALA . 23.1 t -89.63 138.06 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -1.036 . . . . 0.0 109.512 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.75 -146.17 14.09 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -99.14 -37.87 9.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.948 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -64.63 -44.01 91.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.745 . . . . 0.0 109.812 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.043 HD11 ' HB1' ' A' ' 38' ' ' ALA . 41.9 mm -71.2 -44.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.883 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.04 81.44 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 109.768 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -61.02 -39.42 89.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.51 -0.744 . . . . 0.0 109.544 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -63.26 -30.94 71.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.4 mm -64.06 -44.98 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -55.36 -40.95 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -64.26 -28.46 69.74 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.28 -52.57 18.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.608 -0.683 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.941 -0.474 . . . . 0.0 110.028 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.373 -0.83 . . . . 0.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.802 . . . . 0.0 109.47 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.05 -33.57 8.12 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.1 mp -74.13 -51.3 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.871 -0.782 . . . . 0.0 109.286 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.9 t -57.17 -28.54 62.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.68 -27.02 63.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 0.0 109.552 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.637 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.5 mmt -90.3 -19.44 24.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.992 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -89.04 -33.9 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 16' ' ' THR . 46.3 t -79.88 -31.74 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.19 -58.82 3.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.655 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.852 HD11 ' CD1' ' A' ' 39' ' ' TYR . 3.2 pp -62.67 -34.98 78.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.15 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.95 -43.12 63.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.504 -0.748 . . . . 0.0 109.572 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.74 -34.31 78.03 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 29' ' ' VAL . 53.5 t80 -66.2 -26.64 67.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.768 -0.583 . . . . 0.0 109.789 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 55.2 mm-40 -80.44 -52.37 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 53.7 tttt -66.07 -42.85 88.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.409 -0.807 . . . . 0.0 109.145 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -58.62 -26.15 63.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.247 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.3 t -89.34 165.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.6 t -79.39 -70.32 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.446 -0.784 . . . . 0.0 111.238 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -79.13 59.21 2.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.434 -0.791 . . . . 0.0 110.95 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.97 48.69 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.71 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -99.13 -21.9 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -71.97 -51.78 20.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.322 -0.861 . . . . 0.0 108.825 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.03 -23.62 63.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.557 -0.715 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 21.9 t80 -56.72 -51.94 66.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.41 -0.806 . . . . 0.0 109.255 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -62.39 -29.9 70.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.192 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.014 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.96 -65.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.772 . . . . 0.0 109.989 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.852 ' CD1' HD11 ' A' ' 22' ' ' LEU . 81.7 m-85 -72.59 -16.01 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -72.1 -55.23 7.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -65.66 -43.54 89.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.526 -0.733 . . . . 0.0 110.078 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -64.95 -46.48 81.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.0 64.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.629 -0.669 . . . . 0.0 110.082 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -81.2 -52.67 7.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.2 p -63.13 -43.71 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.834 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.482 ' N ' HG13 ' A' ' 45' ' ' VAL . 65.2 mt -68.96 -54.88 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -59.49 -20.88 58.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.503 -0.748 . . . . 0.0 110.371 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -117.43 25.96 10.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.463 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.8 t80 -86.08 140.19 34.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.0 109.198 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.19 9.87 3.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.981 2.454 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 178.68 8.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.291 -0.881 . . . . 0.0 109.645 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -99.41 157.68 16.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.654 -0.654 . . . . 0.0 109.81 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.72 HG23 ' CB ' ' A' ' 58' ' ' GLU . 63.9 mt -102.53 108.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -69.93 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.584 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -111.85 -179.85 3.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.688 -0.632 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.52 64.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.34 70.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -1.068 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.72 ' CB ' HG23 ' A' ' 53' ' ' ILE . 5.2 mp0 -70.55 -25.21 63.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.714 . . . . 0.0 109.695 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.02 -28.24 22.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 109.631 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -75.26 -40.11 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -59.79 -24.21 63.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.605 -0.685 . . . . 0.0 110.04 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.829 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.8 mt -60.23 142.65 89.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.456 -0.778 . . . . 0.0 109.636 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.29 105.62 1.78 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.032 2.488 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.45 -26.16 4.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 70' ' ' ALA . 25.9 t -89.53 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.461 -1.023 . . . . 0.0 109.468 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.63 -140.59 10.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.49 -27.48 14.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.912 . . . . 0.0 109.778 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -66.14 -67.68 0.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.475 -0.766 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.014 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.8 mm -60.03 -44.87 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.29 -35.46 71.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.45 -38.02 82.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 109.443 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -69.8 -25.25 63.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.645 -0.66 . . . . 0.0 109.653 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.705 HG21 ' HB2' ' A' ' 59' ' ' ALA . 40.5 mm -72.81 -48.28 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 109.386 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.36 -47.95 68.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.46 -28.95 70.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.475 -0.766 . . . . 0.0 109.054 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -44.15 79.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.69 . . . . 0.0 109.167 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 77' ' ' LEU . 4.0 mm? -81.66 -23.93 36.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.86 -0.525 . . . . 0.0 110.129 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -78.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.498 -0.752 . . . . 0.0 109.433 179.925 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.0 -35.27 7.2 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.85 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.9 mt -70.94 -57.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.78 -0.836 . . . . 0.0 109.17 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -53.48 -30.96 43.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.776 -0.578 . . . . 0.0 110.668 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.97 -29.48 68.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 110.014 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.506 ' O ' HD23 ' A' ' 22' ' ' LEU . 5.4 mmt -90.13 -23.71 21.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 110.058 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.85 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.8 mp -88.37 -34.27 17.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 108.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 16' ' ' THR . 99.8 t -76.48 -32.92 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -68.6 -61.56 1.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.974 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -61.69 -32.32 72.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.48 -44.35 65.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 109.63 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -35.62 79.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.1 t80 -65.13 -22.83 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.859 -0.526 . . . . 0.0 109.678 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 21.3 mm-40 -78.23 -57.88 3.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -64.99 -40.69 95.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.287 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -58.98 -25.4 63.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.582 -0.698 . . . . 0.0 109.498 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.1 t -89.59 164.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.8 t -76.76 -70.19 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.49 -0.756 . . . . 0.0 111.096 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.46 65.97 9.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.386 -0.821 . . . . 0.0 110.884 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.76 36.89 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -85.86 -26.11 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.316 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' NE2' ' HE3' ' A' ' 35' ' ' LYS . 6.4 p-80 -71.36 -50.76 28.98 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.618 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 10.8 ptpt -66.7 -23.75 66.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.6 t80 -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.475 -0.766 . . . . 0.0 109.648 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -56.71 -24.79 51.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.059 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.14 -59.24 5.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.388 -0.82 . . . . 0.0 109.89 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.974 ' CG ' HD11 ' A' ' 22' ' ' LEU . 48.0 m-85 -85.12 -27.61 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.949 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 28.9 tpt85 -64.41 -42.84 95.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.469 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -78.33 -46.62 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.776 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.37 -44.26 96.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.551 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.73 70.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -66.91 -50.19 63.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.96 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.8 p -72.34 -45.07 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.466 -0.771 . . . . 0.0 110.112 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.486 ' N ' HG13 ' A' ' 45' ' ' VAL . 79.3 mt -64.22 -51.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -63.01 -21.36 66.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 110.076 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.07 27.93 8.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.499 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.4 t80 -90.45 139.38 26.68 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.728 . . . . 0.0 109.129 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.14 10.87 3.49 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.081 2.521 . . . . 0.0 111.263 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.6 m-70 -147.3 171.68 15.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.273 -0.892 . . . . 0.0 109.642 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.98 138.6 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.696 . . . . 0.0 109.665 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 58' ' ' GLU . 49.5 mt -73.12 125.78 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.239 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -81.67 -56.95 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 p -132.21 -179.82 5.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.544 -0.723 . . . . 0.0 109.509 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.8 -29.37 67.31 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.86 72.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.702 ' HB3' HG23 ' A' ' 53' ' ' ILE . 1.1 mm-40 -67.22 -21.33 65.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.718 -0.614 . . . . 0.0 109.9 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -85.99 -27.63 24.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.788 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HG3' ' HB1' ' A' ' 70' ' ' ALA . 23.1 mtpt -73.38 -40.72 64.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.767 . . . . 0.0 109.679 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -60.27 -26.62 66.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.568 -0.708 . . . . 0.0 110.039 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.766 ' HB3' HG21 ' A' ' 45' ' ' VAL . 46.5 mt -63.41 136.65 96.8 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.719 . . . . 0.0 109.297 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.55 108.39 2.12 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.937 2.425 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.05 -19.85 4.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 42' ' ' ALA . 39.5 t -89.27 139.31 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -1.101 . . . . 0.0 109.285 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.38 -149.92 23.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -98.64 -35.56 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.952 . . . . 0.0 109.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -71.86 -39.93 69.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.0 109.74 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.059 HD11 ' HB1' ' A' ' 38' ' ' ALA . 39.0 mm -72.83 -40.56 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -59.6 -50.65 73.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.543 -0.723 . . . . 0.0 110.126 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.97 -34.01 69.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.789 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -62.27 -37.93 87.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.556 -0.715 . . . . 0.0 109.182 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 53' ' ' ILE . 47.2 mm -63.74 -38.31 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.77 -40.3 72.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.525 -0.735 . . . . 0.0 109.617 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.8 -32.98 74.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -53.12 50.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.39 -22.79 61.08 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.962 -0.461 . . . . 0.0 110.168 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.79 -80.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.617 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.42 -34.81 7.76 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.858 HG22 ' CD1' ' A' ' 19' ' ' LEU . 10.0 mt -72.37 -59.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.861 -0.788 . . . . 0.0 109.146 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -53.17 -31.54 43.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.819 -0.551 . . . . 0.0 110.333 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.9 -29.38 69.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.6 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.7 mmt -90.4 -21.74 21.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.821 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.858 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.5 mp -88.78 -34.01 17.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 16' ' ' THR . 60.4 t -77.44 -33.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.77 -60.38 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 109.42 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.943 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -61.51 -34.5 75.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.136 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.25 -41.44 60.36 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.556 -0.715 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -64.25 -37.09 86.26 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 61.7 t80 -64.38 -23.49 67.31 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.667 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.0 mm-40 -76.1 -56.61 4.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.382 -0.823 . . . . 0.0 109.125 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -69.51 -40.48 76.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 109.728 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -57.5 -25.07 59.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' PHE . 67.6 t -89.28 164.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 29' ' ' VAL . 48.3 t -76.72 -70.43 0.46 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.765 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -85.05 64.56 8.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.459 -0.775 . . . . 0.0 110.412 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 48.98 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.683 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 -22.57 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.512 -0.742 . . . . 0.0 109.626 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.436 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.8 p-80 -71.5 -51.65 22.54 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 108.677 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -68.1 -23.27 64.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 109.309 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.5 -55.1 39.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -60.94 -27.44 68.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 0.0 109.565 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.078 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.99 -63.56 1.14 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.436 -0.79 . . . . 0.0 110.067 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 22' ' ' LEU . 63.4 m-85 -78.37 -27.4 46.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.722 -0.611 . . . . 0.0 110.149 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -66.83 -33.87 76.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.66 -49.64 10.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.506 -0.746 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.754 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.71 -50.85 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.53 -0.731 . . . . 0.0 109.454 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -61.61 -27.76 68.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.506 -0.746 . . . . 0.0 109.626 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -73.74 -32.29 63.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.861 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.799 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.7 p -90.1 -35.28 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG12 HD11 ' A' ' 53' ' ' ILE . 73.2 mt -77.09 -48.62 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.515 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -61.24 -20.06 62.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 0.0 110.23 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -121.66 26.17 8.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 109.724 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.51 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.9 t80 -83.72 145.58 47.68 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.057 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -85.29 -0.01 8.85 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.05 2.5 . . . . 0.0 110.989 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.4 m-70 -142.32 177.75 8.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.325 -0.86 . . . . 0.0 109.634 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -103.79 141.51 35.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.591 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.74 HG23 ' CB ' ' A' ' 58' ' ' GLU . 52.2 mt -81.83 130.43 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -94.6 -50.5 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.747 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.4 m -125.77 177.93 5.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.33 -29.46 73.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.97 72.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.74 ' CB ' HG23 ' A' ' 53' ' ' ILE . 2.7 mt-10 -73.34 -25.78 60.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.674 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -89.46 -28.38 19.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.644 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -77.04 -35.63 56.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.735 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -60.25 -23.27 63.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.588 -0.695 . . . . 0.0 110.031 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 45' ' ' VAL . 78.9 mt -60.76 143.54 90.86 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.13 107.45 2.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.972 2.448 . . . . 0.0 110.251 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.49 -29.05 3.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 70' ' ' ALA . 29.1 t -89.82 138.8 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.984 . . . . 0.0 109.479 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.11 -136.67 7.98 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -98.81 -28.35 13.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.976 . . . . 0.0 109.657 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -66.13 -66.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.568 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.078 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.3 mm -61.43 -45.11 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.598 -0.689 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.64 -34.31 71.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.54 -41.41 97.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.575 -0.703 . . . . 0.0 109.451 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -62.45 -29.64 70.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.681 -0.637 . . . . 0.0 109.366 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.674 HG21 ' HB2' ' A' ' 59' ' ' ALA . 46.9 mm -63.6 -46.87 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.719 . . . . 0.0 109.061 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.41 -32.37 66.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.518 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -67.33 -29.85 69.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -73.18 -50.53 22.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.569 0.7 . . . . 0.0 109.428 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.95 -27.62 61.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 122.043 -0.41 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -79.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.763 . . . . 0.0 109.531 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -42.31 5.03 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.858 HG22 ' CD1' ' A' ' 19' ' ' LEU . 5.3 mt -66.5 -58.19 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.96 -0.73 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.1 t -52.6 -31.04 34.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.731 -0.606 . . . . 0.0 110.384 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -63.83 -30.38 71.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.496 -0.752 . . . . 0.0 109.529 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.5 ' O ' HD23 ' A' ' 22' ' ' LEU . 4.8 ttm -90.31 -21.39 22.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.888 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.858 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.3 mp -87.29 -33.95 19.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 16' ' ' THR . 58.3 t -75.8 -35.78 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -65.46 -60.99 2.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.375 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.943 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.7 pp -61.53 -33.66 74.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 109.151 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.88 -41.65 62.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 109.507 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.05 -36.96 85.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.0 t80 -63.87 -23.2 67.26 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.8 mm-40 -77.01 -57.12 4.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 46.7 tttm -68.27 -40.29 81.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.488 -0.757 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -25.53 61.29 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.481 -0.762 . . . . 0.0 109.696 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 25' ' ' PHE . 62.6 t -89.31 164.29 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.14 -70.08 0.49 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.955 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -84.77 62.19 7.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.445 -0.785 . . . . 0.0 110.458 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 53.91 0.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.862 . . . . 0.0 109.684 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.27 -29.71 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.785 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.73 -48.37 74.86 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.37 -22.77 62.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.591 -0.693 . . . . 0.0 109.411 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 25.7 t80 -55.64 -67.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.271 -0.893 . . . . 0.0 109.741 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -55.82 -23.13 28.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.479 -0.763 . . . . 0.0 110.038 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.025 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.47 -63.62 1.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.286 -0.884 . . . . 0.0 109.88 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 22' ' ' LEU . 64.3 m-85 -79.17 -26.8 42.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.024 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -37.86 88.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.319 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -48.28 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.721 -0.612 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.766 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.56 -27.65 69.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.604 -0.685 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.04 57.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.494 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -72.45 -44.11 62.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 109.861 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.752 HG11 HG23 ' A' ' 65' ' ' VAL . 8.1 p -66.03 -36.66 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.455 -0.778 . . . . 0.0 109.766 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.626 HG13 HG13 ' A' ' 45' ' ' VAL . 77.4 mt -84.08 -26.51 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.73 -26.25 21.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -97.9 20.35 12.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.445 -0.785 . . . . 0.0 109.856 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.479 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 6.3 t80 -95.14 137.67 22.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.38 12.4 3.02 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.113 2.542 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.3 m-70 -148.28 -171.58 3.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.527 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -124.96 149.91 47.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.585 -0.697 . . . . 0.0 109.52 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 58' ' ' GLU . 9.8 pt -101.42 158.02 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.53 -0.731 . . . . 0.0 109.506 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -114.01 -32.23 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.712 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -118.46 167.61 11.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.86 -30.58 70.23 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.59 70.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.498 ' HB3' HG22 ' A' ' 53' ' ' ILE . 29.3 mt-10 -68.16 -24.46 64.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.672 -0.642 . . . . 0.0 109.716 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.744 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -80.86 -31.13 35.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HG3' ' HB1' ' A' ' 70' ' ' ALA . 23.2 mttt -73.98 -40.68 62.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.738 . . . . 0.0 110.122 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -59.26 -27.24 65.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.533 -0.729 . . . . 0.0 110.142 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 59' ' ' ALA . 9.9 mt -72.0 149.12 92.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.22 118.54 4.71 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.092 2.528 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.91 -25.69 5.77 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.752 HG23 HG11 ' A' ' 45' ' ' VAL . 38.4 t -89.8 139.71 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -1.018 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -106.16 -150.72 18.6 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -99.55 -29.22 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.612 -0.934 . . . . 0.0 109.612 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -77.26 -59.34 2.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.592 -0.692 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.025 HD11 ' HB1' ' A' ' 38' ' ' ALA . 46.2 mm -62.04 -32.54 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.69 . . . . 0.0 109.457 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -61.19 -38.64 87.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 109.126 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -61.41 -38.93 88.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -62.37 -30.69 71.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.6 mm -63.53 -44.5 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.76 -40.59 72.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.55 -0.719 . . . . 0.0 109.797 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.38 -51.95 45.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.513 0.673 . . . . 0.0 109.278 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.23 -24.08 60.44 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.952 -0.467 . . . . 0.0 110.058 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.63 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 109.731 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.0 109.619 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.59 -41.47 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.796 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.72 -57.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.902 -0.763 . . . . 0.0 109.166 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -52.93 -33.93 52.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.739 -0.601 . . . . 0.0 110.472 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.98 -32.41 72.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.2 tpt -86.74 -20.55 27.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.796 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -86.21 -37.64 18.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 16' ' ' THR . 48.7 t -67.58 -39.59 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.99 -60.18 3.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.742 . . . . 0.0 109.638 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.011 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.0 pp -62.31 -34.07 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 109.239 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.45 -42.32 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.535 -0.728 . . . . 0.0 109.739 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -63.66 -43.81 95.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' O ' HG23 ' A' ' 29' ' ' VAL . 72.6 t80 -49.0 -30.81 6.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.745 -0.597 . . . . 0.0 110.709 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.744 ' OE1' HD12 ' A' ' 22' ' ' LEU . 3.5 mp0 -79.91 -44.23 20.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.066 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -70.26 -49.89 45.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.937 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -14.91 49.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.0 110.239 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 25' ' ' PHE . 36.1 t -87.74 164.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.419 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -73.76 -70.54 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.0 111.531 -177.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -90.63 66.98 6.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 0.0 111.183 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.71 56.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -102.96 -22.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.131 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.469 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.6 p-80 -76.16 -47.14 25.33 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -72.89 -24.67 60.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.533 -0.729 . . . . 0.0 109.044 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -58.02 -49.17 77.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.44 -0.787 . . . . 0.0 109.053 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.57 -25.26 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.605 -0.684 . . . . 0.0 109.48 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.022 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.48 -62.92 1.36 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.327 -0.858 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.011 ' CG ' HD11 ' A' ' 22' ' ' LEU . 80.6 m-85 -76.71 -25.21 53.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 110.847 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -74.27 -37.03 63.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.309 -0.869 . . . . 0.0 109.012 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -76.8 -31.65 57.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.372 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.775 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -85.49 -26.66 26.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -27.93 61.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.617 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -81.56 -45.78 15.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 109.937 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.895 HG11 HG23 ' A' ' 65' ' ' VAL . 7.2 p -63.88 -34.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.464 -0.772 . . . . 0.0 109.756 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.616 HG13 HG13 ' A' ' 45' ' ' VAL . 69.6 mt -85.11 -28.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.5 -21.84 23.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.429 -0.794 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -104.35 22.14 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 109.743 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.4 t80 -94.65 142.9 25.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 109.004 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.5 9.21 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.077 2.518 . . . . 0.0 110.991 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.8 m-70 -146.66 178.69 8.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.216 -0.927 . . . . 0.0 109.56 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -98.52 174.42 6.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.537 -0.727 . . . . 0.0 109.705 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 58' ' ' GLU . 60.8 mt -132.75 106.33 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.664 -0.648 . . . . 0.0 109.42 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.83 34.26 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -165.99 139.81 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 109.402 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.87 -40.37 95.45 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.88 -30.42 71.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.97 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 53' ' ' ILE . 6.0 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.786 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -81.92 -30.53 31.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 3.8 tmtt? -74.72 -38.67 62.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.582 -0.698 . . . . 0.0 110.012 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -59.84 -25.89 65.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.143 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 59' ' ' ALA . 11.1 mt -71.01 152.23 94.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 109.447 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.53 105.99 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 123.073 2.516 . . . . 0.0 110.289 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 -30.82 2.31 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.895 HG23 HG11 ' A' ' 45' ' ' VAL . 33.9 t -90.13 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -108.87 -147.67 12.5 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -98.55 -29.73 12.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 109.61 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.16 -58.63 3.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.022 HD11 ' HB1' ' A' ' 38' ' ' ALA . 45.9 mm -61.82 -34.79 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.738 . . . . 0.0 109.626 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -59.97 -41.35 91.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -60.55 -37.03 79.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.649 -0.657 . . . . 0.0 109.46 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.94 -31.4 72.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.367 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.8 mm -63.8 -46.16 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.89 -39.61 68.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.448 -0.782 . . . . 0.0 109.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.98 -31.85 73.19 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -52.56 37.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.573 0.702 . . . . 0.0 109.326 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.77 -23.15 60.77 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.87 -0.519 . . . . 0.0 110.11 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -0.807 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 109.374 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.76 -34.85 7.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.857 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.6 mp -64.94 -47.09 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.023 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.9 t -56.57 -31.43 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 109.862 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -65.0 -28.41 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.542 -0.724 . . . . 0.0 109.486 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mmt -89.9 -20.98 22.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -85.67 -33.89 21.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 16' ' ' THR . 48.2 t -76.33 -33.05 22.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.21 -61.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.984 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -62.54 -32.06 72.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.23 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.61 -45.85 66.74 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.485 -0.759 . . . . 0.0 109.68 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -63.79 -35.76 81.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.2 t80 -61.19 -26.04 67.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.758 -0.589 . . . . 0.0 109.935 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 18.5 mm-40 -79.88 -55.39 5.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.0 109.153 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 109.423 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.73 -25.1 64.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.416 -0.803 . . . . 0.0 109.455 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 25' ' ' PHE . 50.0 t -89.07 164.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -77.5 -69.32 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.466 -0.771 . . . . 0.0 111.297 -178.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -85.29 62.13 7.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.95 55.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.58 -29.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.405 -0.809 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.36 -48.81 71.66 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.59 -23.01 62.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 109.462 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 24.7 t80 -55.25 -66.5 0.4 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 109.557 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.69 -24.27 21.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.451 -0.78 . . . . 0.0 109.923 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.699 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.19 -55.14 34.57 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.422 -0.799 . . . . 0.0 109.874 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.984 ' CG ' HD11 ' A' ' 22' ' ' LEU . 62.5 m-85 -89.97 -26.4 20.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.594 -0.691 . . . . 0.0 110.11 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -39.29 93.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.793 . . . . 0.0 109.109 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -85.83 -41.89 14.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.776 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -65.57 -29.04 69.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.537 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.49 31.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.681 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -68.23 -48.95 63.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 109.898 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.7 p -64.8 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.0 109.822 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.585 HG13 HG13 ' A' ' 45' ' ' VAL . 66.2 mt -77.19 -27.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.469 -0.769 . . . . 0.0 109.937 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.473 -0.767 . . . . 0.0 110.072 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -120.26 27.05 8.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.7 t80 -82.49 139.92 44.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.88 10.64 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.096 2.531 . . . . 0.0 111.317 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.9 m-70 -146.61 169.0 19.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.681 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -96.44 148.57 22.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 58' ' ' GLU . 57.2 mt -97.86 104.39 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -87.57 -40.87 13.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.656 -0.652 . . . . 0.0 109.565 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -112.38 155.37 24.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.734 . . . . 0.0 109.597 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.53 -27.57 66.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.91 71.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.431 -1.04 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.748 ' CB ' HG23 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -63.72 -25.59 68.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.723 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.35 -26.63 26.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 109.846 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.97 -40.93 62.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.504 -0.748 . . . . 0.0 109.674 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -25.13 66.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 110.002 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.829 ' HB3' HG21 ' A' ' 45' ' ' VAL . 91.4 mt -58.46 137.72 85.57 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 109.928 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -80.85 109.74 2.26 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.055 2.503 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.78 -24.47 5.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 42' ' ' ALA . 22.9 t -89.5 137.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.41 -1.053 . . . . 0.0 109.372 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -95.5 -147.97 23.47 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.9 p -98.98 -28.96 13.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.923 . . . . 0.0 109.696 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -65.41 -65.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.776 HG21 ' CB ' ' A' ' 42' ' ' ALA . 50.0 mm -62.08 -39.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.747 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -57.97 -42.99 86.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.25 -35.15 76.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.566 -0.709 . . . . 0.0 109.395 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -65.69 -31.09 71.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 109.258 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.63 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.3 mm -62.83 -44.76 99.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -57.47 -38.56 74.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.464 -0.772 . . . . 0.0 109.518 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.21 -27.14 69.15 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -49.61 31.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.84 -42.46 60.8 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.899 -0.501 . . . . 0.0 110.17 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -80.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.432 -0.793 . . . . 0.0 109.795 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.55 -48.6 3.18 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 15' ' ' ILE . 2.8 mp -66.87 -52.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.858 -0.79 . . . . 0.0 109.675 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.1 t -57.91 -28.37 64.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 110.037 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.14 -38.26 88.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.73 . . . . 0.0 109.273 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.3 mmt -87.33 -10.18 52.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 110.184 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.676 HD23 ' HD2' ' A' ' 39' ' ' TYR . 4.2 mt -87.86 -35.88 17.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 16' ' ' THR . 43.1 t -78.33 -31.09 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -69.55 -60.24 2.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.599 -0.688 . . . . 0.0 109.719 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.2 pp -63.15 -34.8 78.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.21 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.79 -40.78 60.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.569 -0.707 . . . . 0.0 109.647 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -63.86 -38.91 92.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 29' ' ' VAL . 44.6 t80 -62.11 -22.31 65.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.635 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.5 mm-40 -75.47 -59.07 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.823 . . . . 0.0 109.038 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -67.48 -40.09 85.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.89 -24.7 58.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.35 -0.844 . . . . 0.0 109.688 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 25' ' ' PHE . 53.3 t -89.4 164.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.14 -70.15 0.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -178.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -88.06 67.61 8.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 0.0 110.296 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.71 40.27 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.33 -27.21 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.474 -0.766 . . . . 0.0 109.359 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 5.0 p-80 -68.47 -50.89 49.06 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -67.59 -25.89 66.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.51 -0.744 . . . . 0.0 109.242 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -53.31 -64.29 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.24 -0.912 . . . . 0.0 109.615 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -55.12 -25.46 31.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -57.75 -65.9 0.56 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.382 -0.824 . . . . 0.0 109.79 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.01 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.4 m-85 -72.34 -27.38 62.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.747 -0.596 . . . . 0.0 110.119 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -63.49 -46.1 87.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.447 -0.783 . . . . 0.0 109.393 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -65.85 -46.21 79.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.485 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.787 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.54 -48.34 77.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.422 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -55.14 -23.29 20.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -77.13 -59.84 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.781 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.9 p -63.47 -44.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.47 -0.769 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.494 HG21 ' HB ' ' A' ' 15' ' ' ILE . 50.3 mm -63.18 -28.41 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.369 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.02 -18.7 25.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -116.31 26.8 9.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.3 t80 -88.55 135.66 32.25 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.511 -0.743 . . . . 0.0 109.023 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.4 Cg_endo -85.55 10.41 3.72 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 123.148 2.565 . . . . 0.0 111.58 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.417 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.5 m-70 -148.82 -174.95 4.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.083 -1.011 . . . . 0.0 109.721 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 176.33 5.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.597 -0.689 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.535 HG22 ' HB3' ' A' ' 58' ' ' GLU . 32.7 pt -136.85 141.46 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.632 -0.668 . . . . 0.0 109.552 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -121.83 25.99 8.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.654 -0.654 . . . . 0.0 109.646 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -170.41 150.59 3.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.788 . . . . 0.0 109.356 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -28.94 68.16 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.4 85.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HB3' HG22 ' A' ' 53' ' ' ILE . 1.1 mp0 -64.51 -20.39 66.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.63 -0.669 . . . . 0.0 109.918 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -88.0 -25.14 23.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.348 -0.845 . . . . 0.0 109.883 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -73.38 -41.0 63.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 109.735 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.23 -26.42 66.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.461 -0.775 . . . . 0.0 109.939 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.781 ' HB3' HG21 ' A' ' 45' ' ' VAL . 93.4 mt -55.95 134.65 73.54 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.71 102.55 1.4 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.931 2.42 . . . . 0.0 109.986 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.43 -26.26 2.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.647 HG23 HG11 ' A' ' 45' ' ' VAL . 24.0 t -89.38 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -1.052 . . . . 0.0 109.218 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.79 -156.54 25.35 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -87.96 -7.37 57.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.667 -0.902 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -90.21 -63.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.787 HG21 ' CB ' ' A' ' 42' ' ' ALA . 46.9 mm -67.26 -34.57 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.775 . . . . 0.0 110.445 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -56.76 -55.8 29.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.309 -0.869 . . . . 0.0 109.917 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -59.84 -31.49 69.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 109.512 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -59.96 -43.86 94.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 0.0 109.418 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.556 HD12 ' HB1' ' A' ' 59' ' ' ALA . 65.1 mt -64.1 -29.91 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -56.04 -43.79 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.224 -0.922 . . . . 0.0 108.964 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -31.01 71.74 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -43.08 96.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.551 HD23 HG22 ' A' ' 73' ' ' ILE . 4.0 mm? -83.45 -24.89 31.63 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.086 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.428 -0.795 . . . . 0.0 109.786 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.07 -39.0 5.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.672 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -68.91 -50.7 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.88 -0.776 . . . . 0.0 108.952 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.8 t -59.36 -29.52 67.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.748 -0.595 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.69 -34.58 77.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.629 -0.669 . . . . 0.0 109.22 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.478 ' O ' HD23 ' A' ' 22' ' ' LEU . 35.8 mmm -89.61 -17.17 28.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.127 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.672 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -87.86 -35.63 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 108.489 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 16' ' ' THR . 46.6 t -78.58 -30.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.08 -60.52 2.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.724 . . . . 0.0 109.76 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.991 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.7 pp -62.87 -34.15 76.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.22 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.29 -44.15 61.8 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.626 -0.671 . . . . 0.0 109.917 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.34 -36.65 84.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.9 t80 -63.72 -23.07 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.895 -0.503 . . . . 0.0 109.682 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.2 mm-40 -77.31 -57.74 3.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.346 -0.847 . . . . 0.0 109.106 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -67.01 -40.41 87.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.537 -0.727 . . . . 0.0 109.553 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.12 -25.59 61.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.433 -0.792 . . . . 0.0 109.659 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.6 t -89.47 164.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.438 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.25 -69.77 0.51 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.485 -0.759 . . . . 0.0 110.937 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -85.32 62.15 7.31 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.84 47.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -96.34 -28.6 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.0 109.378 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.3 p-80 -64.59 -48.55 74.54 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.49 -25.78 64.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.616 -0.678 . . . . 0.0 109.347 179.274 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.0 t80 -52.48 -60.72 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.304 -0.872 . . . . 0.0 109.796 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.83 -26.88 64.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.029 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.91 -65.22 0.65 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.411 -0.806 . . . . 0.0 109.77 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.991 ' CG ' HD11 ' A' ' 22' ' ' LEU . 62.4 m-85 -76.38 -26.15 55.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.675 -0.641 . . . . 0.0 110.082 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -63.72 -52.11 61.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.466 -0.771 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.68 -45.69 81.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.772 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.98 -37.04 85.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -64.44 -25.52 68.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.918 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.26 -50.79 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 110.016 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 65' ' ' VAL . 7.7 p -62.79 -34.05 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.557 HG13 HG13 ' A' ' 45' ' ' VAL . 74.4 mt -83.34 -41.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -79.23 -17.59 54.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.328 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.21 23.37 14.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.789 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.58 ' CE1' HD22 ' A' ' 62' ' ' LEU . 2.6 t80 -94.66 144.9 28.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.9 Cg_endo -86.43 4.82 6.2 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 123.128 2.552 . . . . 0.0 110.846 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.6 m-70 -146.61 -175.38 4.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -105.38 160.56 15.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.564 -0.71 . . . . 0.0 109.67 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.766 HG23 ' HB3' ' A' ' 58' ' ' GLU . 52.7 mt -101.71 131.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -77.89 -65.3 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.729 . . . . 0.0 109.719 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 p -114.26 174.97 5.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.43 83.73 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -34.28 76.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.946 . . . . 0.0 109.308 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.766 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.0 mt-10 -67.13 -23.28 65.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.677 . . . . 0.0 109.716 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' ' 53' ' ' ILE . . . -84.76 -28.69 26.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.428 -0.795 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 8.1 tmtt? -74.49 -38.64 62.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -59.59 -26.44 65.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.755 . . . . 0.0 110.075 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.58 HD22 ' CE1' ' A' ' 49' ' ' TYR . 53.7 mt -71.65 150.2 93.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.74 106.31 2.17 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.024 2.483 . . . . 0.0 110.313 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.35 -29.44 2.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 45' ' ' VAL . 36.0 t -89.72 146.0 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -1.004 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.72 -145.77 15.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.4 p -100.15 -39.79 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.895 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -73.43 -44.66 57.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.635 -0.666 . . . . 0.0 109.725 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.029 HD11 ' HB1' ' A' ' 38' ' ' ALA . 43.8 mm -69.62 -38.6 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 60' ' ' LYS . . . -59.64 -41.66 91.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.64 -38.54 85.13 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.481 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -62.28 -30.22 70.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.604 -0.685 . . . . 0.0 109.368 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.0 mm -64.32 -45.51 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -54.84 -40.65 69.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.49 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -53.16 36.68 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.509 0.671 . . . . 0.0 109.308 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.56 -22.3 61.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.948 -0.47 . . . . 0.0 110.14 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.08 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.406 -0.809 . . . . 0.0 109.623 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.71 -32.76 8.93 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.82 HG22 ' CD1' ' A' ' 19' ' ' LEU . 16.6 mt -74.89 -59.08 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.764 -0.845 . . . . 0.0 109.334 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.4 t -51.8 -32.41 31.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.756 -0.59 . . . . 0.0 110.553 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.46 -26.21 64.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.593 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.8 mtp -90.02 -21.32 22.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.956 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.82 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.4 mp -88.65 -33.89 17.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 16' ' ' THR . 54.5 t -76.25 -34.75 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -68.34 -60.2 2.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.656 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.981 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -60.82 -35.2 75.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 109.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -50.68 -42.1 56.48 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.666 -0.646 . . . . 0.0 109.739 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.16 -36.12 83.02 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.5 t80 -65.69 -24.77 67.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.888 -0.507 . . . . 0.0 109.676 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.1 mm-40 -75.8 -57.79 3.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -66.14 -41.94 89.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.0 109.58 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -57.3 -24.7 56.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.4 -0.813 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.6 t -89.66 164.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.6 t -77.19 -70.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 110.876 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -85.05 66.75 9.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.471 -0.768 . . . . 0.0 110.734 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.63 29.18 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -81.89 -21.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.59 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.439 ' CD2' ' HE2' ' A' ' 35' ' ' LYS . 6.4 p-80 -76.09 -49.85 16.28 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -67.62 -26.46 66.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.57 -51.62 67.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.03 -28.13 68.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 0.0 109.532 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.021 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.46 -62.32 1.8 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.981 ' CG ' HD11 ' A' ' 22' ' ' LEU . 66.0 m-85 -78.5 -1.42 33.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.912 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 -87.14 -36.27 18.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -81.1 -46.62 14.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.756 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.45 -42.78 98.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.589 -0.695 . . . . 0.0 109.391 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -68.86 -26.06 64.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.639 -0.663 . . . . 0.0 109.762 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -80.57 -28.93 37.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.783 . . . . 0.0 109.906 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 62' ' ' LEU . 14.5 p -90.0 -44.71 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.417 -0.802 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 53' ' ' ILE . 67.7 mt -69.71 -52.27 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 109.587 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.651 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -60.65 -21.08 62.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -118.1 28.74 8.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.518 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.0 t80 -89.56 145.68 34.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.0 Cg_endo -85.97 2.11 7.64 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.101 2.534 . . . . 0.0 110.979 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.2 m-70 -144.06 -179.35 6.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -105.93 139.68 40.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.717 HG23 ' CB ' ' A' ' 58' ' ' GLU . 60.0 mt -77.12 106.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.605 -0.684 . . . . 0.0 109.356 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.8 mttt -72.36 -69.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.55 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -102.53 174.65 5.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.556 -0.715 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.36 -28.96 71.87 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.86 -30.38 70.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -1.008 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.717 ' CB ' HG23 ' A' ' 53' ' ' ILE . 1.1 mp0 -67.28 -27.61 67.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.651 -0.655 . . . . 0.0 109.628 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.765 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.92 -28.85 22.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.631 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -75.57 -39.04 58.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.475 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -60.51 -24.16 65.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.502 -0.749 . . . . 0.0 110.039 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.806 ' HB3' HG21 ' A' ' 45' ' ' VAL . 81.7 mt -60.84 140.92 93.32 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.426 -0.796 . . . . 0.0 109.545 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.29 107.18 1.99 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.983 2.456 . . . . 0.0 110.14 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.87 -25.38 4.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 70' ' ' ALA . 29.8 t -89.55 138.52 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.978 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.26 -139.65 9.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.39 -29.49 12.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.94 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -67.42 -64.6 0.82 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.021 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.2 mm -61.42 -41.97 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 0.0 109.789 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -59.64 -35.35 74.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.543 -0.723 . . . . 0.0 109.658 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.72 -41.59 95.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.511 -0.743 . . . . 0.0 109.516 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -62.04 -30.4 70.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.615 -0.678 . . . . 0.0 109.31 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.7 mm -63.16 -47.23 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.11 -31.54 65.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 109.606 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.7 -30.67 70.23 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -74.2 -50.79 17.69 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.582 0.705 . . . . 0.0 109.592 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.33 -27.42 62.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.908 -0.495 . . . . 0.0 109.95 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.44 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.81 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.3 -41.49 5.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.508 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.0 mt -66.11 -50.56 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.893 -0.769 . . . . 0.0 109.072 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 5.1 t -58.08 -31.17 66.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.698 -0.626 . . . . 0.0 109.963 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.15 -36.03 76.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 109.381 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtt -87.54 -14.55 39.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.609 -0.682 . . . . 0.0 110.135 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -86.2 -42.55 13.72 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.12 -31.62 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.21 -64.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.977 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.1 pp -62.07 -33.73 74.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.11 -42.5 63.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.86 -36.51 84.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 54.0 t80 -63.73 -22.76 67.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.8 mm-40 -77.48 -57.63 3.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.099 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 71.6 tttt -67.79 -39.48 84.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.51 -0.743 . . . . 0.0 109.622 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.79 -25.7 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.403 -0.811 . . . . 0.0 109.605 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 62.0 t -89.36 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.88 -70.09 0.48 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 0.0 110.98 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -85.12 62.11 7.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 110.407 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.81 53.64 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -0.822 . . . . 0.0 109.68 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -100.18 -30.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.795 . . . . 0.0 109.105 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.451 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.05 -48.43 76.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.66 -23.78 63.51 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 26.7 t80 -54.6 -67.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.22 -0.925 . . . . 0.0 109.694 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -54.74 -24.59 23.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 109.88 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.064 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.14 -65.36 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.977 ' CG ' HD11 ' A' ' 22' ' ' LEU . 58.2 m-85 -79.12 -29.31 43.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.587 -0.695 . . . . 0.0 109.851 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -65.36 -46.34 80.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.486 -0.759 . . . . 0.0 109.456 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -70.59 -40.57 73.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.499 -0.751 . . . . 0.0 109.661 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.719 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -68.88 -39.56 79.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.602 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -62.01 -28.17 69.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -70.84 -51.29 27.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.3 p -69.67 -44.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.487 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.2 mt -67.17 -29.45 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.448 -0.783 . . . . 0.0 109.971 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.402 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -90.05 -13.85 35.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.429 -0.795 . . . . 0.0 110.538 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -123.26 27.99 7.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.475 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.2 t80 -85.24 143.69 39.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.196 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.24 3.87 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.052 2.502 . . . . 0.0 111.066 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.405 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -145.01 -177.72 5.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.645 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 160.8 17.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.7 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 58' ' ' GLU . 24.6 pt -123.41 153.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 109.318 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -137.73 28.58 2.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.511 -0.743 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 t -170.3 151.52 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.02 -28.1 69.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.92 72.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.464 -1.021 . . . . 0.0 109.695 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 53' ' ' ILE . 2.6 mt-10 -73.66 -14.43 61.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.614 -0.679 . . . . 0.0 110.355 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -90.11 -29.72 18.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -29.52 55.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.555 -0.716 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HG21 ' A' ' 45' ' ' VAL . 80.9 mt -61.77 146.17 91.13 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.21 113.13 3.14 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.0 2.466 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.36 -28.54 5.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 70' ' ' ALA . 27.6 t -89.9 138.48 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -1.023 . . . . 0.0 109.392 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -139.75 9.23 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 t -98.87 -28.59 13.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.958 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -67.9 -65.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.47 -0.769 . . . . 0.0 109.503 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.064 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.5 mm -61.34 -41.67 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.828 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.05 -37.05 73.66 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.582 -0.699 . . . . 0.0 109.736 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -61.86 -40.38 95.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.48 -0.762 . . . . 0.0 109.526 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -62.79 -32.68 73.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.0 109.285 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.7 mm -64.14 -42.43 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.79 -40.83 73.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.487 -0.758 . . . . 0.0 109.732 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.5 -29.62 70.86 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.43 -52.7 24.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.538 0.685 . . . . 0.0 109.37 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.23 -24.9 61.45 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.926 -0.484 . . . . 0.0 110.054 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.474 179.958 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.538 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.85 -33.82 8.1 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.589 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.6 mp -69.42 -42.1 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.879 -0.777 . . . . 0.0 109.245 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.4 t -60.73 -30.89 70.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.66 -0.65 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -39.23 93.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.711 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.6 mtm -83.04 -19.31 37.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.648 -0.658 . . . . 0.0 109.87 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -80.35 -37.54 32.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.416 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 16' ' ' THR . 50.8 t -71.67 -28.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.072 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -66.57 -68.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.12 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.788 HD11 ' CE1' ' A' ' 39' ' ' TYR . 2.3 pt? -57.55 -31.0 65.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.939 -1.1 . . . . 0.0 109.491 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.42 68.74 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 78.9 t80 -62.1 -25.47 67.73 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.616 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.5 mp0 -75.5 -57.66 3.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.557 -0.714 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -67.22 -41.61 85.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.556 -0.715 . . . . 0.0 109.524 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.07 -25.18 58.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' PHE . 53.4 t -89.53 164.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.446 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.1 t -78.02 -70.13 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.485 -0.759 . . . . 0.0 111.009 -178.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -82.93 61.63 6.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 45.34 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -27.76 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 6.1 p-80 -70.21 -49.86 45.85 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.79 -18.82 62.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.344 -0.848 . . . . 0.0 109.393 178.948 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 16.7 t80 -59.45 -63.9 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 108.933 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -55.08 -24.11 23.83 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.722 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.96 -65.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.788 ' CE1' HD11 ' A' ' 22' ' ' LEU . 34.5 m-85 -80.59 -31.07 36.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.854 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.0 -48.79 78.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.819 . . . . 0.0 109.814 -179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -72.8 -35.84 67.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 0.0 109.855 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.81 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -67.08 -49.91 63.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.472 -0.767 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -60.44 -26.47 66.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.47 -0.769 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -71.67 -58.88 3.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.3 p -60.54 -43.44 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.482 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.9 mt -68.17 -27.67 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.37 -25.46 29.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.825 . . . . 0.0 109.806 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -107.05 28.13 8.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.506 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 3.6 t80 -93.35 139.48 22.96 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.23 11.54 3.28 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.104 2.536 . . . . 0.0 111.354 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.414 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.22 176.77 9.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -102.13 144.26 30.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.547 -0.72 . . . . 0.0 109.636 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.75 HG23 ' HB3' ' A' ' 58' ' ' GLU . 57.7 mt -82.67 122.1 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.622 -0.674 . . . . 0.0 109.223 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -81.02 -60.8 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -126.24 -179.96 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.19 -27.4 65.1 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.08 95.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -1.081 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.75 ' HB3' HG23 ' A' ' 53' ' ' ILE . 4.2 tt0 -61.7 -20.88 63.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.588 -0.695 . . . . 0.0 109.971 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -86.24 -24.86 25.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 109.895 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -70.34 -43.72 69.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.724 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -60.81 -28.72 68.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.773 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB3' HG21 ' A' ' 45' ' ' VAL . 97.4 mt -56.8 130.47 78.3 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.552 -0.717 . . . . 0.0 109.978 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.69 102.15 1.52 Allowed 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.833 2.356 . . . . 0.0 110.11 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.15 -27.74 1.85 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 t -89.57 138.3 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.545 -0.973 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.56 -143.76 13.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.0 t -98.64 -27.18 14.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.94 . . . . 0.0 109.694 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -82.26 -41.47 20.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.551 -0.718 . . . . 0.0 109.7 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.035 HD11 ' HB1' ' A' ' 38' ' ' ALA . 39.9 mm -72.37 -41.82 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.738 . . . . 0.0 109.884 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.94 71.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -0.811 . . . . 0.0 110.057 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.33 -32.62 68.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -64.73 -33.13 75.25 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.58 -42.8 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.54 -35.53 72.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.695 . . . . 0.0 109.372 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.64 -30.79 71.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -48.99 64.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.514 0.673 . . . . 0.0 109.2 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.7 mm? -74.33 -26.42 60.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.061 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -80.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 0.0 109.698 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 109.472 179.959 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -35.33 7.25 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' A' ' 19' ' ' LEU . 6.7 mt -74.71 -57.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.858 -0.789 . . . . 0.0 108.957 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -56.19 -30.85 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.962 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -32.72 74.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' HD23 ' A' ' 22' ' ' LEU . 9.9 mmm -88.74 -17.67 29.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.741 -0.6 . . . . 0.0 109.944 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -87.34 -35.37 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.528 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' THR . 46.0 t -78.59 -30.82 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -69.97 -59.73 2.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.661 -0.649 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.994 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.3 pp -63.24 -33.73 76.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.16 -41.51 62.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.484 -0.76 . . . . 0.0 109.537 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -64.87 -37.53 87.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.7 t80 -63.49 -24.05 67.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -74.12 -62.99 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.669 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 21.9 tttt -62.1 -41.95 98.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.876 -0.515 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -57.76 -23.94 54.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.772 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' PHE . 48.9 t -89.81 165.11 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.4 t -76.01 -70.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.459 -0.776 . . . . 0.0 111.107 -178.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -88.69 67.73 8.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.815 . . . . 0.0 110.675 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.1 38.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 109.666 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -88.69 -25.59 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.718 . . . . 0.0 109.589 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.472 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.99 -51.82 29.32 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.02 -19.34 63.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.739 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.2 t80 -57.15 -57.67 11.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.216 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.44 -26.77 66.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.655 -0.653 . . . . 0.0 109.469 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.848 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -53.98 -64.79 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.378 -0.826 . . . . 0.0 110.215 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.994 ' CG ' HD11 ' A' ' 22' ' ' LEU . 70.5 m-85 -74.01 -25.44 59.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 110.13 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -63.4 -47.73 80.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.357 -0.839 . . . . 0.0 109.316 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.42 -49.94 50.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.595 -0.691 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.751 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -61.95 -27.35 68.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 109.808 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -72.69 -28.22 62.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.938 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 p -84.81 -46.56 11.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.873 HG11 HG23 ' A' ' 65' ' ' VAL . 8.1 p -64.2 -35.57 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 110.109 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.6 HG13 HG13 ' A' ' 45' ' ' VAL . 66.8 mt -84.22 -37.05 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.951 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -82.61 -19.99 37.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.402 -0.811 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -104.72 21.52 16.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.301 -0.875 . . . . 0.0 110.014 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.528 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.9 t80 -94.07 140.81 23.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -86.32 9.96 3.83 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.015 2.476 . . . . 0.0 111.071 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.18 -176.61 5.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.76 162.64 12.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.714 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.601 HG23 ' HB3' ' A' ' 58' ' ' GLU . 50.7 mt -107.52 144.76 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.616 -0.677 . . . . 0.0 109.195 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -91.6 -63.72 1.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 109.673 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.8 p -124.42 -179.86 4.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.502 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.24 -29.87 72.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -30.36 70.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.991 . . . . 0.0 109.491 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.601 ' HB3' HG23 ' A' ' 53' ' ' ILE . 5.1 mt-10 -81.13 -25.74 36.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.581 -0.699 . . . . 0.0 109.724 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -83.89 -33.62 24.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.477 -0.765 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.526 -0.734 . . . . 0.0 109.974 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -59.68 -25.62 64.9 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.427 -0.796 . . . . 0.0 110.208 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 59' ' ' ALA . 10.9 mt -70.8 152.01 95.16 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.491 -0.756 . . . . 0.0 109.464 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -77.94 103.02 1.64 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.106 2.538 . . . . 0.0 110.297 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.13 -30.4 2.02 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.873 HG23 HG11 ' A' ' 45' ' ' VAL . 38.2 t -89.98 140.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.588 -0.948 . . . . 0.0 109.44 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -105.06 -146.64 15.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -99.47 -36.16 9.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.968 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.05 -60.2 2.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.848 HD11 ' HB1' ' A' ' 38' ' ' ALA . 46.8 mm -61.74 -36.54 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.535 -0.728 . . . . 0.0 109.728 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -57.83 -39.59 78.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -61.72 -39.6 92.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.093 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -62.58 -30.23 71.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.621 -0.674 . . . . 0.0 109.312 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 59' ' ' ALA . 49.5 mm -62.84 -45.13 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.63 -41.79 74.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.42 -28.75 70.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.13 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -52.47 18.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.378 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.75 61.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.972 -0.455 . . . . 0.0 110.086 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.23 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 109.543 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 109.487 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.476 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.09 -39.6 5.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.792 HG22 HD12 ' A' ' 19' ' ' LEU . 2.9 mp -65.77 -41.87 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.874 -0.78 . . . . 0.0 109.202 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 4.6 t -59.65 -31.08 69.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.613 -0.679 . . . . 0.0 109.643 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -65.0 -33.53 76.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.603 ' O ' HD23 ' A' ' 22' ' ' LEU . 15.1 mmt -90.13 -15.22 32.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.667 -0.646 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.792 HD12 HG22 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -88.86 -35.18 16.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 108.519 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 16' ' ' THR . 43.4 t -81.07 -31.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.3 -57.34 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.993 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.5 pp -63.27 -34.65 78.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.7 -44.78 63.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.55 -0.719 . . . . 0.0 109.791 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.91 -35.07 79.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.7 t80 -63.56 -24.66 67.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.854 -0.529 . . . . 0.0 109.898 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 21.2 mm-40 -79.25 -56.63 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.851 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.0 ttpt -64.99 -41.37 95.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.497 -0.752 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -58.51 -26.69 63.74 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.823 . . . . 0.0 109.412 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 25' ' ' PHE . 56.9 t -89.55 164.77 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.2 t -78.63 -70.16 0.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.454 -0.779 . . . . 0.0 111.093 -178.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -81.01 57.85 3.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.511 -0.743 . . . . 0.0 110.905 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.88 62.01 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 179.061 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -109.56 -28.87 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.195 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.437 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -63.35 -49.1 75.24 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.8 -25.99 63.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.594 -0.691 . . . . 0.0 109.312 179.375 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -51.35 -59.01 4.69 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.291 -0.88 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -61.37 -27.84 68.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.531 -0.731 . . . . 0.0 109.318 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.034 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.68 -65.96 0.52 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.461 -0.774 . . . . 0.0 109.953 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.993 ' CG ' HD11 ' A' ' 22' ' ' LEU . 81.1 m-85 -71.27 -8.79 56.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 110.798 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -83.88 -54.41 4.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.119 -0.988 . . . . 0.0 109.3 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -61.07 -29.11 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.516 -0.74 . . . . 0.0 109.83 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.822 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -79.82 -47.17 15.61 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.529 -0.732 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -61.6 -26.24 67.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.879 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 -45.36 27.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.966 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 62' ' ' LEU . 12.6 p -75.51 -44.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -0.777 . . . . 0.0 110.086 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.48 ' N ' HG13 ' A' ' 45' ' ' VAL . 70.3 mt -67.6 -55.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 -179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -61.53 -20.01 62.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -116.02 28.11 8.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 109.575 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.482 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.4 t80 -89.7 141.77 28.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -85.7 8.41 4.56 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.002 2.468 . . . . 0.0 110.998 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.7 m-70 -146.55 175.25 10.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 139.83 36.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.631 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.08 108.36 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.428 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -69.75 -40.34 76.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.821 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.3 m -148.55 -179.88 7.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.532 -0.73 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.33 -26.36 61.59 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.82 96.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.479 -1.012 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.58 -24.99 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.719 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -84.62 -27.67 27.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.415 -0.803 . . . . 0.0 109.733 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -75.9 -40.52 54.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -59.92 -22.4 62.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.788 ' HB3' HG21 ' A' ' 45' ' ' VAL . 86.5 mt -59.3 139.04 88.58 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 109.717 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.45 112.36 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.957 2.438 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.27 -28.52 5.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.78 138.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.932 . . . . 0.0 109.361 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.09 -139.52 10.17 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -99.22 -27.82 13.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.964 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -65.51 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.402 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.034 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.5 mm -61.94 -42.13 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 109.717 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.74 82.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.534 -0.729 . . . . 0.0 109.673 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.7 -35.75 77.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.514 -0.741 . . . . 0.0 109.53 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -68.9 -28.94 67.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.619 -0.676 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.5 mm -63.17 -49.44 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 109.144 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.22 -40.61 74.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.454 -0.779 . . . . 0.0 109.694 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.01 -28.77 70.33 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.43 -51.65 27.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.64 -0.662 . . . . 0.0 109.294 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.65 -25.68 61.37 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.907 -0.496 . . . . 0.0 110.039 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.405 -0.809 . . . . 0.0 109.587 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 109.407 179.867 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -39.52 5.79 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.549 HG23 ' CD2' ' A' ' 76' ' ' PHE . 3.3 mt -68.21 -52.25 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.826 -0.808 . . . . 0.0 109.086 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -55.88 -33.98 65.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.737 -0.602 . . . . 0.0 110.175 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.36 -33.49 73.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.552 -0.718 . . . . 0.0 109.45 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt -86.88 -13.74 43.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.693 -0.629 . . . . 0.0 110.258 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -85.44 -35.71 21.09 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.495 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.54 -31.68 20.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.747 -0.595 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.97 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.6 pp -63.28 -33.05 74.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.08 -41.95 65.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -63.54 -37.77 88.58 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.5 t80 -62.69 -23.58 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.92 -0.487 . . . . 0.0 109.707 178.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.1 mm-40 -77.34 -57.58 3.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.067 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 13.6 tttt -66.47 -41.35 89.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -58.12 -25.27 61.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.732 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.2 t -89.43 164.35 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.8 t -77.01 -70.25 0.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 110.925 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -84.54 61.7 6.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 110.638 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.79 52.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -98.98 -28.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.372 -0.83 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.9 p-80 -65.27 -49.26 70.26 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -69.15 -22.06 63.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.675 . . . . 0.0 109.569 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 26.8 t80 -56.9 -64.59 0.83 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -55.96 -25.02 41.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 109.772 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.09 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.71 -64.87 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.441 -0.787 . . . . 0.0 110.053 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.97 ' CG ' HD11 ' A' ' 22' ' ' LEU . 45.7 m-85 -81.7 -25.76 35.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.667 . . . . 0.0 110.282 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 tpt85 -62.11 -44.47 96.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.8 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -78.0 -42.58 32.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.796 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.795 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.97 -29.74 71.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 109.662 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -76.64 -31.71 57.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -75.49 -41.31 55.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.4 p -70.88 -44.25 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.478 -0.764 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.548 HG13 HG13 ' A' ' 45' ' ' VAL . 69.9 mt -73.41 -27.95 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.471 -0.768 . . . . 0.0 109.853 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.41 -23.3 43.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -116.64 28.14 8.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.586 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.1 t80 -88.1 142.48 31.95 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -85.63 6.78 5.41 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.063 2.509 . . . . 0.0 111.177 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -145.67 170.77 15.81 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -98.26 135.95 39.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.551 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.789 HG23 ' HB3' ' A' ' 58' ' ' GLU . 55.9 mt -73.06 120.66 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.572 -0.705 . . . . 0.0 109.271 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -82.16 -49.64 9.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.543 -0.723 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.48 -179.81 5.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.607 -0.683 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.42 -27.72 71.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.01 96.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.589 -0.948 . . . . 0.0 109.681 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.789 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -61.36 -20.79 63.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.836 179.944 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.87 -26.4 22.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.397 -0.815 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -74.01 -39.92 63.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.504 -0.747 . . . . 0.0 109.71 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.19 -25.86 65.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.55 -0.719 . . . . 0.0 110.01 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HG21 ' A' ' 45' ' ' VAL . 84.3 mt -59.21 144.64 82.89 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.503 -0.748 . . . . 0.0 109.714 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -79.1 112.61 3.09 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.021 2.481 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.13 -28.57 6.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.7 139.6 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 109.343 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.43 -137.61 7.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 p -99.1 -29.34 12.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.601 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -65.92 -65.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.482 -0.761 . . . . 0.0 109.587 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.09 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.7 mm -61.78 -42.78 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.818 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.89 70.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.7 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.43 -43.22 99.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -62.22 -28.45 69.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.315 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.2 mm -63.48 -44.52 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.41 -41.3 76.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.474 -0.766 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.07 -27.54 69.47 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.549 ' CD2' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -71.46 -52.09 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 0.0 109.409 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -71.22 -26.68 63.03 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.949 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 109.527 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.416 -0.803 . . . . 0.0 109.272 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.25 -38.43 5.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.08 -49.52 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.836 -0.802 . . . . 0.0 109.155 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 5.0 t -57.48 -35.01 69.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.055 -179.3 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -59.74 -35.53 74.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.458 -0.776 . . . . 0.0 109.471 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.699 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.1 tpp -90.35 -11.88 39.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.163 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.667 ' CD1' HG22 ' A' ' 15' ' ' ILE . 3.9 mt -87.48 -32.62 19.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.702 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.3 t -85.57 -36.54 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HA ' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -67.04 -47.24 71.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.914 HD11 ' CG ' ' A' ' 39' ' ' TYR . 1.9 pp -73.82 -34.97 64.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 108.437 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.82 -49.9 67.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.675 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -62.4 -33.02 73.94 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 37.5 t80 -64.52 -21.33 66.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.714 -0.616 . . . . 0.0 109.609 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -78.47 -57.81 3.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.366 -0.834 . . . . 0.0 108.85 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.1 tmtt? -66.81 -39.79 87.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 109.426 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -58.7 -26.4 63.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.791 . . . . 0.0 109.603 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 63.1 t -89.44 164.41 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.03 -70.01 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.768 . . . . 0.0 111.012 -178.617 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -84.64 60.34 6.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 110.687 -178.626 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.91 63.96 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -110.12 -31.02 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.812 . . . . 0.0 109.008 179.777 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -60.88 -48.8 80.15 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.426 -0.796 . . . . 0.0 108.904 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.92 -26.02 63.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.645 -0.659 . . . . 0.0 109.544 179.339 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.3 t80 -51.54 -65.56 0.54 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -57.61 -25.06 59.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.058 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -57.42 -67.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.914 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.8 m-85 -72.32 -24.65 61.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.64 -0.663 . . . . 0.0 110.268 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 -62.54 -42.3 99.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -75.12 -44.53 46.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.504 -0.747 . . . . 0.0 109.801 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -62.11 -41.26 98.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -65.21 -29.45 70.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.793 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -70.78 -34.67 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.72 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.842 HG21 ' HB3' ' A' ' 62' ' ' LEU . 13.6 p -90.14 -45.35 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 110.121 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.477 ' N ' HG13 ' A' ' 45' ' ' VAL . 69.7 mt -66.74 -55.64 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.0 109.723 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -59.25 -19.92 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -118.05 28.08 8.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.763 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.614 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.6 t80 -91.05 139.84 25.85 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -85.09 6.95 5.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.034 2.489 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.415 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.7 m-70 -147.14 172.52 13.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.168 -0.957 . . . . 0.0 109.536 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -98.61 144.05 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.553 -0.717 . . . . 0.0 109.512 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.814 HG23 ' HB3' ' A' ' 58' ' ' GLU . 57.3 mt -75.28 108.85 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 109.36 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -71.18 -46.57 61.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.657 -0.652 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.9 173.43 11.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.08 -28.43 68.91 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.44 71.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.654 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.814 ' HB3' HG23 ' A' ' 53' ' ' ILE . 6.4 tt0 -74.36 -24.18 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.556 -0.715 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.755 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.38 -29.31 24.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.41 -0.806 . . . . 0.0 109.587 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -76.22 -38.82 55.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.543 -0.723 . . . . 0.0 109.629 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -60.32 -23.67 64.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 0.0 110.06 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.842 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.9 mt -60.94 141.29 93.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.515 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.54 107.91 2.22 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.939 2.426 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.9 -28.78 3.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 70' ' ' ALA . 28.3 t -89.79 138.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -1.02 . . . . 0.0 109.379 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.7 -137.38 8.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -98.91 -26.69 14.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.598 -0.943 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -69.93 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.058 HD11 ' HB1' ' A' ' 38' ' ' ALA . 48.3 mm -61.42 -45.08 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.733 . . . . 0.0 109.804 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.543 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -57.62 -34.11 68.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.469 -0.77 . . . . 0.0 109.831 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.95 -43.55 98.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.732 . . . . 0.0 109.312 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -63.43 -29.65 70.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.673 . . . . 0.0 109.266 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.755 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.8 mm -63.17 -46.42 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.67 -40.72 72.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.531 -0.731 . . . . 0.0 109.647 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.58 -28.72 70.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -52.31 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.56 -0.712 . . . . 0.0 109.36 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.68 -25.67 61.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.932 -0.48 . . . . 0.0 110.005 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.93 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.451 -0.781 . . . . 0.0 109.435 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt 60.03 85.06 0.11 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.468 -0.77 . . . . 0.0 109.692 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.09 -70.91 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.673 . . . . 0.0 109.465 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm 60.34 83.61 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.671 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -70.8 176.15 2.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 109.463 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.671 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.1 Cg_endo -86.28 157.68 9.65 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.402 2.735 . . . . 0.0 110.477 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -71.33 127.9 34.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.515 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -152.41 162.13 41.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 p -102.65 83.78 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 52' ' ' LYS . 13.0 tp -110.06 -69.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.545 -0.722 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -131.89 37.24 3.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.0 109.289 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.64 0.52 86.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.16 6.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.844 HG22 ' CD1' ' A' ' 19' ' ' LEU . 4.1 mt -65.98 -55.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.853 -0.792 . . . . 0.0 109.021 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -51.49 -31.5 23.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 110.345 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.91 -29.36 70.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.587 -0.696 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.56 ' O ' HD23 ' A' ' 22' ' ' LEU . 14.7 mmt -88.87 -20.09 25.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 0.0 109.869 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.844 ' CD1' HG22 ' A' ' 15' ' ' ILE . 2.5 mp -89.28 -33.54 16.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' THR . 51.5 t -75.06 -34.33 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -59.44 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 0.0 109.308 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.995 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.0 pp -61.56 -30.66 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -55.41 -40.2 71.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 109.139 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.82 -35.84 82.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.3 t80 -64.14 -24.61 67.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.847 -0.533 . . . . 0.0 109.646 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.576 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -74.42 -61.21 1.94 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.543 -0.723 . . . . 0.0 109.292 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.9 tmtm? -63.47 -41.98 98.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.698 -0.626 . . . . 0.0 109.601 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.8 -23.88 54.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' PHE . 50.1 t -89.83 164.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.7 t -75.4 -70.21 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.982 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -89.64 68.18 7.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.46 -0.775 . . . . 0.0 110.702 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.92 44.16 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.617 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -92.44 -26.77 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.46 -49.69 52.54 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.5 -19.87 62.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.755 . . . . 0.0 109.271 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.4 t80 -57.67 -60.13 4.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 34' ' ' HIS . 12.1 p30 -57.96 -28.05 63.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.552 -0.717 . . . . 0.0 109.591 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.03 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -49.76 -63.09 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.612 -0.68 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.995 ' CG ' HD11 ' A' ' 22' ' ' LEU . 58.6 m-85 -80.41 -23.21 40.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.781 -0.574 . . . . 0.0 110.488 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -45.37 94.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.687 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -78.9 -46.73 17.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.871 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.826 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.16 -29.68 70.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.542 -0.724 . . . . 0.0 109.789 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.14 -30.03 54.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 t -79.03 -42.81 25.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.926 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 62' ' ' LEU . 10.6 p -69.18 -44.35 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.021 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.556 HG13 HG13 ' A' ' 45' ' ' VAL . 71.0 mt -73.23 -26.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 109.953 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.42 -20.24 37.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.68 26.54 8.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.872 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.504 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.5 t80 -80.75 140.97 51.13 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.516 -0.74 . . . . 0.0 109.037 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.4 Cg_endo -85.28 7.31 5.2 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.039 2.493 . . . . 0.0 111.172 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.0 179.59 7.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.893 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.698 ' HB3' HD11 ' A' ' 11' ' ' LEU . 2.9 pttm -109.71 169.03 8.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 109.602 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 58' ' ' GLU . 11.9 pt -131.3 156.04 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -140.1 28.76 2.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -170.17 155.25 5.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 109.398 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.21 -30.3 77.1 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.3 93.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.971 . . . . 0.0 109.472 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.482 ' HB3' HG22 ' A' ' 53' ' ' ILE . 5.3 mt-10 -61.37 -21.99 64.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.973 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -90.17 -26.6 20.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.33 -0.857 . . . . 0.0 109.772 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -74.61 -37.87 62.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 109.687 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -59.7 -26.77 65.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.52 -0.737 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.845 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.7 mt -60.4 146.09 85.22 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.56 -0.712 . . . . 0.0 109.599 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.5 109.81 2.54 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.7 -28.47 4.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 42' ' ' ALA . 26.1 t -89.82 138.34 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -1.01 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.29 -141.71 10.14 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 p -96.11 -30.6 13.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.537 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -65.35 -62.14 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.03 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.9 mm -61.63 -44.94 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.732 . . . . 0.0 109.722 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.54 69.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.759 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.91 -41.01 97.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.725 . . . . 0.0 109.405 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -65.49 -31.27 72.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.666 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.1 mm -63.47 -44.52 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -56.61 -40.35 75.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 109.605 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.06 -26.99 69.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 109.122 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -51.36 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.688 . . . . 0.0 109.462 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.39 -29.15 62.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.938 -0.476 . . . . 0.0 110.021 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -123.17 -68.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.421 -0.8 . . . . 0.0 109.461 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.05 -46.08 0.81 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.51 153.86 29.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.609 -0.936 . . . . 0.0 109.462 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -160.34 146.1 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -100.05 -54.84 2.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.552 -0.718 . . . . 0.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -114.87 174.46 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.705 . . . . 0.0 109.414 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -98.72 171.92 7.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.581 -0.699 . . . . 0.0 109.463 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.16 162.88 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.442 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -175.54 130.37 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.497 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -81.07 -59.16 2.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -120.74 135.87 55.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.598 -0.689 . . . . 0.0 109.465 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -85.64 176.28 3.77 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.1 Cg_endo -85.46 139.53 6.89 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.364 2.709 . . . . 0.0 110.512 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -63.26 -39.55 94.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -161.03 147.27 14.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' THR . 4.2 t -82.21 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.737 HD22 ' CG ' ' A' ' 52' ' ' LYS . 29.2 mt -110.06 -69.4 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.544 -0.723 . . . . 0.0 109.417 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -132.91 48.58 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 109.267 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.47 -4.91 72.92 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.9 -37.57 6.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.759 HG22 HD12 ' A' ' 19' ' ' LEU . 1.6 mp -65.78 -43.07 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.811 -0.817 . . . . 0.0 109.102 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.684 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.2 t -57.63 -34.13 68.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.7 . . . . 0.0 109.942 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -31.77 73.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.6 mmm -89.44 -22.16 22.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 109.915 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.768 HD23 ' CD2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -83.43 -37.08 23.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 16' ' ' THR . 50.1 t -75.08 -29.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.49 -64.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -64.26 -30.47 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.5 -46.14 66.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.547 -0.72 . . . . 0.0 109.524 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -36.97 84.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 29' ' ' VAL . 27.0 t80 -62.48 -20.35 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.0 109.926 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -78.92 -57.78 3.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.336 -0.852 . . . . 0.0 109.038 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -68.71 -38.53 80.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.74 -26.77 64.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.752 . . . . 0.0 109.646 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 25' ' ' PHE . 79.1 t -89.4 164.17 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.97 -70.0 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 111.022 -178.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.0 60.87 6.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.04 66.62 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.83 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.16 -32.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 108.88 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.426 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -61.61 -48.61 80.13 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.273 -0.892 . . . . 0.0 108.735 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.54 -20.58 62.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CZ ' ' HG3' ' A' ' 40' ' ' ARG . 23.8 t80 -57.54 -69.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.27 -0.894 . . . . 0.0 109.607 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -52.94 -25.32 11.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.342 -0.849 . . . . 0.0 109.99 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.032 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.98 -55.43 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.482 -0.762 . . . . 0.0 109.859 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.01 ' CG ' HD11 ' A' ' 22' ' ' LEU . 44.7 m-85 -90.02 -29.72 18.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 110.116 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -63.05 -44.62 95.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -75.93 -41.83 50.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.588 -0.695 . . . . 0.0 109.594 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.803 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -62.72 -48.84 77.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.489 -0.757 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -62.11 -27.05 68.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.486 -0.759 . . . . 0.0 109.887 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -75.97 -50.61 14.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.46 -0.775 . . . . 0.0 110.045 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.0 p -66.95 -44.16 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.496 -0.752 . . . . 0.0 110.001 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.485 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.3 mt -68.18 -53.9 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.464 -0.772 . . . . 0.0 109.78 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.28 60.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.42 28.32 8.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.486 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.6 t80 -87.01 139.53 32.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.582 -0.698 . . . . 0.0 109.155 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.99 10.14 3.79 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.067 2.511 . . . . 0.0 111.253 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.3 m-70 -147.09 175.09 10.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 0.0 109.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.737 ' CG ' HD22 ' A' ' 11' ' ' LEU . 5.3 mtmt -91.52 177.95 6.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.687 . . . . 0.0 109.575 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.662 HG23 ' CB ' ' A' ' 58' ' ' GLU . 48.1 mt -121.83 118.44 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -75.08 -43.24 54.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.512 -0.743 . . . . 0.0 109.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 -179.5 7.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.692 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.46 -26.84 60.06 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.98 70.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.465 -1.02 . . . . 0.0 109.367 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.662 ' CB ' HG23 ' A' ' 53' ' ' ILE . 4.1 mp0 -73.24 -20.88 60.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.72 -0.612 . . . . 0.0 109.889 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.53 -26.52 24.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.89 . . . . 0.0 109.798 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -41.78 61.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -59.74 -24.49 64.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 110.02 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.83 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.5 mt -60.42 142.35 90.75 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.488 -0.758 . . . . 0.0 109.52 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.95 109.07 2.33 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.035 2.49 . . . . 0.0 110.253 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.77 5.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.563 HG22 ' HA ' ' A' ' 42' ' ' ALA . 22.0 t -89.53 137.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.435 -1.039 . . . . 0.0 109.39 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.07 -149.06 22.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -98.11 -29.9 12.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.591 -0.947 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -71.06 -44.49 65.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.622 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.032 HD11 ' HB1' ' A' ' 38' ' ' ALA . 40.6 mm -70.34 -44.96 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 0.0 109.811 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.12 87.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.0 109.739 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.47 -37.6 84.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.528 -0.732 . . . . 0.0 109.601 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -63.01 -32.47 73.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 109.392 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.78 -43.05 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -55.93 -41.1 74.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.735 . . . . 0.0 109.674 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.69 -29.37 70.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -52.53 22.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.697 . . . . 0.0 109.393 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.47 61.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.906 -0.496 . . . . 0.0 110.062 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -79.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -61.09 1.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 109.47 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.07 58.87 3.08 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -139.43 140.29 37.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.964 . . . . 0.0 109.532 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.85 51.37 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.559 -0.713 . . . . 0.0 109.411 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -73.81 -72.05 0.29 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -110.51 -41.4 4.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 85' ' ' LEU . 10.0 mp -70.06 135.15 48.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.488 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -94.27 -46.3 7.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.479 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.064 0.459 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 69.41 -67.53 0.22 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.578 -0.701 . . . . 0.0 109.795 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 mtt-85 59.18 91.57 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.391 -0.818 . . . . 0.0 109.826 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -88.5 -48.76 7.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -73.82 169.15 19.97 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.67 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.2 Cg_endo -86.46 158.6 9.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.386 2.724 . . . . 0.0 110.489 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -67.28 144.33 55.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -154.84 170.91 20.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.745 . . . . 0.0 109.547 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 10' ' ' THR . 2.7 t -109.31 81.96 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 0.0 109.472 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 51' ' ' HIS . 6.4 mt -99.92 -70.02 0.75 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.501 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.64 ' O ' HG22 ' A' ' 16' ' ' THR . 30.1 m-80 -94.46 46.78 1.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.2 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.97 -3.84 72.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.893 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.95 -37.96 5.89 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 73' ' ' ILE . 3.0 mp -78.88 -49.4 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.947 -0.737 . . . . 0.0 109.756 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.3 t -58.15 -33.81 69.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.24 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.402 ' O ' HD22 ' A' ' 22' ' ' LEU . 6.2 mtp -84.19 -16.23 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -81.1 -38.68 26.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 16' ' ' THR . 48.8 t -71.94 -28.96 31.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -64.52 -66.6 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.603 -0.686 . . . . 0.0 110.015 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.678 HD11 ' CE1' ' A' ' 39' ' ' TYR . 1.9 pt? -63.76 -33.83 76.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.549 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.36 -41.63 60.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.558 -0.714 . . . . 0.0 109.82 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.14 -38.38 85.42 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 29' ' ' VAL . 66.9 t80 -63.73 -26.09 68.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.745 -0.597 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.663 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.2 mp0 -75.97 -57.83 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 20.1 tttp -65.81 -42.22 90.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 0.0 109.507 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.44 -24.64 56.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.5 t -89.5 164.82 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 47.4 t -77.31 -70.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 111.072 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -83.53 63.12 7.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.696 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.84 38.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.43 -23.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -0.78 . . . . 0.0 109.523 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -73.87 -51.84 14.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.54 -19.88 63.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 109.164 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 18.9 t80 -59.35 -56.15 25.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 0.0 108.915 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -58.97 -26.72 64.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.747 . . . . 0.0 109.494 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.059 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -57.75 -67.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.459 -0.776 . . . . 0.0 109.822 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.678 ' CE1' HD11 ' A' ' 22' ' ' LEU . 20.6 m-85 -75.35 -28.67 59.66 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.579 -0.7 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 23.5 tpt180 -63.5 -52.63 60.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.499 -0.751 . . . . 0.0 109.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -62.28 -39.49 93.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.35 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.903 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -65.02 -39.5 93.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.563 -0.711 . . . . 0.0 109.106 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.2 65.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.449 -0.782 . . . . 0.0 109.704 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 m -82.96 -53.43 5.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.711 HG11 HG23 ' A' ' 65' ' ' VAL . 7.9 p -63.62 -42.5 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.491 -0.756 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.462 ' N ' HG13 ' A' ' 45' ' ' VAL . 48.3 mm -68.9 -36.85 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.777 . . . . 0.0 109.404 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.64 36.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.494 -0.754 . . . . 0.0 110.31 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -101.02 15.8 27.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.487 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.456 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 4.2 t80 -96.8 133.63 24.17 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -86.57 14.94 2.31 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.198 2.599 . . . . 0.0 111.784 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.537 ' HA ' HD13 ' A' ' 11' ' ' LEU . 69.8 m-70 -148.11 175.02 11.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 109.893 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 159.84 14.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.695 . . . . 0.0 109.536 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 58' ' ' GLU . 9.1 mt -98.15 137.22 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -86.0 -47.9 9.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.704 . . . . 0.0 109.649 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 p -136.53 179.58 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.661 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.17 78.46 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.11 71.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.983 . . . . 0.0 109.413 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.695 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.6 mt-10 -70.21 -21.58 63.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.619 -0.676 . . . . 0.0 109.884 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.714 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -80.71 -32.73 35.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 18.0 ttpp -74.43 -38.85 62.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.555 -0.716 . . . . 0.0 110.114 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -59.98 -26.69 66.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' A' ' 59' ' ' ALA . 8.2 mt -71.29 148.44 93.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.363 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.28 106.21 2.11 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.05 2.5 . . . . 0.0 110.351 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.04 2.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.711 HG23 HG11 ' A' ' 45' ' ' VAL . 28.8 t -89.73 139.66 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.993 . . . . 0.0 109.385 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.41 -147.21 21.98 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -30.59 11.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.601 -0.94 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -82.51 -41.7 19.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.658 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.059 HD11 ' HB1' ' A' ' 38' ' ' ALA . 42.8 mm -72.18 -39.89 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.469 -0.769 . . . . 0.0 109.742 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.27 -51.91 67.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.494 -0.754 . . . . 0.0 109.778 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.35 -32.13 68.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.441 -0.787 . . . . 0.0 109.471 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -63.15 -34.51 77.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 15' ' ' ILE . 46.7 mm -64.33 -38.7 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.37 -40.17 74.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.48 -0.763 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.19 -30.57 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -52.47 36.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.282 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.28 -25.2 60.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.903 -0.498 . . . . 0.0 110.165 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.99 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.291 -0.881 . . . . 0.0 109.769 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.0 m -122.64 -61.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.27 -32.5 1.97 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -106.74 169.03 8.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.615 -0.932 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mt -112.58 131.39 55.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.725 . . . . 0.0 109.455 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -89.36 149.69 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -87.4 164.61 16.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.577 -0.702 . . . . 0.0 109.511 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -141.76 38.43 1.65 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.522 -0.736 . . . . 0.0 109.459 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.64 159.28 42.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.496 -0.752 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.5 tttm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.479 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -63.28 -29.98 71.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.577 -0.702 . . . . 0.0 109.65 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -149.49 -44.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.508 -0.745 . . . . 0.0 109.809 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? 61.1 38.79 16.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.387 -0.821 . . . . 0.0 109.568 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.85 111.77 5.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.523 -0.735 . . . . 0.0 109.502 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.02 81.72 1.3 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.132 2.554 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.63 -171.05 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.372 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -83.21 100.44 10.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 10' ' ' THR . 5.0 t -62.78 112.99 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.7 . . . . 0.0 109.585 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -105.45 -73.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 109.515 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.564 ' HB3' HG22 ' A' ' 46' ' ' ILE . 7.6 m120 -92.02 53.57 2.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.579 -0.7 . . . . 0.0 109.142 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -7.0 68.4 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.74 -43.52 4.48 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.806 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.9 mt -68.11 -44.36 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.943 -0.74 . . . . 0.0 109.406 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.726 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 5.0 t -58.32 -34.14 70.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.6 -0.687 . . . . 0.0 109.948 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.08 -34.44 77.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.27 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.511 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.0 mtt -89.9 -15.55 31.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.694 -0.629 . . . . 0.0 110.157 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.806 ' CD1' HG22 ' A' ' 15' ' ' ILE . 2.2 mt -88.19 -35.7 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 108.485 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 16' ' ' THR . 44.7 t -78.94 -31.4 14.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -70.45 -59.33 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.887 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.002 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.3 pp -63.92 -34.71 78.57 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.273 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.93 -42.22 62.63 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.593 -0.692 . . . . 0.0 109.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -63.68 -38.07 89.73 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.1 t80 -61.96 -23.76 66.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.818 -0.551 . . . . 0.0 109.82 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.6 mm-40 -76.88 -57.75 3.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.443 -0.786 . . . . 0.0 109.148 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 14.5 tttm -67.69 -41.12 84.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.537 -0.727 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -57.45 -25.41 59.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.383 -0.823 . . . . 0.0 109.733 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 63.8 t -89.27 164.23 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.62 -70.09 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.463 -0.773 . . . . 0.0 110.905 -178.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -82.79 59.92 5.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.465 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.72 63.57 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -109.7 -29.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 108.957 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -64.11 -49.08 73.63 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.01 -25.45 63.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.629 -0.669 . . . . 0.0 109.421 179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 40' ' ' ARG . 28.0 t80 -52.59 -64.12 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.246 -0.909 . . . . 0.0 109.799 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -57.42 -26.07 60.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.506 -0.746 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.057 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.16 -65.78 0.54 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.002 ' CG ' HD11 ' A' ' 22' ' ' LEU . 72.0 m-85 -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.636 -0.665 . . . . 0.0 110.039 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' HG2' ' HB1' ' A' ' 23' ' ' ALA . 9.1 mmm180 -67.16 -39.68 86.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.527 -0.733 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -72.69 -45.41 58.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -63.37 -40.99 98.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -66.65 -24.76 66.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.548 -0.72 . . . . 0.0 109.883 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -78.13 -36.27 48.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.976 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.812 HG21 ' HB3' ' A' ' 62' ' ' LEU . 13.5 p -90.01 -44.95 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.402 -0.811 . . . . 0.0 110.008 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' A' ' 12' ' ' ASN . 69.8 mt -66.56 -56.03 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.726 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -60.41 -20.26 59.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.6 -0.687 . . . . 0.0 110.3 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 26.7 9.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.523 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.2 t80 -88.52 138.14 30.19 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.183 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.39 12.06 3.12 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.104 2.536 . . . . 0.0 111.342 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 68.2 m-70 -147.69 169.74 19.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -0.971 . . . . 0.0 109.743 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -105.46 141.18 37.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 0.0 109.664 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.662 HG22 ' HB3' ' A' ' 58' ' ' GLU . 17.4 pt -97.51 154.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -114.88 -29.96 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.595 -0.691 . . . . 0.0 109.807 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.43 165.35 23.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 109.625 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.83 -26.03 64.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.35 85.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -1.068 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.662 ' HB3' HG22 ' A' ' 53' ' ' ILE . 7.7 mt-10 -63.69 -19.08 64.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.71 -0.619 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -89.26 -26.4 21.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -38.52 63.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.763 . . . . 0.0 109.656 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -60.48 -26.45 66.81 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.812 ' HB3' HG21 ' A' ' 45' ' ' VAL . 51.9 mt -60.3 141.37 91.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.718 . . . . 0.0 109.563 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -80.02 112.65 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.931 2.421 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.06 -22.68 6.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.36 137.15 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -1.068 . . . . 0.0 109.373 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.07 -146.55 21.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 t -100.22 -30.32 11.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.635 -0.92 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -69.41 -45.33 69.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.552 -0.717 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.057 HD11 ' HB1' ' A' ' 38' ' ' ALA . 43.4 mm -72.85 -42.04 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.35 88.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -61.38 -36.35 80.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.563 -0.71 . . . . 0.0 109.448 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -64.45 -31.43 72.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.662 -0.649 . . . . 0.0 109.412 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.2 mm -63.53 -45.64 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -55.81 -39.72 71.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -64.47 -30.36 71.39 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -51.62 45.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.609 -0.682 . . . . 0.0 109.219 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.73 -25.24 60.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.896 -0.503 . . . . 0.0 110.057 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.7 p -123.27 -51.07 1.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.403 -0.81 . . . . 0.0 109.54 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.09 -58.51 0.45 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -132.03 134.57 45.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.962 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -145.01 137.84 26.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.557 -0.715 . . . . 0.0 109.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -66.23 89.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.59 -0.694 . . . . 0.0 109.494 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -139.41 115.79 10.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.536 -0.728 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.6 mt -136.69 123.65 21.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -122.4 145.42 48.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.451 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 tttm 60.1 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 109.688 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 -64.04 147.67 51.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.612 -0.68 . . . . 0.0 109.571 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.14 85.53 0.11 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.558 -0.713 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 161.49 37.95 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.64 -0.663 . . . . 0.0 109.457 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.51 50.5 2.35 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.399 2.733 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -89.69 158.56 17.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -99.46 172.36 7.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.622 -0.674 . . . . 0.0 109.56 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -118.12 -11.17 10.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 110.468 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.21 -69.68 0.1 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.981 -1.075 . . . . 0.0 110.706 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -109.59 36.1 3.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -4.39 71.71 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -36.29 6.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.8 mp -68.07 -47.9 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.886 -0.773 . . . . 0.0 109.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -60.3 -29.6 68.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.3 -32.79 74.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.593 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -90.0 -14.08 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.632 -0.667 . . . . 0.0 110.139 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 1.5 mt -88.8 -35.11 16.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 16' ' ' THR . 42.9 t -79.67 -31.8 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -70.11 -59.19 3.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.622 -0.674 . . . . 0.0 109.656 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.983 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.0 pp -63.02 -34.96 78.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 109.195 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.88 -42.16 62.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.541 -0.724 . . . . 0.0 109.76 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.2 -35.18 80.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.9 t80 -64.16 -27.16 68.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.846 -0.534 . . . . 0.0 109.582 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.651 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 38.3 mm-40 -78.58 -55.51 5.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.9 ttmt -63.8 -43.59 95.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.502 -0.749 . . . . 0.0 109.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.25 -24.52 59.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' PHE . 46.5 t -89.34 165.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 29' ' ' VAL . 42.5 t -76.81 -70.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.471 -0.768 . . . . 0.0 111.241 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -85.43 65.02 8.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.394 -0.816 . . . . 0.0 110.789 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.82 43.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.348 -0.845 . . . . 0.0 109.667 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -94.54 -23.39 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.777 . . . . 0.0 109.479 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.445 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 p-80 -70.86 -51.69 24.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.375 -0.828 . . . . 0.0 108.808 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.32 -25.41 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 29.0 t80 -53.21 -53.97 42.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.47 -27.43 69.28 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -56.02 -63.71 1.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.507 -0.746 . . . . 0.0 110.435 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.983 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.5 m-85 -71.59 -23.96 61.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.793 -0.567 . . . . 0.0 110.49 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.19 -55.63 23.46 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -62.72 -43.02 99.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 109.811 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.825 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -67.65 -27.73 67.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.577 -0.702 . . . . 0.0 109.801 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -72.2 -24.47 61.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 110.077 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.5 p -90.08 -49.91 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.284 -0.885 . . . . 0.0 110.025 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.778 HG11 HG23 ' A' ' 65' ' ' VAL . 7.4 p -60.87 -33.28 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.554 -0.717 . . . . 0.0 109.901 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.606 HG13 HG13 ' A' ' 45' ' ' VAL . 63.7 mt -87.02 -30.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.442 -0.787 . . . . 0.0 109.976 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -87.21 -18.22 30.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 0.0 110.311 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -112.97 25.88 11.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.579 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.0 t80 -89.91 140.03 27.63 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.419 -0.801 . . . . 0.0 109.125 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.76 12.0 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.113 2.542 . . . . 0.0 111.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.1 m-70 -146.38 170.86 15.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.92 . . . . 0.0 109.734 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -94.42 147.42 23.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.738 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 58' ' ' GLU . 11.0 mt -97.0 134.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -100.77 -57.94 2.0 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 109.587 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -105.22 159.94 15.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.25 -31.26 80.12 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.03 71.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.944 . . . . 0.0 109.377 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' A' ' 53' ' ' ILE . 18.4 tt0 -67.8 -22.35 65.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.644 -0.66 . . . . 0.0 109.806 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.619 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.17 -29.47 24.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.677 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 10.8 ttpp -75.63 -38.13 59.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.845 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -59.85 -24.25 64.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 110.219 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 49' ' ' TYR . 44.0 mt -69.07 151.09 97.34 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.521 -0.737 . . . . 0.0 109.458 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.34 99.94 1.28 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.029 2.486 . . . . 0.0 110.154 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.55 -27.54 1.94 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.778 HG23 HG11 ' A' ' 45' ' ' VAL . 38.5 t -89.68 138.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -1.009 . . . . 0.0 109.538 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -98.93 -146.89 21.19 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -100.1 -28.27 13.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.968 . . . . 0.0 109.726 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.21 -61.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 109.761 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.825 HG21 ' CB ' ' A' ' 42' ' ' ALA . 46.4 mm -65.13 -33.29 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.514 -0.741 . . . . 0.0 109.75 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -52.51 -57.49 9.78 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 110.22 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.15 -31.4 67.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 109.329 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.04 70.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 59' ' ' ALA . 44.6 mm -71.03 -43.87 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 108.978 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -52.36 -50.54 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.62 -30.26 70.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.42 -0.8 . . . . 0.0 109.142 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -42.47 93.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 77' ' ' LEU . 4.1 mm? -83.79 -22.74 31.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.184 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.34 -0.85 . . . . 0.0 109.645 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.47 HG23 ' N ' ' A' ' 80' ' ' GLY . 4.7 t -127.41 -42.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' N ' HG23 ' A' ' 79' ' ' THR . . . 87.1 60.08 1.7 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -138.51 168.01 20.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.576 -0.955 . . . . 0.0 109.486 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' N ' HD22 ' A' ' 82' ' ' LEU . 4.3 mm? -90.43 95.03 9.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -62.87 140.38 58.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -107.05 -62.35 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.46 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.6 mt -82.78 155.79 24.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.06 -31.05 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 tptt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.5 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 149.66 47.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.614 -0.679 . . . . 0.0 109.59 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.54 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.565 -0.709 . . . . 0.0 109.493 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 59.91 168.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.499 -0.751 . . . . 0.0 109.677 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.8 159.09 81.89 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.532 -0.73 . . . . 0.0 109.514 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -86.76 -165.13 0.24 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.475 2.784 . . . . 0.0 110.408 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.55 -173.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -155.53 111.53 3.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.566 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.6 p -117.86 -42.39 2.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.627 -0.671 . . . . 0.0 109.385 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -163.12 0.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.535 -0.728 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' HB2' HG22 ' A' ' 46' ' ' ILE . 17.1 m-80 -90.59 51.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.414 -0.804 . . . . 0.0 109.425 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.48 62.95 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.86 -35.93 6.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.845 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.7 mp -67.82 -48.11 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.88 -0.776 . . . . 0.0 109.117 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -56.77 -28.09 60.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.605 -0.684 . . . . 0.0 109.899 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.54 -27.01 64.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.497 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.5 mmt -89.95 -19.45 24.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 109.966 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.3 mp -86.52 -33.65 20.23 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 16' ' ' THR . 48.7 t -76.23 -36.02 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -58.99 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.616 -0.678 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.97 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -63.06 -31.03 72.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.214 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.71 -41.42 61.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -0.772 . . . . 0.0 109.592 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -40.33 81.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.7 t80 -63.32 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.771 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -76.24 -56.85 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.228 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 24.4 ttpt -61.8 -46.92 87.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -0.788 . . . . 0.0 109.742 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -56.79 -22.46 36.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.367 -0.833 . . . . 0.0 109.93 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 25' ' ' PHE . 40.1 t -88.86 165.29 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 29' ' ' VAL . 42.6 t -76.98 -70.56 0.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 111.402 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -81.23 62.4 5.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.404 -0.81 . . . . 0.0 110.737 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.0 27.55 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -82.18 -30.82 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.448 -0.783 . . . . 0.0 108.921 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 8.2 p-80 -69.66 -44.68 70.01 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 1.6 ptpm? -75.75 -20.45 58.29 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 8.5 t80 -58.41 -58.23 9.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.312 -0.867 . . . . 0.0 108.794 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 34' ' ' HIS . 11.6 p30 -57.56 -28.8 63.88 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.561 -0.712 . . . . 0.0 109.328 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.086 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -50.42 -59.8 3.63 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.97 ' CG ' HD11 ' A' ' 22' ' ' LEU . 44.1 m-85 -82.09 -26.68 33.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.69 . . . . 0.0 110.143 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -40.55 96.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.366 -0.834 . . . . 0.0 109.698 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.5 mtpp -79.0 -49.98 11.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.879 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.764 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -61.6 -35.41 77.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 109.858 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.96 67.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.5 -0.75 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -80.02 -45.65 17.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.857 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.2 p -65.66 -43.05 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.57 -0.706 . . . . 0.0 109.942 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.553 HG13 HG13 ' A' ' 45' ' ' VAL . 75.7 mt -74.12 -33.56 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.439 -0.788 . . . . 0.0 109.911 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.18 -22.7 60.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.835 . . . . 0.0 110.114 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -120.52 26.56 9.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 0.0 109.73 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.503 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.6 t80 -81.78 141.45 47.91 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -86.03 9.11 4.18 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.044 2.496 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.1 m-70 -146.53 175.28 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.244 -0.91 . . . . 0.0 109.632 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -94.61 178.67 5.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.679 . . . . 0.0 109.688 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 58' ' ' GLU . 61.3 mt -135.14 104.43 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.58 -0.7 . . . . 0.0 109.337 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -90.18 -52.46 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.674 -0.641 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.8 p -96.15 150.5 20.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.03 -25.8 64.78 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.97 72.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -1.053 . . . . 0.0 109.624 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -64.89 -20.05 66.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.698 . . . . 0.0 109.769 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.79 -28.73 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -75.71 -38.47 58.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -59.94 -24.66 64.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.555 -0.716 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.857 ' HB3' HG21 ' A' ' 45' ' ' VAL . 85.9 mt -59.8 143.81 86.64 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.47 -0.769 . . . . 0.0 109.738 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.48 111.91 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.981 2.454 . . . . 0.0 110.143 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.78 -29.42 5.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -89.98 137.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.966 . . . . 0.0 109.251 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.23 -139.27 10.01 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -98.21 -28.4 13.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.952 . . . . 0.0 109.604 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -62.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 0.0 109.588 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.086 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.0 mm -62.2 -44.39 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.698 . . . . 0.0 109.735 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.11 83.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.735 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.84 -40.29 88.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.745 . . . . 0.0 109.568 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -63.49 -29.74 70.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.613 -0.68 . . . . 0.0 109.442 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.5 mm -63.5 -46.32 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.725 . . . . 0.0 109.164 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.81 -41.41 74.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.466 -0.771 . . . . 0.0 109.77 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.97 -27.2 69.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 109.206 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -51.62 19.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.9 -27.3 61.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.576 -0.449 . . . . 0.0 109.981 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.421 -0.799 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.5 p -129.96 -56.49 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.406 -0.809 . . . . 0.0 109.323 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.64 58.67 10.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -149.27 -169.34 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.973 . . . . 0.0 109.452 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 82' ' ' LEU . 4.2 mm? -88.5 85.4 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.653 -0.655 . . . . 0.0 109.449 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -85.97 -28.96 23.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -170.08 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -96.45 100.64 12.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.34 -167.44 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.707 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.442 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -72.67 66.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -66.33 -60.24 2.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.522 -0.736 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 60.08 78.96 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.566 -0.709 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -90.05 165.12 25.44 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.727 . . . . 0.0 109.474 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.2 Cg_endo -86.61 51.08 2.45 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.41 2.74 . . . . 0.0 110.519 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' HG3' HG23 ' A' ' 10' ' ' THR . 3.2 pt20 -77.79 -176.47 4.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.16 75.4 1.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.609 -0.682 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.52 HG23 ' HG3' ' A' ' 8' ' ' GLN . 29.2 p -130.11 168.16 17.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.479 -0.763 . . . . 0.0 109.39 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.784 HD13 ' CG ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -109.98 -172.3 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.451 ' OD1' HD12 ' A' ' 11' ' ' LEU . 42.1 m-20 66.76 -62.37 0.29 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.792 -0.567 . . . . 0.0 110.753 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 11' ' ' LEU . . . -56.49 -16.97 17.7 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -50.0 5.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.8 mt -67.51 -46.25 83.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 47' ' ' ALA . 96.0 m -59.25 -29.12 67.31 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.626 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.05 -37.74 88.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.0 mtt -82.57 -17.94 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.22 -36.62 20.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 16' ' ' THR . 48.6 t -76.16 -31.65 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.64 -61.81 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.554 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.998 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.6 pp -64.31 -32.23 73.74 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.094 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.33 -43.35 67.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.582 -0.699 . . . . 0.0 109.54 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -63.72 -37.31 86.88 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.6 t80 -62.38 -23.45 66.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.543 . . . . 0.0 109.792 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.9 -57.74 3.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HD2' HD11 ' A' ' 33' ' ' ILE . 13.0 tptt -67.12 -40.5 86.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.617 -0.677 . . . . 0.0 109.675 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.5 -25.22 62.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.46 -0.775 . . . . 0.0 109.739 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 25' ' ' PHE . 57.8 t -89.4 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 29' ' ' VAL . 35.3 t -76.32 -70.45 0.45 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.518 -0.738 . . . . 0.0 110.974 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -85.92 63.48 8.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.49 -0.756 . . . . 0.0 110.586 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.85 49.0 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 109.741 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.58 HD11 ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -96.3 -28.94 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.418 -0.801 . . . . 0.0 109.332 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.42 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.2 -48.89 71.8 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.633 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.26 -23.62 63.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.685 -0.634 . . . . 0.0 109.438 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CZ ' ' HD3' ' A' ' 40' ' ' ARG . 28.3 t80 -54.87 -62.95 1.33 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.291 -0.88 . . . . 0.0 109.75 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.084 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.5 -59.48 4.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 0.0 110.076 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.998 ' CG ' HD11 ' A' ' 22' ' ' LEU . 35.4 m-85 -88.92 -29.61 19.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.815 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 36' ' ' TYR . 9.1 tpt180 -62.19 -43.21 99.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.53 -0.731 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -79.19 -38.03 36.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 109.695 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.694 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -67.33 -37.97 84.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.688 ' HB1' HG23 ' A' ' 16' ' ' THR . . . -70.83 -29.93 66.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.531 -0.731 . . . . 0.0 109.509 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -67.75 -55.51 12.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.098 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.827 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.3 p -60.35 -43.79 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.502 HG13 HG13 ' A' ' 45' ' ' VAL . 73.4 mt -71.0 -38.16 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.775 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.764 ' HB2' HG21 ' A' ' 16' ' ' THR . . . -64.2 -26.26 68.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.02 27.46 8.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.792 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.531 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 3.2 t80 -84.17 137.05 40.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.73 . . . . 0.0 109.256 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.3 Cg_endo -87.23 14.49 2.4 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 123.195 2.597 . . . . 0.0 111.392 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.4 m-70 -147.87 173.26 13.01 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.218 -0.926 . . . . 0.0 109.762 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.784 ' CG ' HD13 ' A' ' 11' ' ' LEU . 2.6 tmtp? -97.85 139.23 34.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 109.827 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.865 HD12 HG21 ' A' ' 73' ' ' ILE . 17.9 pt -103.88 67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.291 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -69.59 -15.1 63.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.9 m -116.19 139.52 50.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.24 -31.17 65.39 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.76 78.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.634 -0.921 . . . . 0.0 109.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' HB3' HG22 ' A' ' 53' ' ' ILE . 13.6 mt-10 -63.37 -23.02 67.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.673 -0.642 . . . . 0.0 109.831 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.06 25.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -74.42 -42.23 59.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.79 . . . . 0.0 109.615 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -59.28 -23.75 62.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.54 -0.725 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.827 ' HB3' HG21 ' A' ' 45' ' ' VAL . 83.5 mt -59.56 138.82 89.46 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.728 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.98 101.37 1.14 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.046 2.497 . . . . 0.0 110.007 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.86 -19.11 3.75 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 42' ' ' ALA . 33.3 t -89.31 138.42 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.329 -1.1 . . . . 0.0 109.302 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.44 -155.89 25.67 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -96.96 -27.02 14.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.967 . . . . 0.0 109.777 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -83.06 -38.09 22.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.496 -0.753 . . . . 0.0 109.667 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.084 HD11 ' HB1' ' A' ' 38' ' ' ALA . 38.1 mm -72.65 -42.22 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.434 -0.791 . . . . 0.0 109.868 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.84 76.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.781 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.12 -32.39 68.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -33.45 75.61 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.865 HG21 HD12 ' A' ' 53' ' ' ILE . 47.5 mm -63.47 -42.18 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -56.94 -36.84 70.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.629 -0.67 . . . . 0.0 109.588 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.93 -32.38 73.89 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -50.18 65.09 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.59 0.71 . . . . 0.0 109.159 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -74.01 -24.59 59.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.872 -0.517 . . . . 0.0 110.153 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.2 m -113.93 -50.38 2.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 60.01 2.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -157.49 146.19 19.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.998 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.9 tp -108.28 108.25 19.19 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -84.0 153.19 24.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -113.05 -175.43 2.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.671 -0.643 . . . . 0.0 109.386 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.88 163.43 27.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -95.01 146.26 24.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.6 -0.688 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.517 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -114.19 -61.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 109.451 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -31.25 72.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.33 169.39 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 109.778 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -76.4 172.3 9.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.3 Cg_endo -86.54 147.25 8.52 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.506 2.804 . . . . 0.0 110.42 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -89.94 -74.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.35 30.95 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 109.398 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -110.36 143.34 40.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.628 -0.67 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 11' ' ' LEU . 4.9 mp -107.61 -170.11 1.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 59.61 30.71 20.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.674 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.54 82.83 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.18 -34.15 7.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.7 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.6 mt -75.04 -49.34 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.856 -0.791 . . . . 0.0 109.353 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -58.9 -34.69 71.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.664 -0.648 . . . . 0.0 109.898 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -35.24 79.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 109.268 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttm -86.06 -22.95 26.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.626 -0.671 . . . . 0.0 109.779 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.7 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -79.07 -37.75 38.09 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' THR . 58.2 t -72.0 -28.82 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.21 -66.41 0.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.003 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' CZ ' ' A' ' 39' ' ' TYR . 2.2 pt? -64.73 -31.72 73.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -50.82 -40.7 56.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.555 -0.716 . . . . 0.0 110.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.64 69.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 29' ' ' VAL . 30.1 t80 -64.61 -27.21 68.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.729 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -78.36 -56.18 4.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.624 -0.673 . . . . 0.0 109.394 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 14.2 tttp -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -57.15 -25.59 59.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.465 -0.772 . . . . 0.0 109.471 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 25' ' ' PHE . 51.6 t -89.52 165.32 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -80.14 -67.48 0.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 111.211 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -78.85 57.87 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.901 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.03 28.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.27 -33.01 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -67.82 -44.69 76.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 16.3 ptpt -76.51 -16.98 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 4.7 t80 -61.89 -63.29 1.3 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -55.51 -26.13 41.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -0.751 . . . . 0.0 109.632 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.756 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.43 -58.1 9.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.478 -0.763 . . . . 0.0 109.654 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.55 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 27.9 m-85 -84.61 -27.99 26.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 109.674 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -63.15 -53.98 44.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 109.546 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.472 ' O ' HG12 ' A' ' 45' ' ' VAL . 6.6 mttm -67.57 -43.16 81.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.711 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.36 -29.7 70.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.544 -0.723 . . . . 0.0 109.552 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -74.32 -26.22 60.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.558 -0.713 . . . . 0.0 109.796 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -87.88 -48.5 7.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 109.993 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.915 HG22 HD13 ' A' ' 62' ' ' LEU . 7.9 p -61.68 -33.54 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.592 HG13 HG13 ' A' ' 45' ' ' VAL . 72.1 mt -85.8 -25.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.533 -0.729 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.46 -20.98 24.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -108.89 23.45 14.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.606 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.8 t80 -94.59 139.64 22.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 108.935 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.51 12.24 3.06 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.105 2.537 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -146.02 153.58 40.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 0.0 109.795 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -77.23 145.77 37.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 109.772 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.05 81.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -69.66 -27.78 65.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 p -121.52 145.86 47.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.452 -0.78 . . . . 0.0 109.376 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.0 79.23 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -31.41 72.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.542 -0.975 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.31 -22.27 66.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.635 -0.666 . . . . 0.0 109.775 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.75 -32.23 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -76.31 -37.75 57.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.523 -0.735 . . . . 0.0 109.724 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -60.02 -23.31 63.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.185 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.915 HD13 HG22 ' A' ' 45' ' ' VAL . 24.7 mt -63.89 151.1 90.12 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.421 -0.799 . . . . 0.0 109.543 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -81.29 104.14 1.48 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.117 2.545 . . . . 0.0 110.054 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.16 -22.68 4.73 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.792 ' CG2' HG11 ' A' ' 45' ' ' VAL . 40.5 t -89.3 139.84 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.387 -1.066 . . . . 0.0 109.282 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -98.73 -153.48 28.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.0 p -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.489 -1.007 . . . . 0.0 109.624 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -66.57 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.756 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.1 mm -64.08 -35.09 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 109.775 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -60.97 -45.01 96.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.507 -0.745 . . . . 0.0 109.377 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -59.59 -33.73 71.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.598 -0.689 . . . . 0.0 109.428 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -65.87 -30.72 71.37 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.6 mm -63.15 -46.22 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -56.62 -37.5 70.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.475 -0.766 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.57 -31.28 72.43 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -50.49 62.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.562 0.696 . . . . 0.0 109.206 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -74.45 -25.58 59.51 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.027 -0.42 . . . . 0.0 110.143 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.59 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.387 -0.821 . . . . 0.0 109.742 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -129.72 -58.13 1.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.37 -34.05 2.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -113.02 178.11 4.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.476 -1.014 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mt -111.35 143.81 41.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.545 -0.722 . . . . 0.0 109.411 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -100.07 90.52 4.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.651 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -127.78 83.91 2.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.479 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -78.37 152.4 32.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.475 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -106.49 -69.93 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.559 -0.713 . . . . 0.0 109.472 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.436 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -62.22 178.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.566 -0.709 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -63.4 -173.63 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.646 -0.659 . . . . 0.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.29 -58.83 1.85 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.488 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.56 160.11 37.17 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.82 -76.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.385 2.723 . . . . 0.0 110.73 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -90.19 -75.91 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.526 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.99 161.27 8.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 109.452 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 t -130.01 158.99 38.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.636 -0.665 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.86 -170.11 1.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.432 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 58.14 41.25 24.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 109.777 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.91 -3.29 83.27 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.08 -37.01 6.43 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.852 HG22 ' CD1' ' A' ' 19' ' ' LEU . 4.7 mt -69.16 -60.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.892 -0.769 . . . . 0.0 109.184 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.4 t -52.99 -25.9 13.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.811 -0.556 . . . . 0.0 110.525 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.29 -30.38 68.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.69 -21.8 21.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.952 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.852 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.7 mp -86.94 -35.29 18.98 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 16' ' ' THR . 67.7 t -77.22 -31.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -65.35 -61.84 1.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.883 HD21 ' CE2' ' A' ' 39' ' ' TYR . 3.1 pp -63.06 -33.34 75.23 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.06 -36.23 38.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.681 -0.637 . . . . 0.0 109.809 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.92 74.86 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 28.8 t80 -60.83 -21.11 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -77.89 -58.5 3.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.248 -0.907 . . . . 0.0 109.151 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 10.0 tttp -68.78 -38.05 79.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.52 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.65 -27.26 64.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.406 -0.808 . . . . 0.0 109.592 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' PHE . 72.8 t -89.34 164.03 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 29' ' ' VAL . 43.6 t -77.72 -70.22 0.49 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 0.0 110.853 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -81.37 59.15 3.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 65.64 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -30.8 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -62.59 -48.96 77.15 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.338 -0.851 . . . . 0.0 108.829 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -71.15 -20.85 62.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.69 . . . . 0.0 109.641 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 23.8 t80 -57.32 -68.76 0.2 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.866 . . . . 0.0 109.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -55.72 -23.03 26.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.384 -0.822 . . . . 0.0 110.054 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -56.14 -63.53 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.368 -0.832 . . . . 0.0 109.916 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.883 ' CE2' HD21 ' A' ' 22' ' ' LEU . 86.9 m-85 -74.61 -27.34 60.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.713 -0.617 . . . . 0.0 110.086 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -61.57 -37.21 83.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.441 -0.787 . . . . 0.0 109.683 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -81.95 -49.74 9.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.747 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.84 -27.91 69.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 -37.08 62.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.774 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.3 m -71.6 -47.42 54.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.769 HG11 ' CG2' ' A' ' 65' ' ' VAL . 7.4 p -64.01 -35.46 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.554 -0.716 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.633 HG13 HG13 ' A' ' 45' ' ' VAL . 65.6 mt -84.17 -28.27 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.06 -21.15 24.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.47 -0.769 . . . . 0.0 110.039 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.26 22.44 15.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.922 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.47 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.1 t80 -96.02 140.67 22.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 108.998 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.05 8.13 4.66 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.979 2.453 . . . . 0.0 111.226 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.42 -176.28 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.678 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -104.17 160.49 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.532 -0.73 . . . . 0.0 109.57 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 58' ' ' GLU . 50.4 mt -97.05 143.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.68 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -91.48 -65.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.732 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 m -119.88 -179.95 4.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.729 . . . . 0.0 109.537 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.35 -33.8 87.3 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.2 71.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.997 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.747 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.5 mt-10 -71.19 -24.24 62.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.688 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -85.59 -31.96 22.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 0.0 109.662 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.582 ' CG ' ' HB1' ' A' ' 70' ' ' ALA . 5.9 mtpm? -75.33 -36.28 61.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.571 -0.705 . . . . 0.0 110.042 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.57 -27.28 67.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 59' ' ' ALA . 6.4 mt -71.18 146.95 93.05 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 0.0 109.401 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.8 102.45 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.959 2.439 . . . . 0.0 110.272 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.9 -25.84 2.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.769 ' CG2' HG11 ' A' ' 45' ' ' VAL . 36.8 t -89.72 139.16 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.46 -1.023 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -102.2 -151.53 23.94 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -99.05 -29.47 12.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.958 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -72.07 -64.09 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.498 -0.751 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.747 HG21 ' CB ' ' A' ' 42' ' ' ALA . 47.3 mm -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -56.98 -41.76 78.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.45 -38.62 87.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -62.11 -31.14 71.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.6 mm -63.34 -42.47 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.08 -41.04 74.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.413 -0.804 . . . . 0.0 109.548 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -62.89 -28.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -52.13 18.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.395 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.54 -26.79 61.88 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.87 -0.519 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.837 . . . . 0.0 109.525 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m -95.82 -56.35 2.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 109.237 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.47 -48.38 0.97 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.597 ' C ' HD13 ' A' ' 82' ' ' LEU . 21.0 mttp -111.46 161.16 16.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.955 . . . . 0.0 109.584 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -150.17 178.14 9.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.606 -0.684 . . . . 0.0 109.637 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.9 mtp85 -100.06 135.16 41.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.651 -0.656 . . . . 0.0 109.45 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 mtpp -130.55 -173.45 3.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.66 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.51 ' N ' HD22 ' A' ' 85' ' ' LEU . 4.3 mm? -80.57 118.88 22.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.687 . . . . 0.0 109.434 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -143.19 145.12 32.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 tttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.434 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -98.63 -32.29 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -124.4 143.87 50.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -64.56 110.54 2.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.48 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.33 158.25 83.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.659 . . . . 0.0 109.438 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.84 -175.79 1.98 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.401 2.734 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -64.14 -64.25 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -152.94 150.87 29.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -126.62 135.49 51.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 52' ' ' LYS . 4.2 mt -85.23 -170.14 2.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 0.0 109.295 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.75 ' HB3' HG22 ' A' ' 46' ' ' ILE . 11.5 m120 59.51 32.02 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.712 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.29 -9.72 64.87 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.376 -0.916 . . . . 0.0 110.823 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.9 -36.63 6.32 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.873 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.2 mp -78.5 -43.8 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.845 -0.797 . . . . 0.0 109.74 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.718 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 4.6 t -59.44 -26.03 64.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.09 -46.33 57.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.47 -0.769 . . . . 0.0 109.423 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.541 ' O ' HD22 ' A' ' 22' ' ' LEU . 4.7 ppp? -85.24 -8.58 58.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.712 . . . . 0.0 110.456 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.873 ' CD1' HG22 ' A' ' 15' ' ' ILE . 4.9 mt -83.48 -42.1 17.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 16' ' ' THR . 46.9 t -72.09 -30.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.28 -65.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.602 -0.686 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD11 ' CZ ' ' A' ' 39' ' ' TYR . 1.6 pt? -63.14 -35.07 79.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.94 -48.95 64.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.62 -0.675 . . . . 0.0 110.114 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -62.81 -33.85 76.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 29' ' ' VAL . 50.1 t80 -65.41 -22.55 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.739 -0.601 . . . . 0.0 109.876 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.0 mm-40 -78.94 -56.95 4.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.452 -0.78 . . . . 0.0 109.18 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 17.8 tttm -66.37 -39.87 89.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.376 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.15 -26.42 64.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.453 -0.779 . . . . 0.0 109.447 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 25' ' ' PHE . 57.5 t -89.48 164.46 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -78.15 -68.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.435 -0.79 . . . . 0.0 110.939 -178.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -86.18 60.68 6.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.448 -0.782 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.74 57.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 109.542 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.93 -37.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.01 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.8 p-80 -55.73 -46.3 77.81 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.011 -1.056 . . . . 0.0 109.259 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -73.03 -20.41 61.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -57.74 -70.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -53.42 -24.85 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.425 -0.797 . . . . 0.0 109.938 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.043 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.62 -66.34 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.501 -0.749 . . . . 0.0 109.784 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 41.2 m-85 -77.94 -30.36 50.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 110.07 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -42.7 99.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.392 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -69.24 -44.84 71.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.747 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.747 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -63.12 -45.38 92.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.41 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -60.48 -22.94 64.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 0.0 109.901 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -79.61 -54.67 5.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.6 p -72.59 -44.39 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.541 -0.724 . . . . 0.0 110.104 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.75 HG22 ' HB3' ' A' ' 12' ' ' ASN . 78.4 mt -62.87 -58.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.475 -0.765 . . . . 0.0 109.597 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.718 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -60.69 -20.98 62.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.533 -0.729 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -112.21 28.83 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.545 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.1 t80 -94.07 140.47 22.9 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.2 Cg_endo -85.35 8.78 4.41 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.072 2.515 . . . . 0.0 111.284 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 171.18 15.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 11' ' ' LEU . 31.3 ttpt -94.48 145.08 25.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.613 -0.679 . . . . 0.0 109.543 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.518 HG21 HG21 ' A' ' 73' ' ' ILE . 52.6 mt -78.24 115.56 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -74.01 -31.11 62.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 0.0 109.562 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -164.84 -179.79 6.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.578 -0.701 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -28.0 63.54 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.99 95.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.574 -0.956 . . . . 0.0 109.451 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -69.93 -23.28 63.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.71 . . . . 0.0 109.77 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.5 -27.06 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 109.733 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -74.93 -40.99 60.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -59.95 -23.73 63.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.565 -0.709 . . . . 0.0 110.029 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.745 ' HB3' HG21 ' A' ' 45' ' ' VAL . 80.7 mt -59.99 136.83 90.75 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.55 106.03 1.94 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.865 2.377 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.49 -26.39 3.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 42' ' ' ALA . 23.1 t -89.63 138.06 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -1.036 . . . . 0.0 109.512 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.75 -146.17 14.09 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -99.14 -37.87 9.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.948 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -64.63 -44.01 91.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.745 . . . . 0.0 109.812 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.043 HD11 ' HB1' ' A' ' 38' ' ' ALA . 41.9 mm -71.2 -44.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.883 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.04 81.44 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 109.768 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -61.02 -39.42 89.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.51 -0.744 . . . . 0.0 109.544 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -63.26 -30.94 71.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.4 mm -64.06 -44.98 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -55.36 -40.95 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -64.26 -28.46 69.74 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.28 -52.57 18.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.608 -0.683 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.941 -0.474 . . . . 0.0 110.028 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.373 -0.83 . . . . 0.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p -101.55 -57.66 2.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.802 . . . . 0.0 109.47 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.38 55.12 3.31 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -145.96 177.04 9.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.647 -0.913 . . . . 0.0 109.437 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 82' ' ' LEU . 4.3 mm? -83.97 75.79 10.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 109.229 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -76.35 99.06 4.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.499 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -111.9 30.79 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.01 100.88 10.01 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -91.26 -63.68 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.514 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -64.4 -165.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 60.24 165.24 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -91.35 105.29 17.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -89.88 171.37 8.77 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.4 Cg_endo -86.4 151.18 9.13 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 123.405 2.737 . . . . 0.0 110.538 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.07 142.9 57.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -119.71 179.12 4.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.576 -0.702 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 p -74.42 -31.05 62.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 11' ' ' LEU . 1.2 mm? -63.53 -169.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.494 -0.754 . . . . 0.0 109.392 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.594 ' O ' HG22 ' A' ' 16' ' ' THR . 21.0 m-80 -98.3 53.67 1.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.535 -0.728 . . . . 0.0 109.341 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.7 55.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.05 -33.57 8.12 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.1 mp -74.13 -51.3 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.871 -0.782 . . . . 0.0 109.286 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.9 t -57.17 -28.54 62.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.68 -27.02 63.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 0.0 109.552 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.637 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.5 mmt -90.3 -19.44 24.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.992 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -89.04 -33.9 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 16' ' ' THR . 46.3 t -79.88 -31.74 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.19 -58.82 3.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.655 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.852 HD11 ' CD1' ' A' ' 39' ' ' TYR . 3.2 pp -62.67 -34.98 78.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.15 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.95 -43.12 63.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.504 -0.748 . . . . 0.0 109.572 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.74 -34.31 78.03 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 29' ' ' VAL . 53.5 t80 -66.2 -26.64 67.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.768 -0.583 . . . . 0.0 109.789 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 55.2 mm-40 -80.44 -52.37 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 53.7 tttt -66.07 -42.85 88.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.409 -0.807 . . . . 0.0 109.145 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -58.62 -26.15 63.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.247 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.3 t -89.34 165.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.6 t -79.39 -70.32 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.446 -0.784 . . . . 0.0 111.238 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -79.13 59.21 2.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.434 -0.791 . . . . 0.0 110.95 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.97 48.69 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.71 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -99.13 -21.9 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -71.97 -51.78 20.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.322 -0.861 . . . . 0.0 108.825 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.03 -23.62 63.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.557 -0.715 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 21.9 t80 -56.72 -51.94 66.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.41 -0.806 . . . . 0.0 109.255 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -62.39 -29.9 70.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.192 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.014 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.96 -65.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.772 . . . . 0.0 109.989 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.852 ' CD1' HD11 ' A' ' 22' ' ' LEU . 81.7 m-85 -72.59 -16.01 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -72.1 -55.23 7.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -65.66 -43.54 89.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.526 -0.733 . . . . 0.0 110.078 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -64.95 -46.48 81.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.0 64.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.629 -0.669 . . . . 0.0 110.082 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -81.2 -52.67 7.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.2 p -63.13 -43.71 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.834 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.482 ' N ' HG13 ' A' ' 45' ' ' VAL . 65.2 mt -68.96 -54.88 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -59.49 -20.88 58.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.503 -0.748 . . . . 0.0 110.371 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -117.43 25.96 10.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.463 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.8 t80 -86.08 140.19 34.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.0 109.198 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.19 9.87 3.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.981 2.454 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 178.68 8.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.291 -0.881 . . . . 0.0 109.645 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -99.41 157.68 16.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.654 -0.654 . . . . 0.0 109.81 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.72 HG23 ' CB ' ' A' ' 58' ' ' GLU . 63.9 mt -102.53 108.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -69.93 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.584 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -111.85 -179.85 3.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.688 -0.632 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.52 64.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.34 70.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -1.068 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.72 ' CB ' HG23 ' A' ' 53' ' ' ILE . 5.2 mp0 -70.55 -25.21 63.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.714 . . . . 0.0 109.695 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.02 -28.24 22.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 109.631 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -75.26 -40.11 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -59.79 -24.21 63.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.605 -0.685 . . . . 0.0 110.04 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.829 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.8 mt -60.23 142.65 89.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.456 -0.778 . . . . 0.0 109.636 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.29 105.62 1.78 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.032 2.488 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.45 -26.16 4.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 70' ' ' ALA . 25.9 t -89.53 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.461 -1.023 . . . . 0.0 109.468 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.63 -140.59 10.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.49 -27.48 14.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.912 . . . . 0.0 109.778 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -66.14 -67.68 0.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.475 -0.766 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.014 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.8 mm -60.03 -44.87 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.29 -35.46 71.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.45 -38.02 82.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 109.443 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -69.8 -25.25 63.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.645 -0.66 . . . . 0.0 109.653 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.705 HG21 ' HB2' ' A' ' 59' ' ' ALA . 40.5 mm -72.81 -48.28 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 109.386 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.36 -47.95 68.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.46 -28.95 70.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.475 -0.766 . . . . 0.0 109.054 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -44.15 79.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.69 . . . . 0.0 109.167 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 77' ' ' LEU . 4.0 mm? -81.66 -23.93 36.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.86 -0.525 . . . . 0.0 110.129 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -78.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 p -118.61 -59.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.498 -0.752 . . . . 0.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.4 59.99 1.01 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -157.15 40.68 0.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.551 -0.97 . . . . 0.0 109.464 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.038 HD23 HD13 ' A' ' 85' ' ' LEU . 5.6 mt -129.66 92.57 3.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.673 . . . . 0.0 109.47 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' H ' HD12 ' A' ' 85' ' ' LEU . 20.9 tttm -168.49 88.39 0.22 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 109.435 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.038 HD13 HD23 ' A' ' 82' ' ' LEU . 4.9 mp -136.57 154.37 50.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.579 -0.701 . . . . 0.0 109.472 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.88 -36.37 67.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.634 -0.667 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.509 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttt 43.35 -164.8 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.032 0.444 . . . . 0.0 111.315 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 59.61 38.66 22.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.678 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 tttm 60.28 166.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.573 -0.705 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.4 111.47 4.36 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.665 -0.647 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.33 173.99 5.34 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.204 2.603 . . . . 0.0 110.504 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -90.01 157.59 17.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -112.49 119.16 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -105.25 176.81 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mt -74.6 -72.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.615 ' O ' HG22 ' A' ' 16' ' ' THR . 43.2 m-20 -87.88 57.71 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.604 -0.685 . . . . 0.0 109.212 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -15.56 57.31 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.0 -35.27 7.2 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.85 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.9 mt -70.94 -57.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.78 -0.836 . . . . 0.0 109.17 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 12' ' ' ASN . 5.0 t -53.48 -30.96 43.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.776 -0.578 . . . . 0.0 110.668 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.97 -29.48 68.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 110.014 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.506 ' O ' HD23 ' A' ' 22' ' ' LEU . 5.4 mmt -90.13 -23.71 21.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 110.058 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.85 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.8 mp -88.37 -34.27 17.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 108.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 16' ' ' THR . 99.8 t -76.48 -32.92 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -68.6 -61.56 1.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.974 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -61.69 -32.32 72.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.48 -44.35 65.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 109.63 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -35.62 79.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.1 t80 -65.13 -22.83 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.859 -0.526 . . . . 0.0 109.678 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 21.3 mm-40 -78.23 -57.88 3.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -64.99 -40.69 95.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.287 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -58.98 -25.4 63.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.582 -0.698 . . . . 0.0 109.498 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.1 t -89.59 164.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.8 t -76.76 -70.19 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.49 -0.756 . . . . 0.0 111.096 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.46 65.97 9.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.386 -0.821 . . . . 0.0 110.884 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.76 36.89 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -85.86 -26.11 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.316 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' NE2' ' HE3' ' A' ' 35' ' ' LYS . 6.4 p-80 -71.36 -50.76 28.98 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.618 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 10.8 ptpt -66.7 -23.75 66.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.6 t80 -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.475 -0.766 . . . . 0.0 109.648 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -56.71 -24.79 51.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.059 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.14 -59.24 5.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.388 -0.82 . . . . 0.0 109.89 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.974 ' CG ' HD11 ' A' ' 22' ' ' LEU . 48.0 m-85 -85.12 -27.61 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.949 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 28.9 tpt85 -64.41 -42.84 95.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.469 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -78.33 -46.62 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.776 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.37 -44.26 96.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.551 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.73 70.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -66.91 -50.19 63.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.96 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.8 p -72.34 -45.07 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.466 -0.771 . . . . 0.0 110.112 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 12' ' ' ASN . 79.3 mt -64.22 -51.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -63.01 -21.36 66.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 110.076 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.07 27.93 8.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.499 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.4 t80 -90.45 139.38 26.68 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.728 . . . . 0.0 109.129 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.14 10.87 3.49 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.081 2.521 . . . . 0.0 111.263 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.6 m-70 -147.3 171.68 15.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.273 -0.892 . . . . 0.0 109.642 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.98 138.6 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.696 . . . . 0.0 109.665 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 58' ' ' GLU . 49.5 mt -73.12 125.78 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.239 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -81.67 -56.95 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 p -132.21 -179.82 5.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.544 -0.723 . . . . 0.0 109.509 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.8 -29.37 67.31 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.86 72.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.702 ' HB3' HG23 ' A' ' 53' ' ' ILE . 1.1 mm-40 -67.22 -21.33 65.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.718 -0.614 . . . . 0.0 109.9 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -85.99 -27.63 24.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.788 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HG3' ' HB1' ' A' ' 70' ' ' ALA . 23.1 mtpt -73.38 -40.72 64.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.767 . . . . 0.0 109.679 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -60.27 -26.62 66.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.568 -0.708 . . . . 0.0 110.039 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.766 ' HB3' HG21 ' A' ' 45' ' ' VAL . 46.5 mt -63.41 136.65 96.8 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.719 . . . . 0.0 109.297 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.55 108.39 2.12 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.937 2.425 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.05 -19.85 4.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 42' ' ' ALA . 39.5 t -89.27 139.31 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -1.101 . . . . 0.0 109.285 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.38 -149.92 23.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -98.64 -35.56 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.952 . . . . 0.0 109.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -71.86 -39.93 69.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.0 109.74 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.059 HD11 ' HB1' ' A' ' 38' ' ' ALA . 39.0 mm -72.83 -40.56 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -59.6 -50.65 73.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.543 -0.723 . . . . 0.0 110.126 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.97 -34.01 69.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.789 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -62.27 -37.93 87.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.556 -0.715 . . . . 0.0 109.182 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 53' ' ' ILE . 47.2 mm -63.74 -38.31 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.77 -40.3 72.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.525 -0.735 . . . . 0.0 109.617 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.8 -32.98 74.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -53.12 50.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.39 -22.79 61.08 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.962 -0.461 . . . . 0.0 110.168 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.79 -80.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 80' ' ' GLY . 3.5 t -130.03 -43.58 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.617 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 79' ' ' THR . . . 63.45 49.19 71.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -117.2 -37.63 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.34 90.39 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.521 -0.737 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -60.76 175.53 0.47 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.606 -0.684 . . . . 0.0 109.807 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -84.16 104.53 14.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.754 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.24 82.89 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.456 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -170.02 158.22 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.44 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.121 0.486 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -85.21 131.19 34.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 109.412 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 59.39 -174.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 109.744 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -86.56 -33.65 20.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.66 156.06 47.81 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.57 -0.706 . . . . 0.0 109.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.97 143.52 8.1 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 123.379 2.72 . . . . 0.0 110.504 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -90.03 130.54 36.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.73 . . . . 0.0 109.471 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -124.57 106.48 10.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.509 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.3 p -130.06 135.23 48.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.576 -0.703 . . . . 0.0 109.422 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mt -110.06 -73.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.861 ' HB2' HD12 ' A' ' 15' ' ' ILE . 26.5 p30 -101.71 67.55 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.618 -0.676 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 1.32 79.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.42 -34.81 7.76 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.861 HD12 ' HB2' ' A' ' 12' ' ' ASN . 10.0 mt -72.37 -59.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.861 -0.788 . . . . 0.0 109.146 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -53.17 -31.54 43.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.819 -0.551 . . . . 0.0 110.333 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.9 -29.38 69.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.6 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.7 mmt -90.4 -21.74 21.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.821 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.858 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.5 mp -88.78 -34.01 17.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 16' ' ' THR . 60.4 t -77.44 -33.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.77 -60.38 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 109.42 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.943 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -61.51 -34.5 75.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.136 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.25 -41.44 60.36 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.556 -0.715 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -64.25 -37.09 86.26 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 61.7 t80 -64.38 -23.49 67.31 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.667 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.0 mm-40 -76.1 -56.61 4.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.382 -0.823 . . . . 0.0 109.125 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -69.51 -40.48 76.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 109.728 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -57.5 -25.07 59.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' PHE . 67.6 t -89.28 164.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 29' ' ' VAL . 48.3 t -76.72 -70.43 0.46 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.765 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -85.05 64.56 8.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.459 -0.775 . . . . 0.0 110.412 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 48.98 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.683 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 -22.57 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.512 -0.742 . . . . 0.0 109.626 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.436 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.8 p-80 -71.5 -51.65 22.54 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 108.677 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -68.1 -23.27 64.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 109.309 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.5 -55.1 39.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -60.94 -27.44 68.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 0.0 109.565 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.078 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.99 -63.56 1.14 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.436 -0.79 . . . . 0.0 110.067 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 22' ' ' LEU . 63.4 m-85 -78.37 -27.4 46.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.722 -0.611 . . . . 0.0 110.149 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -66.83 -33.87 76.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.66 -49.64 10.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.506 -0.746 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.754 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.71 -50.85 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.53 -0.731 . . . . 0.0 109.454 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -61.61 -27.76 68.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.506 -0.746 . . . . 0.0 109.626 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -73.74 -32.29 63.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.861 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.799 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.7 p -90.1 -35.28 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG12 HD11 ' A' ' 53' ' ' ILE . 73.2 mt -77.09 -48.62 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.515 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -61.24 -20.06 62.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 0.0 110.23 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -121.66 26.17 8.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 109.724 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.51 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.9 t80 -83.72 145.58 47.68 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.057 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -85.29 -0.01 8.85 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.05 2.5 . . . . 0.0 110.989 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.4 m-70 -142.32 177.75 8.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.325 -0.86 . . . . 0.0 109.634 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -103.79 141.51 35.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.591 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.74 HG23 ' CB ' ' A' ' 58' ' ' GLU . 52.2 mt -81.83 130.43 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -94.6 -50.5 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.747 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.4 m -125.77 177.93 5.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.33 -29.46 73.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.97 72.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.74 ' CB ' HG23 ' A' ' 53' ' ' ILE . 2.7 mt-10 -73.34 -25.78 60.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.674 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -89.46 -28.38 19.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.644 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -77.04 -35.63 56.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.735 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -60.25 -23.27 63.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.588 -0.695 . . . . 0.0 110.031 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 45' ' ' VAL . 78.9 mt -60.76 143.54 90.86 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.13 107.45 2.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.972 2.448 . . . . 0.0 110.251 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.49 -29.05 3.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 70' ' ' ALA . 29.1 t -89.82 138.8 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.984 . . . . 0.0 109.479 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.11 -136.67 7.98 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -98.81 -28.35 13.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.976 . . . . 0.0 109.657 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -66.13 -66.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.568 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.078 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.3 mm -61.43 -45.11 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.598 -0.689 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.64 -34.31 71.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.54 -41.41 97.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.575 -0.703 . . . . 0.0 109.451 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.417 ' NZ ' HD12 ' A' ' 85' ' ' LEU . 2.7 mmtm -62.45 -29.64 70.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.681 -0.637 . . . . 0.0 109.366 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.674 HG21 ' HB2' ' A' ' 59' ' ' ALA . 46.9 mm -63.6 -46.87 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.719 . . . . 0.0 109.061 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.41 -32.37 66.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.518 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -67.33 -29.85 69.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -73.18 -50.53 22.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.569 0.7 . . . . 0.0 109.428 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.95 -27.62 61.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 122.043 -0.41 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -79.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.763 . . . . 0.0 109.531 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m -130.06 -65.09 0.84 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.81 59.96 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -126.75 94.72 4.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.973 . . . . 0.0 109.53 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 82' ' ' LEU . 4.3 mm? -86.69 79.34 8.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -87.4 -73.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 109.548 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -169.98 146.44 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.497 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD12 ' NZ ' ' A' ' 72' ' ' LYS . 68.9 mt -143.37 119.48 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.568 -0.708 . . . . 0.0 109.441 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -41.15 12.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.462 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -145.43 139.76 27.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.13 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.559 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.66 161.22 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.455 -0.778 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -77.24 170.48 16.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.3 Cg_endo -86.04 80.88 1.72 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.407 2.738 . . . . 0.0 110.427 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -86.39 85.13 7.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.23 128.89 40.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.8 p -111.31 65.4 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.508 -0.745 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 11' ' ' LEU . 3.6 mm? -110.1 -71.34 0.77 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.516 -0.74 . . . . 0.0 109.472 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.588 ' HB3' HD12 ' A' ' 15' ' ' ILE . 2.9 m-20 -107.27 41.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.602 -0.686 . . . . 0.0 109.463 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.04 0.13 84.11 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -42.31 5.03 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.858 HG22 ' CD1' ' A' ' 19' ' ' LEU . 5.3 mt -66.5 -58.19 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.96 -0.73 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.1 t -52.6 -31.04 34.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.731 -0.606 . . . . 0.0 110.384 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -63.83 -30.38 71.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.496 -0.752 . . . . 0.0 109.529 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.5 ' O ' HD23 ' A' ' 22' ' ' LEU . 4.8 ttm -90.31 -21.39 22.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.888 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.858 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.3 mp -87.29 -33.95 19.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 16' ' ' THR . 58.3 t -75.8 -35.78 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -65.46 -60.99 2.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.375 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.943 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.7 pp -61.53 -33.66 74.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 109.151 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.88 -41.65 62.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 109.507 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.05 -36.96 85.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.0 t80 -63.87 -23.2 67.26 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.8 mm-40 -77.01 -57.12 4.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 46.7 tttm -68.27 -40.29 81.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.488 -0.757 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -25.53 61.29 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.481 -0.762 . . . . 0.0 109.696 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 25' ' ' PHE . 62.6 t -89.31 164.29 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.14 -70.08 0.49 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.955 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -84.77 62.19 7.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.445 -0.785 . . . . 0.0 110.458 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 53.91 0.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.862 . . . . 0.0 109.684 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.27 -29.71 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.785 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.73 -48.37 74.86 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.37 -22.77 62.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.591 -0.693 . . . . 0.0 109.411 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 25.7 t80 -55.64 -67.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.271 -0.893 . . . . 0.0 109.741 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -55.82 -23.13 28.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.479 -0.763 . . . . 0.0 110.038 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.025 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.47 -63.62 1.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.286 -0.884 . . . . 0.0 109.88 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 22' ' ' LEU . 64.3 m-85 -79.17 -26.8 42.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.024 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -37.86 88.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.319 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -48.28 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.721 -0.612 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.766 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.56 -27.65 69.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.604 -0.685 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.04 57.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.494 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -72.45 -44.11 62.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 109.861 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.752 HG11 HG23 ' A' ' 65' ' ' VAL . 8.1 p -66.03 -36.66 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.455 -0.778 . . . . 0.0 109.766 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.626 HG13 HG13 ' A' ' 45' ' ' VAL . 77.4 mt -84.08 -26.51 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.73 -26.25 21.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -97.9 20.35 12.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.445 -0.785 . . . . 0.0 109.856 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.479 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 6.3 t80 -95.14 137.67 22.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.38 12.4 3.02 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.113 2.542 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.3 m-70 -148.28 -171.58 3.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.527 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -124.96 149.91 47.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.585 -0.697 . . . . 0.0 109.52 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 58' ' ' GLU . 9.8 pt -101.42 158.02 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.53 -0.731 . . . . 0.0 109.506 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -114.01 -32.23 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.712 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -118.46 167.61 11.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.86 -30.58 70.23 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.59 70.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.498 ' HB3' HG22 ' A' ' 53' ' ' ILE . 29.3 mt-10 -68.16 -24.46 64.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.672 -0.642 . . . . 0.0 109.716 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.744 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -80.86 -31.13 35.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HG3' ' HB1' ' A' ' 70' ' ' ALA . 23.2 mttt -73.98 -40.68 62.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.738 . . . . 0.0 110.122 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -59.26 -27.24 65.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.533 -0.729 . . . . 0.0 110.142 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 59' ' ' ALA . 9.9 mt -72.0 149.12 92.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.22 118.54 4.71 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.092 2.528 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.91 -25.69 5.77 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.752 HG23 HG11 ' A' ' 45' ' ' VAL . 38.4 t -89.8 139.71 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -1.018 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -106.16 -150.72 18.6 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -99.55 -29.22 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.612 -0.934 . . . . 0.0 109.612 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -77.26 -59.34 2.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.592 -0.692 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.025 HD11 ' HB1' ' A' ' 38' ' ' ALA . 46.2 mm -62.04 -32.54 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.69 . . . . 0.0 109.457 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -61.19 -38.64 87.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 109.126 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -61.41 -38.93 88.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -62.37 -30.69 71.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.6 mm -63.53 -44.5 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.76 -40.59 72.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.55 -0.719 . . . . 0.0 109.797 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.38 -51.95 45.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.513 0.673 . . . . 0.0 109.278 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.23 -24.08 60.44 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.952 -0.467 . . . . 0.0 110.058 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.63 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 109.731 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 80' ' ' GLY . 3.5 t -130.21 -43.73 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.0 109.619 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 79' ' ' THR . . . 113.14 35.37 1.65 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HE2' HG21 ' A' ' 79' ' ' THR . 40.7 mtmt -100.99 128.73 46.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.907 . . . . 0.0 109.407 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.13 60.62 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.682 . . . . 0.0 109.424 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -99.97 141.52 32.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.466 -0.771 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -163.98 156.73 17.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.492 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.498 ' N ' HD22 ' A' ' 85' ' ' LEU . 4.4 mm? -83.16 127.38 33.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.417 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.77 -49.83 6.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.455 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? 59.8 83.29 0.14 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 109.746 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 63.22 -82.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.715 -0.616 . . . . 0.0 109.682 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -116.16 134.84 54.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 109.45 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -76.01 167.42 36.88 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.4 Cg_endo -86.3 67.72 4.87 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.451 2.768 . . . . 0.0 110.457 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -67.68 -48.14 67.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -119.9 94.0 4.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 p -129.97 -57.91 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.715 . . . . 0.0 109.498 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HA ' HD13 ' A' ' 11' ' ' LEU . 3.8 mm? -109.89 -74.41 0.65 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.504 -0.747 . . . . 0.0 109.443 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' O ' HG22 ' A' ' 16' ' ' THR . 28.6 m-20 -112.42 58.66 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.735 . . . . 0.0 109.31 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.04 -0.09 78.13 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.59 -41.47 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.796 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.72 -57.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.902 -0.763 . . . . 0.0 109.166 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -52.93 -33.93 52.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.739 -0.601 . . . . 0.0 110.472 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.98 -32.41 72.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.2 tpt -86.74 -20.55 27.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.796 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -86.21 -37.64 18.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 16' ' ' THR . 48.7 t -67.58 -39.59 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.99 -60.18 3.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.742 . . . . 0.0 109.638 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.011 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.0 pp -62.31 -34.07 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 109.239 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.45 -42.32 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.535 -0.728 . . . . 0.0 109.739 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -63.66 -43.81 95.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' O ' HG23 ' A' ' 29' ' ' VAL . 72.6 t80 -49.0 -30.81 6.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.745 -0.597 . . . . 0.0 110.709 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.744 ' OE1' HD12 ' A' ' 22' ' ' LEU . 3.5 mp0 -79.91 -44.23 20.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.066 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -70.26 -49.89 45.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.937 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -14.91 49.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.0 110.239 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 25' ' ' PHE . 36.1 t -87.74 164.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.419 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -73.76 -70.54 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.0 111.531 -177.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -90.63 66.98 6.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 0.0 111.183 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.71 56.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -102.96 -22.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.131 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.6 p-80 -76.16 -47.14 25.33 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -72.89 -24.67 60.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.533 -0.729 . . . . 0.0 109.044 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -58.02 -49.17 77.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.44 -0.787 . . . . 0.0 109.053 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.57 -25.26 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.605 -0.684 . . . . 0.0 109.48 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.022 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.48 -62.92 1.36 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.327 -0.858 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.011 ' CG ' HD11 ' A' ' 22' ' ' LEU . 80.6 m-85 -76.71 -25.21 53.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 110.847 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -74.27 -37.03 63.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.309 -0.869 . . . . 0.0 109.012 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -76.8 -31.65 57.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.372 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.775 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -85.49 -26.66 26.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -27.93 61.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.617 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -81.56 -45.78 15.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 109.937 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.895 HG11 HG23 ' A' ' 65' ' ' VAL . 7.2 p -63.88 -34.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.464 -0.772 . . . . 0.0 109.756 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.616 HG13 HG13 ' A' ' 45' ' ' VAL . 69.6 mt -85.11 -28.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.5 -21.84 23.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.429 -0.794 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -104.35 22.14 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 109.743 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.4 t80 -94.65 142.9 25.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 109.004 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.5 9.21 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.077 2.518 . . . . 0.0 110.991 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.8 m-70 -146.66 178.69 8.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.216 -0.927 . . . . 0.0 109.56 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -98.52 174.42 6.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.537 -0.727 . . . . 0.0 109.705 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 58' ' ' GLU . 60.8 mt -132.75 106.33 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.664 -0.648 . . . . 0.0 109.42 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.83 34.26 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -165.99 139.81 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 109.402 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.87 -40.37 95.45 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.88 -30.42 71.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.97 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 53' ' ' ILE . 6.0 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.786 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -81.92 -30.53 31.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 3.8 tmtt? -74.72 -38.67 62.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.582 -0.698 . . . . 0.0 110.012 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -59.84 -25.89 65.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.143 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 59' ' ' ALA . 11.1 mt -71.01 152.23 94.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 109.447 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.53 105.99 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 123.073 2.516 . . . . 0.0 110.289 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 -30.82 2.31 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.895 HG23 HG11 ' A' ' 45' ' ' VAL . 33.9 t -90.13 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -108.87 -147.67 12.5 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -98.55 -29.73 12.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 109.61 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.16 -58.63 3.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.022 HD11 ' HB1' ' A' ' 38' ' ' ALA . 45.9 mm -61.82 -34.79 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.738 . . . . 0.0 109.626 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -59.97 -41.35 91.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -60.55 -37.03 79.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.649 -0.657 . . . . 0.0 109.46 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.94 -31.4 72.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.367 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.8 mm -63.8 -46.16 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.89 -39.61 68.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.448 -0.782 . . . . 0.0 109.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.98 -31.85 73.19 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -52.56 37.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.573 0.702 . . . . 0.0 109.326 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.77 -23.15 60.77 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.87 -0.519 . . . . 0.0 110.11 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -0.807 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.29 -46.78 3.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 109.374 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.9 -53.6 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -170.04 -173.3 1.51 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.673 -0.898 . . . . 0.0 109.405 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.8 -179.91 4.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 109.572 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -95.75 164.77 12.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.503 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -115.76 -174.77 2.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.677 . . . . 0.0 109.378 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -91.56 75.29 5.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.426 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.55 -28.0 63.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.726 . . . . 0.0 109.664 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.476 179.961 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -101.61 135.03 43.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.517 -0.739 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -64.14 151.56 42.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.539 -0.726 . . . . 0.0 109.479 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -128.08 -177.82 4.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 109.453 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -83.51 167.2 30.11 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.534 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.2 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.476 2.784 . . . . 0.0 110.554 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -87.72 82.1 7.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.554 -0.716 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -105.08 82.04 1.8 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.426 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -130.08 -44.17 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.708 . . . . 0.0 109.585 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 52' ' ' LYS . 52.6 mt -84.31 -70.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 109.588 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -151.25 35.5 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.522 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.15 0.04 83.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.76 -34.85 7.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.857 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.6 mp -64.94 -47.09 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.023 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.9 t -56.57 -31.43 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 109.862 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -65.0 -28.41 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.542 -0.724 . . . . 0.0 109.486 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mmt -89.9 -20.98 22.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -85.67 -33.89 21.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 16' ' ' THR . 48.2 t -76.33 -33.05 22.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.21 -61.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.984 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -62.54 -32.06 72.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.23 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.61 -45.85 66.74 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.485 -0.759 . . . . 0.0 109.68 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -63.79 -35.76 81.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.2 t80 -61.19 -26.04 67.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.758 -0.589 . . . . 0.0 109.935 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 18.5 mm-40 -79.88 -55.39 5.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.0 109.153 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 109.423 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.73 -25.1 64.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.416 -0.803 . . . . 0.0 109.455 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 25' ' ' PHE . 50.0 t -89.07 164.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -77.5 -69.32 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.466 -0.771 . . . . 0.0 111.297 -178.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -85.29 62.13 7.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.95 55.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.58 -29.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.405 -0.809 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.36 -48.81 71.66 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.59 -23.01 62.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 109.462 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 24.7 t80 -55.25 -66.5 0.4 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 109.557 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.69 -24.27 21.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.451 -0.78 . . . . 0.0 109.923 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.699 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.19 -55.14 34.57 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.422 -0.799 . . . . 0.0 109.874 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.984 ' CG ' HD11 ' A' ' 22' ' ' LEU . 62.5 m-85 -89.97 -26.4 20.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.594 -0.691 . . . . 0.0 110.11 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -39.29 93.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.793 . . . . 0.0 109.109 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -85.83 -41.89 14.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.776 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -65.57 -29.04 69.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.537 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.49 31.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.681 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -68.23 -48.95 63.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 109.898 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.7 p -64.8 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.0 109.822 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.585 HG13 HG13 ' A' ' 45' ' ' VAL . 66.2 mt -77.19 -27.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.469 -0.769 . . . . 0.0 109.937 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.473 -0.767 . . . . 0.0 110.072 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -120.26 27.05 8.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.7 t80 -82.49 139.92 44.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.88 10.64 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.096 2.531 . . . . 0.0 111.317 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.9 m-70 -146.61 169.0 19.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.681 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HB3' HD22 ' A' ' 11' ' ' LEU . 5.2 pttm -96.44 148.57 22.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 58' ' ' GLU . 57.2 mt -97.86 104.39 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -87.57 -40.87 13.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.656 -0.652 . . . . 0.0 109.565 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -112.38 155.37 24.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.734 . . . . 0.0 109.597 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.53 -27.57 66.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.91 71.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.431 -1.04 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.748 ' CB ' HG23 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -63.72 -25.59 68.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.723 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.35 -26.63 26.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 109.846 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.97 -40.93 62.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.504 -0.748 . . . . 0.0 109.674 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -25.13 66.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 110.002 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.829 ' HB3' HG21 ' A' ' 45' ' ' VAL . 91.4 mt -58.46 137.72 85.57 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 109.928 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -80.85 109.74 2.26 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.055 2.503 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.78 -24.47 5.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 42' ' ' ALA . 22.9 t -89.5 137.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.41 -1.053 . . . . 0.0 109.372 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -95.5 -147.97 23.47 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.9 p -98.98 -28.96 13.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.923 . . . . 0.0 109.696 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -65.41 -65.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.776 HG21 ' CB ' ' A' ' 42' ' ' ALA . 50.0 mm -62.08 -39.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.747 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -57.97 -42.99 86.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.25 -35.15 76.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.566 -0.709 . . . . 0.0 109.395 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -65.69 -31.09 71.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 109.258 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.63 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.3 mm -62.83 -44.76 99.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -57.47 -38.56 74.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.464 -0.772 . . . . 0.0 109.518 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.21 -27.14 69.15 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -49.61 31.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.84 -42.46 60.8 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.899 -0.501 . . . . 0.0 110.17 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -80.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.432 -0.793 . . . . 0.0 109.795 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.22 -70.14 0.67 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.0 53.3 0.7 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.98 87.97 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.999 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.4 tp -111.58 94.15 4.82 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -99.99 -67.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.717 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.426 ' C ' HD12 ' A' ' 85' ' ' LEU . 6.7 mptt -146.52 82.68 1.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.374 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 84' ' ' LYS . 4.1 mp -137.72 125.81 22.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.61 -0.681 . . . . 0.0 109.47 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -91.35 -49.98 6.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 pttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.496 179.97 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -104.73 -44.12 4.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -146.5 81.11 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mttt 59.64 83.04 0.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.488 -0.757 . . . . 0.0 109.763 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 111.74 4.87 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.71 -25.83 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.095 2.53 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -63.37 136.0 57.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.734 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.4 -169.51 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 t -123.3 31.58 5.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.682 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -75.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.55 ' O ' HG22 ' A' ' 16' ' ' THR . 2.5 m120 -100.06 65.25 1.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.21 0.94 79.17 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.55 -48.6 3.18 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 15' ' ' ILE . 2.8 mp -66.87 -52.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.858 -0.79 . . . . 0.0 109.675 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 12' ' ' ASN . 5.1 t -57.91 -28.37 64.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 110.037 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.14 -38.26 88.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.73 . . . . 0.0 109.273 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.3 mmt -87.33 -10.18 52.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 110.184 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.676 HD23 ' HD2' ' A' ' 39' ' ' TYR . 4.2 mt -87.86 -35.88 17.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 16' ' ' THR . 43.1 t -78.33 -31.09 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -69.55 -60.24 2.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.599 -0.688 . . . . 0.0 109.719 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.2 pp -63.15 -34.8 78.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.21 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.79 -40.78 60.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.569 -0.707 . . . . 0.0 109.647 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -63.86 -38.91 92.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 29' ' ' VAL . 44.6 t80 -62.11 -22.31 65.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.635 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.5 mm-40 -75.47 -59.07 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.823 . . . . 0.0 109.038 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -67.48 -40.09 85.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.89 -24.7 58.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.35 -0.844 . . . . 0.0 109.688 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 25' ' ' PHE . 53.3 t -89.4 164.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.14 -70.15 0.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -178.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -88.06 67.61 8.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 0.0 110.296 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.71 40.27 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.33 -27.21 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.474 -0.766 . . . . 0.0 109.359 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 5.0 p-80 -68.47 -50.89 49.06 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -67.59 -25.89 66.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.51 -0.744 . . . . 0.0 109.242 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -53.31 -64.29 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.24 -0.912 . . . . 0.0 109.615 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -55.12 -25.46 31.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -57.75 -65.9 0.56 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.382 -0.824 . . . . 0.0 109.79 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.01 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.4 m-85 -72.34 -27.38 62.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.747 -0.596 . . . . 0.0 110.119 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -63.49 -46.1 87.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.447 -0.783 . . . . 0.0 109.393 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -65.85 -46.21 79.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.485 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.787 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.54 -48.34 77.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.422 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -55.14 -23.29 20.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -77.13 -59.84 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.781 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.9 p -63.47 -44.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.47 -0.769 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.494 HG21 ' HB ' ' A' ' 15' ' ' ILE . 50.3 mm -63.18 -28.41 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.369 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.02 -18.7 25.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -116.31 26.8 9.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.3 t80 -88.55 135.66 32.25 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.511 -0.743 . . . . 0.0 109.023 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.4 Cg_endo -85.55 10.41 3.72 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 123.148 2.565 . . . . 0.0 111.58 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.417 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.5 m-70 -148.82 -174.95 4.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.083 -1.011 . . . . 0.0 109.721 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 176.33 5.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.597 -0.689 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.535 HG22 ' HB3' ' A' ' 58' ' ' GLU . 32.7 pt -136.85 141.46 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.632 -0.668 . . . . 0.0 109.552 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -121.83 25.99 8.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.654 -0.654 . . . . 0.0 109.646 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -170.41 150.59 3.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.788 . . . . 0.0 109.356 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -28.94 68.16 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.4 85.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HB3' HG22 ' A' ' 53' ' ' ILE . 1.1 mp0 -64.51 -20.39 66.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.63 -0.669 . . . . 0.0 109.918 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -88.0 -25.14 23.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.348 -0.845 . . . . 0.0 109.883 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -73.38 -41.0 63.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 109.735 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.23 -26.42 66.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.461 -0.775 . . . . 0.0 109.939 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.781 ' HB3' HG21 ' A' ' 45' ' ' VAL . 93.4 mt -55.95 134.65 73.54 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.71 102.55 1.4 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.931 2.42 . . . . 0.0 109.986 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.43 -26.26 2.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.647 HG23 HG11 ' A' ' 45' ' ' VAL . 24.0 t -89.38 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -1.052 . . . . 0.0 109.218 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.79 -156.54 25.35 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -87.96 -7.37 57.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.667 -0.902 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -90.21 -63.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.787 HG21 ' CB ' ' A' ' 42' ' ' ALA . 46.9 mm -67.26 -34.57 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.775 . . . . 0.0 110.445 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -56.76 -55.8 29.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.309 -0.869 . . . . 0.0 109.917 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -59.84 -31.49 69.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 109.512 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -59.96 -43.86 94.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 0.0 109.418 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.556 HD12 ' HB1' ' A' ' 59' ' ' ALA . 65.1 mt -64.1 -29.91 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -56.04 -43.79 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.224 -0.922 . . . . 0.0 108.964 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -31.01 71.74 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -43.08 96.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.551 HD23 HG22 ' A' ' 73' ' ' ILE . 4.0 mm? -83.45 -24.89 31.63 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.086 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.428 -0.795 . . . . 0.0 109.786 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.6 m -110.71 -58.48 2.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.77 -49.68 0.92 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -158.68 -59.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.665 -0.903 . . . . 0.0 109.508 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.8 -173.79 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.438 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -77.34 97.31 4.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.566 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -134.86 160.7 37.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.488 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.45 124.53 13.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -72.06 162.5 29.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.711 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mttm . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.465 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -71.24 153.1 42.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 60.16 87.47 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.716 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -125.57 -43.63 1.88 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.484 -0.76 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -89.19 165.61 25.55 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.1 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.466 2.777 . . . . 0.0 110.511 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -88.55 -173.5 4.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.96 38.57 1.9 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.593 -0.692 . . . . 0.0 109.492 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.2 p -97.43 178.04 5.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.57 -0.706 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 52' ' ' LYS . 12.1 mt -75.74 -170.0 1.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.705 . . . . 0.0 109.497 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.659 ' HB3' HG22 ' A' ' 46' ' ' ILE . 4.5 m120 60.51 40.2 17.27 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.461 -0.774 . . . . 0.0 109.568 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.01 -10.37 64.64 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.07 -39.0 5.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.672 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -68.91 -50.7 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.88 -0.776 . . . . 0.0 108.952 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.8 t -59.36 -29.52 67.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.748 -0.595 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.69 -34.58 77.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.629 -0.669 . . . . 0.0 109.22 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.478 ' O ' HD23 ' A' ' 22' ' ' LEU . 35.8 mmm -89.61 -17.17 28.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.127 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.672 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -87.86 -35.63 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 108.489 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 16' ' ' THR . 46.6 t -78.58 -30.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.08 -60.52 2.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.724 . . . . 0.0 109.76 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.991 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.7 pp -62.87 -34.15 76.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.22 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.29 -44.15 61.8 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.626 -0.671 . . . . 0.0 109.917 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.34 -36.65 84.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.9 t80 -63.72 -23.07 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.895 -0.503 . . . . 0.0 109.682 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.2 mm-40 -77.31 -57.74 3.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.346 -0.847 . . . . 0.0 109.106 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -67.01 -40.41 87.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.537 -0.727 . . . . 0.0 109.553 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.12 -25.59 61.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.433 -0.792 . . . . 0.0 109.659 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.6 t -89.47 164.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.438 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.25 -69.77 0.51 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.485 -0.759 . . . . 0.0 110.937 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -85.32 62.15 7.31 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.84 47.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -96.34 -28.6 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.0 109.378 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.3 p-80 -64.59 -48.55 74.54 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.49 -25.78 64.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.616 -0.678 . . . . 0.0 109.347 179.274 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.0 t80 -52.48 -60.72 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.304 -0.872 . . . . 0.0 109.796 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.83 -26.88 64.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.029 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.91 -65.22 0.65 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.411 -0.806 . . . . 0.0 109.77 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.991 ' CG ' HD11 ' A' ' 22' ' ' LEU . 62.4 m-85 -76.38 -26.15 55.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.675 -0.641 . . . . 0.0 110.082 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -63.72 -52.11 61.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.466 -0.771 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.68 -45.69 81.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.772 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.98 -37.04 85.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -64.44 -25.52 68.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.918 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.26 -50.79 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 110.016 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 65' ' ' VAL . 7.7 p -62.79 -34.05 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.659 HG22 ' HB3' ' A' ' 12' ' ' ASN . 74.4 mt -83.34 -41.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -79.23 -17.59 54.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.328 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.21 23.37 14.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.789 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.58 ' CE1' HD22 ' A' ' 62' ' ' LEU . 2.6 t80 -94.66 144.9 28.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.9 Cg_endo -86.43 4.82 6.2 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 123.128 2.552 . . . . 0.0 110.846 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.6 m-70 -146.61 -175.38 4.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HG3' HD13 ' A' ' 11' ' ' LEU . 17.1 mtpp -105.38 160.56 15.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.564 -0.71 . . . . 0.0 109.67 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.766 HG23 ' HB3' ' A' ' 58' ' ' GLU . 52.7 mt -101.71 131.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -77.89 -65.3 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.729 . . . . 0.0 109.719 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 p -114.26 174.97 5.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.43 83.73 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -34.28 76.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.946 . . . . 0.0 109.308 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.766 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.0 mt-10 -67.13 -23.28 65.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.677 . . . . 0.0 109.716 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' ' 53' ' ' ILE . . . -84.76 -28.69 26.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.428 -0.795 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 8.1 tmtt? -74.49 -38.64 62.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -59.59 -26.44 65.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.755 . . . . 0.0 110.075 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.58 HD22 ' CE1' ' A' ' 49' ' ' TYR . 53.7 mt -71.65 150.2 93.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.74 106.31 2.17 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.024 2.483 . . . . 0.0 110.313 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.35 -29.44 2.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 45' ' ' VAL . 36.0 t -89.72 146.0 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -1.004 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.72 -145.77 15.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.4 p -100.15 -39.79 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.895 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -73.43 -44.66 57.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.635 -0.666 . . . . 0.0 109.725 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.029 HD11 ' HB1' ' A' ' 38' ' ' ALA . 43.8 mm -69.62 -38.6 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 60' ' ' LYS . . . -59.64 -41.66 91.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.64 -38.54 85.13 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.481 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -62.28 -30.22 70.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.604 -0.685 . . . . 0.0 109.368 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.0 mm -64.32 -45.51 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -54.84 -40.65 69.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HG3' HD23 ' A' ' 82' ' ' LEU . 2.0 mp0 -63.49 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -53.16 36.68 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.509 0.671 . . . . 0.0 109.308 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.56 -22.3 61.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.948 -0.47 . . . . 0.0 110.14 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.08 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 80' ' ' GLY . 3.2 t -126.48 -42.32 1.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.406 -0.809 . . . . 0.0 109.623 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.448 ' N ' HG23 ' A' ' 79' ' ' THR . . . 143.29 -46.48 0.84 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.4 tttt -132.33 79.3 1.85 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 109.554 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD21 ' HE2' ' A' ' 84' ' ' LYS . 29.6 tp -113.05 93.95 4.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -74.92 138.62 42.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.493 ' HE2' HD21 ' A' ' 82' ' ' LEU . 21.6 mtmt -165.07 97.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.705 . . . . 0.0 109.396 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.494 ' N ' HD22 ' A' ' 85' ' ' LEU . 4.4 mm? -70.27 -73.99 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.422 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -109.54 158.83 17.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 pttp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.471 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -159.48 94.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.685 . . . . 0.0 109.436 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -158.26 30.84 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.568 -0.708 . . . . 0.0 109.435 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -79.68 147.24 32.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.591 -0.693 . . . . 0.0 109.506 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -65.75 168.42 8.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.723 . . . . 0.0 109.455 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.0 Cg_endo -86.55 123.75 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.498 2.799 . . . . 0.0 110.483 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.89 -166.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -79.07 155.81 28.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.606 -0.683 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.3 p -99.87 -175.83 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.595 -0.691 . . . . 0.0 109.455 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.25 -69.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.811 ' HB2' HD12 ' A' ' 15' ' ' ILE . 29.1 p30 -76.0 73.74 2.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.643 -0.661 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.19 0.96 79.26 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.71 -32.76 8.93 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.82 HG22 ' CD1' ' A' ' 19' ' ' LEU . 16.6 mt -74.89 -59.08 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.764 -0.845 . . . . 0.0 109.334 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.4 t -51.8 -32.41 31.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.756 -0.59 . . . . 0.0 110.553 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.46 -26.21 64.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.593 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.8 mtp -90.02 -21.32 22.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.956 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.82 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.4 mp -88.65 -33.89 17.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 16' ' ' THR . 54.5 t -76.25 -34.75 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -68.34 -60.2 2.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.656 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.981 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -60.82 -35.2 75.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 109.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -50.68 -42.1 56.48 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.666 -0.646 . . . . 0.0 109.739 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.16 -36.12 83.02 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.5 t80 -65.69 -24.77 67.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.888 -0.507 . . . . 0.0 109.676 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.1 mm-40 -75.8 -57.79 3.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -66.14 -41.94 89.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.0 109.58 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -57.3 -24.7 56.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.4 -0.813 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.6 t -89.66 164.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.6 t -77.19 -70.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 110.876 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -85.05 66.75 9.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.471 -0.768 . . . . 0.0 110.734 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.63 29.18 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -81.89 -21.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.59 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.439 ' CD2' ' HE2' ' A' ' 35' ' ' LYS . 6.4 p-80 -76.09 -49.85 16.28 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -67.62 -26.46 66.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.57 -51.62 67.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.03 -28.13 68.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 0.0 109.532 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.021 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.46 -62.32 1.8 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.981 ' CG ' HD11 ' A' ' 22' ' ' LEU . 66.0 m-85 -78.5 -1.42 33.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.912 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 -87.14 -36.27 18.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -81.1 -46.62 14.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.756 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.45 -42.78 98.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.589 -0.695 . . . . 0.0 109.391 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -68.86 -26.06 64.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.639 -0.663 . . . . 0.0 109.762 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -80.57 -28.93 37.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.783 . . . . 0.0 109.906 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 62' ' ' LEU . 14.5 p -90.0 -44.71 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.417 -0.802 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 53' ' ' ILE . 67.7 mt -69.71 -52.27 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 109.587 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.651 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -60.65 -21.08 62.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -118.1 28.74 8.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.518 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.0 t80 -89.56 145.68 34.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.0 Cg_endo -85.97 2.11 7.64 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.101 2.534 . . . . 0.0 110.979 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.2 m-70 -144.06 -179.35 6.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -105.93 139.68 40.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.717 HG23 ' CB ' ' A' ' 58' ' ' GLU . 60.0 mt -77.12 106.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.605 -0.684 . . . . 0.0 109.356 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.8 mttt -72.36 -69.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.55 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -102.53 174.65 5.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.556 -0.715 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.36 -28.96 71.87 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.86 -30.38 70.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -1.008 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.717 ' CB ' HG23 ' A' ' 53' ' ' ILE . 1.1 mp0 -67.28 -27.61 67.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.651 -0.655 . . . . 0.0 109.628 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.765 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.92 -28.85 22.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.631 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -75.57 -39.04 58.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.475 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -60.51 -24.16 65.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.502 -0.749 . . . . 0.0 110.039 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.806 ' HB3' HG21 ' A' ' 45' ' ' VAL . 81.7 mt -60.84 140.92 93.32 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.426 -0.796 . . . . 0.0 109.545 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.29 107.18 1.99 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.983 2.456 . . . . 0.0 110.14 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.87 -25.38 4.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 70' ' ' ALA . 29.8 t -89.55 138.52 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.978 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.26 -139.65 9.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.39 -29.49 12.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.94 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -67.42 -64.6 0.82 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.021 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.2 mm -61.42 -41.97 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 0.0 109.789 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -59.64 -35.35 74.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.543 -0.723 . . . . 0.0 109.658 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.72 -41.59 95.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.511 -0.743 . . . . 0.0 109.516 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -62.04 -30.4 70.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.615 -0.678 . . . . 0.0 109.31 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.7 mm -63.16 -47.23 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.11 -31.54 65.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 109.606 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.7 -30.67 70.23 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -74.2 -50.79 17.69 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.582 0.705 . . . . 0.0 109.592 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.33 -27.42 62.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.908 -0.495 . . . . 0.0 109.95 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.44 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.81 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -104.83 -62.05 1.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.45 -48.27 0.86 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -146.92 -172.98 4.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.941 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 82' ' ' LEU . 1.2 pp -158.49 45.47 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.567 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -62.89 148.41 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.575 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -105.82 -173.71 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.718 . . . . 0.0 109.424 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 mt -113.6 -59.92 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.545 -0.722 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.0 -179.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.553 -0.717 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 118.058 -0.973 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 118.56 27.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.659 -0.651 . . . . 0.0 109.469 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -130.1 89.57 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -172.9 36.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -76.06 167.07 40.0 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.541 -0.724 . . . . 0.0 109.513 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.3 Cg_endo -86.38 145.55 8.29 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.511 2.807 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -89.28 116.83 27.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.642 -0.661 . . . . 0.0 109.415 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.5 151.89 28.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -129.95 33.15 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.519 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 52' ' ' LYS . 4.0 mm? -105.69 -74.05 0.66 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 109.366 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -131.06 41.53 3.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.66 -2.17 90.61 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.3 -41.49 5.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.508 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.0 mt -66.11 -50.56 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.893 -0.769 . . . . 0.0 109.072 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 5.1 t -58.08 -31.17 66.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.698 -0.626 . . . . 0.0 109.963 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.15 -36.03 76.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 109.381 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtt -87.54 -14.55 39.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.609 -0.682 . . . . 0.0 110.135 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -86.2 -42.55 13.72 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.12 -31.62 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.21 -64.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.977 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.1 pp -62.07 -33.73 74.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.11 -42.5 63.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.86 -36.51 84.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 54.0 t80 -63.73 -22.76 67.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.8 mm-40 -77.48 -57.63 3.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.099 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 71.6 tttt -67.79 -39.48 84.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.51 -0.743 . . . . 0.0 109.622 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.79 -25.7 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.403 -0.811 . . . . 0.0 109.605 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 62.0 t -89.36 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.88 -70.09 0.48 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 0.0 110.98 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -85.12 62.11 7.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 110.407 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.81 53.64 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -0.822 . . . . 0.0 109.68 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -100.18 -30.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.795 . . . . 0.0 109.105 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.451 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.05 -48.43 76.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.66 -23.78 63.51 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 26.7 t80 -54.6 -67.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.22 -0.925 . . . . 0.0 109.694 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -54.74 -24.59 23.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 109.88 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.064 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.14 -65.36 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.977 ' CG ' HD11 ' A' ' 22' ' ' LEU . 58.2 m-85 -79.12 -29.31 43.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.587 -0.695 . . . . 0.0 109.851 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -65.36 -46.34 80.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.486 -0.759 . . . . 0.0 109.456 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -70.59 -40.57 73.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.499 -0.751 . . . . 0.0 109.661 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.719 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -68.88 -39.56 79.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.602 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -62.01 -28.17 69.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -70.84 -51.29 27.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.3 p -69.67 -44.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.487 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.2 mt -67.17 -29.45 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.448 -0.783 . . . . 0.0 109.971 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.402 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -90.05 -13.85 35.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.429 -0.795 . . . . 0.0 110.538 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -123.26 27.99 7.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.475 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.2 t80 -85.24 143.69 39.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.196 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.24 3.87 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.052 2.502 . . . . 0.0 111.066 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.405 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -145.01 -177.72 5.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.645 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.504 ' HB2' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -112.34 160.8 17.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.7 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 58' ' ' GLU . 24.6 pt -123.41 153.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 109.318 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -137.73 28.58 2.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.511 -0.743 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 t -170.3 151.52 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.02 -28.1 69.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.92 72.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.464 -1.021 . . . . 0.0 109.695 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 53' ' ' ILE . 2.6 mt-10 -73.66 -14.43 61.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.614 -0.679 . . . . 0.0 110.355 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -90.11 -29.72 18.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -29.52 55.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.555 -0.716 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HG21 ' A' ' 45' ' ' VAL . 80.9 mt -61.77 146.17 91.13 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.21 113.13 3.14 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.0 2.466 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.36 -28.54 5.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 70' ' ' ALA . 27.6 t -89.9 138.48 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -1.023 . . . . 0.0 109.392 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -139.75 9.23 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 t -98.87 -28.59 13.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.958 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -67.9 -65.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.47 -0.769 . . . . 0.0 109.503 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.064 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.5 mm -61.34 -41.67 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.828 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.05 -37.05 73.66 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.582 -0.699 . . . . 0.0 109.736 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -61.86 -40.38 95.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.48 -0.762 . . . . 0.0 109.526 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -62.79 -32.68 73.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.0 109.285 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.7 mm -64.14 -42.43 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.79 -40.83 73.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.487 -0.758 . . . . 0.0 109.732 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.54 ' HG2' HD21 ' A' ' 82' ' ' LEU . 1.6 mp0 -63.5 -29.62 70.86 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.43 -52.7 24.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.538 0.685 . . . . 0.0 109.37 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.23 -24.9 61.45 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.926 -0.484 . . . . 0.0 110.054 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -113.95 -53.0 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.71 -55.31 0.76 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -102.29 137.34 40.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.983 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.585 ' HA ' HD23 ' A' ' 85' ' ' LEU . 5.7 mt -92.84 80.42 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.513 -0.742 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -100.14 -62.51 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.616 -0.677 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -132.75 47.56 2.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.517 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 82' ' ' LEU . 4.4 mm? -70.08 133.7 47.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.53 -0.731 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -153.32 -176.77 5.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.603 -0.685 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.514 -179.922 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mttp 59.76 95.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -0.754 . . . . 0.0 109.763 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 59.55 -175.64 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.715 . . . . 0.0 109.726 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -132.58 150.02 52.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -71.96 172.83 6.32 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.685 . . . . 0.0 109.453 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.0 Cg_endo -86.5 -165.53 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.424 2.749 . . . . 0.0 110.521 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.06 161.99 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.502 -0.749 . . . . 0.0 109.477 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -138.15 40.04 2.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.7 p -110.62 37.45 2.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.518 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -66.86 -69.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -98.18 39.88 1.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.342 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.55 84.46 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.85 -33.82 8.1 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.589 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.6 mp -69.42 -42.1 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.879 -0.777 . . . . 0.0 109.245 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.4 t -60.73 -30.89 70.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.66 -0.65 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -39.23 93.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.711 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.6 mtm -83.04 -19.31 37.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.648 -0.658 . . . . 0.0 109.87 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -80.35 -37.54 32.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.416 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 16' ' ' THR . 50.8 t -71.67 -28.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.072 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -66.57 -68.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.12 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.788 HD11 ' CE1' ' A' ' 39' ' ' TYR . 2.3 pt? -57.55 -31.0 65.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.939 -1.1 . . . . 0.0 109.491 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.42 68.74 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 78.9 t80 -62.1 -25.47 67.73 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.616 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.5 mp0 -75.5 -57.66 3.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.557 -0.714 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -67.22 -41.61 85.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.556 -0.715 . . . . 0.0 109.524 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.07 -25.18 58.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' PHE . 53.4 t -89.53 164.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.446 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.1 t -78.02 -70.13 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.485 -0.759 . . . . 0.0 111.009 -178.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -82.93 61.63 6.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 45.34 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -27.76 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 6.1 p-80 -70.21 -49.86 45.85 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.79 -18.82 62.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.344 -0.848 . . . . 0.0 109.393 178.948 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 16.7 t80 -59.45 -63.9 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 108.933 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -55.08 -24.11 23.83 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.722 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.96 -65.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.788 ' CE1' HD11 ' A' ' 22' ' ' LEU . 34.5 m-85 -80.59 -31.07 36.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.854 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.0 -48.79 78.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.819 . . . . 0.0 109.814 -179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -72.8 -35.84 67.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 0.0 109.855 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.81 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -67.08 -49.91 63.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.472 -0.767 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -60.44 -26.47 66.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.47 -0.769 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -71.67 -58.88 3.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.3 p -60.54 -43.44 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.482 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.9 mt -68.17 -27.67 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.37 -25.46 29.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.825 . . . . 0.0 109.806 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -107.05 28.13 8.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.506 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 3.6 t80 -93.35 139.48 22.96 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.23 11.54 3.28 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.104 2.536 . . . . 0.0 111.354 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.414 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.22 176.77 9.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -102.13 144.26 30.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.547 -0.72 . . . . 0.0 109.636 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.75 HG23 ' HB3' ' A' ' 58' ' ' GLU . 57.7 mt -82.67 122.1 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.622 -0.674 . . . . 0.0 109.223 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -81.02 -60.8 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -126.24 -179.96 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.19 -27.4 65.1 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.08 95.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -1.081 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.75 ' HB3' HG23 ' A' ' 53' ' ' ILE . 4.2 tt0 -61.7 -20.88 63.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.588 -0.695 . . . . 0.0 109.971 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -86.24 -24.86 25.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 109.895 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -70.34 -43.72 69.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.724 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -60.81 -28.72 68.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.773 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB3' HG21 ' A' ' 45' ' ' VAL . 97.4 mt -56.8 130.47 78.3 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.552 -0.717 . . . . 0.0 109.978 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.69 102.15 1.52 Allowed 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.833 2.356 . . . . 0.0 110.11 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.15 -27.74 1.85 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 t -89.57 138.3 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.545 -0.973 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.56 -143.76 13.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.0 t -98.64 -27.18 14.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.94 . . . . 0.0 109.694 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -82.26 -41.47 20.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.551 -0.718 . . . . 0.0 109.7 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.035 HD11 ' HB1' ' A' ' 38' ' ' ALA . 39.9 mm -72.37 -41.82 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.738 . . . . 0.0 109.884 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.94 71.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -0.811 . . . . 0.0 110.057 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.33 -32.62 68.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -64.73 -33.13 75.25 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.58 -42.8 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.54 -35.53 72.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.695 . . . . 0.0 109.372 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.64 -30.79 71.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -48.99 64.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.514 0.673 . . . . 0.0 109.2 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.7 mm? -74.33 -26.42 60.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.061 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -80.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 0.0 109.698 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 p -127.11 -62.32 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.67 60.14 0.24 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -136.92 165.14 26.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.511 -0.993 . . . . 0.0 109.524 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt -141.67 97.86 3.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.537 -0.727 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -100.09 89.25 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.6 pttt -170.07 137.96 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -142.6 30.73 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.482 -179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -138.46 151.36 47.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.569 -0.707 . . . . 0.0 109.464 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 169.41 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.597 -0.689 . . . . 0.0 109.479 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 68.88 -69.59 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.524 -0.735 . . . . 0.0 109.683 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -110.29 128.8 55.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.762 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 160.39 44.45 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.48 52.47 2.79 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.397 2.731 . . . . 0.0 110.557 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -91.06 20.09 5.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.582 -0.699 . . . . 0.0 110.454 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.569 ' OE1' HD23 ' A' ' 11' ' ' LEU . 3.5 mt-10 -158.57 152.63 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 t -112.63 36.13 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.569 HD23 ' OE1' ' A' ' 9' ' ' GLU . 1.2 mm? -76.11 -168.74 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.601 -0.687 . . . . 0.0 109.284 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.873 ' HB3' HD12 ' A' ' 15' ' ' ILE . 8.9 m120 -70.06 77.12 0.5 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.703 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.25 1.06 79.25 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -35.33 7.25 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 12' ' ' ASN . 6.7 mt -74.71 -57.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.858 -0.789 . . . . 0.0 108.957 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -56.19 -30.85 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.962 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -32.72 74.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' HD23 ' A' ' 22' ' ' LEU . 9.9 mmm -88.74 -17.67 29.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.741 -0.6 . . . . 0.0 109.944 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -87.34 -35.37 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.528 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' THR . 46.0 t -78.59 -30.82 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -69.97 -59.73 2.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.661 -0.649 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.994 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.3 pp -63.24 -33.73 76.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.16 -41.51 62.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.484 -0.76 . . . . 0.0 109.537 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -64.87 -37.53 87.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.7 t80 -63.49 -24.05 67.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -74.12 -62.99 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.669 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 21.9 tttt -62.1 -41.95 98.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.876 -0.515 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -57.76 -23.94 54.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.772 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' PHE . 48.9 t -89.81 165.11 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.4 t -76.01 -70.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.459 -0.776 . . . . 0.0 111.107 -178.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -88.69 67.73 8.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.815 . . . . 0.0 110.675 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.1 38.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 109.666 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -88.69 -25.59 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.718 . . . . 0.0 109.589 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.472 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.99 -51.82 29.32 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.02 -19.34 63.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.739 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.2 t80 -57.15 -57.67 11.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.216 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.44 -26.77 66.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.655 -0.653 . . . . 0.0 109.469 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.848 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -53.98 -64.79 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.378 -0.826 . . . . 0.0 110.215 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.994 ' CG ' HD11 ' A' ' 22' ' ' LEU . 70.5 m-85 -74.01 -25.44 59.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 110.13 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -63.4 -47.73 80.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.357 -0.839 . . . . 0.0 109.316 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.42 -49.94 50.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.595 -0.691 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.751 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -61.95 -27.35 68.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 109.808 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -72.69 -28.22 62.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.938 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 p -84.81 -46.56 11.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.873 HG11 HG23 ' A' ' 65' ' ' VAL . 8.1 p -64.2 -35.57 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 110.109 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.6 HG13 HG13 ' A' ' 45' ' ' VAL . 66.8 mt -84.22 -37.05 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.951 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -82.61 -19.99 37.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.402 -0.811 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -104.72 21.52 16.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.301 -0.875 . . . . 0.0 110.014 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.528 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.9 t80 -94.07 140.81 23.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -86.32 9.96 3.83 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.015 2.476 . . . . 0.0 111.071 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.18 -176.61 5.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.76 162.64 12.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.714 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.601 HG23 ' HB3' ' A' ' 58' ' ' GLU . 50.7 mt -107.52 144.76 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.616 -0.677 . . . . 0.0 109.195 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -91.6 -63.72 1.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 109.673 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.8 p -124.42 -179.86 4.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.502 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.24 -29.87 72.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -30.36 70.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.991 . . . . 0.0 109.491 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.601 ' HB3' HG23 ' A' ' 53' ' ' ILE . 5.1 mt-10 -81.13 -25.74 36.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.581 -0.699 . . . . 0.0 109.724 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -83.89 -33.62 24.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.477 -0.765 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.526 -0.734 . . . . 0.0 109.974 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -59.68 -25.62 64.9 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.427 -0.796 . . . . 0.0 110.208 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 59' ' ' ALA . 10.9 mt -70.8 152.01 95.16 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.491 -0.756 . . . . 0.0 109.464 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -77.94 103.02 1.64 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.106 2.538 . . . . 0.0 110.297 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.13 -30.4 2.02 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.873 HG23 HG11 ' A' ' 45' ' ' VAL . 38.2 t -89.98 140.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.588 -0.948 . . . . 0.0 109.44 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -105.06 -146.64 15.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -99.47 -36.16 9.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.968 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.05 -60.2 2.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.848 HD11 ' HB1' ' A' ' 38' ' ' ALA . 46.8 mm -61.74 -36.54 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.535 -0.728 . . . . 0.0 109.728 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -57.83 -39.59 78.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -61.72 -39.6 92.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.093 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -62.58 -30.23 71.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.621 -0.674 . . . . 0.0 109.312 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 59' ' ' ALA . 49.5 mm -62.84 -45.13 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.63 -41.79 74.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.42 -28.75 70.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.13 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -52.47 18.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.378 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.75 61.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.972 -0.455 . . . . 0.0 110.086 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.23 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 109.543 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.9 m -107.55 -60.78 1.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.74 56.6 4.1 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -144.12 35.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.547 -0.972 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.73 104.93 8.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.499 -0.751 . . . . 0.0 109.459 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.3 mtm-85 -99.32 -41.75 7.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -73.32 151.87 41.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 mt -105.52 168.14 9.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -111.0 141.24 44.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.663 . . . . 0.0 109.53 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.489 -179.973 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt 60.12 36.27 21.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.559 -0.713 . . . . 0.0 109.734 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -108.86 -30.96 7.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.82 -81.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.731 -0.606 . . . . 0.0 109.721 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.24 148.06 98.18 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 0.0 109.441 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.03 -26.84 1.35 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.203 2.602 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -62.52 164.12 7.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.41 -0.806 . . . . 0.0 109.645 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.77 -166.21 0.64 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.697 -0.627 . . . . 0.0 109.319 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.699 . . . . 0.0 109.407 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.25 -164.55 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.437 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.54 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -88.66 53.3 2.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 0.39 78.12 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.09 -39.6 5.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.792 HG22 HD12 ' A' ' 19' ' ' LEU . 2.9 mp -65.77 -41.87 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.874 -0.78 . . . . 0.0 109.202 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 4.6 t -59.65 -31.08 69.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.613 -0.679 . . . . 0.0 109.643 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -65.0 -33.53 76.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.603 ' O ' HD23 ' A' ' 22' ' ' LEU . 15.1 mmt -90.13 -15.22 32.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.667 -0.646 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.792 HD12 HG22 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -88.86 -35.18 16.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 108.519 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 16' ' ' THR . 43.4 t -81.07 -31.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.3 -57.34 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.993 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.5 pp -63.27 -34.65 78.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.7 -44.78 63.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.55 -0.719 . . . . 0.0 109.791 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.91 -35.07 79.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.7 t80 -63.56 -24.66 67.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.854 -0.529 . . . . 0.0 109.898 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 21.2 mm-40 -79.25 -56.63 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.851 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.0 ttpt -64.99 -41.37 95.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.497 -0.752 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -58.51 -26.69 63.74 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.823 . . . . 0.0 109.412 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 25' ' ' PHE . 56.9 t -89.55 164.77 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.2 t -78.63 -70.16 0.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.454 -0.779 . . . . 0.0 111.093 -178.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -81.01 57.85 3.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.511 -0.743 . . . . 0.0 110.905 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.88 62.01 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 179.061 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -109.56 -28.87 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.195 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.437 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -63.35 -49.1 75.24 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.8 -25.99 63.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.594 -0.691 . . . . 0.0 109.312 179.375 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -51.35 -59.01 4.69 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.291 -0.88 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -61.37 -27.84 68.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.531 -0.731 . . . . 0.0 109.318 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.034 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.68 -65.96 0.52 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.461 -0.774 . . . . 0.0 109.953 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.993 ' CG ' HD11 ' A' ' 22' ' ' LEU . 81.1 m-85 -71.27 -8.79 56.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 110.798 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -83.88 -54.41 4.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.119 -0.988 . . . . 0.0 109.3 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -61.07 -29.11 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.516 -0.74 . . . . 0.0 109.83 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.822 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -79.82 -47.17 15.61 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.529 -0.732 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -61.6 -26.24 67.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.879 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 -45.36 27.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.966 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 62' ' ' LEU . 12.6 p -75.51 -44.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -0.777 . . . . 0.0 110.086 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.48 ' N ' HG13 ' A' ' 45' ' ' VAL . 70.3 mt -67.6 -55.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 -179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -61.53 -20.01 62.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -116.02 28.11 8.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 109.575 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.482 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.4 t80 -89.7 141.77 28.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -85.7 8.41 4.56 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.002 2.468 . . . . 0.0 110.998 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.7 m-70 -146.55 175.25 10.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 139.83 36.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.631 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.08 108.36 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.428 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -69.75 -40.34 76.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.821 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.3 m -148.55 -179.88 7.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.532 -0.73 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.33 -26.36 61.59 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.82 96.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.479 -1.012 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.58 -24.99 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.719 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -84.62 -27.67 27.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.415 -0.803 . . . . 0.0 109.733 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -75.9 -40.52 54.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -59.92 -22.4 62.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.788 ' HB3' HG21 ' A' ' 45' ' ' VAL . 86.5 mt -59.3 139.04 88.58 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 109.717 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.45 112.36 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.957 2.438 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.27 -28.52 5.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.78 138.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.932 . . . . 0.0 109.361 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.09 -139.52 10.17 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -99.22 -27.82 13.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.964 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -65.51 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.402 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.034 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.5 mm -61.94 -42.13 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 109.717 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.74 82.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.534 -0.729 . . . . 0.0 109.673 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.7 -35.75 77.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.514 -0.741 . . . . 0.0 109.53 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -68.9 -28.94 67.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.619 -0.676 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.5 mm -63.17 -49.44 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 109.144 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.22 -40.61 74.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.454 -0.779 . . . . 0.0 109.694 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.01 -28.77 70.33 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.43 -51.65 27.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.64 -0.662 . . . . 0.0 109.294 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.65 -25.68 61.37 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.907 -0.496 . . . . 0.0 110.039 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.405 -0.809 . . . . 0.0 109.587 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -106.44 -54.75 2.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 109.407 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.56 3.19 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -170.17 155.01 5.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -1.016 . . . . 0.0 109.539 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 82' ' ' LEU . 9.5 mt -103.91 99.27 9.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.552 -0.717 . . . . 0.0 109.359 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -66.82 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.701 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 144.58 25.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.59 -0.694 . . . . 0.0 109.541 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -99.99 123.57 44.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.48 166.43 10.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.423 -179.95 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -85.14 155.26 21.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.622 -0.674 . . . . 0.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 59.92 92.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -85.59 -51.64 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.73 163.46 15.68 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.619 -0.676 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.54 177.68 4.21 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.34 2.693 . . . . 0.0 110.505 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -89.13 81.74 6.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.589 -0.695 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.95 105.07 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.738 . . . . 0.0 109.359 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -91.94 85.56 5.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.538 -0.727 . . . . 0.0 109.58 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mt -68.37 -69.74 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 109.286 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.69 ' HB2' HD12 ' A' ' 15' ' ' ILE . 24.1 p30 -83.8 57.83 4.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.609 -0.682 . . . . 0.0 109.496 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.29 0.51 78.28 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -39.52 5.79 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.69 HD12 ' HB2' ' A' ' 12' ' ' ASN . 3.3 mt -68.21 -52.25 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.826 -0.808 . . . . 0.0 109.086 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -55.88 -33.98 65.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.737 -0.602 . . . . 0.0 110.175 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.36 -33.49 73.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.552 -0.718 . . . . 0.0 109.45 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt -86.88 -13.74 43.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.693 -0.629 . . . . 0.0 110.258 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -85.44 -35.71 21.09 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.495 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.54 -31.68 20.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.747 -0.595 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.97 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.6 pp -63.28 -33.05 74.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.08 -41.95 65.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -63.54 -37.77 88.58 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.5 t80 -62.69 -23.58 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.92 -0.487 . . . . 0.0 109.707 178.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.1 mm-40 -77.34 -57.58 3.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.067 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 13.6 tttt -66.47 -41.35 89.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -58.12 -25.27 61.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.732 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.2 t -89.43 164.35 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.8 t -77.01 -70.25 0.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 110.925 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -84.54 61.7 6.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 110.638 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.79 52.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -98.98 -28.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.372 -0.83 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.9 p-80 -65.27 -49.26 70.26 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -69.15 -22.06 63.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.675 . . . . 0.0 109.569 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 26.8 t80 -56.9 -64.59 0.83 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -55.96 -25.02 41.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 109.772 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.09 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.71 -64.87 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.441 -0.787 . . . . 0.0 110.053 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.97 ' CG ' HD11 ' A' ' 22' ' ' LEU . 45.7 m-85 -81.7 -25.76 35.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.667 . . . . 0.0 110.282 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 tpt85 -62.11 -44.47 96.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.8 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -78.0 -42.58 32.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.796 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.795 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.97 -29.74 71.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 109.662 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -76.64 -31.71 57.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -75.49 -41.31 55.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.4 p -70.88 -44.25 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.478 -0.764 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.548 HG13 HG13 ' A' ' 45' ' ' VAL . 69.9 mt -73.41 -27.95 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.471 -0.768 . . . . 0.0 109.853 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.41 -23.3 43.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -116.64 28.14 8.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.586 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.1 t80 -88.1 142.48 31.95 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -85.63 6.78 5.41 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.063 2.509 . . . . 0.0 111.177 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -145.67 170.77 15.81 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -98.26 135.95 39.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.551 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.789 HG23 ' HB3' ' A' ' 58' ' ' GLU . 55.9 mt -73.06 120.66 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.572 -0.705 . . . . 0.0 109.271 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -82.16 -49.64 9.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.543 -0.723 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.48 -179.81 5.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.607 -0.683 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.42 -27.72 71.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.01 96.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.589 -0.948 . . . . 0.0 109.681 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.789 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -61.36 -20.79 63.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.836 179.944 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.87 -26.4 22.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.397 -0.815 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -74.01 -39.92 63.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.504 -0.747 . . . . 0.0 109.71 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.19 -25.86 65.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.55 -0.719 . . . . 0.0 110.01 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HG21 ' A' ' 45' ' ' VAL . 84.3 mt -59.21 144.64 82.89 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.503 -0.748 . . . . 0.0 109.714 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -79.1 112.61 3.09 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.021 2.481 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.13 -28.57 6.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.7 139.6 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 109.343 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.43 -137.61 7.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 p -99.1 -29.34 12.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.601 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -65.92 -65.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.482 -0.761 . . . . 0.0 109.587 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.09 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.7 mm -61.78 -42.78 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.818 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.89 70.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.7 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.43 -43.22 99.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -62.22 -28.45 69.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.315 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.2 mm -63.48 -44.52 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.41 -41.3 76.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.474 -0.766 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.07 -27.54 69.47 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.549 ' CD2' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -71.46 -52.09 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 0.0 109.409 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -71.22 -26.68 63.03 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.949 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 109.527 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 -66.63 1.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.416 -0.803 . . . . 0.0 109.272 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.25 41.91 98.49 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.19 -52.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.692 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -108.6 123.51 49.05 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -65.84 143.24 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.676 . . . . 0.0 109.455 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.74 19.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 109.491 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.51 ' N ' HD22 ' A' ' 85' ' ' LEU . 4.3 mm? -71.14 -176.41 1.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.412 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.98 80.24 1.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.6 -0.687 . . . . 0.0 109.49 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.6 tptp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.386 -179.906 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -78.29 -35.45 47.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.12 -82.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -145.53 143.23 29.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.85 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.89 159.72 84.53 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.451 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.5 -168.94 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.412 2.741 . . . . 0.0 110.575 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -84.87 99.48 10.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.632 -0.668 . . . . 0.0 109.48 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -149.78 30.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.602 -0.686 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 p -86.15 145.25 27.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.685 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 52' ' ' LYS . 4.4 mt -83.15 -170.31 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.725 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.68 ' HB3' HG22 ' A' ' 46' ' ' ILE . 69.4 m-20 58.37 29.84 18.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.493 -0.754 . . . . 0.0 109.921 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 -17.22 54.09 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.25 -38.43 5.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 12' ' ' ASN . 3.2 mt -69.08 -49.52 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.836 -0.802 . . . . 0.0 109.155 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 5.0 t -57.48 -35.01 69.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.055 -179.3 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -59.74 -35.53 74.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.458 -0.776 . . . . 0.0 109.471 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.699 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.1 tpp -90.35 -11.88 39.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.163 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.667 ' CD1' HG22 ' A' ' 15' ' ' ILE . 3.9 mt -87.48 -32.62 19.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.702 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.3 t -85.57 -36.54 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HA ' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -67.04 -47.24 71.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.914 HD11 ' CG ' ' A' ' 39' ' ' TYR . 1.9 pp -73.82 -34.97 64.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 108.437 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.82 -49.9 67.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.675 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -62.4 -33.02 73.94 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 37.5 t80 -64.52 -21.33 66.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.714 -0.616 . . . . 0.0 109.609 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -78.47 -57.81 3.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.366 -0.834 . . . . 0.0 108.85 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.1 tmtt? -66.81 -39.79 87.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 109.426 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -58.7 -26.4 63.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.791 . . . . 0.0 109.603 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 63.1 t -89.44 164.41 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.03 -70.01 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.768 . . . . 0.0 111.012 -178.617 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -84.64 60.34 6.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 110.687 -178.626 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.91 63.96 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -110.12 -31.02 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.812 . . . . 0.0 109.008 179.777 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -60.88 -48.8 80.15 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.426 -0.796 . . . . 0.0 108.904 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.92 -26.02 63.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.645 -0.659 . . . . 0.0 109.544 179.339 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.3 t80 -51.54 -65.56 0.54 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -57.61 -25.06 59.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.058 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -57.42 -67.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.914 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.8 m-85 -72.32 -24.65 61.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.64 -0.663 . . . . 0.0 110.268 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 -62.54 -42.3 99.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -75.12 -44.53 46.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.504 -0.747 . . . . 0.0 109.801 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -62.11 -41.26 98.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -65.21 -29.45 70.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.793 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -70.78 -34.67 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.72 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.842 HG21 ' HB3' ' A' ' 62' ' ' LEU . 13.6 p -90.14 -45.35 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 110.121 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.68 HG22 ' HB3' ' A' ' 12' ' ' ASN . 69.7 mt -66.74 -55.64 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.0 109.723 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -59.25 -19.92 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -118.05 28.08 8.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.763 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.614 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.6 t80 -91.05 139.84 25.85 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -85.09 6.95 5.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.034 2.489 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 66.7 m-70 -147.14 172.52 13.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.168 -0.957 . . . . 0.0 109.536 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HB3' HD13 ' A' ' 11' ' ' LEU . 5.5 pttm -98.61 144.05 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.553 -0.717 . . . . 0.0 109.512 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.814 HG23 ' HB3' ' A' ' 58' ' ' GLU . 57.3 mt -75.28 108.85 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 109.36 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -71.18 -46.57 61.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.657 -0.652 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.9 173.43 11.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.08 -28.43 68.91 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.44 71.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.654 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.814 ' HB3' HG23 ' A' ' 53' ' ' ILE . 6.4 tt0 -74.36 -24.18 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.556 -0.715 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.755 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.38 -29.31 24.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.41 -0.806 . . . . 0.0 109.587 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -76.22 -38.82 55.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.543 -0.723 . . . . 0.0 109.629 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -60.32 -23.67 64.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 0.0 110.06 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.842 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.9 mt -60.94 141.29 93.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.515 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.54 107.91 2.22 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.939 2.426 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.9 -28.78 3.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 70' ' ' ALA . 28.3 t -89.79 138.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -1.02 . . . . 0.0 109.379 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.7 -137.38 8.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -98.91 -26.69 14.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.598 -0.943 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -69.93 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.058 HD11 ' HB1' ' A' ' 38' ' ' ALA . 48.3 mm -61.42 -45.08 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.733 . . . . 0.0 109.804 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -57.62 -34.11 68.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.469 -0.77 . . . . 0.0 109.831 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.95 -43.55 98.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.732 . . . . 0.0 109.312 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -63.43 -29.65 70.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.673 . . . . 0.0 109.266 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.755 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.8 mm -63.17 -46.42 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.67 -40.72 72.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.531 -0.731 . . . . 0.0 109.647 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.58 -28.72 70.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -52.31 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.56 -0.712 . . . . 0.0 109.36 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.68 -25.67 61.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.932 -0.48 . . . . 0.0 110.005 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.93 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -58.19 1.93 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.451 -0.781 . . . . 0.0 109.435 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.66 37.32 4.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -170.07 179.24 3.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.541 -0.976 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 mt -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 0.0 109.461 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.05 100.65 11.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.735 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -139.21 76.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 85' ' ' LEU . 4.5 mm? -70.87 161.47 30.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.422 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.54 35.73 2.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.517 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 tttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.442 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.16 6.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.844 HG22 ' CD1' ' A' ' 19' ' ' LEU . 4.1 mt -65.98 -55.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.853 -0.792 . . . . 0.0 109.021 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -51.49 -31.5 23.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 110.345 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.91 -29.36 70.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.587 -0.696 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.56 ' O ' HD23 ' A' ' 22' ' ' LEU . 14.7 mmt -88.87 -20.09 25.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 0.0 109.869 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.844 ' CD1' HG22 ' A' ' 15' ' ' ILE . 2.5 mp -89.28 -33.54 16.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' THR . 51.5 t -75.06 -34.33 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -59.44 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 0.0 109.308 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.995 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.0 pp -61.56 -30.66 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -55.41 -40.2 71.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 109.139 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.82 -35.84 82.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.3 t80 -64.14 -24.61 67.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.847 -0.533 . . . . 0.0 109.646 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.576 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -74.42 -61.21 1.94 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.543 -0.723 . . . . 0.0 109.292 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.9 tmtm? -63.47 -41.98 98.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.698 -0.626 . . . . 0.0 109.601 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.8 -23.88 54.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' PHE . 50.1 t -89.83 164.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.7 t -75.4 -70.21 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.982 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -89.64 68.18 7.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.46 -0.775 . . . . 0.0 110.702 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.92 44.16 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.617 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -92.44 -26.77 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.46 -49.69 52.54 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.5 -19.87 62.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.755 . . . . 0.0 109.271 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.4 t80 -57.67 -60.13 4.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 -28.05 63.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.552 -0.717 . . . . 0.0 109.591 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.03 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -49.76 -63.09 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.612 -0.68 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.995 ' CG ' HD11 ' A' ' 22' ' ' LEU . 58.6 m-85 -80.41 -23.21 40.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.781 -0.574 . . . . 0.0 110.488 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -45.37 94.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.687 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -78.9 -46.73 17.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.871 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.826 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.16 -29.68 70.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.542 -0.724 . . . . 0.0 109.789 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.14 -30.03 54.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 t -79.03 -42.81 25.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.926 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 62' ' ' LEU . 10.6 p -69.18 -44.35 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.021 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.556 HG13 HG13 ' A' ' 45' ' ' VAL . 71.0 mt -73.23 -26.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 109.953 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.42 -20.24 37.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.68 26.54 8.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.872 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.504 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.5 t80 -80.75 140.97 51.13 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.516 -0.74 . . . . 0.0 109.037 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.4 Cg_endo -85.28 7.31 5.2 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.039 2.493 . . . . 0.0 111.172 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.0 179.59 7.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.893 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -109.71 169.03 8.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 109.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 58' ' ' GLU . 11.9 pt -131.3 156.04 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -140.1 28.76 2.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -170.17 155.25 5.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 109.398 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.21 -30.3 77.1 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.3 93.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.971 . . . . 0.0 109.472 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.482 ' HB3' HG22 ' A' ' 53' ' ' ILE . 5.3 mt-10 -61.37 -21.99 64.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.973 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -90.17 -26.6 20.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.33 -0.857 . . . . 0.0 109.772 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -74.61 -37.87 62.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 109.687 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -59.7 -26.77 65.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.52 -0.737 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.845 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.7 mt -60.4 146.09 85.22 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.56 -0.712 . . . . 0.0 109.599 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.5 109.81 2.54 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.7 -28.47 4.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 42' ' ' ALA . 26.1 t -89.82 138.34 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -1.01 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.29 -141.71 10.14 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 p -96.11 -30.6 13.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.537 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -65.35 -62.14 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.03 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.9 mm -61.63 -44.94 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.732 . . . . 0.0 109.722 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.54 69.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.759 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.91 -41.01 97.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.725 . . . . 0.0 109.405 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -65.49 -31.27 72.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.666 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.1 mm -63.47 -44.52 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -56.61 -40.35 75.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 109.605 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.06 -26.99 69.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 109.122 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -51.36 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.688 . . . . 0.0 109.462 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.39 -29.15 62.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.938 -0.476 . . . . 0.0 110.021 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.421 -0.8 . . . . 0.0 109.461 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.9 -37.57 6.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.759 HG22 HD12 ' A' ' 19' ' ' LEU . 1.6 mp -65.78 -43.07 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.811 -0.817 . . . . 0.0 109.102 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.684 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.2 t -57.63 -34.13 68.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.7 . . . . 0.0 109.942 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -31.77 73.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.6 mmm -89.44 -22.16 22.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 109.915 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.768 HD23 ' CD2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -83.43 -37.08 23.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 16' ' ' THR . 50.1 t -75.08 -29.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.49 -64.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -64.26 -30.47 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.5 -46.14 66.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.547 -0.72 . . . . 0.0 109.524 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -36.97 84.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 29' ' ' VAL . 27.0 t80 -62.48 -20.35 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.0 109.926 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -78.92 -57.78 3.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.336 -0.852 . . . . 0.0 109.038 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -68.71 -38.53 80.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.74 -26.77 64.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.752 . . . . 0.0 109.646 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 25' ' ' PHE . 79.1 t -89.4 164.17 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.97 -70.0 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 111.022 -178.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 60.87 6.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.04 66.62 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.83 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.16 -32.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 108.88 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.426 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -61.61 -48.61 80.13 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.273 -0.892 . . . . 0.0 108.735 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.54 -20.58 62.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CZ ' ' HG3' ' A' ' 40' ' ' ARG . 23.8 t80 -57.54 -69.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.27 -0.894 . . . . 0.0 109.607 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -52.94 -25.32 11.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.342 -0.849 . . . . 0.0 109.99 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.032 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.98 -55.43 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.482 -0.762 . . . . 0.0 109.859 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.01 ' CG ' HD11 ' A' ' 22' ' ' LEU . 44.7 m-85 -90.02 -29.72 18.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 110.116 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -63.05 -44.62 95.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -75.93 -41.83 50.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.588 -0.695 . . . . 0.0 109.594 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.803 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -62.72 -48.84 77.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.489 -0.757 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -62.11 -27.05 68.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.486 -0.759 . . . . 0.0 109.887 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -75.97 -50.61 14.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.46 -0.775 . . . . 0.0 110.045 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.0 p -66.95 -44.16 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.496 -0.752 . . . . 0.0 110.001 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.485 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.3 mt -68.18 -53.9 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.464 -0.772 . . . . 0.0 109.78 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.28 60.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.42 28.32 8.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.486 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.6 t80 -87.01 139.53 32.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.582 -0.698 . . . . 0.0 109.155 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.99 10.14 3.79 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.067 2.511 . . . . 0.0 111.253 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.3 m-70 -147.09 175.09 10.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 0.0 109.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -91.52 177.95 6.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.687 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.662 HG23 ' CB ' ' A' ' 58' ' ' GLU . 48.1 mt -121.83 118.44 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -75.08 -43.24 54.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.512 -0.743 . . . . 0.0 109.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 -179.5 7.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.692 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.46 -26.84 60.06 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.98 70.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.465 -1.02 . . . . 0.0 109.367 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.662 ' CB ' HG23 ' A' ' 53' ' ' ILE . 4.1 mp0 -73.24 -20.88 60.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.72 -0.612 . . . . 0.0 109.889 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.53 -26.52 24.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.89 . . . . 0.0 109.798 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -41.78 61.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -59.74 -24.49 64.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 110.02 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.83 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.5 mt -60.42 142.35 90.75 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.488 -0.758 . . . . 0.0 109.52 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.95 109.07 2.33 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.035 2.49 . . . . 0.0 110.253 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.77 5.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.563 HG22 ' HA ' ' A' ' 42' ' ' ALA . 22.0 t -89.53 137.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.435 -1.039 . . . . 0.0 109.39 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.07 -149.06 22.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -98.11 -29.9 12.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.591 -0.947 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -71.06 -44.49 65.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.622 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.032 HD11 ' HB1' ' A' ' 38' ' ' ALA . 40.6 mm -70.34 -44.96 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 0.0 109.811 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.12 87.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.0 109.739 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.47 -37.6 84.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.528 -0.732 . . . . 0.0 109.601 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -63.01 -32.47 73.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 109.392 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.78 -43.05 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -55.93 -41.1 74.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.735 . . . . 0.0 109.674 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.69 -29.37 70.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -52.53 22.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.697 . . . . 0.0 109.393 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.47 61.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.906 -0.496 . . . . 0.0 110.062 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -79.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.95 -37.96 5.89 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 73' ' ' ILE . 3.0 mp -78.88 -49.4 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.947 -0.737 . . . . 0.0 109.756 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.3 t -58.15 -33.81 69.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.24 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.402 ' O ' HD22 ' A' ' 22' ' ' LEU . 6.2 mtp -84.19 -16.23 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -81.1 -38.68 26.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 16' ' ' THR . 48.8 t -71.94 -28.96 31.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -64.52 -66.6 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.603 -0.686 . . . . 0.0 110.015 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.678 HD11 ' CE1' ' A' ' 39' ' ' TYR . 1.9 pt? -63.76 -33.83 76.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.549 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.36 -41.63 60.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.558 -0.714 . . . . 0.0 109.82 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.14 -38.38 85.42 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 29' ' ' VAL . 66.9 t80 -63.73 -26.09 68.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.745 -0.597 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.663 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.2 mp0 -75.97 -57.83 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 20.1 tttp -65.81 -42.22 90.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 0.0 109.507 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.44 -24.64 56.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.5 t -89.5 164.82 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 47.4 t -77.31 -70.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 111.072 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -83.53 63.12 7.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.696 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.84 38.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.43 -23.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -0.78 . . . . 0.0 109.523 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -73.87 -51.84 14.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.54 -19.88 63.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 109.164 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 18.9 t80 -59.35 -56.15 25.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 0.0 108.915 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -58.97 -26.72 64.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.747 . . . . 0.0 109.494 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.059 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -57.75 -67.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.459 -0.776 . . . . 0.0 109.822 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.678 ' CE1' HD11 ' A' ' 22' ' ' LEU . 20.6 m-85 -75.35 -28.67 59.66 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.579 -0.7 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 23.5 tpt180 -63.5 -52.63 60.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.499 -0.751 . . . . 0.0 109.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -62.28 -39.49 93.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.35 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.903 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -65.02 -39.5 93.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.563 -0.711 . . . . 0.0 109.106 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.2 65.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.449 -0.782 . . . . 0.0 109.704 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 m -82.96 -53.43 5.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.711 HG11 HG23 ' A' ' 65' ' ' VAL . 7.9 p -63.62 -42.5 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.491 -0.756 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.462 ' N ' HG13 ' A' ' 45' ' ' VAL . 48.3 mm -68.9 -36.85 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.777 . . . . 0.0 109.404 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.64 36.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.494 -0.754 . . . . 0.0 110.31 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -101.02 15.8 27.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.487 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.456 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 4.2 t80 -96.8 133.63 24.17 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -86.57 14.94 2.31 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.198 2.599 . . . . 0.0 111.784 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.414 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.8 m-70 -148.11 175.02 11.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 109.893 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 159.84 14.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.695 . . . . 0.0 109.536 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 58' ' ' GLU . 9.1 mt -98.15 137.22 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -86.0 -47.9 9.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.704 . . . . 0.0 109.649 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 p -136.53 179.58 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.661 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.17 78.46 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.11 71.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.983 . . . . 0.0 109.413 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.695 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.6 mt-10 -70.21 -21.58 63.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.619 -0.676 . . . . 0.0 109.884 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.714 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -80.71 -32.73 35.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 18.0 ttpp -74.43 -38.85 62.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.555 -0.716 . . . . 0.0 110.114 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -59.98 -26.69 66.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' A' ' 59' ' ' ALA . 8.2 mt -71.29 148.44 93.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.363 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.28 106.21 2.11 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.05 2.5 . . . . 0.0 110.351 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.04 2.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.711 HG23 HG11 ' A' ' 45' ' ' VAL . 28.8 t -89.73 139.66 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.993 . . . . 0.0 109.385 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.41 -147.21 21.98 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -30.59 11.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.601 -0.94 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -82.51 -41.7 19.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.658 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.059 HD11 ' HB1' ' A' ' 38' ' ' ALA . 42.8 mm -72.18 -39.89 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.469 -0.769 . . . . 0.0 109.742 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.27 -51.91 67.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.494 -0.754 . . . . 0.0 109.778 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.35 -32.13 68.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.441 -0.787 . . . . 0.0 109.471 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -63.15 -34.51 77.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 15' ' ' ILE . 46.7 mm -64.33 -38.7 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.37 -40.17 74.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.48 -0.763 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.19 -30.57 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -52.47 36.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.282 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.28 -25.2 60.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.903 -0.498 . . . . 0.0 110.165 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.99 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.291 -0.881 . . . . 0.0 109.769 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.74 -43.52 4.48 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.806 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.9 mt -68.11 -44.36 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.943 -0.74 . . . . 0.0 109.406 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.726 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 5.0 t -58.32 -34.14 70.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.6 -0.687 . . . . 0.0 109.948 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.08 -34.44 77.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.27 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.511 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.0 mtt -89.9 -15.55 31.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.694 -0.629 . . . . 0.0 110.157 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.806 ' CD1' HG22 ' A' ' 15' ' ' ILE . 2.2 mt -88.19 -35.7 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 108.485 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 16' ' ' THR . 44.7 t -78.94 -31.4 14.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -70.45 -59.33 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.887 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.002 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.3 pp -63.92 -34.71 78.57 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.273 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.93 -42.22 62.63 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.593 -0.692 . . . . 0.0 109.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -63.68 -38.07 89.73 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.1 t80 -61.96 -23.76 66.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.818 -0.551 . . . . 0.0 109.82 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.6 mm-40 -76.88 -57.75 3.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.443 -0.786 . . . . 0.0 109.148 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 14.5 tttm -67.69 -41.12 84.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.537 -0.727 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -57.45 -25.41 59.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.383 -0.823 . . . . 0.0 109.733 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 63.8 t -89.27 164.23 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.62 -70.09 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.463 -0.773 . . . . 0.0 110.905 -178.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -82.79 59.92 5.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.465 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.72 63.57 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -109.7 -29.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 108.957 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -64.11 -49.08 73.63 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.01 -25.45 63.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.629 -0.669 . . . . 0.0 109.421 179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 40' ' ' ARG . 28.0 t80 -52.59 -64.12 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.246 -0.909 . . . . 0.0 109.799 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -57.42 -26.07 60.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.506 -0.746 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.057 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.16 -65.78 0.54 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.002 ' CG ' HD11 ' A' ' 22' ' ' LEU . 72.0 m-85 -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.636 -0.665 . . . . 0.0 110.039 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' HG2' ' HB1' ' A' ' 23' ' ' ALA . 9.1 mmm180 -67.16 -39.68 86.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.527 -0.733 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -72.69 -45.41 58.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -63.37 -40.99 98.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -66.65 -24.76 66.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.548 -0.72 . . . . 0.0 109.883 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -78.13 -36.27 48.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.976 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.812 HG21 ' HB3' ' A' ' 62' ' ' LEU . 13.5 p -90.01 -44.95 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.402 -0.811 . . . . 0.0 110.008 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.481 ' N ' HG13 ' A' ' 45' ' ' VAL . 69.8 mt -66.56 -56.03 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.726 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -60.41 -20.26 59.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.6 -0.687 . . . . 0.0 110.3 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 26.7 9.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.523 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.2 t80 -88.52 138.14 30.19 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.183 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.39 12.06 3.12 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.104 2.536 . . . . 0.0 111.342 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.411 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 68.2 m-70 -147.69 169.74 19.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -0.971 . . . . 0.0 109.743 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -105.46 141.18 37.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 0.0 109.664 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.662 HG22 ' HB3' ' A' ' 58' ' ' GLU . 17.4 pt -97.51 154.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -114.88 -29.96 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.595 -0.691 . . . . 0.0 109.807 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.43 165.35 23.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 109.625 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.83 -26.03 64.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.35 85.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -1.068 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.662 ' HB3' HG22 ' A' ' 53' ' ' ILE . 7.7 mt-10 -63.69 -19.08 64.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.71 -0.619 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -89.26 -26.4 21.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -38.52 63.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.763 . . . . 0.0 109.656 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -60.48 -26.45 66.81 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.812 ' HB3' HG21 ' A' ' 45' ' ' VAL . 51.9 mt -60.3 141.37 91.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.718 . . . . 0.0 109.563 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -80.02 112.65 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.931 2.421 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.06 -22.68 6.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.36 137.15 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -1.068 . . . . 0.0 109.373 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.07 -146.55 21.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 t -100.22 -30.32 11.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.635 -0.92 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -69.41 -45.33 69.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.552 -0.717 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.057 HD11 ' HB1' ' A' ' 38' ' ' ALA . 43.4 mm -72.85 -42.04 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.35 88.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -61.38 -36.35 80.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.563 -0.71 . . . . 0.0 109.448 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -64.45 -31.43 72.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.662 -0.649 . . . . 0.0 109.412 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.2 mm -63.53 -45.64 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -55.81 -39.72 71.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -64.47 -30.36 71.39 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -51.62 45.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.609 -0.682 . . . . 0.0 109.219 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.73 -25.24 60.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.896 -0.503 . . . . 0.0 110.057 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.403 -0.81 . . . . 0.0 109.54 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -36.29 6.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.8 mp -68.07 -47.9 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.886 -0.773 . . . . 0.0 109.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -60.3 -29.6 68.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.3 -32.79 74.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.593 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -90.0 -14.08 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.632 -0.667 . . . . 0.0 110.139 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 1.5 mt -88.8 -35.11 16.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 16' ' ' THR . 42.9 t -79.67 -31.8 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -70.11 -59.19 3.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.622 -0.674 . . . . 0.0 109.656 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.983 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.0 pp -63.02 -34.96 78.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 109.195 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.88 -42.16 62.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.541 -0.724 . . . . 0.0 109.76 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.2 -35.18 80.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.9 t80 -64.16 -27.16 68.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.846 -0.534 . . . . 0.0 109.582 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.651 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 38.3 mm-40 -78.58 -55.51 5.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.9 ttmt -63.8 -43.59 95.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.502 -0.749 . . . . 0.0 109.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.25 -24.52 59.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' PHE . 46.5 t -89.34 165.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 29' ' ' VAL . 42.5 t -76.81 -70.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.471 -0.768 . . . . 0.0 111.241 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -85.43 65.02 8.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.394 -0.816 . . . . 0.0 110.789 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.82 43.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.348 -0.845 . . . . 0.0 109.667 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -94.54 -23.39 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.777 . . . . 0.0 109.479 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.445 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 p-80 -70.86 -51.69 24.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.375 -0.828 . . . . 0.0 108.808 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.32 -25.41 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 29.0 t80 -53.21 -53.97 42.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.47 -27.43 69.28 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -56.02 -63.71 1.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.507 -0.746 . . . . 0.0 110.435 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.983 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.5 m-85 -71.59 -23.96 61.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.793 -0.567 . . . . 0.0 110.49 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.19 -55.63 23.46 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -62.72 -43.02 99.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 109.811 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.825 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -67.65 -27.73 67.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.577 -0.702 . . . . 0.0 109.801 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -72.2 -24.47 61.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 110.077 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.5 p -90.08 -49.91 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.284 -0.885 . . . . 0.0 110.025 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.778 HG11 HG23 ' A' ' 65' ' ' VAL . 7.4 p -60.87 -33.28 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.554 -0.717 . . . . 0.0 109.901 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.606 HG13 HG13 ' A' ' 45' ' ' VAL . 63.7 mt -87.02 -30.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.442 -0.787 . . . . 0.0 109.976 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -87.21 -18.22 30.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 0.0 110.311 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -112.97 25.88 11.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.579 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.0 t80 -89.91 140.03 27.63 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.419 -0.801 . . . . 0.0 109.125 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.76 12.0 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.113 2.542 . . . . 0.0 111.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.1 m-70 -146.38 170.86 15.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.92 . . . . 0.0 109.734 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -94.42 147.42 23.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.738 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 58' ' ' GLU . 11.0 mt -97.0 134.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -100.77 -57.94 2.0 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 109.587 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -105.22 159.94 15.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.25 -31.26 80.12 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.03 71.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.944 . . . . 0.0 109.377 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' A' ' 53' ' ' ILE . 18.4 tt0 -67.8 -22.35 65.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.644 -0.66 . . . . 0.0 109.806 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.619 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.17 -29.47 24.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.677 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 10.8 ttpp -75.63 -38.13 59.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.845 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -59.85 -24.25 64.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 110.219 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 49' ' ' TYR . 44.0 mt -69.07 151.09 97.34 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.521 -0.737 . . . . 0.0 109.458 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.34 99.94 1.28 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.029 2.486 . . . . 0.0 110.154 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.55 -27.54 1.94 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.778 HG23 HG11 ' A' ' 45' ' ' VAL . 38.5 t -89.68 138.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -1.009 . . . . 0.0 109.538 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -98.93 -146.89 21.19 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -100.1 -28.27 13.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.968 . . . . 0.0 109.726 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.21 -61.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 109.761 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.825 HG21 ' CB ' ' A' ' 42' ' ' ALA . 46.4 mm -65.13 -33.29 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.514 -0.741 . . . . 0.0 109.75 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -52.51 -57.49 9.78 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 110.22 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.15 -31.4 67.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 109.329 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.04 70.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 59' ' ' ALA . 44.6 mm -71.03 -43.87 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 108.978 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -52.36 -50.54 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.62 -30.26 70.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.42 -0.8 . . . . 0.0 109.142 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -42.47 93.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 77' ' ' LEU . 4.1 mm? -83.79 -22.74 31.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.184 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.34 -0.85 . . . . 0.0 109.645 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.86 -35.93 6.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.845 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.7 mp -67.82 -48.11 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.88 -0.776 . . . . 0.0 109.117 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -56.77 -28.09 60.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.605 -0.684 . . . . 0.0 109.899 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.54 -27.01 64.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.497 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.5 mmt -89.95 -19.45 24.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 109.966 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.3 mp -86.52 -33.65 20.23 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 16' ' ' THR . 48.7 t -76.23 -36.02 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -58.99 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.616 -0.678 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.97 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -63.06 -31.03 72.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.214 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.71 -41.42 61.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -0.772 . . . . 0.0 109.592 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.32 -40.33 81.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.7 t80 -63.32 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.771 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -76.24 -56.85 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.228 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 24.4 ttpt -61.8 -46.92 87.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -0.788 . . . . 0.0 109.742 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -56.79 -22.46 36.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.367 -0.833 . . . . 0.0 109.93 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 25' ' ' PHE . 40.1 t -88.86 165.29 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 29' ' ' VAL . 42.6 t -76.98 -70.56 0.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 111.402 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -81.23 62.4 5.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.404 -0.81 . . . . 0.0 110.737 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.0 27.55 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -82.18 -30.82 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.448 -0.783 . . . . 0.0 108.921 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -69.66 -44.68 70.01 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 1.6 ptpm? -75.75 -20.45 58.29 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 8.5 t80 -58.41 -58.23 9.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.312 -0.867 . . . . 0.0 108.794 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -57.56 -28.8 63.88 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.561 -0.712 . . . . 0.0 109.328 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.086 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -50.42 -59.8 3.63 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.97 ' CG ' HD11 ' A' ' 22' ' ' LEU . 44.1 m-85 -82.09 -26.68 33.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.69 . . . . 0.0 110.143 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -40.55 96.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.366 -0.834 . . . . 0.0 109.698 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.5 mtpp -79.0 -49.98 11.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.879 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.764 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -61.6 -35.41 77.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 109.858 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.96 67.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.5 -0.75 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -80.02 -45.65 17.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.857 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.2 p -65.66 -43.05 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.57 -0.706 . . . . 0.0 109.942 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.553 HG13 HG13 ' A' ' 45' ' ' VAL . 75.7 mt -74.12 -33.56 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.439 -0.788 . . . . 0.0 109.911 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.18 -22.7 60.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.835 . . . . 0.0 110.114 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -120.52 26.56 9.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 0.0 109.73 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.503 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.6 t80 -81.78 141.45 47.91 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -86.03 9.11 4.18 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.044 2.496 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.1 m-70 -146.53 175.28 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.244 -0.91 . . . . 0.0 109.632 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -94.61 178.67 5.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.679 . . . . 0.0 109.688 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 58' ' ' GLU . 61.3 mt -135.14 104.43 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.58 -0.7 . . . . 0.0 109.337 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -90.18 -52.46 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.674 -0.641 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.8 p -96.15 150.5 20.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.03 -25.8 64.78 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.97 72.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -1.053 . . . . 0.0 109.624 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -64.89 -20.05 66.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.698 . . . . 0.0 109.769 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.79 -28.73 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -75.71 -38.47 58.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -59.94 -24.66 64.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.555 -0.716 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.857 ' HB3' HG21 ' A' ' 45' ' ' VAL . 85.9 mt -59.8 143.81 86.64 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.47 -0.769 . . . . 0.0 109.738 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.48 111.91 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.981 2.454 . . . . 0.0 110.143 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.78 -29.42 5.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -89.98 137.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.966 . . . . 0.0 109.251 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.23 -139.27 10.01 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -98.21 -28.4 13.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.952 . . . . 0.0 109.604 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -62.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 0.0 109.588 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.086 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.0 mm -62.2 -44.39 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.698 . . . . 0.0 109.735 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.11 83.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.735 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.84 -40.29 88.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.745 . . . . 0.0 109.568 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -63.49 -29.74 70.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.613 -0.68 . . . . 0.0 109.442 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.5 mm -63.5 -46.32 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.725 . . . . 0.0 109.164 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.81 -41.41 74.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.466 -0.771 . . . . 0.0 109.77 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.97 -27.2 69.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 109.206 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -51.62 19.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.9 -27.3 61.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.576 -0.449 . . . . 0.0 109.981 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.421 -0.799 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.406 -0.809 . . . . 0.0 109.323 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.535 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -50.0 5.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.8 mt -67.51 -46.25 83.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 47' ' ' ALA . 96.0 m -59.25 -29.12 67.31 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.626 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.05 -37.74 88.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.0 mtt -82.57 -17.94 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.22 -36.62 20.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 16' ' ' THR . 48.6 t -76.16 -31.65 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.64 -61.81 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.554 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.998 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.6 pp -64.31 -32.23 73.74 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.094 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.33 -43.35 67.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.582 -0.699 . . . . 0.0 109.54 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -63.72 -37.31 86.88 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.6 t80 -62.38 -23.45 66.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.543 . . . . 0.0 109.792 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.9 -57.74 3.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HD2' HD11 ' A' ' 33' ' ' ILE . 13.0 tptt -67.12 -40.5 86.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.617 -0.677 . . . . 0.0 109.675 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.5 -25.22 62.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.46 -0.775 . . . . 0.0 109.739 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 25' ' ' PHE . 57.8 t -89.4 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 29' ' ' VAL . 35.3 t -76.32 -70.45 0.45 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.518 -0.738 . . . . 0.0 110.974 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -85.92 63.48 8.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.49 -0.756 . . . . 0.0 110.586 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.85 49.0 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 109.741 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.58 HD11 ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -96.3 -28.94 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.418 -0.801 . . . . 0.0 109.332 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.42 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.2 -48.89 71.8 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.633 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.26 -23.62 63.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.685 -0.634 . . . . 0.0 109.438 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CZ ' ' HD3' ' A' ' 40' ' ' ARG . 28.3 t80 -54.87 -62.95 1.33 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.291 -0.88 . . . . 0.0 109.75 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.084 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.5 -59.48 4.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 0.0 110.076 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.998 ' CG ' HD11 ' A' ' 22' ' ' LEU . 35.4 m-85 -88.92 -29.61 19.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.815 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 36' ' ' TYR . 9.1 tpt180 -62.19 -43.21 99.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.53 -0.731 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -79.19 -38.03 36.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 109.695 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.694 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -67.33 -37.97 84.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.688 ' HB1' HG23 ' A' ' 16' ' ' THR . . . -70.83 -29.93 66.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.531 -0.731 . . . . 0.0 109.509 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -67.75 -55.51 12.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.098 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.827 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.3 p -60.35 -43.79 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.502 HG13 HG13 ' A' ' 45' ' ' VAL . 73.4 mt -71.0 -38.16 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.775 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.764 ' HB2' HG21 ' A' ' 16' ' ' THR . . . -64.2 -26.26 68.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.02 27.46 8.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.792 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.531 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 3.2 t80 -84.17 137.05 40.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.73 . . . . 0.0 109.256 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.3 Cg_endo -87.23 14.49 2.4 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 123.195 2.597 . . . . 0.0 111.392 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.4 m-70 -147.87 173.26 13.01 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.218 -0.926 . . . . 0.0 109.762 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -97.85 139.23 34.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 109.827 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.865 HD12 HG21 ' A' ' 73' ' ' ILE . 17.9 pt -103.88 67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.291 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -69.59 -15.1 63.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.9 m -116.19 139.52 50.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.24 -31.17 65.39 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.76 78.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.634 -0.921 . . . . 0.0 109.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' HB3' HG22 ' A' ' 53' ' ' ILE . 13.6 mt-10 -63.37 -23.02 67.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.673 -0.642 . . . . 0.0 109.831 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.06 25.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -74.42 -42.23 59.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.79 . . . . 0.0 109.615 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -59.28 -23.75 62.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.54 -0.725 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.827 ' HB3' HG21 ' A' ' 45' ' ' VAL . 83.5 mt -59.56 138.82 89.46 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.728 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.98 101.37 1.14 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.046 2.497 . . . . 0.0 110.007 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.86 -19.11 3.75 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 42' ' ' ALA . 33.3 t -89.31 138.42 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.329 -1.1 . . . . 0.0 109.302 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.44 -155.89 25.67 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -96.96 -27.02 14.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.967 . . . . 0.0 109.777 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -83.06 -38.09 22.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.496 -0.753 . . . . 0.0 109.667 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.084 HD11 ' HB1' ' A' ' 38' ' ' ALA . 38.1 mm -72.65 -42.22 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.434 -0.791 . . . . 0.0 109.868 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.84 76.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.781 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.12 -32.39 68.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -33.45 75.61 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.865 HG21 HD12 ' A' ' 53' ' ' ILE . 47.5 mm -63.47 -42.18 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -56.94 -36.84 70.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.629 -0.67 . . . . 0.0 109.588 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.93 -32.38 73.89 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -50.18 65.09 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.59 0.71 . . . . 0.0 109.159 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -74.01 -24.59 59.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.872 -0.517 . . . . 0.0 110.153 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.18 -34.15 7.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.7 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.6 mt -75.04 -49.34 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.856 -0.791 . . . . 0.0 109.353 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -58.9 -34.69 71.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.664 -0.648 . . . . 0.0 109.898 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -35.24 79.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 109.268 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttm -86.06 -22.95 26.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.626 -0.671 . . . . 0.0 109.779 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.7 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -79.07 -37.75 38.09 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' THR . 58.2 t -72.0 -28.82 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.21 -66.41 0.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.003 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' CZ ' ' A' ' 39' ' ' TYR . 2.2 pt? -64.73 -31.72 73.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -50.82 -40.7 56.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.555 -0.716 . . . . 0.0 110.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.64 69.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 29' ' ' VAL . 30.1 t80 -64.61 -27.21 68.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.729 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -78.36 -56.18 4.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.624 -0.673 . . . . 0.0 109.394 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 14.2 tttp -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -57.15 -25.59 59.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.465 -0.772 . . . . 0.0 109.471 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 25' ' ' PHE . 51.6 t -89.52 165.32 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -80.14 -67.48 0.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 111.211 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -78.85 57.87 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.901 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.03 28.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.27 -33.01 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -67.82 -44.69 76.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 16.3 ptpt -76.51 -16.98 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 4.7 t80 -61.89 -63.29 1.3 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -55.51 -26.13 41.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -0.751 . . . . 0.0 109.632 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.756 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.43 -58.1 9.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.478 -0.763 . . . . 0.0 109.654 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.55 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 27.9 m-85 -84.61 -27.99 26.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 109.674 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -63.15 -53.98 44.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 109.546 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.472 ' O ' HG12 ' A' ' 45' ' ' VAL . 6.6 mttm -67.57 -43.16 81.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.711 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.36 -29.7 70.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.544 -0.723 . . . . 0.0 109.552 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -74.32 -26.22 60.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.558 -0.713 . . . . 0.0 109.796 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -87.88 -48.5 7.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 109.993 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.915 HG22 HD13 ' A' ' 62' ' ' LEU . 7.9 p -61.68 -33.54 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.592 HG13 HG13 ' A' ' 45' ' ' VAL . 72.1 mt -85.8 -25.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.533 -0.729 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.46 -20.98 24.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -108.89 23.45 14.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.606 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.8 t80 -94.59 139.64 22.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 108.935 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.51 12.24 3.06 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.105 2.537 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -146.02 153.58 40.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 0.0 109.795 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -77.23 145.77 37.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 109.772 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.05 81.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -69.66 -27.78 65.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 p -121.52 145.86 47.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.452 -0.78 . . . . 0.0 109.376 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.0 79.23 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -31.41 72.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.542 -0.975 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.31 -22.27 66.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.635 -0.666 . . . . 0.0 109.775 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.75 -32.23 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -76.31 -37.75 57.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.523 -0.735 . . . . 0.0 109.724 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -60.02 -23.31 63.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.185 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.915 HD13 HG22 ' A' ' 45' ' ' VAL . 24.7 mt -63.89 151.1 90.12 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.421 -0.799 . . . . 0.0 109.543 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -81.29 104.14 1.48 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.117 2.545 . . . . 0.0 110.054 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.16 -22.68 4.73 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.792 ' CG2' HG11 ' A' ' 45' ' ' VAL . 40.5 t -89.3 139.84 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.387 -1.066 . . . . 0.0 109.282 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -98.73 -153.48 28.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.0 p -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.489 -1.007 . . . . 0.0 109.624 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -66.57 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.756 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.1 mm -64.08 -35.09 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 109.775 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -60.97 -45.01 96.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.507 -0.745 . . . . 0.0 109.377 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -59.59 -33.73 71.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.598 -0.689 . . . . 0.0 109.428 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -65.87 -30.72 71.37 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.6 mm -63.15 -46.22 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -56.62 -37.5 70.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.475 -0.766 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.57 -31.28 72.43 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -50.49 62.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.562 0.696 . . . . 0.0 109.206 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -74.45 -25.58 59.51 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.027 -0.42 . . . . 0.0 110.143 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.59 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.387 -0.821 . . . . 0.0 109.742 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.436 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.08 -37.01 6.43 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.852 HG22 ' CD1' ' A' ' 19' ' ' LEU . 4.7 mt -69.16 -60.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.892 -0.769 . . . . 0.0 109.184 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.4 t -52.99 -25.9 13.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.811 -0.556 . . . . 0.0 110.525 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.29 -30.38 68.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.69 -21.8 21.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.952 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.852 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.7 mp -86.94 -35.29 18.98 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 16' ' ' THR . 67.7 t -77.22 -31.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -65.35 -61.84 1.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.883 HD21 ' CE2' ' A' ' 39' ' ' TYR . 3.1 pp -63.06 -33.34 75.23 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.06 -36.23 38.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.681 -0.637 . . . . 0.0 109.809 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.92 74.86 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 28.8 t80 -60.83 -21.11 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -77.89 -58.5 3.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.248 -0.907 . . . . 0.0 109.151 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 10.0 tttp -68.78 -38.05 79.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.52 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.65 -27.26 64.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.406 -0.808 . . . . 0.0 109.592 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' PHE . 72.8 t -89.34 164.03 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 29' ' ' VAL . 43.6 t -77.72 -70.22 0.49 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 0.0 110.853 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -81.37 59.15 3.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 65.64 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -30.8 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -62.59 -48.96 77.15 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.338 -0.851 . . . . 0.0 108.829 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -71.15 -20.85 62.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.69 . . . . 0.0 109.641 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 23.8 t80 -57.32 -68.76 0.2 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.866 . . . . 0.0 109.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -55.72 -23.03 26.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.384 -0.822 . . . . 0.0 110.054 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -56.14 -63.53 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.368 -0.832 . . . . 0.0 109.916 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.883 ' CE2' HD21 ' A' ' 22' ' ' LEU . 86.9 m-85 -74.61 -27.34 60.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.713 -0.617 . . . . 0.0 110.086 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -61.57 -37.21 83.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.441 -0.787 . . . . 0.0 109.683 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -81.95 -49.74 9.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.747 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.84 -27.91 69.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 -37.08 62.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.774 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.3 m -71.6 -47.42 54.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.769 HG11 ' CG2' ' A' ' 65' ' ' VAL . 7.4 p -64.01 -35.46 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.554 -0.716 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.633 HG13 HG13 ' A' ' 45' ' ' VAL . 65.6 mt -84.17 -28.27 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.06 -21.15 24.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.47 -0.769 . . . . 0.0 110.039 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.26 22.44 15.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.922 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.47 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.1 t80 -96.02 140.67 22.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 108.998 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.05 8.13 4.66 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.979 2.453 . . . . 0.0 111.226 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.42 -176.28 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.678 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -104.17 160.49 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.532 -0.73 . . . . 0.0 109.57 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 58' ' ' GLU . 50.4 mt -97.05 143.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.68 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -91.48 -65.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.732 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 m -119.88 -179.95 4.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.729 . . . . 0.0 109.537 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.35 -33.8 87.3 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.2 71.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.997 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.747 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.5 mt-10 -71.19 -24.24 62.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.688 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -85.59 -31.96 22.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 0.0 109.662 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.582 ' CG ' ' HB1' ' A' ' 70' ' ' ALA . 5.9 mtpm? -75.33 -36.28 61.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.571 -0.705 . . . . 0.0 110.042 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.57 -27.28 67.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 59' ' ' ALA . 6.4 mt -71.18 146.95 93.05 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 0.0 109.401 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.8 102.45 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.959 2.439 . . . . 0.0 110.272 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.9 -25.84 2.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.769 ' CG2' HG11 ' A' ' 45' ' ' VAL . 36.8 t -89.72 139.16 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.46 -1.023 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -102.2 -151.53 23.94 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -99.05 -29.47 12.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.958 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -72.07 -64.09 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.498 -0.751 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.747 HG21 ' CB ' ' A' ' 42' ' ' ALA . 47.3 mm -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -56.98 -41.76 78.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.45 -38.62 87.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -62.11 -31.14 71.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.6 mm -63.34 -42.47 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.08 -41.04 74.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.413 -0.804 . . . . 0.0 109.548 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -62.89 -28.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -52.13 18.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.395 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.54 -26.79 61.88 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.87 -0.519 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.837 . . . . 0.0 109.525 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 109.237 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.9 -36.63 6.32 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.873 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.2 mp -78.5 -43.8 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.845 -0.797 . . . . 0.0 109.74 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.718 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 4.6 t -59.44 -26.03 64.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.09 -46.33 57.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.47 -0.769 . . . . 0.0 109.423 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.541 ' O ' HD22 ' A' ' 22' ' ' LEU . 4.7 ppp? -85.24 -8.58 58.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.712 . . . . 0.0 110.456 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.873 ' CD1' HG22 ' A' ' 15' ' ' ILE . 4.9 mt -83.48 -42.1 17.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 16' ' ' THR . 46.9 t -72.09 -30.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.28 -65.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.602 -0.686 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD11 ' CZ ' ' A' ' 39' ' ' TYR . 1.6 pt? -63.14 -35.07 79.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.94 -48.95 64.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.62 -0.675 . . . . 0.0 110.114 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -62.81 -33.85 76.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 29' ' ' VAL . 50.1 t80 -65.41 -22.55 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.739 -0.601 . . . . 0.0 109.876 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.0 mm-40 -78.94 -56.95 4.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.452 -0.78 . . . . 0.0 109.18 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 17.8 tttm -66.37 -39.87 89.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.376 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.15 -26.42 64.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.453 -0.779 . . . . 0.0 109.447 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 25' ' ' PHE . 57.5 t -89.48 164.46 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -78.15 -68.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.435 -0.79 . . . . 0.0 110.939 -178.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -86.18 60.68 6.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.448 -0.782 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.74 57.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 109.542 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.93 -37.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.01 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.8 p-80 -55.73 -46.3 77.81 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.011 -1.056 . . . . 0.0 109.259 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -73.03 -20.41 61.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -57.74 -70.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -53.42 -24.85 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.425 -0.797 . . . . 0.0 109.938 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.043 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.62 -66.34 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.501 -0.749 . . . . 0.0 109.784 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 41.2 m-85 -77.94 -30.36 50.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 110.07 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -42.7 99.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.392 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -69.24 -44.84 71.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.747 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.747 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -63.12 -45.38 92.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.41 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -60.48 -22.94 64.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 0.0 109.901 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -79.61 -54.67 5.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.6 p -72.59 -44.39 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.541 -0.724 . . . . 0.0 110.104 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.497 ' CD1' ' HB1' ' A' ' 42' ' ' ALA . 78.4 mt -62.87 -58.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.475 -0.765 . . . . 0.0 109.597 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.718 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -60.69 -20.98 62.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.533 -0.729 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -112.21 28.83 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.545 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.1 t80 -94.07 140.47 22.9 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.2 Cg_endo -85.35 8.78 4.41 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.072 2.515 . . . . 0.0 111.284 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 171.18 15.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -94.48 145.08 25.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.613 -0.679 . . . . 0.0 109.543 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.518 HG21 HG21 ' A' ' 73' ' ' ILE . 52.6 mt -78.24 115.56 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -74.01 -31.11 62.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 0.0 109.562 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -164.84 -179.79 6.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.578 -0.701 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -28.0 63.54 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.99 95.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.574 -0.956 . . . . 0.0 109.451 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -69.93 -23.28 63.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.71 . . . . 0.0 109.77 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.5 -27.06 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 109.733 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -74.93 -40.99 60.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -59.95 -23.73 63.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.565 -0.709 . . . . 0.0 110.029 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.745 ' HB3' HG21 ' A' ' 45' ' ' VAL . 80.7 mt -59.99 136.83 90.75 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.55 106.03 1.94 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.865 2.377 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.49 -26.39 3.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 42' ' ' ALA . 23.1 t -89.63 138.06 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -1.036 . . . . 0.0 109.512 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.75 -146.17 14.09 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -99.14 -37.87 9.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.948 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -64.63 -44.01 91.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.745 . . . . 0.0 109.812 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.043 HD11 ' HB1' ' A' ' 38' ' ' ALA . 41.9 mm -71.2 -44.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.883 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.04 81.44 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 109.768 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -61.02 -39.42 89.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.51 -0.744 . . . . 0.0 109.544 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -63.26 -30.94 71.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.4 mm -64.06 -44.98 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -55.36 -40.95 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -64.26 -28.46 69.74 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.28 -52.57 18.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.608 -0.683 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.941 -0.474 . . . . 0.0 110.028 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.373 -0.83 . . . . 0.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.802 . . . . 0.0 109.47 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.05 -33.57 8.12 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.1 mp -74.13 -51.3 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.871 -0.782 . . . . 0.0 109.286 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.9 t -57.17 -28.54 62.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.68 -27.02 63.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 0.0 109.552 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.637 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.5 mmt -90.3 -19.44 24.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.992 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -89.04 -33.9 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 16' ' ' THR . 46.3 t -79.88 -31.74 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.19 -58.82 3.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.655 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.852 HD11 ' CD1' ' A' ' 39' ' ' TYR . 3.2 pp -62.67 -34.98 78.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.15 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.95 -43.12 63.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.504 -0.748 . . . . 0.0 109.572 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.74 -34.31 78.03 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 29' ' ' VAL . 53.5 t80 -66.2 -26.64 67.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.768 -0.583 . . . . 0.0 109.789 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 55.2 mm-40 -80.44 -52.37 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 53.7 tttt -66.07 -42.85 88.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.409 -0.807 . . . . 0.0 109.145 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -58.62 -26.15 63.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.247 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.3 t -89.34 165.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.6 t -79.39 -70.32 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.446 -0.784 . . . . 0.0 111.238 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -79.13 59.21 2.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.434 -0.791 . . . . 0.0 110.95 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.97 48.69 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.71 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -99.13 -21.9 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -71.97 -51.78 20.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.322 -0.861 . . . . 0.0 108.825 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.03 -23.62 63.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.557 -0.715 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 21.9 t80 -56.72 -51.94 66.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.41 -0.806 . . . . 0.0 109.255 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -62.39 -29.9 70.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.192 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.014 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.96 -65.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.772 . . . . 0.0 109.989 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.852 ' CD1' HD11 ' A' ' 22' ' ' LEU . 81.7 m-85 -72.59 -16.01 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -72.1 -55.23 7.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -65.66 -43.54 89.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.526 -0.733 . . . . 0.0 110.078 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -64.95 -46.48 81.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.0 64.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.629 -0.669 . . . . 0.0 110.082 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -81.2 -52.67 7.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.2 p -63.13 -43.71 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.834 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.482 ' N ' HG13 ' A' ' 45' ' ' VAL . 65.2 mt -68.96 -54.88 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -59.49 -20.88 58.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.503 -0.748 . . . . 0.0 110.371 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -117.43 25.96 10.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.463 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.8 t80 -86.08 140.19 34.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.0 109.198 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.19 9.87 3.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.981 2.454 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 178.68 8.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.291 -0.881 . . . . 0.0 109.645 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -99.41 157.68 16.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.654 -0.654 . . . . 0.0 109.81 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.72 HG23 ' CB ' ' A' ' 58' ' ' GLU . 63.9 mt -102.53 108.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -69.93 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.584 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -111.85 -179.85 3.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.688 -0.632 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.52 64.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.34 70.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -1.068 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.72 ' CB ' HG23 ' A' ' 53' ' ' ILE . 5.2 mp0 -70.55 -25.21 63.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.714 . . . . 0.0 109.695 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.02 -28.24 22.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 109.631 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -75.26 -40.11 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -59.79 -24.21 63.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.605 -0.685 . . . . 0.0 110.04 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.829 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.8 mt -60.23 142.65 89.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.456 -0.778 . . . . 0.0 109.636 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.29 105.62 1.78 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.032 2.488 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.45 -26.16 4.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 70' ' ' ALA . 25.9 t -89.53 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.461 -1.023 . . . . 0.0 109.468 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.63 -140.59 10.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.49 -27.48 14.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.912 . . . . 0.0 109.778 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -66.14 -67.68 0.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.475 -0.766 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.014 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.8 mm -60.03 -44.87 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.29 -35.46 71.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.45 -38.02 82.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 109.443 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -69.8 -25.25 63.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.645 -0.66 . . . . 0.0 109.653 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.705 HG21 ' HB2' ' A' ' 59' ' ' ALA . 40.5 mm -72.81 -48.28 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 109.386 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.36 -47.95 68.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.46 -28.95 70.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.475 -0.766 . . . . 0.0 109.054 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -44.15 79.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.69 . . . . 0.0 109.167 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 77' ' ' LEU . 4.0 mm? -81.66 -23.93 36.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.86 -0.525 . . . . 0.0 110.129 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -78.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.498 -0.752 . . . . 0.0 109.433 179.925 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.0 -35.27 7.2 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.85 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.9 mt -70.94 -57.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.78 -0.836 . . . . 0.0 109.17 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -53.48 -30.96 43.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.776 -0.578 . . . . 0.0 110.668 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.97 -29.48 68.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 110.014 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.506 ' O ' HD23 ' A' ' 22' ' ' LEU . 5.4 mmt -90.13 -23.71 21.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 110.058 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.85 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.8 mp -88.37 -34.27 17.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 108.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 16' ' ' THR . 99.8 t -76.48 -32.92 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -68.6 -61.56 1.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.974 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -61.69 -32.32 72.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.48 -44.35 65.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 109.63 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -35.62 79.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.1 t80 -65.13 -22.83 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.859 -0.526 . . . . 0.0 109.678 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 21.3 mm-40 -78.23 -57.88 3.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -64.99 -40.69 95.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.287 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -58.98 -25.4 63.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.582 -0.698 . . . . 0.0 109.498 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.1 t -89.59 164.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.8 t -76.76 -70.19 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.49 -0.756 . . . . 0.0 111.096 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.46 65.97 9.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.386 -0.821 . . . . 0.0 110.884 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.76 36.89 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -85.86 -26.11 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.316 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' NE2' ' HE3' ' A' ' 35' ' ' LYS . 6.4 p-80 -71.36 -50.76 28.98 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.618 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 10.8 ptpt -66.7 -23.75 66.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.6 t80 -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.475 -0.766 . . . . 0.0 109.648 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -56.71 -24.79 51.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.059 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.14 -59.24 5.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.388 -0.82 . . . . 0.0 109.89 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.974 ' CG ' HD11 ' A' ' 22' ' ' LEU . 48.0 m-85 -85.12 -27.61 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.949 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 28.9 tpt85 -64.41 -42.84 95.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.469 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -78.33 -46.62 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.776 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.37 -44.26 96.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.551 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.73 70.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -66.91 -50.19 63.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.96 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.8 p -72.34 -45.07 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.466 -0.771 . . . . 0.0 110.112 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.486 ' N ' HG13 ' A' ' 45' ' ' VAL . 79.3 mt -64.22 -51.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -63.01 -21.36 66.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 110.076 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.07 27.93 8.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.499 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.4 t80 -90.45 139.38 26.68 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.728 . . . . 0.0 109.129 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.14 10.87 3.49 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.081 2.521 . . . . 0.0 111.263 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.6 m-70 -147.3 171.68 15.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.273 -0.892 . . . . 0.0 109.642 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.98 138.6 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.696 . . . . 0.0 109.665 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 58' ' ' GLU . 49.5 mt -73.12 125.78 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.239 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -81.67 -56.95 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 p -132.21 -179.82 5.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.544 -0.723 . . . . 0.0 109.509 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.8 -29.37 67.31 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.86 72.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.702 ' HB3' HG23 ' A' ' 53' ' ' ILE . 1.1 mm-40 -67.22 -21.33 65.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.718 -0.614 . . . . 0.0 109.9 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -85.99 -27.63 24.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.788 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HG3' ' HB1' ' A' ' 70' ' ' ALA . 23.1 mtpt -73.38 -40.72 64.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.767 . . . . 0.0 109.679 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -60.27 -26.62 66.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.568 -0.708 . . . . 0.0 110.039 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.766 ' HB3' HG21 ' A' ' 45' ' ' VAL . 46.5 mt -63.41 136.65 96.8 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.719 . . . . 0.0 109.297 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.55 108.39 2.12 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.937 2.425 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.05 -19.85 4.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 42' ' ' ALA . 39.5 t -89.27 139.31 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -1.101 . . . . 0.0 109.285 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.38 -149.92 23.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -98.64 -35.56 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.952 . . . . 0.0 109.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -71.86 -39.93 69.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.0 109.74 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.059 HD11 ' HB1' ' A' ' 38' ' ' ALA . 39.0 mm -72.83 -40.56 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -59.6 -50.65 73.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.543 -0.723 . . . . 0.0 110.126 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.97 -34.01 69.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.789 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -62.27 -37.93 87.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.556 -0.715 . . . . 0.0 109.182 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 53' ' ' ILE . 47.2 mm -63.74 -38.31 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.77 -40.3 72.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.525 -0.735 . . . . 0.0 109.617 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.8 -32.98 74.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -53.12 50.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.39 -22.79 61.08 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.962 -0.461 . . . . 0.0 110.168 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.79 -80.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.617 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.42 -34.81 7.76 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.858 HG22 ' CD1' ' A' ' 19' ' ' LEU . 10.0 mt -72.37 -59.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.861 -0.788 . . . . 0.0 109.146 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -53.17 -31.54 43.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.819 -0.551 . . . . 0.0 110.333 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.9 -29.38 69.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.6 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.7 mmt -90.4 -21.74 21.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.821 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.858 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.5 mp -88.78 -34.01 17.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 16' ' ' THR . 60.4 t -77.44 -33.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.77 -60.38 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 109.42 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.943 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -61.51 -34.5 75.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.136 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.25 -41.44 60.36 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.556 -0.715 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -64.25 -37.09 86.26 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 61.7 t80 -64.38 -23.49 67.31 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.667 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.0 mm-40 -76.1 -56.61 4.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.382 -0.823 . . . . 0.0 109.125 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -69.51 -40.48 76.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 109.728 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -57.5 -25.07 59.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' PHE . 67.6 t -89.28 164.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 29' ' ' VAL . 48.3 t -76.72 -70.43 0.46 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.765 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -85.05 64.56 8.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.459 -0.775 . . . . 0.0 110.412 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 48.98 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.683 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 -22.57 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.512 -0.742 . . . . 0.0 109.626 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.436 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.8 p-80 -71.5 -51.65 22.54 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 108.677 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -68.1 -23.27 64.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 109.309 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.5 -55.1 39.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -60.94 -27.44 68.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 0.0 109.565 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.078 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.99 -63.56 1.14 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.436 -0.79 . . . . 0.0 110.067 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 22' ' ' LEU . 63.4 m-85 -78.37 -27.4 46.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.722 -0.611 . . . . 0.0 110.149 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -66.83 -33.87 76.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.66 -49.64 10.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.506 -0.746 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.754 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.71 -50.85 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.53 -0.731 . . . . 0.0 109.454 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -61.61 -27.76 68.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.506 -0.746 . . . . 0.0 109.626 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -73.74 -32.29 63.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.861 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.799 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.7 p -90.1 -35.28 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG12 HD11 ' A' ' 53' ' ' ILE . 73.2 mt -77.09 -48.62 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.515 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -61.24 -20.06 62.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 0.0 110.23 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -121.66 26.17 8.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 109.724 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.51 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.9 t80 -83.72 145.58 47.68 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.057 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -85.29 -0.01 8.85 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.05 2.5 . . . . 0.0 110.989 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.4 m-70 -142.32 177.75 8.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.325 -0.86 . . . . 0.0 109.634 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -103.79 141.51 35.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.591 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.74 HG23 ' CB ' ' A' ' 58' ' ' GLU . 52.2 mt -81.83 130.43 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -94.6 -50.5 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.747 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.4 m -125.77 177.93 5.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.33 -29.46 73.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.97 72.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.74 ' CB ' HG23 ' A' ' 53' ' ' ILE . 2.7 mt-10 -73.34 -25.78 60.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.674 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -89.46 -28.38 19.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.644 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -77.04 -35.63 56.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.735 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -60.25 -23.27 63.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.588 -0.695 . . . . 0.0 110.031 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 45' ' ' VAL . 78.9 mt -60.76 143.54 90.86 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.13 107.45 2.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.972 2.448 . . . . 0.0 110.251 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.49 -29.05 3.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 70' ' ' ALA . 29.1 t -89.82 138.8 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.984 . . . . 0.0 109.479 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.11 -136.67 7.98 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -98.81 -28.35 13.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.976 . . . . 0.0 109.657 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -66.13 -66.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.568 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.078 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.3 mm -61.43 -45.11 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.598 -0.689 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.64 -34.31 71.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.54 -41.41 97.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.575 -0.703 . . . . 0.0 109.451 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -62.45 -29.64 70.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.681 -0.637 . . . . 0.0 109.366 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.674 HG21 ' HB2' ' A' ' 59' ' ' ALA . 46.9 mm -63.6 -46.87 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.719 . . . . 0.0 109.061 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.41 -32.37 66.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.518 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -67.33 -29.85 69.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -73.18 -50.53 22.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.569 0.7 . . . . 0.0 109.428 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.95 -27.62 61.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 122.043 -0.41 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -79.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.763 . . . . 0.0 109.531 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -42.31 5.03 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.858 HG22 ' CD1' ' A' ' 19' ' ' LEU . 5.3 mt -66.5 -58.19 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.96 -0.73 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.1 t -52.6 -31.04 34.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.731 -0.606 . . . . 0.0 110.384 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -63.83 -30.38 71.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.496 -0.752 . . . . 0.0 109.529 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.5 ' O ' HD23 ' A' ' 22' ' ' LEU . 4.8 ttm -90.31 -21.39 22.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.888 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.858 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.3 mp -87.29 -33.95 19.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 16' ' ' THR . 58.3 t -75.8 -35.78 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -65.46 -60.99 2.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.375 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.943 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.7 pp -61.53 -33.66 74.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 109.151 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.88 -41.65 62.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 109.507 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.05 -36.96 85.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.0 t80 -63.87 -23.2 67.26 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.8 mm-40 -77.01 -57.12 4.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 46.7 tttm -68.27 -40.29 81.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.488 -0.757 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -25.53 61.29 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.481 -0.762 . . . . 0.0 109.696 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 25' ' ' PHE . 62.6 t -89.31 164.29 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.14 -70.08 0.49 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.955 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -84.77 62.19 7.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.445 -0.785 . . . . 0.0 110.458 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 53.91 0.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.862 . . . . 0.0 109.684 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.27 -29.71 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.785 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.73 -48.37 74.86 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.37 -22.77 62.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.591 -0.693 . . . . 0.0 109.411 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 25.7 t80 -55.64 -67.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.271 -0.893 . . . . 0.0 109.741 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -55.82 -23.13 28.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.479 -0.763 . . . . 0.0 110.038 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.025 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.47 -63.62 1.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.286 -0.884 . . . . 0.0 109.88 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 22' ' ' LEU . 64.3 m-85 -79.17 -26.8 42.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.024 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -37.86 88.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.319 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -48.28 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.721 -0.612 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.766 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.56 -27.65 69.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.604 -0.685 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.04 57.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.494 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -72.45 -44.11 62.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 109.861 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.752 HG11 HG23 ' A' ' 65' ' ' VAL . 8.1 p -66.03 -36.66 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.455 -0.778 . . . . 0.0 109.766 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.626 HG13 HG13 ' A' ' 45' ' ' VAL . 77.4 mt -84.08 -26.51 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.73 -26.25 21.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -97.9 20.35 12.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.445 -0.785 . . . . 0.0 109.856 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.479 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 6.3 t80 -95.14 137.67 22.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.38 12.4 3.02 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.113 2.542 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.3 m-70 -148.28 -171.58 3.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.527 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -124.96 149.91 47.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.585 -0.697 . . . . 0.0 109.52 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 58' ' ' GLU . 9.8 pt -101.42 158.02 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.53 -0.731 . . . . 0.0 109.506 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -114.01 -32.23 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.712 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -118.46 167.61 11.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.86 -30.58 70.23 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.59 70.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.498 ' HB3' HG22 ' A' ' 53' ' ' ILE . 29.3 mt-10 -68.16 -24.46 64.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.672 -0.642 . . . . 0.0 109.716 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.744 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -80.86 -31.13 35.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HG3' ' HB1' ' A' ' 70' ' ' ALA . 23.2 mttt -73.98 -40.68 62.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.738 . . . . 0.0 110.122 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -59.26 -27.24 65.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.533 -0.729 . . . . 0.0 110.142 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 59' ' ' ALA . 9.9 mt -72.0 149.12 92.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.22 118.54 4.71 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.092 2.528 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.91 -25.69 5.77 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.752 HG23 HG11 ' A' ' 45' ' ' VAL . 38.4 t -89.8 139.71 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -1.018 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -106.16 -150.72 18.6 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -99.55 -29.22 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.612 -0.934 . . . . 0.0 109.612 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -77.26 -59.34 2.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.592 -0.692 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.025 HD11 ' HB1' ' A' ' 38' ' ' ALA . 46.2 mm -62.04 -32.54 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.69 . . . . 0.0 109.457 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -61.19 -38.64 87.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 109.126 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -61.41 -38.93 88.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -62.37 -30.69 71.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.6 mm -63.53 -44.5 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.76 -40.59 72.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.55 -0.719 . . . . 0.0 109.797 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.38 -51.95 45.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.513 0.673 . . . . 0.0 109.278 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.23 -24.08 60.44 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.952 -0.467 . . . . 0.0 110.058 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.63 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 109.731 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.0 109.619 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.59 -41.47 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.796 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.72 -57.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.902 -0.763 . . . . 0.0 109.166 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -52.93 -33.93 52.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.739 -0.601 . . . . 0.0 110.472 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.98 -32.41 72.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.2 tpt -86.74 -20.55 27.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.796 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -86.21 -37.64 18.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 16' ' ' THR . 48.7 t -67.58 -39.59 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.99 -60.18 3.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.742 . . . . 0.0 109.638 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.011 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.0 pp -62.31 -34.07 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 109.239 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.45 -42.32 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.535 -0.728 . . . . 0.0 109.739 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -63.66 -43.81 95.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' O ' HG23 ' A' ' 29' ' ' VAL . 72.6 t80 -49.0 -30.81 6.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.745 -0.597 . . . . 0.0 110.709 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.744 ' OE1' HD12 ' A' ' 22' ' ' LEU . 3.5 mp0 -79.91 -44.23 20.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.066 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -70.26 -49.89 45.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.937 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -14.91 49.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.0 110.239 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 25' ' ' PHE . 36.1 t -87.74 164.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.419 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -73.76 -70.54 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.0 111.531 -177.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -90.63 66.98 6.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 0.0 111.183 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.71 56.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -102.96 -22.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.131 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.469 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.6 p-80 -76.16 -47.14 25.33 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -72.89 -24.67 60.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.533 -0.729 . . . . 0.0 109.044 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -58.02 -49.17 77.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.44 -0.787 . . . . 0.0 109.053 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.57 -25.26 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.605 -0.684 . . . . 0.0 109.48 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.022 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.48 -62.92 1.36 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.327 -0.858 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.011 ' CG ' HD11 ' A' ' 22' ' ' LEU . 80.6 m-85 -76.71 -25.21 53.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 110.847 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -74.27 -37.03 63.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.309 -0.869 . . . . 0.0 109.012 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -76.8 -31.65 57.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.372 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.775 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -85.49 -26.66 26.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -27.93 61.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.617 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -81.56 -45.78 15.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 109.937 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.895 HG11 HG23 ' A' ' 65' ' ' VAL . 7.2 p -63.88 -34.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.464 -0.772 . . . . 0.0 109.756 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.616 HG13 HG13 ' A' ' 45' ' ' VAL . 69.6 mt -85.11 -28.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.5 -21.84 23.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.429 -0.794 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -104.35 22.14 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 109.743 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.4 t80 -94.65 142.9 25.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 109.004 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.5 9.21 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.077 2.518 . . . . 0.0 110.991 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.8 m-70 -146.66 178.69 8.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.216 -0.927 . . . . 0.0 109.56 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -98.52 174.42 6.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.537 -0.727 . . . . 0.0 109.705 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 58' ' ' GLU . 60.8 mt -132.75 106.33 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.664 -0.648 . . . . 0.0 109.42 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.83 34.26 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -165.99 139.81 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 109.402 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.87 -40.37 95.45 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.88 -30.42 71.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.97 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 53' ' ' ILE . 6.0 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.786 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -81.92 -30.53 31.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 3.8 tmtt? -74.72 -38.67 62.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.582 -0.698 . . . . 0.0 110.012 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -59.84 -25.89 65.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.143 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 59' ' ' ALA . 11.1 mt -71.01 152.23 94.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 109.447 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.53 105.99 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 123.073 2.516 . . . . 0.0 110.289 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 -30.82 2.31 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.895 HG23 HG11 ' A' ' 45' ' ' VAL . 33.9 t -90.13 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -108.87 -147.67 12.5 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -98.55 -29.73 12.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 109.61 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.16 -58.63 3.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.022 HD11 ' HB1' ' A' ' 38' ' ' ALA . 45.9 mm -61.82 -34.79 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.738 . . . . 0.0 109.626 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -59.97 -41.35 91.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -60.55 -37.03 79.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.649 -0.657 . . . . 0.0 109.46 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.94 -31.4 72.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.367 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.8 mm -63.8 -46.16 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.89 -39.61 68.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.448 -0.782 . . . . 0.0 109.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.98 -31.85 73.19 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -52.56 37.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.573 0.702 . . . . 0.0 109.326 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.77 -23.15 60.77 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.87 -0.519 . . . . 0.0 110.11 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -0.807 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 109.374 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.76 -34.85 7.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.857 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.6 mp -64.94 -47.09 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.023 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.9 t -56.57 -31.43 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 109.862 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -65.0 -28.41 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.542 -0.724 . . . . 0.0 109.486 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mmt -89.9 -20.98 22.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -85.67 -33.89 21.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 16' ' ' THR . 48.2 t -76.33 -33.05 22.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.21 -61.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.984 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -62.54 -32.06 72.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.23 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.61 -45.85 66.74 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.485 -0.759 . . . . 0.0 109.68 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -63.79 -35.76 81.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.2 t80 -61.19 -26.04 67.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.758 -0.589 . . . . 0.0 109.935 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 18.5 mm-40 -79.88 -55.39 5.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.0 109.153 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 109.423 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.73 -25.1 64.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.416 -0.803 . . . . 0.0 109.455 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 25' ' ' PHE . 50.0 t -89.07 164.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -77.5 -69.32 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.466 -0.771 . . . . 0.0 111.297 -178.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -85.29 62.13 7.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.95 55.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.58 -29.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.405 -0.809 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.36 -48.81 71.66 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.59 -23.01 62.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 109.462 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 24.7 t80 -55.25 -66.5 0.4 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 109.557 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.69 -24.27 21.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.451 -0.78 . . . . 0.0 109.923 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.699 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.19 -55.14 34.57 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.422 -0.799 . . . . 0.0 109.874 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.984 ' CG ' HD11 ' A' ' 22' ' ' LEU . 62.5 m-85 -89.97 -26.4 20.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.594 -0.691 . . . . 0.0 110.11 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -39.29 93.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.793 . . . . 0.0 109.109 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -85.83 -41.89 14.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.776 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -65.57 -29.04 69.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.537 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.49 31.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.681 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -68.23 -48.95 63.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 109.898 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.7 p -64.8 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.0 109.822 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.585 HG13 HG13 ' A' ' 45' ' ' VAL . 66.2 mt -77.19 -27.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.469 -0.769 . . . . 0.0 109.937 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.473 -0.767 . . . . 0.0 110.072 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -120.26 27.05 8.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.7 t80 -82.49 139.92 44.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.88 10.64 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.096 2.531 . . . . 0.0 111.317 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.9 m-70 -146.61 169.0 19.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.681 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -96.44 148.57 22.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 58' ' ' GLU . 57.2 mt -97.86 104.39 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -87.57 -40.87 13.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.656 -0.652 . . . . 0.0 109.565 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -112.38 155.37 24.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.734 . . . . 0.0 109.597 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.53 -27.57 66.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.91 71.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.431 -1.04 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.748 ' CB ' HG23 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -63.72 -25.59 68.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.723 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.35 -26.63 26.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 109.846 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.97 -40.93 62.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.504 -0.748 . . . . 0.0 109.674 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -25.13 66.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 110.002 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.829 ' HB3' HG21 ' A' ' 45' ' ' VAL . 91.4 mt -58.46 137.72 85.57 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 109.928 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -80.85 109.74 2.26 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.055 2.503 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.78 -24.47 5.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 42' ' ' ALA . 22.9 t -89.5 137.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.41 -1.053 . . . . 0.0 109.372 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -95.5 -147.97 23.47 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.9 p -98.98 -28.96 13.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.923 . . . . 0.0 109.696 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -65.41 -65.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.776 HG21 ' CB ' ' A' ' 42' ' ' ALA . 50.0 mm -62.08 -39.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.747 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -57.97 -42.99 86.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.25 -35.15 76.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.566 -0.709 . . . . 0.0 109.395 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -65.69 -31.09 71.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 109.258 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.63 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.3 mm -62.83 -44.76 99.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -57.47 -38.56 74.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.464 -0.772 . . . . 0.0 109.518 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.21 -27.14 69.15 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -49.61 31.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.84 -42.46 60.8 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.899 -0.501 . . . . 0.0 110.17 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -80.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.432 -0.793 . . . . 0.0 109.795 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.55 -48.6 3.18 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 15' ' ' ILE . 2.8 mp -66.87 -52.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.858 -0.79 . . . . 0.0 109.675 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.1 t -57.91 -28.37 64.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 110.037 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.14 -38.26 88.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.73 . . . . 0.0 109.273 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.3 mmt -87.33 -10.18 52.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 110.184 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.676 HD23 ' HD2' ' A' ' 39' ' ' TYR . 4.2 mt -87.86 -35.88 17.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 16' ' ' THR . 43.1 t -78.33 -31.09 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -69.55 -60.24 2.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.599 -0.688 . . . . 0.0 109.719 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.2 pp -63.15 -34.8 78.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.21 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.79 -40.78 60.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.569 -0.707 . . . . 0.0 109.647 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -63.86 -38.91 92.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 29' ' ' VAL . 44.6 t80 -62.11 -22.31 65.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.635 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.5 mm-40 -75.47 -59.07 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.823 . . . . 0.0 109.038 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -67.48 -40.09 85.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.89 -24.7 58.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.35 -0.844 . . . . 0.0 109.688 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 25' ' ' PHE . 53.3 t -89.4 164.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.14 -70.15 0.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -178.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -88.06 67.61 8.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 0.0 110.296 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.71 40.27 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.33 -27.21 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.474 -0.766 . . . . 0.0 109.359 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 5.0 p-80 -68.47 -50.89 49.06 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -67.59 -25.89 66.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.51 -0.744 . . . . 0.0 109.242 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -53.31 -64.29 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.24 -0.912 . . . . 0.0 109.615 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -55.12 -25.46 31.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -57.75 -65.9 0.56 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.382 -0.824 . . . . 0.0 109.79 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.01 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.4 m-85 -72.34 -27.38 62.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.747 -0.596 . . . . 0.0 110.119 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -63.49 -46.1 87.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.447 -0.783 . . . . 0.0 109.393 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -65.85 -46.21 79.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.485 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.787 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.54 -48.34 77.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.422 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -55.14 -23.29 20.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -77.13 -59.84 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.781 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.9 p -63.47 -44.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.47 -0.769 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.494 HG21 ' HB ' ' A' ' 15' ' ' ILE . 50.3 mm -63.18 -28.41 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.369 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.02 -18.7 25.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -116.31 26.8 9.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.3 t80 -88.55 135.66 32.25 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.511 -0.743 . . . . 0.0 109.023 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.4 Cg_endo -85.55 10.41 3.72 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 123.148 2.565 . . . . 0.0 111.58 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.417 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.5 m-70 -148.82 -174.95 4.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.083 -1.011 . . . . 0.0 109.721 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 176.33 5.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.597 -0.689 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.535 HG22 ' HB3' ' A' ' 58' ' ' GLU . 32.7 pt -136.85 141.46 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.632 -0.668 . . . . 0.0 109.552 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -121.83 25.99 8.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.654 -0.654 . . . . 0.0 109.646 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -170.41 150.59 3.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.788 . . . . 0.0 109.356 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -28.94 68.16 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.4 85.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HB3' HG22 ' A' ' 53' ' ' ILE . 1.1 mp0 -64.51 -20.39 66.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.63 -0.669 . . . . 0.0 109.918 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -88.0 -25.14 23.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.348 -0.845 . . . . 0.0 109.883 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -73.38 -41.0 63.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 109.735 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.23 -26.42 66.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.461 -0.775 . . . . 0.0 109.939 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.781 ' HB3' HG21 ' A' ' 45' ' ' VAL . 93.4 mt -55.95 134.65 73.54 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.71 102.55 1.4 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.931 2.42 . . . . 0.0 109.986 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.43 -26.26 2.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.647 HG23 HG11 ' A' ' 45' ' ' VAL . 24.0 t -89.38 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -1.052 . . . . 0.0 109.218 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.79 -156.54 25.35 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -87.96 -7.37 57.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.667 -0.902 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -90.21 -63.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.787 HG21 ' CB ' ' A' ' 42' ' ' ALA . 46.9 mm -67.26 -34.57 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.775 . . . . 0.0 110.445 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -56.76 -55.8 29.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.309 -0.869 . . . . 0.0 109.917 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -59.84 -31.49 69.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 109.512 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -59.96 -43.86 94.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 0.0 109.418 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.556 HD12 ' HB1' ' A' ' 59' ' ' ALA . 65.1 mt -64.1 -29.91 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -56.04 -43.79 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.224 -0.922 . . . . 0.0 108.964 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -31.01 71.74 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -43.08 96.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.551 HD23 HG22 ' A' ' 73' ' ' ILE . 4.0 mm? -83.45 -24.89 31.63 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.086 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.428 -0.795 . . . . 0.0 109.786 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.07 -39.0 5.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.672 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -68.91 -50.7 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.88 -0.776 . . . . 0.0 108.952 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.8 t -59.36 -29.52 67.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.748 -0.595 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.69 -34.58 77.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.629 -0.669 . . . . 0.0 109.22 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.478 ' O ' HD23 ' A' ' 22' ' ' LEU . 35.8 mmm -89.61 -17.17 28.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.127 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.672 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -87.86 -35.63 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 108.489 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 16' ' ' THR . 46.6 t -78.58 -30.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.08 -60.52 2.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.724 . . . . 0.0 109.76 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.991 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.7 pp -62.87 -34.15 76.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.22 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.29 -44.15 61.8 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.626 -0.671 . . . . 0.0 109.917 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.34 -36.65 84.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.9 t80 -63.72 -23.07 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.895 -0.503 . . . . 0.0 109.682 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.2 mm-40 -77.31 -57.74 3.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.346 -0.847 . . . . 0.0 109.106 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -67.01 -40.41 87.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.537 -0.727 . . . . 0.0 109.553 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.12 -25.59 61.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.433 -0.792 . . . . 0.0 109.659 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.6 t -89.47 164.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.438 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.25 -69.77 0.51 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.485 -0.759 . . . . 0.0 110.937 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -85.32 62.15 7.31 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.84 47.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -96.34 -28.6 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.0 109.378 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.3 p-80 -64.59 -48.55 74.54 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.49 -25.78 64.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.616 -0.678 . . . . 0.0 109.347 179.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.0 t80 -52.48 -60.72 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.304 -0.872 . . . . 0.0 109.796 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.83 -26.88 64.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.029 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.91 -65.22 0.65 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.411 -0.806 . . . . 0.0 109.77 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.991 ' CG ' HD11 ' A' ' 22' ' ' LEU . 62.4 m-85 -76.38 -26.15 55.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.675 -0.641 . . . . 0.0 110.082 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -63.72 -52.11 61.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.466 -0.771 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.68 -45.69 81.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.772 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.98 -37.04 85.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -64.44 -25.52 68.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.918 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.26 -50.79 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 110.016 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 65' ' ' VAL . 7.7 p -62.79 -34.05 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.557 HG13 HG13 ' A' ' 45' ' ' VAL . 74.4 mt -83.34 -41.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -79.23 -17.59 54.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.328 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.21 23.37 14.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.789 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.58 ' CE1' HD22 ' A' ' 62' ' ' LEU . 2.6 t80 -94.66 144.9 28.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.9 Cg_endo -86.43 4.82 6.2 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 123.128 2.552 . . . . 0.0 110.846 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.6 m-70 -146.61 -175.38 4.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -105.38 160.56 15.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.564 -0.71 . . . . 0.0 109.67 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.766 HG23 ' HB3' ' A' ' 58' ' ' GLU . 52.7 mt -101.71 131.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -77.89 -65.3 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.729 . . . . 0.0 109.719 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 p -114.26 174.97 5.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.43 83.73 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -34.28 76.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.946 . . . . 0.0 109.308 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.766 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.0 mt-10 -67.13 -23.28 65.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.677 . . . . 0.0 109.716 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' ' 53' ' ' ILE . . . -84.76 -28.69 26.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.428 -0.795 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 8.1 tmtt? -74.49 -38.64 62.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -59.59 -26.44 65.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.755 . . . . 0.0 110.075 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.58 HD22 ' CE1' ' A' ' 49' ' ' TYR . 53.7 mt -71.65 150.2 93.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.74 106.31 2.17 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.024 2.483 . . . . 0.0 110.313 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.35 -29.44 2.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 45' ' ' VAL . 36.0 t -89.72 146.0 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -1.004 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.72 -145.77 15.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.4 p -100.15 -39.79 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.895 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -73.43 -44.66 57.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.635 -0.666 . . . . 0.0 109.725 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.029 HD11 ' HB1' ' A' ' 38' ' ' ALA . 43.8 mm -69.62 -38.6 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 60' ' ' LYS . . . -59.64 -41.66 91.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.64 -38.54 85.13 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.481 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -62.28 -30.22 70.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.604 -0.685 . . . . 0.0 109.368 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.0 mm -64.32 -45.51 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -54.84 -40.65 69.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.49 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -53.16 36.68 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.509 0.671 . . . . 0.0 109.308 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.56 -22.3 61.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.948 -0.47 . . . . 0.0 110.14 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.08 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.406 -0.809 . . . . 0.0 109.623 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.71 -32.76 8.93 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.82 HG22 ' CD1' ' A' ' 19' ' ' LEU . 16.6 mt -74.89 -59.08 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.764 -0.845 . . . . 0.0 109.334 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.4 t -51.8 -32.41 31.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.756 -0.59 . . . . 0.0 110.553 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.46 -26.21 64.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.593 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.8 mtp -90.02 -21.32 22.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.956 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.82 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.4 mp -88.65 -33.89 17.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 16' ' ' THR . 54.5 t -76.25 -34.75 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -68.34 -60.2 2.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.656 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.981 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -60.82 -35.2 75.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 109.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -50.68 -42.1 56.48 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.666 -0.646 . . . . 0.0 109.739 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.16 -36.12 83.02 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.5 t80 -65.69 -24.77 67.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.888 -0.507 . . . . 0.0 109.676 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.1 mm-40 -75.8 -57.79 3.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -66.14 -41.94 89.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.0 109.58 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -57.3 -24.7 56.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.4 -0.813 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.6 t -89.66 164.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.6 t -77.19 -70.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 110.876 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -85.05 66.75 9.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.471 -0.768 . . . . 0.0 110.734 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.63 29.18 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -81.89 -21.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.59 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.439 ' CD2' ' HE2' ' A' ' 35' ' ' LYS . 6.4 p-80 -76.09 -49.85 16.28 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -67.62 -26.46 66.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.57 -51.62 67.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.03 -28.13 68.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 0.0 109.532 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.021 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.46 -62.32 1.8 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.981 ' CG ' HD11 ' A' ' 22' ' ' LEU . 66.0 m-85 -78.5 -1.42 33.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.912 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 -87.14 -36.27 18.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -81.1 -46.62 14.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.756 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.45 -42.78 98.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.589 -0.695 . . . . 0.0 109.391 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -68.86 -26.06 64.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.639 -0.663 . . . . 0.0 109.762 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -80.57 -28.93 37.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.783 . . . . 0.0 109.906 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 62' ' ' LEU . 14.5 p -90.0 -44.71 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.417 -0.802 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 53' ' ' ILE . 67.7 mt -69.71 -52.27 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 109.587 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.651 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -60.65 -21.08 62.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -118.1 28.74 8.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.518 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.0 t80 -89.56 145.68 34.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.0 Cg_endo -85.97 2.11 7.64 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.101 2.534 . . . . 0.0 110.979 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.2 m-70 -144.06 -179.35 6.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -105.93 139.68 40.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.717 HG23 ' CB ' ' A' ' 58' ' ' GLU . 60.0 mt -77.12 106.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.605 -0.684 . . . . 0.0 109.356 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.8 mttt -72.36 -69.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.55 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -102.53 174.65 5.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.556 -0.715 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.36 -28.96 71.87 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.86 -30.38 70.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -1.008 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.717 ' CB ' HG23 ' A' ' 53' ' ' ILE . 1.1 mp0 -67.28 -27.61 67.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.651 -0.655 . . . . 0.0 109.628 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.765 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.92 -28.85 22.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.631 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -75.57 -39.04 58.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.475 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -60.51 -24.16 65.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.502 -0.749 . . . . 0.0 110.039 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.806 ' HB3' HG21 ' A' ' 45' ' ' VAL . 81.7 mt -60.84 140.92 93.32 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.426 -0.796 . . . . 0.0 109.545 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.29 107.18 1.99 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.983 2.456 . . . . 0.0 110.14 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.87 -25.38 4.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 70' ' ' ALA . 29.8 t -89.55 138.52 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.978 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.26 -139.65 9.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.39 -29.49 12.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.94 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -67.42 -64.6 0.82 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.021 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.2 mm -61.42 -41.97 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 0.0 109.789 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -59.64 -35.35 74.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.543 -0.723 . . . . 0.0 109.658 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.72 -41.59 95.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.511 -0.743 . . . . 0.0 109.516 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -62.04 -30.4 70.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.615 -0.678 . . . . 0.0 109.31 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.7 mm -63.16 -47.23 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.11 -31.54 65.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 109.606 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.7 -30.67 70.23 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -74.2 -50.79 17.69 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.582 0.705 . . . . 0.0 109.592 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.33 -27.42 62.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.908 -0.495 . . . . 0.0 109.95 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.44 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.81 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.3 -41.49 5.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.508 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.0 mt -66.11 -50.56 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.893 -0.769 . . . . 0.0 109.072 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 5.1 t -58.08 -31.17 66.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.698 -0.626 . . . . 0.0 109.963 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.15 -36.03 76.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 109.381 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtt -87.54 -14.55 39.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.609 -0.682 . . . . 0.0 110.135 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -86.2 -42.55 13.72 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.12 -31.62 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.21 -64.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.977 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.1 pp -62.07 -33.73 74.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.11 -42.5 63.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.86 -36.51 84.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 54.0 t80 -63.73 -22.76 67.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.8 mm-40 -77.48 -57.63 3.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.099 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 71.6 tttt -67.79 -39.48 84.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.51 -0.743 . . . . 0.0 109.622 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.79 -25.7 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.403 -0.811 . . . . 0.0 109.605 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 62.0 t -89.36 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.88 -70.09 0.48 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 0.0 110.98 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -85.12 62.11 7.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 110.407 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.81 53.64 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -0.822 . . . . 0.0 109.68 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -100.18 -30.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.795 . . . . 0.0 109.105 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.451 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.05 -48.43 76.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.66 -23.78 63.51 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 26.7 t80 -54.6 -67.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.22 -0.925 . . . . 0.0 109.694 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -54.74 -24.59 23.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 109.88 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.064 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.14 -65.36 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.977 ' CG ' HD11 ' A' ' 22' ' ' LEU . 58.2 m-85 -79.12 -29.31 43.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.587 -0.695 . . . . 0.0 109.851 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -65.36 -46.34 80.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.486 -0.759 . . . . 0.0 109.456 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -70.59 -40.57 73.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.499 -0.751 . . . . 0.0 109.661 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.719 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -68.88 -39.56 79.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.602 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -62.01 -28.17 69.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -70.84 -51.29 27.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.3 p -69.67 -44.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.487 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.2 mt -67.17 -29.45 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.448 -0.783 . . . . 0.0 109.971 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.402 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -90.05 -13.85 35.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.429 -0.795 . . . . 0.0 110.538 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -123.26 27.99 7.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.475 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.2 t80 -85.24 143.69 39.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.196 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.24 3.87 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.052 2.502 . . . . 0.0 111.066 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.405 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -145.01 -177.72 5.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.645 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 160.8 17.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.7 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 58' ' ' GLU . 24.6 pt -123.41 153.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 109.318 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -137.73 28.58 2.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.511 -0.743 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 t -170.3 151.52 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.02 -28.1 69.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.92 72.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.464 -1.021 . . . . 0.0 109.695 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 53' ' ' ILE . 2.6 mt-10 -73.66 -14.43 61.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.614 -0.679 . . . . 0.0 110.355 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -90.11 -29.72 18.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -29.52 55.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.555 -0.716 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HG21 ' A' ' 45' ' ' VAL . 80.9 mt -61.77 146.17 91.13 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.21 113.13 3.14 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.0 2.466 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.36 -28.54 5.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 70' ' ' ALA . 27.6 t -89.9 138.48 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -1.023 . . . . 0.0 109.392 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -139.75 9.23 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 t -98.87 -28.59 13.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.958 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -67.9 -65.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.47 -0.769 . . . . 0.0 109.503 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.064 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.5 mm -61.34 -41.67 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.828 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.05 -37.05 73.66 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.582 -0.699 . . . . 0.0 109.736 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -61.86 -40.38 95.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.48 -0.762 . . . . 0.0 109.526 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -62.79 -32.68 73.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.0 109.285 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.7 mm -64.14 -42.43 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.79 -40.83 73.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.487 -0.758 . . . . 0.0 109.732 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.5 -29.62 70.86 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.43 -52.7 24.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.538 0.685 . . . . 0.0 109.37 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.23 -24.9 61.45 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.926 -0.484 . . . . 0.0 110.054 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.474 179.958 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.538 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.85 -33.82 8.1 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.589 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.6 mp -69.42 -42.1 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.879 -0.777 . . . . 0.0 109.245 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.4 t -60.73 -30.89 70.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.66 -0.65 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -39.23 93.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.711 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.6 mtm -83.04 -19.31 37.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.648 -0.658 . . . . 0.0 109.87 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -80.35 -37.54 32.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.416 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 16' ' ' THR . 50.8 t -71.67 -28.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -66.57 -68.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.12 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.788 HD11 ' CE1' ' A' ' 39' ' ' TYR . 2.3 pt? -57.55 -31.0 65.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.939 -1.1 . . . . 0.0 109.491 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.42 68.74 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 78.9 t80 -62.1 -25.47 67.73 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.616 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.5 mp0 -75.5 -57.66 3.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.557 -0.714 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -67.22 -41.61 85.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.556 -0.715 . . . . 0.0 109.524 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.07 -25.18 58.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' PHE . 53.4 t -89.53 164.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.446 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.1 t -78.02 -70.13 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.485 -0.759 . . . . 0.0 111.009 -178.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -82.93 61.63 6.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 45.34 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -27.76 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 6.1 p-80 -70.21 -49.86 45.85 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.79 -18.82 62.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.344 -0.848 . . . . 0.0 109.393 178.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 16.7 t80 -59.45 -63.9 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 108.933 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -55.08 -24.11 23.83 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.722 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.96 -65.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.788 ' CE1' HD11 ' A' ' 22' ' ' LEU . 34.5 m-85 -80.59 -31.07 36.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.854 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.0 -48.79 78.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.819 . . . . 0.0 109.814 -179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -72.8 -35.84 67.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 0.0 109.855 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.81 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -67.08 -49.91 63.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.472 -0.767 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -60.44 -26.47 66.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.47 -0.769 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -71.67 -58.88 3.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.3 p -60.54 -43.44 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.482 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.9 mt -68.17 -27.67 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.37 -25.46 29.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.825 . . . . 0.0 109.806 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -107.05 28.13 8.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.506 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 3.6 t80 -93.35 139.48 22.96 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.23 11.54 3.28 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.104 2.536 . . . . 0.0 111.354 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.414 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.22 176.77 9.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -102.13 144.26 30.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.547 -0.72 . . . . 0.0 109.636 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.75 HG23 ' HB3' ' A' ' 58' ' ' GLU . 57.7 mt -82.67 122.1 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.622 -0.674 . . . . 0.0 109.223 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -81.02 -60.8 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -126.24 -179.96 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.19 -27.4 65.1 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.08 95.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -1.081 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.75 ' HB3' HG23 ' A' ' 53' ' ' ILE . 4.2 tt0 -61.7 -20.88 63.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.588 -0.695 . . . . 0.0 109.971 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -86.24 -24.86 25.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 109.895 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -70.34 -43.72 69.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.724 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -60.81 -28.72 68.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.773 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB3' HG21 ' A' ' 45' ' ' VAL . 97.4 mt -56.8 130.47 78.3 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.552 -0.717 . . . . 0.0 109.978 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.69 102.15 1.52 Allowed 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.833 2.356 . . . . 0.0 110.11 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.15 -27.74 1.85 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 t -89.57 138.3 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.545 -0.973 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.56 -143.76 13.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.0 t -98.64 -27.18 14.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.94 . . . . 0.0 109.694 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -82.26 -41.47 20.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.551 -0.718 . . . . 0.0 109.7 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.035 HD11 ' HB1' ' A' ' 38' ' ' ALA . 39.9 mm -72.37 -41.82 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.738 . . . . 0.0 109.884 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.94 71.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -0.811 . . . . 0.0 110.057 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.33 -32.62 68.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -64.73 -33.13 75.25 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.58 -42.8 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.54 -35.53 72.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.695 . . . . 0.0 109.372 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.64 -30.79 71.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -48.99 64.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.514 0.673 . . . . 0.0 109.2 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.7 mm? -74.33 -26.42 60.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.061 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -80.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 0.0 109.698 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 109.472 179.959 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -35.33 7.25 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' A' ' 19' ' ' LEU . 6.7 mt -74.71 -57.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.858 -0.789 . . . . 0.0 108.957 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -56.19 -30.85 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.962 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -32.72 74.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' HD23 ' A' ' 22' ' ' LEU . 9.9 mmm -88.74 -17.67 29.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.741 -0.6 . . . . 0.0 109.944 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -87.34 -35.37 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.528 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' THR . 46.0 t -78.59 -30.82 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -69.97 -59.73 2.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.661 -0.649 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.994 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.3 pp -63.24 -33.73 76.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.16 -41.51 62.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.484 -0.76 . . . . 0.0 109.537 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -64.87 -37.53 87.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.7 t80 -63.49 -24.05 67.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -74.12 -62.99 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.669 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 21.9 tttt -62.1 -41.95 98.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.876 -0.515 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -57.76 -23.94 54.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.772 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' PHE . 48.9 t -89.81 165.11 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.4 t -76.01 -70.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.459 -0.776 . . . . 0.0 111.107 -178.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -88.69 67.73 8.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.815 . . . . 0.0 110.675 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.1 38.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 109.666 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -88.69 -25.59 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.718 . . . . 0.0 109.589 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.472 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.99 -51.82 29.32 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.02 -19.34 63.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.739 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.2 t80 -57.15 -57.67 11.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.216 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.44 -26.77 66.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.655 -0.653 . . . . 0.0 109.469 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.848 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -53.98 -64.79 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.378 -0.826 . . . . 0.0 110.215 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.994 ' CG ' HD11 ' A' ' 22' ' ' LEU . 70.5 m-85 -74.01 -25.44 59.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 110.13 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -63.4 -47.73 80.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.357 -0.839 . . . . 0.0 109.316 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.42 -49.94 50.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.595 -0.691 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.751 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -61.95 -27.35 68.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 109.808 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -72.69 -28.22 62.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.938 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 p -84.81 -46.56 11.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.873 HG11 HG23 ' A' ' 65' ' ' VAL . 8.1 p -64.2 -35.57 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 110.109 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.6 HG13 HG13 ' A' ' 45' ' ' VAL . 66.8 mt -84.22 -37.05 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.951 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -82.61 -19.99 37.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.402 -0.811 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -104.72 21.52 16.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.301 -0.875 . . . . 0.0 110.014 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.528 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.9 t80 -94.07 140.81 23.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -86.32 9.96 3.83 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.015 2.476 . . . . 0.0 111.071 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.18 -176.61 5.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.76 162.64 12.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.714 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.601 HG23 ' HB3' ' A' ' 58' ' ' GLU . 50.7 mt -107.52 144.76 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.616 -0.677 . . . . 0.0 109.195 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -91.6 -63.72 1.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 109.673 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.8 p -124.42 -179.86 4.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.502 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.24 -29.87 72.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -30.36 70.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.991 . . . . 0.0 109.491 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.601 ' HB3' HG23 ' A' ' 53' ' ' ILE . 5.1 mt-10 -81.13 -25.74 36.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.581 -0.699 . . . . 0.0 109.724 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -83.89 -33.62 24.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.477 -0.765 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.526 -0.734 . . . . 0.0 109.974 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -59.68 -25.62 64.9 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.427 -0.796 . . . . 0.0 110.208 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 59' ' ' ALA . 10.9 mt -70.8 152.01 95.16 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.491 -0.756 . . . . 0.0 109.464 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -77.94 103.02 1.64 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.106 2.538 . . . . 0.0 110.297 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.13 -30.4 2.02 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.873 HG23 HG11 ' A' ' 45' ' ' VAL . 38.2 t -89.98 140.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.588 -0.948 . . . . 0.0 109.44 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -105.06 -146.64 15.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -99.47 -36.16 9.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.968 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.05 -60.2 2.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.848 HD11 ' HB1' ' A' ' 38' ' ' ALA . 46.8 mm -61.74 -36.54 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.535 -0.728 . . . . 0.0 109.728 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -57.83 -39.59 78.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -61.72 -39.6 92.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.093 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -62.58 -30.23 71.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.621 -0.674 . . . . 0.0 109.312 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 59' ' ' ALA . 49.5 mm -62.84 -45.13 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.63 -41.79 74.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.42 -28.75 70.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.13 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -52.47 18.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.378 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.75 61.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.972 -0.455 . . . . 0.0 110.086 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.23 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 109.543 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 109.487 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.476 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.09 -39.6 5.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.792 HG22 HD12 ' A' ' 19' ' ' LEU . 2.9 mp -65.77 -41.87 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.874 -0.78 . . . . 0.0 109.202 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 4.6 t -59.65 -31.08 69.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.613 -0.679 . . . . 0.0 109.643 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -65.0 -33.53 76.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.603 ' O ' HD23 ' A' ' 22' ' ' LEU . 15.1 mmt -90.13 -15.22 32.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.667 -0.646 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.792 HD12 HG22 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -88.86 -35.18 16.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 108.519 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 16' ' ' THR . 43.4 t -81.07 -31.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.3 -57.34 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.993 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.5 pp -63.27 -34.65 78.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.7 -44.78 63.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.55 -0.719 . . . . 0.0 109.791 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.91 -35.07 79.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.7 t80 -63.56 -24.66 67.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.854 -0.529 . . . . 0.0 109.898 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 21.2 mm-40 -79.25 -56.63 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.851 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.0 ttpt -64.99 -41.37 95.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.497 -0.752 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -58.51 -26.69 63.74 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.823 . . . . 0.0 109.412 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 25' ' ' PHE . 56.9 t -89.55 164.77 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.2 t -78.63 -70.16 0.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.454 -0.779 . . . . 0.0 111.093 -178.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -81.01 57.85 3.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.511 -0.743 . . . . 0.0 110.905 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.88 62.01 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 179.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -109.56 -28.87 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.195 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.437 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -63.35 -49.1 75.24 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.8 -25.99 63.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.594 -0.691 . . . . 0.0 109.312 179.375 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -51.35 -59.01 4.69 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.291 -0.88 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -61.37 -27.84 68.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.531 -0.731 . . . . 0.0 109.318 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.034 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.68 -65.96 0.52 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.461 -0.774 . . . . 0.0 109.953 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.993 ' CG ' HD11 ' A' ' 22' ' ' LEU . 81.1 m-85 -71.27 -8.79 56.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 110.798 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -83.88 -54.41 4.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.119 -0.988 . . . . 0.0 109.3 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -61.07 -29.11 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.516 -0.74 . . . . 0.0 109.83 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.822 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -79.82 -47.17 15.61 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.529 -0.732 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -61.6 -26.24 67.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.879 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 -45.36 27.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.966 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 62' ' ' LEU . 12.6 p -75.51 -44.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -0.777 . . . . 0.0 110.086 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.48 ' N ' HG13 ' A' ' 45' ' ' VAL . 70.3 mt -67.6 -55.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 -179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -61.53 -20.01 62.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -116.02 28.11 8.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 109.575 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.482 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.4 t80 -89.7 141.77 28.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -85.7 8.41 4.56 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.002 2.468 . . . . 0.0 110.998 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.7 m-70 -146.55 175.25 10.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 139.83 36.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.631 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.08 108.36 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.428 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -69.75 -40.34 76.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.821 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.3 m -148.55 -179.88 7.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.532 -0.73 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.33 -26.36 61.59 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.82 96.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.479 -1.012 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.58 -24.99 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.719 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -84.62 -27.67 27.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.415 -0.803 . . . . 0.0 109.733 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -75.9 -40.52 54.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -59.92 -22.4 62.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.788 ' HB3' HG21 ' A' ' 45' ' ' VAL . 86.5 mt -59.3 139.04 88.58 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 109.717 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.45 112.36 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.957 2.438 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.27 -28.52 5.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.78 138.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.932 . . . . 0.0 109.361 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.09 -139.52 10.17 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -99.22 -27.82 13.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.964 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -65.51 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.402 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.034 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.5 mm -61.94 -42.13 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 109.717 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.74 82.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.534 -0.729 . . . . 0.0 109.673 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.7 -35.75 77.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.514 -0.741 . . . . 0.0 109.53 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -68.9 -28.94 67.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.619 -0.676 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.5 mm -63.17 -49.44 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 109.144 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.22 -40.61 74.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.454 -0.779 . . . . 0.0 109.694 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.01 -28.77 70.33 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.43 -51.65 27.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.64 -0.662 . . . . 0.0 109.294 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.65 -25.68 61.37 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.907 -0.496 . . . . 0.0 110.039 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.405 -0.809 . . . . 0.0 109.587 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 109.407 179.867 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -39.52 5.79 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.549 HG23 ' CD2' ' A' ' 76' ' ' PHE . 3.3 mt -68.21 -52.25 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.826 -0.808 . . . . 0.0 109.086 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -55.88 -33.98 65.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.737 -0.602 . . . . 0.0 110.175 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.36 -33.49 73.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.552 -0.718 . . . . 0.0 109.45 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt -86.88 -13.74 43.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.693 -0.629 . . . . 0.0 110.258 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -85.44 -35.71 21.09 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.495 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.54 -31.68 20.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.747 -0.595 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.97 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.6 pp -63.28 -33.05 74.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.08 -41.95 65.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -63.54 -37.77 88.58 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.5 t80 -62.69 -23.58 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.92 -0.487 . . . . 0.0 109.707 178.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.1 mm-40 -77.34 -57.58 3.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.067 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 13.6 tttt -66.47 -41.35 89.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -58.12 -25.27 61.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.732 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.2 t -89.43 164.35 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.8 t -77.01 -70.25 0.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 110.925 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -84.54 61.7 6.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 110.638 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.79 52.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -98.98 -28.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.372 -0.83 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.9 p-80 -65.27 -49.26 70.26 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -69.15 -22.06 63.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.675 . . . . 0.0 109.569 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 26.8 t80 -56.9 -64.59 0.83 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -55.96 -25.02 41.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 109.772 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.09 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.71 -64.87 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.441 -0.787 . . . . 0.0 110.053 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.97 ' CG ' HD11 ' A' ' 22' ' ' LEU . 45.7 m-85 -81.7 -25.76 35.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.667 . . . . 0.0 110.282 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 tpt85 -62.11 -44.47 96.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.8 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -78.0 -42.58 32.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.796 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.795 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.97 -29.74 71.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 109.662 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -76.64 -31.71 57.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -75.49 -41.31 55.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.4 p -70.88 -44.25 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.478 -0.764 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.548 HG13 HG13 ' A' ' 45' ' ' VAL . 69.9 mt -73.41 -27.95 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.471 -0.768 . . . . 0.0 109.853 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.41 -23.3 43.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -116.64 28.14 8.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.586 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.1 t80 -88.1 142.48 31.95 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -85.63 6.78 5.41 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.063 2.509 . . . . 0.0 111.177 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -145.67 170.77 15.81 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -98.26 135.95 39.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.551 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.789 HG23 ' HB3' ' A' ' 58' ' ' GLU . 55.9 mt -73.06 120.66 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.572 -0.705 . . . . 0.0 109.271 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -82.16 -49.64 9.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.543 -0.723 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.48 -179.81 5.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.607 -0.683 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.42 -27.72 71.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.01 96.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.589 -0.948 . . . . 0.0 109.681 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.789 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -61.36 -20.79 63.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.836 179.944 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.87 -26.4 22.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.397 -0.815 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -74.01 -39.92 63.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.504 -0.747 . . . . 0.0 109.71 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.19 -25.86 65.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.55 -0.719 . . . . 0.0 110.01 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HG21 ' A' ' 45' ' ' VAL . 84.3 mt -59.21 144.64 82.89 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.503 -0.748 . . . . 0.0 109.714 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -79.1 112.61 3.09 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.021 2.481 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.13 -28.57 6.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.7 139.6 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 109.343 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.43 -137.61 7.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 p -99.1 -29.34 12.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.601 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -65.92 -65.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.482 -0.761 . . . . 0.0 109.587 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.09 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.7 mm -61.78 -42.78 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.818 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.89 70.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.7 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.43 -43.22 99.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -62.22 -28.45 69.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.315 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.2 mm -63.48 -44.52 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.41 -41.3 76.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.474 -0.766 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.07 -27.54 69.47 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.549 ' CD2' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -71.46 -52.09 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 0.0 109.409 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -71.22 -26.68 63.03 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.949 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 109.527 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.416 -0.803 . . . . 0.0 109.272 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.25 -38.43 5.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.08 -49.52 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.836 -0.802 . . . . 0.0 109.155 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 5.0 t -57.48 -35.01 69.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.055 -179.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -59.74 -35.53 74.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.458 -0.776 . . . . 0.0 109.471 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.699 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.1 tpp -90.35 -11.88 39.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.163 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.667 ' CD1' HG22 ' A' ' 15' ' ' ILE . 3.9 mt -87.48 -32.62 19.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.702 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.3 t -85.57 -36.54 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HA ' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -67.04 -47.24 71.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.914 HD11 ' CG ' ' A' ' 39' ' ' TYR . 1.9 pp -73.82 -34.97 64.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 108.437 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.82 -49.9 67.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.675 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -62.4 -33.02 73.94 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 37.5 t80 -64.52 -21.33 66.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.714 -0.616 . . . . 0.0 109.609 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -78.47 -57.81 3.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.366 -0.834 . . . . 0.0 108.85 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.1 tmtt? -66.81 -39.79 87.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 109.426 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -58.7 -26.4 63.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.791 . . . . 0.0 109.603 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 63.1 t -89.44 164.41 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.03 -70.01 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.768 . . . . 0.0 111.012 -178.617 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -84.64 60.34 6.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 110.687 -178.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.91 63.96 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -110.12 -31.02 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.812 . . . . 0.0 109.008 179.777 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -60.88 -48.8 80.15 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.426 -0.796 . . . . 0.0 108.904 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.92 -26.02 63.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.645 -0.659 . . . . 0.0 109.544 179.339 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.3 t80 -51.54 -65.56 0.54 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -57.61 -25.06 59.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.058 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -57.42 -67.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.914 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.8 m-85 -72.32 -24.65 61.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.64 -0.663 . . . . 0.0 110.268 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 -62.54 -42.3 99.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -75.12 -44.53 46.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.504 -0.747 . . . . 0.0 109.801 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -62.11 -41.26 98.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -65.21 -29.45 70.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.793 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -70.78 -34.67 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.72 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.842 HG21 ' HB3' ' A' ' 62' ' ' LEU . 13.6 p -90.14 -45.35 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 110.121 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.477 ' N ' HG13 ' A' ' 45' ' ' VAL . 69.7 mt -66.74 -55.64 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.0 109.723 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -59.25 -19.92 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -118.05 28.08 8.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.763 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.614 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.6 t80 -91.05 139.84 25.85 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -85.09 6.95 5.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.034 2.489 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.415 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.7 m-70 -147.14 172.52 13.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.168 -0.957 . . . . 0.0 109.536 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -98.61 144.05 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.553 -0.717 . . . . 0.0 109.512 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.814 HG23 ' HB3' ' A' ' 58' ' ' GLU . 57.3 mt -75.28 108.85 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 109.36 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -71.18 -46.57 61.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.657 -0.652 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.9 173.43 11.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.08 -28.43 68.91 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.44 71.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.654 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.814 ' HB3' HG23 ' A' ' 53' ' ' ILE . 6.4 tt0 -74.36 -24.18 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.556 -0.715 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.755 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.38 -29.31 24.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.41 -0.806 . . . . 0.0 109.587 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -76.22 -38.82 55.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.543 -0.723 . . . . 0.0 109.629 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -60.32 -23.67 64.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 0.0 110.06 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.842 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.9 mt -60.94 141.29 93.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.515 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.54 107.91 2.22 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.939 2.426 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.9 -28.78 3.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 70' ' ' ALA . 28.3 t -89.79 138.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -1.02 . . . . 0.0 109.379 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.7 -137.38 8.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -98.91 -26.69 14.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.598 -0.943 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -69.93 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.058 HD11 ' HB1' ' A' ' 38' ' ' ALA . 48.3 mm -61.42 -45.08 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.733 . . . . 0.0 109.804 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.543 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -57.62 -34.11 68.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.469 -0.77 . . . . 0.0 109.831 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.95 -43.55 98.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.732 . . . . 0.0 109.312 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -63.43 -29.65 70.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.673 . . . . 0.0 109.266 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.755 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.8 mm -63.17 -46.42 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.67 -40.72 72.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.531 -0.731 . . . . 0.0 109.647 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.58 -28.72 70.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -52.31 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.56 -0.712 . . . . 0.0 109.36 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.68 -25.67 61.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.932 -0.48 . . . . 0.0 110.005 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.93 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.451 -0.781 . . . . 0.0 109.435 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt 60.03 85.06 0.11 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.468 -0.77 . . . . 0.0 109.692 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.09 -70.91 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.673 . . . . 0.0 109.465 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm 60.34 83.61 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.671 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -70.8 176.15 2.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 109.463 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.671 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.1 Cg_endo -86.28 157.68 9.65 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.402 2.735 . . . . 0.0 110.477 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -71.33 127.9 34.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.515 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -152.41 162.13 41.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 p -102.65 83.78 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 52' ' ' LYS . 13.0 tp -110.06 -69.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.545 -0.722 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -131.89 37.24 3.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.0 109.289 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.64 0.52 86.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.16 6.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.844 HG22 ' CD1' ' A' ' 19' ' ' LEU . 4.1 mt -65.98 -55.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.853 -0.792 . . . . 0.0 109.021 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -51.49 -31.5 23.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 110.345 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.91 -29.36 70.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.587 -0.696 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.56 ' O ' HD23 ' A' ' 22' ' ' LEU . 14.7 mmt -88.87 -20.09 25.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 0.0 109.869 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.844 ' CD1' HG22 ' A' ' 15' ' ' ILE . 2.5 mp -89.28 -33.54 16.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' THR . 51.5 t -75.06 -34.33 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -59.44 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 0.0 109.308 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.995 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.0 pp -61.56 -30.66 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.418 -0.801 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -55.41 -40.2 71.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 109.139 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -64.82 -35.84 82.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.3 t80 -64.14 -24.61 67.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.847 -0.533 . . . . 0.0 109.646 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.576 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -74.42 -61.21 1.94 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.543 -0.723 . . . . 0.0 109.292 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.9 tmtm? -63.47 -41.98 98.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.698 -0.626 . . . . 0.0 109.601 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.8 -23.88 54.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' PHE . 50.1 t -89.83 164.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.7 t -75.4 -70.21 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.982 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -89.64 68.18 7.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.46 -0.775 . . . . 0.0 110.702 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.92 44.16 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.617 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -92.44 -26.77 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.46 -49.69 52.54 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.5 -19.87 62.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.755 . . . . 0.0 109.271 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.4 t80 -57.67 -60.13 4.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 -28.05 63.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.552 -0.717 . . . . 0.0 109.591 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.03 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -49.76 -63.09 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.612 -0.68 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.995 ' CG ' HD11 ' A' ' 22' ' ' LEU . 58.6 m-85 -80.41 -23.21 40.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.781 -0.574 . . . . 0.0 110.488 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -45.37 94.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.687 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -78.9 -46.73 17.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.871 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.826 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.16 -29.68 70.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.542 -0.724 . . . . 0.0 109.789 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.14 -30.03 54.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 t -79.03 -42.81 25.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.926 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 62' ' ' LEU . 10.6 p -69.18 -44.35 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.021 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.556 HG13 HG13 ' A' ' 45' ' ' VAL . 71.0 mt -73.23 -26.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 109.953 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.42 -20.24 37.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.68 26.54 8.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.872 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.504 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.5 t80 -80.75 140.97 51.13 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.516 -0.74 . . . . 0.0 109.037 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.4 Cg_endo -85.28 7.31 5.2 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.039 2.493 . . . . 0.0 111.172 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.0 179.59 7.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.893 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.698 ' HB3' HD11 ' A' ' 11' ' ' LEU . 2.9 pttm -109.71 169.03 8.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 109.602 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 58' ' ' GLU . 11.9 pt -131.3 156.04 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -140.1 28.76 2.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -170.17 155.25 5.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 109.398 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.21 -30.3 77.1 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.3 93.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.971 . . . . 0.0 109.472 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.482 ' HB3' HG22 ' A' ' 53' ' ' ILE . 5.3 mt-10 -61.37 -21.99 64.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.973 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -90.17 -26.6 20.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.33 -0.857 . . . . 0.0 109.772 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -74.61 -37.87 62.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 109.687 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -59.7 -26.77 65.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.52 -0.737 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.845 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.7 mt -60.4 146.09 85.22 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.56 -0.712 . . . . 0.0 109.599 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.5 109.81 2.54 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.7 -28.47 4.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 42' ' ' ALA . 26.1 t -89.82 138.34 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -1.01 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.29 -141.71 10.14 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 p -96.11 -30.6 13.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.537 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -65.35 -62.14 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.03 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.9 mm -61.63 -44.94 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.732 . . . . 0.0 109.722 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.54 69.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.759 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.91 -41.01 97.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.725 . . . . 0.0 109.405 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -65.49 -31.27 72.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.666 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.1 mm -63.47 -44.52 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -56.61 -40.35 75.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 109.605 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.06 -26.99 69.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 109.122 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -51.36 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.688 . . . . 0.0 109.462 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.39 -29.15 62.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.938 -0.476 . . . . 0.0 110.021 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -123.17 -68.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.421 -0.8 . . . . 0.0 109.461 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.05 -46.08 0.81 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.51 153.86 29.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.609 -0.936 . . . . 0.0 109.462 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -160.34 146.1 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -100.05 -54.84 2.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.552 -0.718 . . . . 0.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -114.87 174.46 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.705 . . . . 0.0 109.414 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -98.72 171.92 7.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.581 -0.699 . . . . 0.0 109.463 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.16 162.88 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.491 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.442 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -175.54 130.37 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.497 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -81.07 -59.16 2.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -120.74 135.87 55.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.598 -0.689 . . . . 0.0 109.465 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -85.64 176.28 3.77 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.1 Cg_endo -85.46 139.53 6.89 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.364 2.709 . . . . 0.0 110.512 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -63.26 -39.55 94.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -161.03 147.27 14.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' THR . 4.2 t -82.21 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.737 HD22 ' CG ' ' A' ' 52' ' ' LYS . 29.2 mt -110.06 -69.4 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.544 -0.723 . . . . 0.0 109.417 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -132.91 48.58 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 109.267 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.47 -4.91 72.92 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.9 -37.57 6.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.759 HG22 HD12 ' A' ' 19' ' ' LEU . 1.6 mp -65.78 -43.07 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.811 -0.817 . . . . 0.0 109.102 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.684 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.2 t -57.63 -34.13 68.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.7 . . . . 0.0 109.942 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -31.77 73.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.6 mmm -89.44 -22.16 22.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 109.915 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.768 HD23 ' CD2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -83.43 -37.08 23.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 16' ' ' THR . 50.1 t -75.08 -29.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.49 -64.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -64.26 -30.47 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.5 -46.14 66.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.547 -0.72 . . . . 0.0 109.524 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -36.97 84.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 29' ' ' VAL . 27.0 t80 -62.48 -20.35 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.0 109.926 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -78.92 -57.78 3.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.336 -0.852 . . . . 0.0 109.038 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -68.71 -38.53 80.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.74 -26.77 64.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.752 . . . . 0.0 109.646 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 25' ' ' PHE . 79.1 t -89.4 164.17 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.97 -70.0 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 111.022 -178.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 60.87 6.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.04 66.62 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.83 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.16 -32.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 108.88 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.426 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -61.61 -48.61 80.13 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.273 -0.892 . . . . 0.0 108.735 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.54 -20.58 62.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CZ ' ' HG3' ' A' ' 40' ' ' ARG . 23.8 t80 -57.54 -69.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.27 -0.894 . . . . 0.0 109.607 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -52.94 -25.32 11.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.342 -0.849 . . . . 0.0 109.99 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.032 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.98 -55.43 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.482 -0.762 . . . . 0.0 109.859 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.01 ' CG ' HD11 ' A' ' 22' ' ' LEU . 44.7 m-85 -90.02 -29.72 18.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 110.116 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -63.05 -44.62 95.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -75.93 -41.83 50.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.588 -0.695 . . . . 0.0 109.594 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.803 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -62.72 -48.84 77.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.489 -0.757 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -62.11 -27.05 68.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.486 -0.759 . . . . 0.0 109.887 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -75.97 -50.61 14.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.46 -0.775 . . . . 0.0 110.045 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.0 p -66.95 -44.16 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.496 -0.752 . . . . 0.0 110.001 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.485 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.3 mt -68.18 -53.9 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.464 -0.772 . . . . 0.0 109.78 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.28 60.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.42 28.32 8.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.486 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.6 t80 -87.01 139.53 32.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.582 -0.698 . . . . 0.0 109.155 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.99 10.14 3.79 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.067 2.511 . . . . 0.0 111.253 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.3 m-70 -147.09 175.09 10.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 0.0 109.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.737 ' CG ' HD22 ' A' ' 11' ' ' LEU . 5.3 mtmt -91.52 177.95 6.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.687 . . . . 0.0 109.575 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.662 HG23 ' CB ' ' A' ' 58' ' ' GLU . 48.1 mt -121.83 118.44 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -75.08 -43.24 54.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.512 -0.743 . . . . 0.0 109.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 -179.5 7.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.692 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.46 -26.84 60.06 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.98 70.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.465 -1.02 . . . . 0.0 109.367 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.662 ' CB ' HG23 ' A' ' 53' ' ' ILE . 4.1 mp0 -73.24 -20.88 60.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.72 -0.612 . . . . 0.0 109.889 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.53 -26.52 24.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.89 . . . . 0.0 109.798 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -41.78 61.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -59.74 -24.49 64.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 110.02 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.83 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.5 mt -60.42 142.35 90.75 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.488 -0.758 . . . . 0.0 109.52 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.95 109.07 2.33 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.035 2.49 . . . . 0.0 110.253 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.77 5.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.563 HG22 ' HA ' ' A' ' 42' ' ' ALA . 22.0 t -89.53 137.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.435 -1.039 . . . . 0.0 109.39 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.07 -149.06 22.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -98.11 -29.9 12.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.591 -0.947 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -71.06 -44.49 65.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.622 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.032 HD11 ' HB1' ' A' ' 38' ' ' ALA . 40.6 mm -70.34 -44.96 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 0.0 109.811 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.12 87.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.0 109.739 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.47 -37.6 84.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.528 -0.732 . . . . 0.0 109.601 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -63.01 -32.47 73.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 109.392 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.78 -43.05 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -55.93 -41.1 74.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.735 . . . . 0.0 109.674 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.69 -29.37 70.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -52.53 22.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.697 . . . . 0.0 109.393 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.47 61.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.906 -0.496 . . . . 0.0 110.062 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -79.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -61.09 1.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 109.47 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.07 58.87 3.08 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -139.43 140.29 37.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.964 . . . . 0.0 109.532 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.85 51.37 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.559 -0.713 . . . . 0.0 109.411 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -73.81 -72.05 0.29 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -110.51 -41.4 4.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 85' ' ' LEU . 10.0 mp -70.06 135.15 48.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.488 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -94.27 -46.3 7.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.479 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.064 0.459 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 69.41 -67.53 0.22 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.578 -0.701 . . . . 0.0 109.795 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 mtt-85 59.18 91.57 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.391 -0.818 . . . . 0.0 109.826 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -88.5 -48.76 7.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -73.82 169.15 19.97 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.67 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.2 Cg_endo -86.46 158.6 9.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.386 2.724 . . . . 0.0 110.489 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -67.28 144.33 55.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -154.84 170.91 20.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.745 . . . . 0.0 109.547 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 10' ' ' THR . 2.7 t -109.31 81.96 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 0.0 109.472 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 51' ' ' HIS . 6.4 mt -99.92 -70.02 0.75 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.501 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.64 ' O ' HG22 ' A' ' 16' ' ' THR . 20.1 m120 -94.46 46.78 1.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.2 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.97 -3.84 72.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.893 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.95 -37.96 5.89 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 73' ' ' ILE . 3.0 mp -78.88 -49.4 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.947 -0.737 . . . . 0.0 109.756 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.3 t -58.15 -33.81 69.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.24 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.402 ' O ' HD22 ' A' ' 22' ' ' LEU . 6.2 mtp -84.19 -16.23 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -81.1 -38.68 26.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 16' ' ' THR . 48.8 t -71.94 -28.96 31.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -64.52 -66.6 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.603 -0.686 . . . . 0.0 110.015 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.678 HD11 ' CE1' ' A' ' 39' ' ' TYR . 1.9 pt? -63.76 -33.83 76.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.549 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.36 -41.63 60.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.558 -0.714 . . . . 0.0 109.82 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.14 -38.38 85.42 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 29' ' ' VAL . 66.9 t80 -63.73 -26.09 68.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.745 -0.597 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.663 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.2 mp0 -75.97 -57.83 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 20.1 tttp -65.81 -42.22 90.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 0.0 109.507 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.44 -24.64 56.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.5 t -89.5 164.82 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 47.4 t -77.31 -70.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 111.072 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -83.53 63.12 7.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.696 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.84 38.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.43 -23.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -0.78 . . . . 0.0 109.523 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.466 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -73.87 -51.84 14.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.54 -19.88 63.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 109.164 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 18.9 t80 -59.35 -56.15 25.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 0.0 108.915 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -58.97 -26.72 64.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.747 . . . . 0.0 109.494 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.059 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -57.75 -67.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.459 -0.776 . . . . 0.0 109.822 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.678 ' CE1' HD11 ' A' ' 22' ' ' LEU . 20.6 m-85 -75.35 -28.67 59.66 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.579 -0.7 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 23.5 tpt180 -63.5 -52.63 60.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.499 -0.751 . . . . 0.0 109.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -62.28 -39.49 93.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.35 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.903 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -65.02 -39.5 93.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.563 -0.711 . . . . 0.0 109.106 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.2 65.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.449 -0.782 . . . . 0.0 109.704 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 m -82.96 -53.43 5.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.711 HG11 HG23 ' A' ' 65' ' ' VAL . 7.9 p -63.62 -42.5 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.491 -0.756 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.462 ' N ' HG13 ' A' ' 45' ' ' VAL . 48.3 mm -68.9 -36.85 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.777 . . . . 0.0 109.404 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.64 36.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.494 -0.754 . . . . 0.0 110.31 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -101.02 15.8 27.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.487 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.456 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 4.2 t80 -96.8 133.63 24.17 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -86.57 14.94 2.31 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.198 2.599 . . . . 0.0 111.784 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.537 ' HA ' HD13 ' A' ' 11' ' ' LEU . 69.8 m-70 -148.11 175.02 11.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 109.893 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 159.84 14.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.695 . . . . 0.0 109.536 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 58' ' ' GLU . 9.1 mt -98.15 137.22 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -86.0 -47.9 9.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.704 . . . . 0.0 109.649 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 p -136.53 179.58 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.661 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.17 78.46 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.11 71.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.983 . . . . 0.0 109.413 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.695 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.6 mt-10 -70.21 -21.58 63.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.619 -0.676 . . . . 0.0 109.884 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.714 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -80.71 -32.73 35.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 18.0 ttpp -74.43 -38.85 62.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.555 -0.716 . . . . 0.0 110.114 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -59.98 -26.69 66.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' A' ' 59' ' ' ALA . 8.2 mt -71.29 148.44 93.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.363 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.28 106.21 2.11 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.05 2.5 . . . . 0.0 110.351 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.04 2.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.711 HG23 HG11 ' A' ' 45' ' ' VAL . 28.8 t -89.73 139.66 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.993 . . . . 0.0 109.385 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.41 -147.21 21.98 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -30.59 11.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.601 -0.94 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -82.51 -41.7 19.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.658 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.059 HD11 ' HB1' ' A' ' 38' ' ' ALA . 42.8 mm -72.18 -39.89 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.469 -0.769 . . . . 0.0 109.742 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.27 -51.91 67.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.494 -0.754 . . . . 0.0 109.778 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.35 -32.13 68.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.441 -0.787 . . . . 0.0 109.471 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -63.15 -34.51 77.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 15' ' ' ILE . 46.7 mm -64.33 -38.7 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.37 -40.17 74.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.48 -0.763 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.19 -30.57 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -52.47 36.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.282 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.28 -25.2 60.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.903 -0.498 . . . . 0.0 110.165 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.99 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.291 -0.881 . . . . 0.0 109.769 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.0 m -122.64 -61.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.27 -32.5 1.97 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -106.74 169.03 8.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.615 -0.932 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mt -112.58 131.39 55.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.725 . . . . 0.0 109.455 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -89.36 149.69 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -87.4 164.61 16.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.577 -0.702 . . . . 0.0 109.511 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -141.76 38.43 1.65 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.522 -0.736 . . . . 0.0 109.459 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -140.64 159.28 42.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.496 -0.752 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.5 tttm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.479 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -63.28 -29.98 71.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.577 -0.702 . . . . 0.0 109.65 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -149.49 -44.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.508 -0.745 . . . . 0.0 109.809 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? 61.1 38.79 16.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.387 -0.821 . . . . 0.0 109.568 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.85 111.77 5.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.523 -0.735 . . . . 0.0 109.502 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.02 81.72 1.3 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.132 2.554 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.63 -171.05 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.372 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -83.21 100.44 10.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 10' ' ' THR . 5.0 t -62.78 112.99 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.7 . . . . 0.0 109.585 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -105.45 -73.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 109.515 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.564 ' HB3' HG22 ' A' ' 46' ' ' ILE . 7.6 m120 -92.02 53.57 2.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.579 -0.7 . . . . 0.0 109.142 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -7.0 68.4 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.74 -43.52 4.48 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.806 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.9 mt -68.11 -44.36 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.943 -0.74 . . . . 0.0 109.406 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.726 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 5.0 t -58.32 -34.14 70.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.6 -0.687 . . . . 0.0 109.948 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.08 -34.44 77.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.27 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.511 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.0 mtt -89.9 -15.55 31.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.694 -0.629 . . . . 0.0 110.157 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.806 ' CD1' HG22 ' A' ' 15' ' ' ILE . 2.2 mt -88.19 -35.7 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 108.485 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 16' ' ' THR . 44.7 t -78.94 -31.4 14.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -70.45 -59.33 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.887 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.002 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.3 pp -63.92 -34.71 78.57 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.273 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.93 -42.22 62.63 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.593 -0.692 . . . . 0.0 109.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -63.68 -38.07 89.73 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.1 t80 -61.96 -23.76 66.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.818 -0.551 . . . . 0.0 109.82 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.6 mm-40 -76.88 -57.75 3.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.443 -0.786 . . . . 0.0 109.148 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 14.5 tttm -67.69 -41.12 84.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.537 -0.727 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -57.45 -25.41 59.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.383 -0.823 . . . . 0.0 109.733 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 63.8 t -89.27 164.23 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.62 -70.09 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.463 -0.773 . . . . 0.0 110.905 -178.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -82.79 59.92 5.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.465 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.72 63.57 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -109.7 -29.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 108.957 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -64.11 -49.08 73.63 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.01 -25.45 63.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.629 -0.669 . . . . 0.0 109.421 179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 40' ' ' ARG . 28.0 t80 -52.59 -64.12 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.246 -0.909 . . . . 0.0 109.799 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -57.42 -26.07 60.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.506 -0.746 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.057 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.16 -65.78 0.54 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.002 ' CG ' HD11 ' A' ' 22' ' ' LEU . 72.0 m-85 -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.636 -0.665 . . . . 0.0 110.039 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' HG2' ' HB1' ' A' ' 23' ' ' ALA . 9.1 mmm180 -67.16 -39.68 86.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.527 -0.733 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -72.69 -45.41 58.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -63.37 -40.99 98.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -66.65 -24.76 66.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.548 -0.72 . . . . 0.0 109.883 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -78.13 -36.27 48.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.976 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.812 HG21 ' HB3' ' A' ' 62' ' ' LEU . 13.5 p -90.01 -44.95 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.402 -0.811 . . . . 0.0 110.008 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' A' ' 12' ' ' ASN . 69.8 mt -66.56 -56.03 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.726 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -60.41 -20.26 59.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.6 -0.687 . . . . 0.0 110.3 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 26.7 9.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.523 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.2 t80 -88.52 138.14 30.19 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.183 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.39 12.06 3.12 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.104 2.536 . . . . 0.0 111.342 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 68.2 m-70 -147.69 169.74 19.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -0.971 . . . . 0.0 109.743 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -105.46 141.18 37.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 0.0 109.664 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.662 HG22 ' HB3' ' A' ' 58' ' ' GLU . 17.4 pt -97.51 154.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -114.88 -29.96 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.595 -0.691 . . . . 0.0 109.807 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.43 165.35 23.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 109.625 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.83 -26.03 64.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.35 85.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -1.068 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.662 ' HB3' HG22 ' A' ' 53' ' ' ILE . 7.7 mt-10 -63.69 -19.08 64.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.71 -0.619 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -89.26 -26.4 21.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -38.52 63.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.763 . . . . 0.0 109.656 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -60.48 -26.45 66.81 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.812 ' HB3' HG21 ' A' ' 45' ' ' VAL . 51.9 mt -60.3 141.37 91.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.718 . . . . 0.0 109.563 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -80.02 112.65 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.931 2.421 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.06 -22.68 6.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.36 137.15 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -1.068 . . . . 0.0 109.373 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.07 -146.55 21.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 t -100.22 -30.32 11.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.635 -0.92 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -69.41 -45.33 69.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.552 -0.717 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.057 HD11 ' HB1' ' A' ' 38' ' ' ALA . 43.4 mm -72.85 -42.04 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.35 88.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -61.38 -36.35 80.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.563 -0.71 . . . . 0.0 109.448 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -64.45 -31.43 72.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.662 -0.649 . . . . 0.0 109.412 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.2 mm -63.53 -45.64 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -55.81 -39.72 71.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -64.47 -30.36 71.39 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -51.62 45.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.609 -0.682 . . . . 0.0 109.219 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.73 -25.24 60.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.896 -0.503 . . . . 0.0 110.057 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.7 p -123.27 -51.07 1.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.403 -0.81 . . . . 0.0 109.54 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.09 -58.51 0.45 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -132.03 134.57 45.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.962 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -145.01 137.84 26.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.557 -0.715 . . . . 0.0 109.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -66.23 89.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.59 -0.694 . . . . 0.0 109.494 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -139.41 115.79 10.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.536 -0.728 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.6 mt -136.69 123.65 21.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -122.4 145.42 48.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.451 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 tttm 60.1 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 109.688 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 -64.04 147.67 51.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.612 -0.68 . . . . 0.0 109.571 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.14 85.53 0.11 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.558 -0.713 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.02 161.49 37.95 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.64 -0.663 . . . . 0.0 109.457 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.51 50.5 2.35 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.399 2.733 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -89.69 158.56 17.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -99.46 172.36 7.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.622 -0.674 . . . . 0.0 109.56 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -118.12 -11.17 10.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 110.468 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.21 -69.68 0.1 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.981 -1.075 . . . . 0.0 110.706 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -109.59 36.1 3.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -4.39 71.71 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -36.29 6.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.8 mp -68.07 -47.9 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.886 -0.773 . . . . 0.0 109.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -60.3 -29.6 68.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.3 -32.79 74.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.593 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -90.0 -14.08 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.632 -0.667 . . . . 0.0 110.139 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 1.5 mt -88.8 -35.11 16.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 16' ' ' THR . 42.9 t -79.67 -31.8 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -70.11 -59.19 3.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.622 -0.674 . . . . 0.0 109.656 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.983 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.0 pp -63.02 -34.96 78.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 109.195 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.88 -42.16 62.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.541 -0.724 . . . . 0.0 109.76 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.2 -35.18 80.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.9 t80 -64.16 -27.16 68.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.846 -0.534 . . . . 0.0 109.582 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.651 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 38.3 mm-40 -78.58 -55.51 5.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.9 ttmt -63.8 -43.59 95.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.502 -0.749 . . . . 0.0 109.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.25 -24.52 59.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' PHE . 46.5 t -89.34 165.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 29' ' ' VAL . 42.5 t -76.81 -70.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.471 -0.768 . . . . 0.0 111.241 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -85.43 65.02 8.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.394 -0.816 . . . . 0.0 110.789 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.82 43.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.348 -0.845 . . . . 0.0 109.667 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -94.54 -23.39 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.777 . . . . 0.0 109.479 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.445 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 p-80 -70.86 -51.69 24.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.375 -0.828 . . . . 0.0 108.808 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.32 -25.41 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 29.0 t80 -53.21 -53.97 42.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.47 -27.43 69.28 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -56.02 -63.71 1.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.507 -0.746 . . . . 0.0 110.435 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.983 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.5 m-85 -71.59 -23.96 61.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.793 -0.567 . . . . 0.0 110.49 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.19 -55.63 23.46 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -62.72 -43.02 99.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 109.811 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.825 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -67.65 -27.73 67.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.577 -0.702 . . . . 0.0 109.801 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -72.2 -24.47 61.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 110.077 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.5 p -90.08 -49.91 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.284 -0.885 . . . . 0.0 110.025 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.778 HG11 HG23 ' A' ' 65' ' ' VAL . 7.4 p -60.87 -33.28 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.554 -0.717 . . . . 0.0 109.901 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.606 HG13 HG13 ' A' ' 45' ' ' VAL . 63.7 mt -87.02 -30.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.442 -0.787 . . . . 0.0 109.976 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -87.21 -18.22 30.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 0.0 110.311 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -112.97 25.88 11.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.579 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.0 t80 -89.91 140.03 27.63 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.419 -0.801 . . . . 0.0 109.125 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.76 12.0 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.113 2.542 . . . . 0.0 111.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.1 m-70 -146.38 170.86 15.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.92 . . . . 0.0 109.734 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -94.42 147.42 23.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.738 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 58' ' ' GLU . 11.0 mt -97.0 134.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -100.77 -57.94 2.0 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 109.587 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -105.22 159.94 15.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.25 -31.26 80.12 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.03 71.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.944 . . . . 0.0 109.377 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' A' ' 53' ' ' ILE . 18.4 tt0 -67.8 -22.35 65.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.644 -0.66 . . . . 0.0 109.806 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.619 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.17 -29.47 24.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.677 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 10.8 ttpp -75.63 -38.13 59.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.845 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -59.85 -24.25 64.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 110.219 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 49' ' ' TYR . 44.0 mt -69.07 151.09 97.34 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.521 -0.737 . . . . 0.0 109.458 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.34 99.94 1.28 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.029 2.486 . . . . 0.0 110.154 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.55 -27.54 1.94 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.778 HG23 HG11 ' A' ' 45' ' ' VAL . 38.5 t -89.68 138.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -1.009 . . . . 0.0 109.538 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -98.93 -146.89 21.19 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -100.1 -28.27 13.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.968 . . . . 0.0 109.726 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.21 -61.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 109.761 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.825 HG21 ' CB ' ' A' ' 42' ' ' ALA . 46.4 mm -65.13 -33.29 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.514 -0.741 . . . . 0.0 109.75 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -52.51 -57.49 9.78 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 110.22 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.15 -31.4 67.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 109.329 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.04 70.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 59' ' ' ALA . 44.6 mm -71.03 -43.87 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 108.978 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -52.36 -50.54 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.62 -30.26 70.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.42 -0.8 . . . . 0.0 109.142 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -42.47 93.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 77' ' ' LEU . 4.1 mm? -83.79 -22.74 31.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.184 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.34 -0.85 . . . . 0.0 109.645 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.47 HG23 ' N ' ' A' ' 80' ' ' GLY . 4.7 t -127.41 -42.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' N ' HG23 ' A' ' 79' ' ' THR . . . 87.1 60.08 1.7 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -138.51 168.01 20.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.576 -0.955 . . . . 0.0 109.486 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' N ' HD22 ' A' ' 82' ' ' LEU . 4.3 mm? -90.43 95.03 9.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -62.87 140.38 58.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -107.05 -62.35 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.46 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.6 mt -82.78 155.79 24.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.06 -31.05 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 tptt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.5 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 149.66 47.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.614 -0.679 . . . . 0.0 109.59 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.54 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.565 -0.709 . . . . 0.0 109.493 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 59.91 168.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.499 -0.751 . . . . 0.0 109.677 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.8 159.09 81.89 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.532 -0.73 . . . . 0.0 109.514 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -86.76 -165.13 0.24 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.475 2.784 . . . . 0.0 110.408 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.55 -173.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -155.53 111.53 3.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.566 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.6 p -117.86 -42.39 2.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.627 -0.671 . . . . 0.0 109.385 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -163.12 0.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.535 -0.728 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' HB2' HG22 ' A' ' 46' ' ' ILE . 17.1 m-80 -90.59 51.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.414 -0.804 . . . . 0.0 109.425 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.48 62.95 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.86 -35.93 6.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.845 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.7 mp -67.82 -48.11 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.88 -0.776 . . . . 0.0 109.117 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -56.77 -28.09 60.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.605 -0.684 . . . . 0.0 109.899 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.54 -27.01 64.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.497 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.5 mmt -89.95 -19.45 24.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 109.966 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.3 mp -86.52 -33.65 20.23 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 16' ' ' THR . 48.7 t -76.23 -36.02 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -58.99 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.616 -0.678 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.97 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -63.06 -31.03 72.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.214 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.71 -41.42 61.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -0.772 . . . . 0.0 109.592 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.32 -40.33 81.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.7 t80 -63.32 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.771 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -76.24 -56.85 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.228 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 24.4 ttpt -61.8 -46.92 87.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -0.788 . . . . 0.0 109.742 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -56.79 -22.46 36.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.367 -0.833 . . . . 0.0 109.93 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 25' ' ' PHE . 40.1 t -88.86 165.29 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 29' ' ' VAL . 42.6 t -76.98 -70.56 0.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 111.402 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -81.23 62.4 5.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.404 -0.81 . . . . 0.0 110.737 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.0 27.55 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -82.18 -30.82 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.448 -0.783 . . . . 0.0 108.921 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -69.66 -44.68 70.01 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 1.6 ptpm? -75.75 -20.45 58.29 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 8.5 t80 -58.41 -58.23 9.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.312 -0.867 . . . . 0.0 108.794 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -57.56 -28.8 63.88 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.561 -0.712 . . . . 0.0 109.328 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.086 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -50.42 -59.8 3.63 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.97 ' CG ' HD11 ' A' ' 22' ' ' LEU . 44.1 m-85 -82.09 -26.68 33.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.69 . . . . 0.0 110.143 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -40.55 96.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.366 -0.834 . . . . 0.0 109.698 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.5 mtpp -79.0 -49.98 11.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.879 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.764 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -61.6 -35.41 77.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 109.858 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.96 67.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.5 -0.75 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -80.02 -45.65 17.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.857 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.2 p -65.66 -43.05 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.57 -0.706 . . . . 0.0 109.942 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.553 HG13 HG13 ' A' ' 45' ' ' VAL . 75.7 mt -74.12 -33.56 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.439 -0.788 . . . . 0.0 109.911 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.18 -22.7 60.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.835 . . . . 0.0 110.114 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -120.52 26.56 9.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 0.0 109.73 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.503 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.6 t80 -81.78 141.45 47.91 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -86.03 9.11 4.18 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.044 2.496 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.1 m-70 -146.53 175.28 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.244 -0.91 . . . . 0.0 109.632 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -94.61 178.67 5.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.614 -0.679 . . . . 0.0 109.688 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 58' ' ' GLU . 61.3 mt -135.14 104.43 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.58 -0.7 . . . . 0.0 109.337 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -90.18 -52.46 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.674 -0.641 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.8 p -96.15 150.5 20.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.03 -25.8 64.78 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.97 72.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -1.053 . . . . 0.0 109.624 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -64.89 -20.05 66.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.698 . . . . 0.0 109.769 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.79 -28.73 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -75.71 -38.47 58.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -59.94 -24.66 64.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.555 -0.716 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.857 ' HB3' HG21 ' A' ' 45' ' ' VAL . 85.9 mt -59.8 143.81 86.64 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.47 -0.769 . . . . 0.0 109.738 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.48 111.91 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.981 2.454 . . . . 0.0 110.143 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.78 -29.42 5.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -89.98 137.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.966 . . . . 0.0 109.251 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.23 -139.27 10.01 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -98.21 -28.4 13.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.952 . . . . 0.0 109.604 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -62.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 0.0 109.588 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.086 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.0 mm -62.2 -44.39 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.698 . . . . 0.0 109.735 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.11 83.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.735 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.84 -40.29 88.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.745 . . . . 0.0 109.568 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -63.49 -29.74 70.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.613 -0.68 . . . . 0.0 109.442 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.5 mm -63.5 -46.32 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.725 . . . . 0.0 109.164 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.81 -41.41 74.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.466 -0.771 . . . . 0.0 109.77 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.97 -27.2 69.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 109.206 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -51.62 19.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.9 -27.3 61.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.576 -0.449 . . . . 0.0 109.981 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.421 -0.799 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.5 p -129.96 -56.49 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.406 -0.809 . . . . 0.0 109.323 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.64 58.67 10.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -149.27 -169.34 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.973 . . . . 0.0 109.452 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 82' ' ' LEU . 4.2 mm? -88.5 85.4 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.653 -0.655 . . . . 0.0 109.449 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -85.97 -28.96 23.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -170.08 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -96.45 100.64 12.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.34 -167.44 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.707 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.442 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -72.67 66.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -66.33 -60.24 2.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.522 -0.736 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 60.08 78.96 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.566 -0.709 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -90.05 165.12 25.44 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.727 . . . . 0.0 109.474 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.2 Cg_endo -86.61 51.08 2.45 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.41 2.74 . . . . 0.0 110.519 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' HG3' HG23 ' A' ' 10' ' ' THR . 3.2 pt20 -77.79 -176.47 4.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.16 75.4 1.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.609 -0.682 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.52 HG23 ' HG3' ' A' ' 8' ' ' GLN . 29.2 p -130.11 168.16 17.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.479 -0.763 . . . . 0.0 109.39 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.784 HD13 ' CG ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -109.98 -172.3 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.601 ' ND2' HD12 ' A' ' 11' ' ' LEU . 9.6 m120 66.76 -62.37 0.29 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.792 -0.567 . . . . 0.0 110.753 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 11' ' ' LEU . . . -56.49 -16.97 17.7 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -50.0 5.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.8 mt -67.51 -46.25 83.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 47' ' ' ALA . 96.0 m -59.25 -29.12 67.31 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.626 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.05 -37.74 88.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.0 mtt -82.57 -17.94 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.22 -36.62 20.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 16' ' ' THR . 48.6 t -76.16 -31.65 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.64 -61.81 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.71 -0.619 . . . . 0.0 109.554 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.998 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.6 pp -64.31 -32.23 73.74 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.094 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.33 -43.35 67.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.582 -0.699 . . . . 0.0 109.54 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -63.72 -37.31 86.88 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.6 t80 -62.38 -23.45 66.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.543 . . . . 0.0 109.792 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.9 -57.74 3.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HD2' HD11 ' A' ' 33' ' ' ILE . 13.0 tptt -67.12 -40.5 86.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.617 -0.677 . . . . 0.0 109.675 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.5 -25.22 62.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.46 -0.775 . . . . 0.0 109.739 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 25' ' ' PHE . 57.8 t -89.4 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 29' ' ' VAL . 35.3 t -76.32 -70.45 0.45 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.518 -0.738 . . . . 0.0 110.974 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -85.92 63.48 8.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.49 -0.756 . . . . 0.0 110.586 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.85 49.0 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 109.741 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.58 HD11 ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -96.3 -28.94 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.418 -0.801 . . . . 0.0 109.332 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.42 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.2 -48.89 71.8 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.633 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.26 -23.62 63.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.685 -0.634 . . . . 0.0 109.438 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CZ ' ' HD3' ' A' ' 40' ' ' ARG . 28.3 t80 -54.87 -62.95 1.33 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.291 -0.88 . . . . 0.0 109.75 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.084 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.5 -59.48 4.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 0.0 110.076 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.998 ' CG ' HD11 ' A' ' 22' ' ' LEU . 35.4 m-85 -88.92 -29.61 19.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.815 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 36' ' ' TYR . 9.1 tpt180 -62.19 -43.21 99.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.53 -0.731 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -79.19 -38.03 36.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 109.695 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.694 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -67.33 -37.97 84.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.688 ' HB1' HG23 ' A' ' 16' ' ' THR . . . -70.83 -29.93 66.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.531 -0.731 . . . . 0.0 109.509 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -67.75 -55.51 12.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.098 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.827 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.3 p -60.35 -43.79 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.502 HG13 HG13 ' A' ' 45' ' ' VAL . 73.4 mt -71.0 -38.16 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.775 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.764 ' HB2' HG21 ' A' ' 16' ' ' THR . . . -64.2 -26.26 68.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.02 27.46 8.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.792 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.531 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 3.2 t80 -84.17 137.05 40.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.73 . . . . 0.0 109.256 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.3 Cg_endo -87.23 14.49 2.4 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 123.195 2.597 . . . . 0.0 111.392 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 69.4 m-70 -147.87 173.26 13.01 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.218 -0.926 . . . . 0.0 109.762 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.784 ' CG ' HD13 ' A' ' 11' ' ' LEU . 2.6 tmtp? -97.85 139.23 34.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 109.827 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.865 HD12 HG21 ' A' ' 73' ' ' ILE . 17.9 pt -103.88 67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.291 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -69.59 -15.1 63.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.9 m -116.19 139.52 50.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.24 -31.17 65.39 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.76 78.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.634 -0.921 . . . . 0.0 109.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' HB3' HG22 ' A' ' 53' ' ' ILE . 13.6 mt-10 -63.37 -23.02 67.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.673 -0.642 . . . . 0.0 109.831 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.06 25.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -74.42 -42.23 59.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.79 . . . . 0.0 109.615 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -59.28 -23.75 62.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.54 -0.725 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.827 ' HB3' HG21 ' A' ' 45' ' ' VAL . 83.5 mt -59.56 138.82 89.46 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.812 . . . . 0.0 109.728 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.98 101.37 1.14 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.046 2.497 . . . . 0.0 110.007 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.86 -19.11 3.75 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 42' ' ' ALA . 33.3 t -89.31 138.42 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.329 -1.1 . . . . 0.0 109.302 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.44 -155.89 25.67 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -96.96 -27.02 14.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.967 . . . . 0.0 109.777 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -83.06 -38.09 22.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.496 -0.753 . . . . 0.0 109.667 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.084 HD11 ' HB1' ' A' ' 38' ' ' ALA . 38.1 mm -72.65 -42.22 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.434 -0.791 . . . . 0.0 109.868 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.84 76.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.781 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.12 -32.39 68.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -33.45 75.61 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.865 HG21 HD12 ' A' ' 53' ' ' ILE . 47.5 mm -63.47 -42.18 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -56.94 -36.84 70.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.629 -0.67 . . . . 0.0 109.588 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.93 -32.38 73.89 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -50.18 65.09 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.59 0.71 . . . . 0.0 109.159 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -74.01 -24.59 59.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.872 -0.517 . . . . 0.0 110.153 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.2 m -113.93 -50.38 2.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 60.01 2.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -157.49 146.19 19.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.998 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.9 tp -108.28 108.25 19.19 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -84.0 153.19 24.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -113.05 -175.43 2.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.671 -0.643 . . . . 0.0 109.386 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.88 163.43 27.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -95.01 146.26 24.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.6 -0.688 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.517 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -114.19 -61.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 109.451 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -31.25 72.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.33 169.39 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 109.778 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -76.4 172.3 9.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.3 Cg_endo -86.54 147.25 8.52 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.506 2.804 . . . . 0.0 110.42 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -89.94 -74.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.35 30.95 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 109.398 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -110.36 143.34 40.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.628 -0.67 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 11' ' ' LEU . 4.9 mp -107.61 -170.11 1.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 59.61 30.71 20.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.674 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.54 82.83 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.18 -34.15 7.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.7 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.6 mt -75.04 -49.34 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.856 -0.791 . . . . 0.0 109.353 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -58.9 -34.69 71.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.664 -0.648 . . . . 0.0 109.898 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -35.24 79.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 109.268 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttm -86.06 -22.95 26.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.626 -0.671 . . . . 0.0 109.779 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.7 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -79.07 -37.75 38.09 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' THR . 58.2 t -72.0 -28.82 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.21 -66.41 0.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.003 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' CZ ' ' A' ' 39' ' ' TYR . 2.2 pt? -64.73 -31.72 73.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -50.82 -40.7 56.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.555 -0.716 . . . . 0.0 110.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -39.64 69.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 29' ' ' VAL . 30.1 t80 -64.61 -27.21 68.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.729 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -78.36 -56.18 4.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.624 -0.673 . . . . 0.0 109.394 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 14.2 tttp -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -57.15 -25.59 59.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.465 -0.772 . . . . 0.0 109.471 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 25' ' ' PHE . 51.6 t -89.52 165.32 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -80.14 -67.48 0.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 111.211 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -78.85 57.87 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.901 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.03 28.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.27 -33.01 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -67.82 -44.69 76.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 16.3 ptpt -76.51 -16.98 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 4.7 t80 -61.89 -63.29 1.3 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -55.51 -26.13 41.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -0.751 . . . . 0.0 109.632 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.756 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.43 -58.1 9.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.478 -0.763 . . . . 0.0 109.654 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.55 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 27.9 m-85 -84.61 -27.99 26.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 109.674 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -63.15 -53.98 44.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 109.546 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.472 ' O ' HG12 ' A' ' 45' ' ' VAL . 6.6 mttm -67.57 -43.16 81.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.711 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.36 -29.7 70.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.544 -0.723 . . . . 0.0 109.552 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -74.32 -26.22 60.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.558 -0.713 . . . . 0.0 109.796 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -87.88 -48.5 7.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 109.993 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.915 HG22 HD13 ' A' ' 62' ' ' LEU . 7.9 p -61.68 -33.54 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.592 HG13 HG13 ' A' ' 45' ' ' VAL . 72.1 mt -85.8 -25.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.533 -0.729 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.46 -20.98 24.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -108.89 23.45 14.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.606 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.8 t80 -94.59 139.64 22.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 108.935 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.51 12.24 3.06 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.105 2.537 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -146.02 153.58 40.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 0.0 109.795 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -77.23 145.77 37.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 109.772 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.05 81.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -69.66 -27.78 65.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 p -121.52 145.86 47.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.452 -0.78 . . . . 0.0 109.376 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.0 79.23 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -31.41 72.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.542 -0.975 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.31 -22.27 66.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.635 -0.666 . . . . 0.0 109.775 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.75 -32.23 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -76.31 -37.75 57.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.523 -0.735 . . . . 0.0 109.724 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -60.02 -23.31 63.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.185 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.915 HD13 HG22 ' A' ' 45' ' ' VAL . 24.7 mt -63.89 151.1 90.12 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.421 -0.799 . . . . 0.0 109.543 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -81.29 104.14 1.48 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.117 2.545 . . . . 0.0 110.054 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.16 -22.68 4.73 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.792 ' CG2' HG11 ' A' ' 45' ' ' VAL . 40.5 t -89.3 139.84 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.387 -1.066 . . . . 0.0 109.282 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -98.73 -153.48 28.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.0 p -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.489 -1.007 . . . . 0.0 109.624 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -66.57 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.503 -0.748 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.756 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.1 mm -64.08 -35.09 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 109.775 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -60.97 -45.01 96.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.507 -0.745 . . . . 0.0 109.377 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -59.59 -33.73 71.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.598 -0.689 . . . . 0.0 109.428 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -65.87 -30.72 71.37 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.6 mm -63.15 -46.22 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -56.62 -37.5 70.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.475 -0.766 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.57 -31.28 72.43 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -50.49 62.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.562 0.696 . . . . 0.0 109.206 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -74.45 -25.58 59.51 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.027 -0.42 . . . . 0.0 110.143 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.59 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.387 -0.821 . . . . 0.0 109.742 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -129.72 -58.13 1.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.37 -34.05 2.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -113.02 178.11 4.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.476 -1.014 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mt -111.35 143.81 41.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.545 -0.722 . . . . 0.0 109.411 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -100.07 90.52 4.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.651 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -127.78 83.91 2.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.479 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -78.37 152.4 32.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.475 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -106.49 -69.93 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.559 -0.713 . . . . 0.0 109.472 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.436 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -62.22 178.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.566 -0.709 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -63.4 -173.63 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.646 -0.659 . . . . 0.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.29 -58.83 1.85 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.488 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.56 160.11 37.17 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.82 -76.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.385 2.723 . . . . 0.0 110.73 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -90.19 -75.91 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.526 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.99 161.27 8.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 109.452 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 t -130.01 158.99 38.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.636 -0.665 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.86 -170.11 1.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.432 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 58.14 41.25 24.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 109.777 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.91 -3.29 83.27 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.08 -37.01 6.43 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.852 HG22 ' CD1' ' A' ' 19' ' ' LEU . 4.7 mt -69.16 -60.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.892 -0.769 . . . . 0.0 109.184 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.4 t -52.99 -25.9 13.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.811 -0.556 . . . . 0.0 110.525 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.29 -30.38 68.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.69 -21.8 21.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.0 109.952 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.852 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.7 mp -86.94 -35.29 18.98 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 16' ' ' THR . 67.7 t -77.22 -31.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -65.35 -61.84 1.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.883 HD21 ' CE2' ' A' ' 39' ' ' TYR . 3.1 pp -63.06 -33.34 75.23 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.06 -36.23 38.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.681 -0.637 . . . . 0.0 109.809 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.92 74.86 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 28.8 t80 -60.83 -21.11 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -77.89 -58.5 3.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.248 -0.907 . . . . 0.0 109.151 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 10.0 tttp -68.78 -38.05 79.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.52 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.65 -27.26 64.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.406 -0.808 . . . . 0.0 109.592 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' PHE . 72.8 t -89.34 164.03 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 29' ' ' VAL . 43.6 t -77.72 -70.22 0.49 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 0.0 110.853 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -81.37 59.15 3.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 65.64 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -30.8 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -62.59 -48.96 77.15 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.338 -0.851 . . . . 0.0 108.829 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -71.15 -20.85 62.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.69 . . . . 0.0 109.641 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 23.8 t80 -57.32 -68.76 0.2 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.866 . . . . 0.0 109.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -55.72 -23.03 26.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.384 -0.822 . . . . 0.0 110.054 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -56.14 -63.53 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.368 -0.832 . . . . 0.0 109.916 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.883 ' CE2' HD21 ' A' ' 22' ' ' LEU . 86.9 m-85 -74.61 -27.34 60.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.713 -0.617 . . . . 0.0 110.086 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -61.57 -37.21 83.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.441 -0.787 . . . . 0.0 109.683 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -81.95 -49.74 9.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.747 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.84 -27.91 69.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 -37.08 62.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.774 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.3 m -71.6 -47.42 54.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.769 HG11 ' CG2' ' A' ' 65' ' ' VAL . 7.4 p -64.01 -35.46 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.554 -0.716 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.633 HG13 HG13 ' A' ' 45' ' ' VAL . 65.6 mt -84.17 -28.27 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.06 -21.15 24.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.47 -0.769 . . . . 0.0 110.039 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.26 22.44 15.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.922 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.47 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.1 t80 -96.02 140.67 22.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 108.998 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.05 8.13 4.66 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.979 2.453 . . . . 0.0 111.226 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.0 m-70 -147.42 -176.28 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.678 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -104.17 160.49 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.532 -0.73 . . . . 0.0 109.57 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 58' ' ' GLU . 50.4 mt -97.05 143.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.68 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -91.48 -65.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.732 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 m -119.88 -179.95 4.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.729 . . . . 0.0 109.537 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.35 -33.8 87.3 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.2 71.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.997 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.747 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.5 mt-10 -71.19 -24.24 62.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.688 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -85.59 -31.96 22.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 0.0 109.662 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.582 ' CG ' ' HB1' ' A' ' 70' ' ' ALA . 5.9 mtpm? -75.33 -36.28 61.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.571 -0.705 . . . . 0.0 110.042 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.57 -27.28 67.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 59' ' ' ALA . 6.4 mt -71.18 146.95 93.05 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 0.0 109.401 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.8 102.45 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.959 2.439 . . . . 0.0 110.272 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.9 -25.84 2.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.769 ' CG2' HG11 ' A' ' 45' ' ' VAL . 36.8 t -89.72 139.16 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.46 -1.023 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -102.2 -151.53 23.94 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -99.05 -29.47 12.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.958 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -72.07 -64.09 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.498 -0.751 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.747 HG21 ' CB ' ' A' ' 42' ' ' ALA . 47.3 mm -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -56.98 -41.76 78.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.45 -38.62 87.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -62.11 -31.14 71.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.6 mm -63.34 -42.47 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.08 -41.04 74.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.413 -0.804 . . . . 0.0 109.548 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -62.89 -28.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -52.13 18.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.395 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.54 -26.79 61.88 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.87 -0.519 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.837 . . . . 0.0 109.525 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m -95.82 -56.35 2.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 109.237 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.47 -48.38 0.97 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.597 ' C ' HD13 ' A' ' 82' ' ' LEU . 21.0 mttp -111.46 161.16 16.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.955 . . . . 0.0 109.584 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -150.17 178.14 9.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.606 -0.684 . . . . 0.0 109.637 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.9 mtp85 -100.06 135.16 41.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.651 -0.656 . . . . 0.0 109.45 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 mtpp -130.55 -173.45 3.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.66 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.51 ' N ' HD22 ' A' ' 85' ' ' LEU . 4.3 mm? -80.57 118.88 22.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.687 . . . . 0.0 109.434 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -143.19 145.12 32.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.531 -0.731 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 tttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.434 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -98.63 -32.29 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -124.4 143.87 50.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -64.56 110.54 2.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.48 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.33 158.25 83.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.659 . . . . 0.0 109.438 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.84 -175.79 1.98 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.401 2.734 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -64.14 -64.25 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -152.94 150.87 29.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -126.62 135.49 51.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 52' ' ' LYS . 4.2 mt -85.23 -170.14 2.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 0.0 109.295 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.75 ' HB3' HG22 ' A' ' 46' ' ' ILE . 11.5 m120 59.51 32.02 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.712 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.29 -9.72 64.87 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.376 -0.916 . . . . 0.0 110.823 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.9 -36.63 6.32 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.873 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.2 mp -78.5 -43.8 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.845 -0.797 . . . . 0.0 109.74 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.718 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 4.6 t -59.44 -26.03 64.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.09 -46.33 57.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.47 -0.769 . . . . 0.0 109.423 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.541 ' O ' HD22 ' A' ' 22' ' ' LEU . 4.7 ppp? -85.24 -8.58 58.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.712 . . . . 0.0 110.456 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.873 ' CD1' HG22 ' A' ' 15' ' ' ILE . 4.9 mt -83.48 -42.1 17.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 16' ' ' THR . 46.9 t -72.09 -30.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.28 -65.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.602 -0.686 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD11 ' CZ ' ' A' ' 39' ' ' TYR . 1.6 pt? -63.14 -35.07 79.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.94 -48.95 64.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.62 -0.675 . . . . 0.0 110.114 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -62.81 -33.85 76.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 29' ' ' VAL . 50.1 t80 -65.41 -22.55 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.739 -0.601 . . . . 0.0 109.876 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.0 mm-40 -78.94 -56.95 4.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.452 -0.78 . . . . 0.0 109.18 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 17.8 tttm -66.37 -39.87 89.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.376 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.15 -26.42 64.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.453 -0.779 . . . . 0.0 109.447 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 25' ' ' PHE . 57.5 t -89.48 164.46 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -78.15 -68.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.435 -0.79 . . . . 0.0 110.939 -178.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -86.18 60.68 6.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.448 -0.782 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.74 57.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 109.542 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.93 -37.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.01 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.8 p-80 -55.73 -46.3 77.81 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.011 -1.056 . . . . 0.0 109.259 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -73.03 -20.41 61.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -57.74 -70.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -53.42 -24.85 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.425 -0.797 . . . . 0.0 109.938 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.043 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.62 -66.34 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.501 -0.749 . . . . 0.0 109.784 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 41.2 m-85 -77.94 -30.36 50.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 110.07 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -42.7 99.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.392 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -69.24 -44.84 71.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.747 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.747 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -63.12 -45.38 92.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.41 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -60.48 -22.94 64.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 0.0 109.901 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -79.61 -54.67 5.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.6 p -72.59 -44.39 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.541 -0.724 . . . . 0.0 110.104 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.75 HG22 ' HB3' ' A' ' 12' ' ' ASN . 78.4 mt -62.87 -58.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.475 -0.765 . . . . 0.0 109.597 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.718 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -60.69 -20.98 62.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.533 -0.729 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -112.21 28.83 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.545 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.1 t80 -94.07 140.47 22.9 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.2 Cg_endo -85.35 8.78 4.41 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.072 2.515 . . . . 0.0 111.284 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 171.18 15.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 11' ' ' LEU . 31.3 ttpt -94.48 145.08 25.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.613 -0.679 . . . . 0.0 109.543 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.518 HG21 HG21 ' A' ' 73' ' ' ILE . 52.6 mt -78.24 115.56 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -74.01 -31.11 62.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 0.0 109.562 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -164.84 -179.79 6.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.578 -0.701 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -28.0 63.54 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.99 95.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.574 -0.956 . . . . 0.0 109.451 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -69.93 -23.28 63.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.71 . . . . 0.0 109.77 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.5 -27.06 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 109.733 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -74.93 -40.99 60.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 109.605 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -59.95 -23.73 63.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.565 -0.709 . . . . 0.0 110.029 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.745 ' HB3' HG21 ' A' ' 45' ' ' VAL . 80.7 mt -59.99 136.83 90.75 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.55 106.03 1.94 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.865 2.377 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.49 -26.39 3.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 42' ' ' ALA . 23.1 t -89.63 138.06 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -1.036 . . . . 0.0 109.512 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.75 -146.17 14.09 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -99.14 -37.87 9.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.948 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -64.63 -44.01 91.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.745 . . . . 0.0 109.812 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.043 HD11 ' HB1' ' A' ' 38' ' ' ALA . 41.9 mm -71.2 -44.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.883 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.04 81.44 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 109.768 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -61.02 -39.42 89.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.51 -0.744 . . . . 0.0 109.544 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -63.26 -30.94 71.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.4 mm -64.06 -44.98 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -55.36 -40.95 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -64.26 -28.46 69.74 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.28 -52.57 18.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.608 -0.683 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.941 -0.474 . . . . 0.0 110.028 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.32 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.373 -0.83 . . . . 0.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p -101.55 -57.66 2.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.802 . . . . 0.0 109.47 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.38 55.12 3.31 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -145.96 177.04 9.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.647 -0.913 . . . . 0.0 109.437 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 82' ' ' LEU . 4.3 mm? -83.97 75.79 10.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 109.229 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -76.35 99.06 4.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.499 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -111.9 30.79 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.01 100.88 10.01 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -91.26 -63.68 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.514 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -64.4 -165.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 60.24 165.24 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -91.35 105.29 17.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -89.88 171.37 8.77 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.4 Cg_endo -86.4 151.18 9.13 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 123.405 2.737 . . . . 0.0 110.538 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.07 142.9 57.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -119.71 179.12 4.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.576 -0.702 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 p -74.42 -31.05 62.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 11' ' ' LEU . 1.2 mm? -63.53 -169.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.494 -0.754 . . . . 0.0 109.392 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.594 ' O ' HG22 ' A' ' 16' ' ' THR . 21.0 m-80 -98.3 53.67 1.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.535 -0.728 . . . . 0.0 109.341 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.7 55.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.05 -33.57 8.12 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.1 mp -74.13 -51.3 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.871 -0.782 . . . . 0.0 109.286 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.9 t -57.17 -28.54 62.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.68 -27.02 63.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 0.0 109.552 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.637 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.5 mmt -90.3 -19.44 24.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.992 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -89.04 -33.9 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 16' ' ' THR . 46.3 t -79.88 -31.74 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.19 -58.82 3.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.655 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.852 HD11 ' CD1' ' A' ' 39' ' ' TYR . 3.2 pp -62.67 -34.98 78.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.15 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.95 -43.12 63.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.504 -0.748 . . . . 0.0 109.572 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.74 -34.31 78.03 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 29' ' ' VAL . 53.5 t80 -66.2 -26.64 67.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.768 -0.583 . . . . 0.0 109.789 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 55.2 mm-40 -80.44 -52.37 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 53.7 tttt -66.07 -42.85 88.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.409 -0.807 . . . . 0.0 109.145 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -58.62 -26.15 63.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.247 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.3 t -89.34 165.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.6 t -79.39 -70.32 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.446 -0.784 . . . . 0.0 111.238 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -79.13 59.21 2.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.434 -0.791 . . . . 0.0 110.95 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.97 48.69 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.71 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -99.13 -21.9 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.9 p-80 -71.97 -51.78 20.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.322 -0.861 . . . . 0.0 108.825 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.03 -23.62 63.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.557 -0.715 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 21.9 t80 -56.72 -51.94 66.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.41 -0.806 . . . . 0.0 109.255 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -62.39 -29.9 70.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.192 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.014 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.96 -65.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.772 . . . . 0.0 109.989 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.852 ' CD1' HD11 ' A' ' 22' ' ' LEU . 81.7 m-85 -72.59 -16.01 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -72.1 -55.23 7.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -65.66 -43.54 89.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.526 -0.733 . . . . 0.0 110.078 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -64.95 -46.48 81.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.0 64.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.629 -0.669 . . . . 0.0 110.082 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -81.2 -52.67 7.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.2 p -63.13 -43.71 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.834 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.482 ' N ' HG13 ' A' ' 45' ' ' VAL . 65.2 mt -68.96 -54.88 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -59.49 -20.88 58.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.503 -0.748 . . . . 0.0 110.371 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -117.43 25.96 10.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.463 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.8 t80 -86.08 140.19 34.76 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.0 109.198 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.19 9.87 3.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.981 2.454 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -147.05 178.68 8.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.291 -0.881 . . . . 0.0 109.645 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -99.41 157.68 16.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.654 -0.654 . . . . 0.0 109.81 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.72 HG23 ' CB ' ' A' ' 58' ' ' GLU . 63.9 mt -102.53 108.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -69.93 -71.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.584 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -111.85 -179.85 3.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.688 -0.632 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.52 64.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.34 70.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -1.068 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.72 ' CB ' HG23 ' A' ' 53' ' ' ILE . 5.2 mp0 -70.55 -25.21 63.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.714 . . . . 0.0 109.695 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.02 -28.24 22.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 109.631 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -75.26 -40.11 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -59.79 -24.21 63.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.605 -0.685 . . . . 0.0 110.04 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.829 ' HB3' HG21 ' A' ' 45' ' ' VAL . 82.8 mt -60.23 142.65 89.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.456 -0.778 . . . . 0.0 109.636 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.29 105.62 1.78 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.032 2.488 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.45 -26.16 4.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 70' ' ' ALA . 25.9 t -89.53 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.461 -1.023 . . . . 0.0 109.468 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.63 -140.59 10.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.49 -27.48 14.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.912 . . . . 0.0 109.778 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -66.14 -67.68 0.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.475 -0.766 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.014 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.8 mm -60.03 -44.87 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.29 -35.46 71.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.45 -38.02 82.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 109.443 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -69.8 -25.25 63.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.645 -0.66 . . . . 0.0 109.653 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.705 HG21 ' HB2' ' A' ' 59' ' ' ALA . 40.5 mm -72.81 -48.28 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 109.386 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.36 -47.95 68.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.46 -28.95 70.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.475 -0.766 . . . . 0.0 109.054 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -44.15 79.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.69 . . . . 0.0 109.167 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 77' ' ' LEU . 4.0 mm? -81.66 -23.93 36.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.86 -0.525 . . . . 0.0 110.129 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -78.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 p -118.61 -59.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.498 -0.752 . . . . 0.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.4 59.99 1.01 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -157.15 40.68 0.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.551 -0.97 . . . . 0.0 109.464 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.038 HD23 HD13 ' A' ' 85' ' ' LEU . 5.6 mt -129.66 92.57 3.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.673 . . . . 0.0 109.47 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -99.93 -28.64 13.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' H ' HD12 ' A' ' 85' ' ' LEU . 20.9 tttm -168.49 88.39 0.22 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 109.435 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.038 HD13 HD23 ' A' ' 82' ' ' LEU . 4.9 mp -136.57 154.37 50.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.579 -0.701 . . . . 0.0 109.472 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.88 -36.37 67.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.634 -0.667 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.509 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttt 43.35 -164.8 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.032 0.444 . . . . 0.0 111.315 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 59.61 38.66 22.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.678 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 tttm 60.28 166.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.573 -0.705 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.4 111.47 4.36 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.665 -0.647 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.33 173.99 5.34 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.204 2.603 . . . . 0.0 110.504 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -90.01 157.59 17.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -112.49 119.16 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -105.25 176.81 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mt -74.6 -72.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.615 ' O ' HG22 ' A' ' 16' ' ' THR . 9.5 m120 -87.88 57.71 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.604 -0.685 . . . . 0.0 109.212 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.13 -15.56 57.31 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.0 -35.27 7.2 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.85 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.9 mt -70.94 -57.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.78 -0.836 . . . . 0.0 109.17 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 12' ' ' ASN . 5.0 t -53.48 -30.96 43.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.776 -0.578 . . . . 0.0 110.668 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.97 -29.48 68.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 110.014 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.506 ' O ' HD23 ' A' ' 22' ' ' LEU . 5.4 mmt -90.13 -23.71 21.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 110.058 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.85 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.8 mp -88.37 -34.27 17.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 108.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 16' ' ' THR . 99.8 t -76.48 -32.92 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -68.6 -61.56 1.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.483 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.974 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -61.69 -32.32 72.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.48 -44.35 65.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 109.63 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -35.62 79.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.1 t80 -65.13 -22.83 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.859 -0.526 . . . . 0.0 109.678 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 21.3 mm-40 -78.23 -57.88 3.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -64.99 -40.69 95.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.287 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -58.98 -25.4 63.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.582 -0.698 . . . . 0.0 109.498 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.1 t -89.59 164.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.8 t -76.76 -70.19 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.49 -0.756 . . . . 0.0 111.096 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.46 65.97 9.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.386 -0.821 . . . . 0.0 110.884 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.76 36.89 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -85.86 -26.11 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.316 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' NE2' ' HE3' ' A' ' 35' ' ' LYS . 6.4 p-80 -71.36 -50.76 28.98 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.618 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 10.8 ptpt -66.7 -23.75 66.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.6 t80 -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.475 -0.766 . . . . 0.0 109.648 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -56.71 -24.79 51.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.059 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.14 -59.24 5.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.388 -0.82 . . . . 0.0 109.89 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.974 ' CG ' HD11 ' A' ' 22' ' ' LEU . 48.0 m-85 -85.12 -27.61 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.949 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HD3' ' CE1' ' A' ' 36' ' ' TYR . 28.9 tpt85 -64.41 -42.84 95.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.469 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -78.33 -46.62 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.776 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.37 -44.26 96.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.551 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.73 70.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -66.91 -50.19 63.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.96 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.8 p -72.34 -45.07 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.466 -0.771 . . . . 0.0 110.112 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 12' ' ' ASN . 79.3 mt -64.22 -51.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -63.01 -21.36 66.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 110.076 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.07 27.93 8.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.499 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.4 t80 -90.45 139.38 26.68 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.728 . . . . 0.0 109.129 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -86.14 10.87 3.49 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.081 2.521 . . . . 0.0 111.263 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.6 m-70 -147.3 171.68 15.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.273 -0.892 . . . . 0.0 109.642 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.98 138.6 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.696 . . . . 0.0 109.665 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 58' ' ' GLU . 49.5 mt -73.12 125.78 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.239 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -81.67 -56.95 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 p -132.21 -179.82 5.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.544 -0.723 . . . . 0.0 109.509 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.8 -29.37 67.31 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.86 72.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.563 -0.963 . . . . 0.0 109.387 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.702 ' HB3' HG23 ' A' ' 53' ' ' ILE . 1.1 mm-40 -67.22 -21.33 65.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.718 -0.614 . . . . 0.0 109.9 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -85.99 -27.63 24.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.788 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HG3' ' HB1' ' A' ' 70' ' ' ALA . 23.1 mtpt -73.38 -40.72 64.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.767 . . . . 0.0 109.679 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -60.27 -26.62 66.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.568 -0.708 . . . . 0.0 110.039 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.766 ' HB3' HG21 ' A' ' 45' ' ' VAL . 46.5 mt -63.41 136.65 96.8 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.719 . . . . 0.0 109.297 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.55 108.39 2.12 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.937 2.425 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.05 -19.85 4.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 42' ' ' ALA . 39.5 t -89.27 139.31 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -1.101 . . . . 0.0 109.285 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.38 -149.92 23.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -98.64 -35.56 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.952 . . . . 0.0 109.643 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -71.86 -39.93 69.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.0 109.74 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.059 HD11 ' HB1' ' A' ' 38' ' ' ALA . 39.0 mm -72.83 -40.56 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -59.6 -50.65 73.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.543 -0.723 . . . . 0.0 110.126 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.97 -34.01 69.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.789 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -62.27 -37.93 87.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.556 -0.715 . . . . 0.0 109.182 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 53' ' ' ILE . 47.2 mm -63.74 -38.31 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.77 -40.3 72.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.525 -0.735 . . . . 0.0 109.617 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.8 -32.98 74.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -53.12 50.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.39 -22.79 61.08 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.962 -0.461 . . . . 0.0 110.168 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.79 -80.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 80' ' ' GLY . 3.5 t -130.03 -43.58 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.617 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 79' ' ' THR . . . 63.45 49.19 71.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -117.2 -37.63 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.34 90.39 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.521 -0.737 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -60.76 175.53 0.47 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.606 -0.684 . . . . 0.0 109.807 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -84.16 104.53 14.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.754 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.24 82.89 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.456 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -170.02 158.22 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.44 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.121 0.486 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -85.21 131.19 34.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 109.412 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 59.39 -174.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 109.744 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -86.56 -33.65 20.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.66 156.06 47.81 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.57 -0.706 . . . . 0.0 109.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.97 143.52 8.1 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 123.379 2.72 . . . . 0.0 110.504 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -90.03 130.54 36.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.73 . . . . 0.0 109.471 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -124.57 106.48 10.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.509 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.3 p -130.06 135.23 48.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.576 -0.703 . . . . 0.0 109.422 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mt -110.06 -73.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.861 ' HB2' HD12 ' A' ' 15' ' ' ILE . 26.5 p30 -101.71 67.55 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.618 -0.676 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 1.32 79.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.42 -34.81 7.76 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.861 HD12 ' HB2' ' A' ' 12' ' ' ASN . 10.0 mt -72.37 -59.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.861 -0.788 . . . . 0.0 109.146 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -53.17 -31.54 43.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.819 -0.551 . . . . 0.0 110.333 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.9 -29.38 69.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.6 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.7 mmt -90.4 -21.74 21.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 0.0 109.821 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.858 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.5 mp -88.78 -34.01 17.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 16' ' ' THR . 60.4 t -77.44 -33.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.77 -60.38 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 109.42 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.943 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -61.51 -34.5 75.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.136 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.25 -41.44 60.36 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.556 -0.715 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -64.25 -37.09 86.26 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 61.7 t80 -64.38 -23.49 67.31 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.667 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.0 mm-40 -76.1 -56.61 4.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.382 -0.823 . . . . 0.0 109.125 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -69.51 -40.48 76.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 109.728 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -57.5 -25.07 59.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' PHE . 67.6 t -89.28 164.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 29' ' ' VAL . 48.3 t -76.72 -70.43 0.46 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.765 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -85.05 64.56 8.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.459 -0.775 . . . . 0.0 110.412 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 48.98 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.683 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 -22.57 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.512 -0.742 . . . . 0.0 109.626 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.436 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 3.8 p-80 -71.5 -51.65 22.54 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 108.677 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -68.1 -23.27 64.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 109.309 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.5 -55.1 39.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -60.94 -27.44 68.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 0.0 109.565 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.078 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.99 -63.56 1.14 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.436 -0.79 . . . . 0.0 110.067 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 22' ' ' LEU . 63.4 m-85 -78.37 -27.4 46.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.722 -0.611 . . . . 0.0 110.149 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -66.83 -33.87 76.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.66 -49.64 10.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.506 -0.746 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.754 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.71 -50.85 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.53 -0.731 . . . . 0.0 109.454 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -61.61 -27.76 68.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.506 -0.746 . . . . 0.0 109.626 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -73.74 -32.29 63.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.861 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.799 HG21 ' HB3' ' A' ' 62' ' ' LEU . 9.7 p -90.1 -35.28 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG12 HD11 ' A' ' 53' ' ' ILE . 73.2 mt -77.09 -48.62 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.515 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -61.24 -20.06 62.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 0.0 110.23 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -121.66 26.17 8.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 109.724 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.51 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.9 t80 -83.72 145.58 47.68 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.057 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.6 Cg_endo -85.29 -0.01 8.85 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.05 2.5 . . . . 0.0 110.989 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.4 m-70 -142.32 177.75 8.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.325 -0.86 . . . . 0.0 109.634 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -103.79 141.51 35.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.591 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.74 HG23 ' CB ' ' A' ' 58' ' ' GLU . 52.2 mt -81.83 130.43 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -94.6 -50.5 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.747 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.4 m -125.77 177.93 5.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.33 -29.46 73.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.97 72.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.74 ' CB ' HG23 ' A' ' 53' ' ' ILE . 2.7 mt-10 -73.34 -25.78 60.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.674 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -89.46 -28.38 19.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.454 -0.779 . . . . 0.0 109.644 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -77.04 -35.63 56.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.735 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -60.25 -23.27 63.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.588 -0.695 . . . . 0.0 110.031 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 45' ' ' VAL . 78.9 mt -60.76 143.54 90.86 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.13 107.45 2.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.972 2.448 . . . . 0.0 110.251 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.49 -29.05 3.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 70' ' ' ALA . 29.1 t -89.82 138.8 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.984 . . . . 0.0 109.479 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.11 -136.67 7.98 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -98.81 -28.35 13.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.976 . . . . 0.0 109.657 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -66.13 -66.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.568 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.078 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.3 mm -61.43 -45.11 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.598 -0.689 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.64 -34.31 71.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.54 -41.41 97.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.575 -0.703 . . . . 0.0 109.451 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.417 ' NZ ' HD12 ' A' ' 85' ' ' LEU . 2.7 mmtm -62.45 -29.64 70.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.681 -0.637 . . . . 0.0 109.366 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.674 HG21 ' HB2' ' A' ' 59' ' ' ALA . 46.9 mm -63.6 -46.87 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.719 . . . . 0.0 109.061 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.41 -32.37 66.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.518 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -67.33 -29.85 69.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -73.18 -50.53 22.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.569 0.7 . . . . 0.0 109.428 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.95 -27.62 61.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 122.043 -0.41 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -79.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.763 . . . . 0.0 109.531 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m -130.06 -65.09 0.84 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.81 59.96 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -126.75 94.72 4.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.973 . . . . 0.0 109.53 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 82' ' ' LEU . 4.3 mm? -86.69 79.34 8.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -87.4 -73.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 109.548 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -169.98 146.44 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.497 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD12 ' NZ ' ' A' ' 72' ' ' LYS . 68.9 mt -143.37 119.48 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.568 -0.708 . . . . 0.0 109.441 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -41.15 12.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.462 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -145.43 139.76 27.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.13 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.559 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.66 161.22 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.455 -0.778 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -77.24 170.48 16.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.3 Cg_endo -86.04 80.88 1.72 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.407 2.738 . . . . 0.0 110.427 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -86.39 85.13 7.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.23 128.89 40.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.8 p -111.31 65.4 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.508 -0.745 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 11' ' ' LEU . 3.6 mm? -110.1 -71.34 0.77 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.516 -0.74 . . . . 0.0 109.472 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.588 ' HB3' HD12 ' A' ' 15' ' ' ILE . 2.9 m-20 -107.27 41.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.602 -0.686 . . . . 0.0 109.463 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.04 0.13 84.11 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.04 -42.31 5.03 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.858 HG22 ' CD1' ' A' ' 19' ' ' LEU . 5.3 mt -66.5 -58.19 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.96 -0.73 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.1 t -52.6 -31.04 34.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.731 -0.606 . . . . 0.0 110.384 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -63.83 -30.38 71.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.496 -0.752 . . . . 0.0 109.529 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.5 ' O ' HD23 ' A' ' 22' ' ' LEU . 4.8 ttm -90.31 -21.39 22.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.888 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.858 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.3 mp -87.29 -33.95 19.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 16' ' ' THR . 58.3 t -75.8 -35.78 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -65.46 -60.99 2.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.375 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.943 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.7 pp -61.53 -33.66 74.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 109.151 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.88 -41.65 62.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 109.507 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.05 -36.96 85.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.0 t80 -63.87 -23.2 67.26 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.8 mm-40 -77.01 -57.12 4.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 46.7 tttm -68.27 -40.29 81.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.488 -0.757 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -25.53 61.29 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.481 -0.762 . . . . 0.0 109.696 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 25' ' ' PHE . 62.6 t -89.31 164.29 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.14 -70.08 0.49 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.955 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -84.77 62.19 7.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.445 -0.785 . . . . 0.0 110.458 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 53.91 0.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.862 . . . . 0.0 109.684 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.27 -29.71 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.785 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.73 -48.37 74.86 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.37 -22.77 62.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.591 -0.693 . . . . 0.0 109.411 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 25.7 t80 -55.64 -67.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.271 -0.893 . . . . 0.0 109.741 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -55.82 -23.13 28.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.479 -0.763 . . . . 0.0 110.038 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.025 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.47 -63.62 1.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.286 -0.884 . . . . 0.0 109.88 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 22' ' ' LEU . 64.3 m-85 -79.17 -26.8 42.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.024 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -37.86 88.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.319 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -48.28 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.721 -0.612 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.766 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.56 -27.65 69.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.604 -0.685 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.04 57.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.494 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -72.45 -44.11 62.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 109.861 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.752 HG11 HG23 ' A' ' 65' ' ' VAL . 8.1 p -66.03 -36.66 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.455 -0.778 . . . . 0.0 109.766 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.626 HG13 HG13 ' A' ' 45' ' ' VAL . 77.4 mt -84.08 -26.51 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.73 -26.25 21.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -97.9 20.35 12.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.445 -0.785 . . . . 0.0 109.856 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.479 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 6.3 t80 -95.14 137.67 22.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.38 12.4 3.02 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.113 2.542 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.3 m-70 -148.28 -171.58 3.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.527 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -124.96 149.91 47.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.585 -0.697 . . . . 0.0 109.52 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 58' ' ' GLU . 9.8 pt -101.42 158.02 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.53 -0.731 . . . . 0.0 109.506 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -114.01 -32.23 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.712 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -118.46 167.61 11.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.86 -30.58 70.23 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.59 70.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.498 ' HB3' HG22 ' A' ' 53' ' ' ILE . 29.3 mt-10 -68.16 -24.46 64.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.672 -0.642 . . . . 0.0 109.716 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.744 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -80.86 -31.13 35.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HG3' ' HB1' ' A' ' 70' ' ' ALA . 23.2 mttt -73.98 -40.68 62.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.738 . . . . 0.0 110.122 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -59.26 -27.24 65.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.533 -0.729 . . . . 0.0 110.142 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 59' ' ' ALA . 9.9 mt -72.0 149.12 92.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.22 118.54 4.71 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.092 2.528 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.91 -25.69 5.77 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.752 HG23 HG11 ' A' ' 45' ' ' VAL . 38.4 t -89.8 139.71 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -1.018 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -106.16 -150.72 18.6 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -99.55 -29.22 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.612 -0.934 . . . . 0.0 109.612 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -77.26 -59.34 2.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.592 -0.692 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.025 HD11 ' HB1' ' A' ' 38' ' ' ALA . 46.2 mm -62.04 -32.54 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.69 . . . . 0.0 109.457 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -61.19 -38.64 87.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 109.126 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -61.41 -38.93 88.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -62.37 -30.69 71.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.6 mm -63.53 -44.5 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.76 -40.59 72.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.55 -0.719 . . . . 0.0 109.797 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.38 -51.95 45.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.513 0.673 . . . . 0.0 109.278 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.23 -24.08 60.44 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.952 -0.467 . . . . 0.0 110.058 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.63 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 109.731 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 80' ' ' GLY . 3.5 t -130.21 -43.73 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.0 109.619 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 79' ' ' THR . . . 113.14 35.37 1.65 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HE2' HG21 ' A' ' 79' ' ' THR . 40.7 mtmt -100.99 128.73 46.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.907 . . . . 0.0 109.407 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.13 60.62 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.682 . . . . 0.0 109.424 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -99.97 141.52 32.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.466 -0.771 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -163.98 156.73 17.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.492 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.498 ' N ' HD22 ' A' ' 85' ' ' LEU . 4.4 mm? -83.16 127.38 33.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.417 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.77 -49.83 6.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.455 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? 59.8 83.29 0.14 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 109.746 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 63.22 -82.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.715 -0.616 . . . . 0.0 109.682 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -116.16 134.84 54.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 109.45 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -76.01 167.42 36.88 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.4 Cg_endo -86.3 67.72 4.87 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.451 2.768 . . . . 0.0 110.457 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -67.68 -48.14 67.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -119.9 94.0 4.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 p -129.97 -57.91 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.715 . . . . 0.0 109.498 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HA ' HD13 ' A' ' 11' ' ' LEU . 3.8 mm? -109.89 -74.41 0.65 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.504 -0.747 . . . . 0.0 109.443 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' O ' HG22 ' A' ' 16' ' ' THR . 28.6 m-20 -112.42 58.66 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.735 . . . . 0.0 109.31 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.04 -0.09 78.13 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.59 -41.47 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.796 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.72 -57.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.902 -0.763 . . . . 0.0 109.166 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.0 t -52.93 -33.93 52.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.739 -0.601 . . . . 0.0 110.472 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.98 -32.41 72.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.2 tpt -86.74 -20.55 27.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.796 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -86.21 -37.64 18.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 16' ' ' THR . 48.7 t -67.58 -39.59 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.99 -60.18 3.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.742 . . . . 0.0 109.638 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.011 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.0 pp -62.31 -34.07 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 109.239 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.45 -42.32 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.535 -0.728 . . . . 0.0 109.739 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -63.66 -43.81 95.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' O ' HG23 ' A' ' 29' ' ' VAL . 72.6 t80 -49.0 -30.81 6.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.745 -0.597 . . . . 0.0 110.709 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.744 ' OE1' HD12 ' A' ' 22' ' ' LEU . 3.5 mp0 -79.91 -44.23 20.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.066 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -70.26 -49.89 45.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.937 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -14.91 49.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.0 110.239 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 25' ' ' PHE . 36.1 t -87.74 164.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.419 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -73.76 -70.54 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.0 111.531 -177.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -90.63 66.98 6.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 0.0 111.183 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.71 56.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -102.96 -22.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.131 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.6 p-80 -76.16 -47.14 25.33 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -72.89 -24.67 60.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.533 -0.729 . . . . 0.0 109.044 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -58.02 -49.17 77.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.44 -0.787 . . . . 0.0 109.053 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.57 -25.26 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.605 -0.684 . . . . 0.0 109.48 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.022 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.48 -62.92 1.36 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.327 -0.858 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.011 ' CG ' HD11 ' A' ' 22' ' ' LEU . 80.6 m-85 -76.71 -25.21 53.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 110.847 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -74.27 -37.03 63.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.309 -0.869 . . . . 0.0 109.012 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -76.8 -31.65 57.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.372 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.775 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -85.49 -26.66 26.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -27.93 61.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.617 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -81.56 -45.78 15.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 109.937 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.895 HG11 HG23 ' A' ' 65' ' ' VAL . 7.2 p -63.88 -34.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.464 -0.772 . . . . 0.0 109.756 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.616 HG13 HG13 ' A' ' 45' ' ' VAL . 69.6 mt -85.11 -28.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -88.5 -21.84 23.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.429 -0.794 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -104.35 22.14 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 109.743 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.4 t80 -94.65 142.9 25.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 109.004 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.4 Cg_endo -86.5 9.21 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.077 2.518 . . . . 0.0 110.991 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.8 m-70 -146.66 178.69 8.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.216 -0.927 . . . . 0.0 109.56 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -98.52 174.42 6.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.537 -0.727 . . . . 0.0 109.705 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 58' ' ' GLU . 60.8 mt -132.75 106.33 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.664 -0.648 . . . . 0.0 109.42 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.83 34.26 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -165.99 139.81 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 109.402 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.87 -40.37 95.45 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.88 -30.42 71.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.97 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 53' ' ' ILE . 6.0 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.786 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -81.92 -30.53 31.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 3.8 tmtt? -74.72 -38.67 62.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.582 -0.698 . . . . 0.0 110.012 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -59.84 -25.89 65.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.143 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 59' ' ' ALA . 11.1 mt -71.01 152.23 94.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 109.447 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.53 105.99 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 123.073 2.516 . . . . 0.0 110.289 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 -30.82 2.31 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.895 HG23 HG11 ' A' ' 45' ' ' VAL . 33.9 t -90.13 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -108.87 -147.67 12.5 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -98.55 -29.73 12.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 109.61 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.16 -58.63 3.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.022 HD11 ' HB1' ' A' ' 38' ' ' ALA . 45.9 mm -61.82 -34.79 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.738 . . . . 0.0 109.626 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -59.97 -41.35 91.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -60.55 -37.03 79.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.649 -0.657 . . . . 0.0 109.46 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.94 -31.4 72.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.367 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 59' ' ' ALA . 48.8 mm -63.8 -46.16 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.89 -39.61 68.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.448 -0.782 . . . . 0.0 109.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.98 -31.85 73.19 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -52.56 37.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.573 0.702 . . . . 0.0 109.326 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.77 -23.15 60.77 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.87 -0.519 . . . . 0.0 110.11 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -0.807 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.29 -46.78 3.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 109.374 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.9 -53.6 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -170.04 -173.3 1.51 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.673 -0.898 . . . . 0.0 109.405 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.8 -179.91 4.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 109.572 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -95.75 164.77 12.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.503 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -115.76 -174.77 2.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.677 . . . . 0.0 109.378 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -91.56 75.29 5.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.426 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.55 -28.0 63.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.726 . . . . 0.0 109.664 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.476 179.961 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -101.61 135.03 43.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.517 -0.739 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -64.14 151.56 42.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.539 -0.726 . . . . 0.0 109.479 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -128.08 -177.82 4.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 109.453 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -83.51 167.2 30.11 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.534 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.2 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.476 2.784 . . . . 0.0 110.554 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -87.72 82.1 7.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.554 -0.716 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -105.08 82.04 1.8 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.426 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -130.08 -44.17 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.708 . . . . 0.0 109.585 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 52' ' ' LYS . 52.6 mt -84.31 -70.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 109.588 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -151.25 35.5 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.522 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.15 0.04 83.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.76 -34.85 7.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.857 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.6 mp -64.94 -47.09 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.023 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.9 t -56.57 -31.43 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 109.862 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -65.0 -28.41 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.542 -0.724 . . . . 0.0 109.486 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mmt -89.9 -20.98 22.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -85.67 -33.89 21.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 16' ' ' THR . 48.2 t -76.33 -33.05 22.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.21 -61.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.984 HD11 ' CG ' ' A' ' 39' ' ' TYR . 4.2 pp -62.54 -32.06 72.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.23 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.61 -45.85 66.74 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.485 -0.759 . . . . 0.0 109.68 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -63.79 -35.76 81.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.2 t80 -61.19 -26.04 67.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.758 -0.589 . . . . 0.0 109.935 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 18.5 mm-40 -79.88 -55.39 5.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.0 109.153 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.79 -42.94 99.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 109.423 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.73 -25.1 64.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.416 -0.803 . . . . 0.0 109.455 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 25' ' ' PHE . 50.0 t -89.07 164.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -77.5 -69.32 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.466 -0.771 . . . . 0.0 111.297 -178.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -85.29 62.13 7.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.95 55.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.58 -29.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.405 -0.809 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.2 p-80 -65.36 -48.81 71.66 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.59 -23.01 62.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 109.462 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 24.7 t80 -55.25 -66.5 0.4 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 109.557 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.69 -24.27 21.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.451 -0.78 . . . . 0.0 109.923 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.699 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -55.19 -55.14 34.57 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.422 -0.799 . . . . 0.0 109.874 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.984 ' CG ' HD11 ' A' ' 22' ' ' LEU . 62.5 m-85 -89.97 -26.4 20.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.594 -0.691 . . . . 0.0 110.11 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -39.29 93.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.793 . . . . 0.0 109.109 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -85.83 -41.89 14.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.776 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -65.57 -29.04 69.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.537 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.49 31.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.681 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -68.23 -48.95 63.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 109.898 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.7 p -64.8 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.0 109.822 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.585 HG13 HG13 ' A' ' 45' ' ' VAL . 66.2 mt -77.19 -27.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.469 -0.769 . . . . 0.0 109.937 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.473 -0.767 . . . . 0.0 110.072 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -120.26 27.05 8.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.7 t80 -82.49 139.92 44.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.5 Cg_endo -85.88 10.64 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.096 2.531 . . . . 0.0 111.317 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.9 m-70 -146.61 169.0 19.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.681 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HB3' HD22 ' A' ' 11' ' ' LEU . 5.2 pttm -96.44 148.57 22.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 58' ' ' GLU . 57.2 mt -97.86 104.39 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -87.57 -40.87 13.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.656 -0.652 . . . . 0.0 109.565 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -112.38 155.37 24.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.734 . . . . 0.0 109.597 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.53 -27.57 66.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.91 71.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.431 -1.04 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.748 ' CB ' HG23 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -63.72 -25.59 68.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.723 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.35 -26.63 26.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 109.846 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.97 -40.93 62.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.504 -0.748 . . . . 0.0 109.674 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -25.13 66.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 110.002 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.829 ' HB3' HG21 ' A' ' 45' ' ' VAL . 91.4 mt -58.46 137.72 85.57 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 109.928 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -80.85 109.74 2.26 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.055 2.503 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.78 -24.47 5.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 42' ' ' ALA . 22.9 t -89.5 137.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.41 -1.053 . . . . 0.0 109.372 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -95.5 -147.97 23.47 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.9 p -98.98 -28.96 13.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.923 . . . . 0.0 109.696 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -65.41 -65.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.776 HG21 ' CB ' ' A' ' 42' ' ' ALA . 50.0 mm -62.08 -39.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.747 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -57.97 -42.99 86.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.25 -35.15 76.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.566 -0.709 . . . . 0.0 109.395 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -65.69 -31.09 71.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 109.258 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.63 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.3 mm -62.83 -44.76 99.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -57.47 -38.56 74.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.464 -0.772 . . . . 0.0 109.518 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.21 -27.14 69.15 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -49.61 31.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -73.84 -42.46 60.8 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.899 -0.501 . . . . 0.0 110.17 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -80.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.432 -0.793 . . . . 0.0 109.795 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.22 -70.14 0.67 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.0 53.3 0.7 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.98 87.97 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.999 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.4 tp -111.58 94.15 4.82 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -99.99 -67.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.717 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.426 ' C ' HD12 ' A' ' 85' ' ' LEU . 6.7 mptt -146.52 82.68 1.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.374 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 84' ' ' LYS . 4.1 mp -137.72 125.81 22.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.61 -0.681 . . . . 0.0 109.47 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -91.35 -49.98 6.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.647 -0.658 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 pttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.496 179.97 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -104.73 -44.12 4.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -146.5 81.11 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mttt 59.64 83.04 0.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.488 -0.757 . . . . 0.0 109.763 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 111.74 4.87 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.71 -25.83 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.095 2.53 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -63.37 136.0 57.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.734 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.4 -169.51 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 t -123.3 31.58 5.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.682 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -75.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.55 ' O ' HG22 ' A' ' 16' ' ' THR . 2.5 m120 -100.06 65.25 1.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.21 0.94 79.17 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.55 -48.6 3.18 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 15' ' ' ILE . 2.8 mp -66.87 -52.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.858 -0.79 . . . . 0.0 109.675 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 12' ' ' ASN . 5.1 t -57.91 -28.37 64.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 110.037 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.14 -38.26 88.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.73 . . . . 0.0 109.273 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.3 mmt -87.33 -10.18 52.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 110.184 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.676 HD23 ' HD2' ' A' ' 39' ' ' TYR . 4.2 mt -87.86 -35.88 17.51 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 16' ' ' THR . 43.1 t -78.33 -31.09 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -69.55 -60.24 2.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.599 -0.688 . . . . 0.0 109.719 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.2 pp -63.15 -34.8 78.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.21 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.79 -40.78 60.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.569 -0.707 . . . . 0.0 109.647 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -63.86 -38.91 92.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 29' ' ' VAL . 44.6 t80 -62.11 -22.31 65.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.635 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.5 mm-40 -75.47 -59.07 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.823 . . . . 0.0 109.038 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -67.48 -40.09 85.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.89 -24.7 58.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.35 -0.844 . . . . 0.0 109.688 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 25' ' ' PHE . 53.3 t -89.4 164.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.14 -70.15 0.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -178.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -88.06 67.61 8.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 0.0 110.296 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.71 40.27 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.33 -27.21 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.474 -0.766 . . . . 0.0 109.359 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 5.0 p-80 -68.47 -50.89 49.06 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -67.59 -25.89 66.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.51 -0.744 . . . . 0.0 109.242 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -53.31 -64.29 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.24 -0.912 . . . . 0.0 109.615 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -55.12 -25.46 31.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -57.75 -65.9 0.56 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.382 -0.824 . . . . 0.0 109.79 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.01 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.4 m-85 -72.34 -27.38 62.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.747 -0.596 . . . . 0.0 110.119 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -63.49 -46.1 87.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.447 -0.783 . . . . 0.0 109.393 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -65.85 -46.21 79.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 109.485 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.787 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.54 -48.34 77.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.422 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -55.14 -23.29 20.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -77.13 -59.84 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.781 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.9 p -63.47 -44.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.47 -0.769 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.494 HG21 ' HB ' ' A' ' 15' ' ' ILE . 50.3 mm -63.18 -28.41 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.369 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.02 -18.7 25.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -116.31 26.8 9.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 3.3 t80 -88.55 135.66 32.25 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.511 -0.743 . . . . 0.0 109.023 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.4 Cg_endo -85.55 10.41 3.72 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 123.148 2.565 . . . . 0.0 111.58 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.417 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 67.5 m-70 -148.82 -174.95 4.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.083 -1.011 . . . . 0.0 109.721 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 176.33 5.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.597 -0.689 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.535 HG22 ' HB3' ' A' ' 58' ' ' GLU . 32.7 pt -136.85 141.46 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.632 -0.668 . . . . 0.0 109.552 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -121.83 25.99 8.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.654 -0.654 . . . . 0.0 109.646 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -170.41 150.59 3.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.788 . . . . 0.0 109.356 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -28.94 68.16 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.4 85.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HB3' HG22 ' A' ' 53' ' ' ILE . 1.1 mp0 -64.51 -20.39 66.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.63 -0.669 . . . . 0.0 109.918 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -88.0 -25.14 23.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.348 -0.845 . . . . 0.0 109.883 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -73.38 -41.0 63.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 109.735 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.23 -26.42 66.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.461 -0.775 . . . . 0.0 109.939 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.781 ' HB3' HG21 ' A' ' 45' ' ' VAL . 93.4 mt -55.95 134.65 73.54 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.71 102.55 1.4 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.931 2.42 . . . . 0.0 109.986 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.43 -26.26 2.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.647 HG23 HG11 ' A' ' 45' ' ' VAL . 24.0 t -89.38 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -1.052 . . . . 0.0 109.218 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.79 -156.54 25.35 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -87.96 -7.37 57.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.667 -0.902 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -90.21 -63.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.787 HG21 ' CB ' ' A' ' 42' ' ' ALA . 46.9 mm -67.26 -34.57 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.775 . . . . 0.0 110.445 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -56.76 -55.8 29.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.309 -0.869 . . . . 0.0 109.917 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -59.84 -31.49 69.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 109.512 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -59.96 -43.86 94.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 0.0 109.418 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.556 HD12 ' HB1' ' A' ' 59' ' ' ALA . 65.1 mt -64.1 -29.91 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -56.04 -43.79 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.224 -0.922 . . . . 0.0 108.964 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -31.01 71.74 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -43.08 96.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.551 HD23 HG22 ' A' ' 73' ' ' ILE . 4.0 mm? -83.45 -24.89 31.63 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.086 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.428 -0.795 . . . . 0.0 109.786 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.6 m -110.71 -58.48 2.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.77 -49.68 0.92 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -158.68 -59.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.665 -0.903 . . . . 0.0 109.508 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.8 -173.79 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.438 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -77.34 97.31 4.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.566 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -134.86 160.7 37.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.488 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.45 124.53 13.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -72.06 162.5 29.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.711 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mttm . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.465 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -71.24 153.1 42.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 60.16 87.47 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.716 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -125.57 -43.63 1.88 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.484 -0.76 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -89.19 165.61 25.55 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.1 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.466 2.777 . . . . 0.0 110.511 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -88.55 -173.5 4.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.96 38.57 1.9 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.593 -0.692 . . . . 0.0 109.492 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.2 p -97.43 178.04 5.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.57 -0.706 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 52' ' ' LYS . 12.1 mt -75.74 -170.0 1.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.705 . . . . 0.0 109.497 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.659 ' HB3' HG22 ' A' ' 46' ' ' ILE . 4.5 m120 60.51 40.2 17.27 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.461 -0.774 . . . . 0.0 109.568 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.01 -10.37 64.64 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.07 -39.0 5.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.672 HG22 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -68.91 -50.7 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.88 -0.776 . . . . 0.0 108.952 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.8 t -59.36 -29.52 67.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.748 -0.595 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.69 -34.58 77.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.629 -0.669 . . . . 0.0 109.22 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.478 ' O ' HD23 ' A' ' 22' ' ' LEU . 35.8 mmm -89.61 -17.17 28.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.127 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.672 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -87.86 -35.63 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 108.489 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 16' ' ' THR . 46.6 t -78.58 -30.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.08 -60.52 2.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.724 . . . . 0.0 109.76 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.991 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.7 pp -62.87 -34.15 76.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.22 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.29 -44.15 61.8 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.626 -0.671 . . . . 0.0 109.917 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.34 -36.65 84.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.9 t80 -63.72 -23.07 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.895 -0.503 . . . . 0.0 109.682 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.2 mm-40 -77.31 -57.74 3.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.346 -0.847 . . . . 0.0 109.106 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -67.01 -40.41 87.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.537 -0.727 . . . . 0.0 109.553 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -58.12 -25.59 61.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.433 -0.792 . . . . 0.0 109.659 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.6 t -89.47 164.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.438 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.25 -69.77 0.51 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.485 -0.759 . . . . 0.0 110.937 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -85.32 62.15 7.31 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.84 47.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -96.34 -28.6 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.0 109.378 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 5.3 p-80 -64.59 -48.55 74.54 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.49 -25.78 64.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.616 -0.678 . . . . 0.0 109.347 179.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.0 t80 -52.48 -60.72 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.304 -0.872 . . . . 0.0 109.796 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.83 -26.88 64.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.029 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.91 -65.22 0.65 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.411 -0.806 . . . . 0.0 109.77 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.991 ' CG ' HD11 ' A' ' 22' ' ' LEU . 62.4 m-85 -76.38 -26.15 55.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.675 -0.641 . . . . 0.0 110.082 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -63.72 -52.11 61.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.466 -0.771 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.68 -45.69 81.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.772 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.98 -37.04 85.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -64.44 -25.52 68.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.918 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.26 -50.79 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 110.016 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 65' ' ' VAL . 7.7 p -62.79 -34.05 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.659 HG22 ' HB3' ' A' ' 12' ' ' ASN . 74.4 mt -83.34 -41.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -79.23 -17.59 54.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.328 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.21 23.37 14.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.789 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.58 ' CE1' HD22 ' A' ' 62' ' ' LEU . 2.6 t80 -94.66 144.9 28.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.9 Cg_endo -86.43 4.82 6.2 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 123.128 2.552 . . . . 0.0 110.846 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 64.6 m-70 -146.61 -175.38 4.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HG3' HD13 ' A' ' 11' ' ' LEU . 17.1 mtpp -105.38 160.56 15.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.564 -0.71 . . . . 0.0 109.67 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.766 HG23 ' HB3' ' A' ' 58' ' ' GLU . 52.7 mt -101.71 131.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -77.89 -65.3 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.533 -0.729 . . . . 0.0 109.719 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 p -114.26 174.97 5.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.43 83.73 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -34.28 76.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.946 . . . . 0.0 109.308 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.766 ' HB3' HG23 ' A' ' 53' ' ' ILE . 2.0 mt-10 -67.13 -23.28 65.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.677 . . . . 0.0 109.716 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' ' 53' ' ' ILE . . . -84.76 -28.69 26.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.428 -0.795 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 8.1 tmtt? -74.49 -38.64 62.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -59.59 -26.44 65.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.755 . . . . 0.0 110.075 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.58 HD22 ' CE1' ' A' ' 49' ' ' TYR . 53.7 mt -71.65 150.2 93.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.74 106.31 2.17 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.024 2.483 . . . . 0.0 110.313 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.35 -29.44 2.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 45' ' ' VAL . 36.0 t -89.72 146.0 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -1.004 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.72 -145.77 15.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.4 p -100.15 -39.79 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.895 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -73.43 -44.66 57.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.635 -0.666 . . . . 0.0 109.725 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.029 HD11 ' HB1' ' A' ' 38' ' ' ALA . 43.8 mm -69.62 -38.6 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 60' ' ' LYS . . . -59.64 -41.66 91.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.64 -38.54 85.13 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.481 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -62.28 -30.22 70.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.604 -0.685 . . . . 0.0 109.368 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.0 mm -64.32 -45.51 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -54.84 -40.65 69.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HG3' HD23 ' A' ' 82' ' ' LEU . 2.0 mp0 -63.49 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -53.16 36.68 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.509 0.671 . . . . 0.0 109.308 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.56 -22.3 61.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.948 -0.47 . . . . 0.0 110.14 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.08 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 80' ' ' GLY . 3.2 t -126.48 -42.32 1.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.406 -0.809 . . . . 0.0 109.623 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.448 ' N ' HG23 ' A' ' 79' ' ' THR . . . 143.29 -46.48 0.84 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.4 tttt -132.33 79.3 1.85 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 109.554 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD21 ' HE2' ' A' ' 84' ' ' LYS . 29.6 tp -113.05 93.95 4.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -74.92 138.62 42.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.493 ' HE2' HD21 ' A' ' 82' ' ' LEU . 21.6 mtmt -165.07 97.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.705 . . . . 0.0 109.396 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.494 ' N ' HD22 ' A' ' 85' ' ' LEU . 4.4 mm? -70.27 -73.99 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.422 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -109.54 158.83 17.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 pttp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.471 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -159.48 94.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.685 . . . . 0.0 109.436 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -158.26 30.84 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.568 -0.708 . . . . 0.0 109.435 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -79.68 147.24 32.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.591 -0.693 . . . . 0.0 109.506 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -65.75 168.42 8.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.723 . . . . 0.0 109.455 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.0 Cg_endo -86.55 123.75 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.498 2.799 . . . . 0.0 110.483 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -166.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -79.07 155.81 28.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.606 -0.683 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.3 p -99.87 -175.83 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.595 -0.691 . . . . 0.0 109.455 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.25 -69.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.811 ' HB2' HD12 ' A' ' 15' ' ' ILE . 29.1 p30 -76.0 73.74 2.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.643 -0.661 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.19 0.96 79.26 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.71 -32.76 8.93 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.82 HG22 ' CD1' ' A' ' 19' ' ' LEU . 16.6 mt -74.89 -59.08 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.764 -0.845 . . . . 0.0 109.334 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.4 t -51.8 -32.41 31.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.756 -0.59 . . . . 0.0 110.553 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.46 -26.21 64.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.593 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.8 mtp -90.02 -21.32 22.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.956 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.82 ' CD1' HG22 ' A' ' 15' ' ' ILE . 1.4 mp -88.65 -33.89 17.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 16' ' ' THR . 54.5 t -76.25 -34.75 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -68.34 -60.2 2.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.656 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.981 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.8 pp -60.82 -35.2 75.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 109.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -50.68 -42.1 56.48 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.666 -0.646 . . . . 0.0 109.739 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.16 -36.12 83.02 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.5 t80 -65.69 -24.77 67.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.888 -0.507 . . . . 0.0 109.676 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.1 mm-40 -75.8 -57.79 3.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -66.14 -41.94 89.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.0 109.58 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -57.3 -24.7 56.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.4 -0.813 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 25' ' ' PHE . 55.6 t -89.66 164.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.6 t -77.19 -70.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.526 -0.734 . . . . 0.0 110.876 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -85.05 66.75 9.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.471 -0.768 . . . . 0.0 110.734 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.63 29.18 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -81.89 -21.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.59 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.439 ' CD2' ' HE2' ' A' ' 35' ' ' LYS . 6.4 p-80 -76.09 -49.85 16.28 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -67.62 -26.46 66.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.57 -51.62 67.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.03 -28.13 68.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 0.0 109.532 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.021 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.46 -62.32 1.8 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.981 ' CG ' HD11 ' A' ' 22' ' ' LEU . 66.0 m-85 -78.5 -1.42 33.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.912 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 -87.14 -36.27 18.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -81.1 -46.62 14.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.756 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -63.45 -42.78 98.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.589 -0.695 . . . . 0.0 109.391 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -68.86 -26.06 64.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.639 -0.663 . . . . 0.0 109.762 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -80.57 -28.93 37.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.783 . . . . 0.0 109.906 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 62' ' ' LEU . 14.5 p -90.0 -44.71 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.417 -0.802 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 53' ' ' ILE . 67.7 mt -69.71 -52.27 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 109.587 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.651 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -60.65 -21.08 62.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -118.1 28.74 8.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.518 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.0 t80 -89.56 145.68 34.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 42.0 Cg_endo -85.97 2.11 7.64 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.101 2.534 . . . . 0.0 110.979 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.412 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 65.2 m-70 -144.06 -179.35 6.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -105.93 139.68 40.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.717 HG23 ' CB ' ' A' ' 58' ' ' GLU . 60.0 mt -77.12 106.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.605 -0.684 . . . . 0.0 109.356 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.8 mttt -72.36 -69.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.55 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -102.53 174.65 5.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.556 -0.715 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.36 -28.96 71.87 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.86 -30.38 70.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -1.008 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.717 ' CB ' HG23 ' A' ' 53' ' ' ILE . 1.1 mp0 -67.28 -27.61 67.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.651 -0.655 . . . . 0.0 109.628 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.765 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -86.92 -28.85 22.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.631 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -75.57 -39.04 58.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.475 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -60.51 -24.16 65.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.502 -0.749 . . . . 0.0 110.039 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.806 ' HB3' HG21 ' A' ' 45' ' ' VAL . 81.7 mt -60.84 140.92 93.32 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.426 -0.796 . . . . 0.0 109.545 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.29 107.18 1.99 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.983 2.456 . . . . 0.0 110.14 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.87 -25.38 4.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 70' ' ' ALA . 29.8 t -89.55 138.52 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.978 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.26 -139.65 9.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.39 -29.49 12.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.94 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -67.42 -64.6 0.82 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.021 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.2 mm -61.42 -41.97 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 0.0 109.789 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -59.64 -35.35 74.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.543 -0.723 . . . . 0.0 109.658 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.72 -41.59 95.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.511 -0.743 . . . . 0.0 109.516 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -62.04 -30.4 70.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.615 -0.678 . . . . 0.0 109.31 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.7 mm -63.16 -47.23 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.11 -31.54 65.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.581 -0.7 . . . . 0.0 109.606 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.7 -30.67 70.23 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -74.2 -50.79 17.69 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.582 0.705 . . . . 0.0 109.592 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.33 -27.42 62.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.908 -0.495 . . . . 0.0 109.95 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.44 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.81 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -104.83 -62.05 1.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.45 -48.27 0.86 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -146.92 -172.98 4.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.941 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 82' ' ' LEU . 1.2 pp -158.49 45.47 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.567 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -62.89 148.41 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.575 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -105.82 -173.71 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.718 . . . . 0.0 109.424 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 mt -113.6 -59.92 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.545 -0.722 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.0 -179.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.553 -0.717 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 118.058 -0.973 . . . . 0.0 109.55 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 118.56 27.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.659 -0.651 . . . . 0.0 109.469 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -130.1 89.57 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.678 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -172.9 36.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.588 -0.695 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -76.06 167.07 40.0 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.541 -0.724 . . . . 0.0 109.513 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.3 Cg_endo -86.38 145.55 8.29 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.511 2.807 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -89.28 116.83 27.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.642 -0.661 . . . . 0.0 109.415 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.5 151.89 28.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -129.95 33.15 4.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.567 -0.708 . . . . 0.0 109.519 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 52' ' ' LYS . 4.0 mm? -105.69 -74.05 0.66 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 109.366 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -131.06 41.53 3.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.66 -2.17 90.61 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.3 -41.49 5.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.508 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.0 mt -66.11 -50.56 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.893 -0.769 . . . . 0.0 109.072 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 5.1 t -58.08 -31.17 66.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.698 -0.626 . . . . 0.0 109.963 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.15 -36.03 76.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 109.381 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtt -87.54 -14.55 39.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.609 -0.682 . . . . 0.0 110.135 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -86.2 -42.55 13.72 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.12 -31.62 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.21 -64.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.977 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.1 pp -62.07 -33.73 74.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.11 -42.5 63.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.86 -36.51 84.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 54.0 t80 -63.73 -22.76 67.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.8 mm-40 -77.48 -57.63 3.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.099 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 71.6 tttt -67.79 -39.48 84.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.51 -0.743 . . . . 0.0 109.622 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.79 -25.7 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.403 -0.811 . . . . 0.0 109.605 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 62.0 t -89.36 164.33 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.88 -70.09 0.48 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 0.0 110.98 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -85.12 62.11 7.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 110.407 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.81 53.64 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -0.822 . . . . 0.0 109.68 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -100.18 -30.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.795 . . . . 0.0 109.105 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.451 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.0 p-80 -64.05 -48.43 76.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.66 -23.78 63.51 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.612 -0.68 . . . . 0.0 109.343 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 26.7 t80 -54.6 -67.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.22 -0.925 . . . . 0.0 109.694 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -54.74 -24.59 23.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 109.88 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.064 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.14 -65.36 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.977 ' CG ' HD11 ' A' ' 22' ' ' LEU . 58.2 m-85 -79.12 -29.31 43.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.587 -0.695 . . . . 0.0 109.851 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -65.36 -46.34 80.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.486 -0.759 . . . . 0.0 109.456 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -70.59 -40.57 73.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.499 -0.751 . . . . 0.0 109.661 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.719 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -68.88 -39.56 79.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.602 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -62.01 -28.17 69.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -70.84 -51.29 27.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.3 p -69.67 -44.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.487 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.2 mt -67.17 -29.45 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.448 -0.783 . . . . 0.0 109.971 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.402 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -90.05 -13.85 35.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.429 -0.795 . . . . 0.0 110.538 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -123.26 27.99 7.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.475 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.2 t80 -85.24 143.69 39.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.196 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.6 Cg_endo -86.24 3.87 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.052 2.502 . . . . 0.0 111.066 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.405 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.8 m-70 -145.01 -177.72 5.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.645 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.504 ' HB2' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -112.34 160.8 17.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.7 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 58' ' ' GLU . 24.6 pt -123.41 153.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 109.318 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -137.73 28.58 2.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.511 -0.743 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 t -170.3 151.52 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.02 -28.1 69.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.92 72.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.464 -1.021 . . . . 0.0 109.695 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 53' ' ' ILE . 2.6 mt-10 -73.66 -14.43 61.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.614 -0.679 . . . . 0.0 110.355 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -90.11 -29.72 18.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -29.52 55.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.555 -0.716 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HG21 ' A' ' 45' ' ' VAL . 80.9 mt -61.77 146.17 91.13 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.21 113.13 3.14 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.0 2.466 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.36 -28.54 5.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 70' ' ' ALA . 27.6 t -89.9 138.48 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -1.023 . . . . 0.0 109.392 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -139.75 9.23 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 t -98.87 -28.59 13.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.958 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -67.9 -65.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.47 -0.769 . . . . 0.0 109.503 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.064 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.5 mm -61.34 -41.67 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.828 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -58.05 -37.05 73.66 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.582 -0.699 . . . . 0.0 109.736 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -61.86 -40.38 95.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.48 -0.762 . . . . 0.0 109.526 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -62.79 -32.68 73.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.0 109.285 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.7 mm -64.14 -42.43 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.79 -40.83 73.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.487 -0.758 . . . . 0.0 109.732 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.54 ' HG2' HD21 ' A' ' 82' ' ' LEU . 1.6 mp0 -63.5 -29.62 70.86 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.43 -52.7 24.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.538 0.685 . . . . 0.0 109.37 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.23 -24.9 61.45 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.926 -0.484 . . . . 0.0 110.054 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -113.95 -53.0 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.71 -55.31 0.76 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -102.29 137.34 40.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.983 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.585 ' HA ' HD23 ' A' ' 85' ' ' LEU . 5.7 mt -92.84 80.42 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.513 -0.742 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -100.14 -62.51 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.616 -0.677 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -132.75 47.56 2.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.517 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 82' ' ' LEU . 4.4 mm? -70.08 133.7 47.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.53 -0.731 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -153.32 -176.77 5.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.603 -0.685 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.514 -179.922 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mttp 59.76 95.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -0.754 . . . . 0.0 109.763 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 59.55 -175.64 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.715 . . . . 0.0 109.726 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -132.58 150.02 52.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -71.96 172.83 6.32 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.685 . . . . 0.0 109.453 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 43.0 Cg_endo -86.5 -165.53 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.424 2.749 . . . . 0.0 110.521 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.06 161.99 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.502 -0.749 . . . . 0.0 109.477 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -138.15 40.04 2.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.7 p -110.62 37.45 2.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.518 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -66.86 -69.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -98.18 39.88 1.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.342 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.55 84.46 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.85 -33.82 8.1 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.589 HG22 ' CD1' ' A' ' 19' ' ' LEU . 1.6 mp -69.42 -42.1 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.879 -0.777 . . . . 0.0 109.245 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.4 t -60.73 -30.89 70.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.66 -0.65 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -39.23 93.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.711 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.6 mtm -83.04 -19.31 37.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.648 -0.658 . . . . 0.0 109.87 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -80.35 -37.54 32.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.416 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 16' ' ' THR . 50.8 t -71.67 -28.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -66.57 -68.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.12 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.788 HD11 ' CE1' ' A' ' 39' ' ' TYR . 2.3 pt? -57.55 -31.0 65.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.939 -1.1 . . . . 0.0 109.491 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.42 68.74 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 78.9 t80 -62.1 -25.47 67.73 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.616 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.5 mp0 -75.5 -57.66 3.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.557 -0.714 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -67.22 -41.61 85.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.556 -0.715 . . . . 0.0 109.524 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.07 -25.18 58.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' PHE . 53.4 t -89.53 164.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.446 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.1 t -78.02 -70.13 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.485 -0.759 . . . . 0.0 111.009 -178.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -82.93 61.63 6.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.77 45.34 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -27.76 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.464 ' CD2' ' HD3' ' A' ' 35' ' ' LYS . 6.1 p-80 -70.21 -49.86 45.85 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.79 -18.82 62.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.344 -0.848 . . . . 0.0 109.393 178.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 16.7 t80 -59.45 -63.9 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 108.933 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -55.08 -24.11 23.83 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.722 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.96 -65.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.788 ' CE1' HD11 ' A' ' 22' ' ' LEU . 34.5 m-85 -80.59 -31.07 36.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.854 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -62.0 -48.79 78.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.819 . . . . 0.0 109.814 -179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -72.8 -35.84 67.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 0.0 109.855 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.81 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -67.08 -49.91 63.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.472 -0.767 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -60.44 -26.47 66.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.47 -0.769 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -71.67 -58.88 3.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 62' ' ' LEU . 8.3 p -60.54 -43.44 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.482 ' N ' HG13 ' A' ' 45' ' ' VAL . 73.9 mt -68.17 -27.67 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 109.628 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.37 -25.46 29.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.825 . . . . 0.0 109.806 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -107.05 28.13 8.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.506 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 3.6 t80 -93.35 139.48 22.96 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.9 Cg_endo -86.23 11.54 3.28 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.104 2.536 . . . . 0.0 111.354 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.414 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.22 176.77 9.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -102.13 144.26 30.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.547 -0.72 . . . . 0.0 109.636 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.75 HG23 ' HB3' ' A' ' 58' ' ' GLU . 57.7 mt -82.67 122.1 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.622 -0.674 . . . . 0.0 109.223 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -81.02 -60.8 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -126.24 -179.96 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.19 -27.4 65.1 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.08 95.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -1.081 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.75 ' HB3' HG23 ' A' ' 53' ' ' ILE . 4.2 tt0 -61.7 -20.88 63.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.588 -0.695 . . . . 0.0 109.971 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -86.24 -24.86 25.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 109.895 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -70.34 -43.72 69.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.724 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -60.81 -28.72 68.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.773 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB3' HG21 ' A' ' 45' ' ' VAL . 97.4 mt -56.8 130.47 78.3 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.552 -0.717 . . . . 0.0 109.978 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.69 102.15 1.52 Allowed 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.833 2.356 . . . . 0.0 110.11 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.15 -27.74 1.85 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 t -89.57 138.3 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.545 -0.973 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.56 -143.76 13.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.0 t -98.64 -27.18 14.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.94 . . . . 0.0 109.694 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -82.26 -41.47 20.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.551 -0.718 . . . . 0.0 109.7 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.035 HD11 ' HB1' ' A' ' 38' ' ' ALA . 39.9 mm -72.37 -41.82 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.738 . . . . 0.0 109.884 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.94 71.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -0.811 . . . . 0.0 110.057 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.33 -32.62 68.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -64.73 -33.13 75.25 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.58 -42.8 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.54 -35.53 72.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.695 . . . . 0.0 109.372 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.64 -30.79 71.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -48.99 64.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.514 0.673 . . . . 0.0 109.2 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.7 mm? -74.33 -26.42 60.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.061 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -80.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 0.0 109.698 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 p -127.11 -62.32 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.67 60.14 0.24 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -136.92 165.14 26.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.511 -0.993 . . . . 0.0 109.524 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt -141.67 97.86 3.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.537 -0.727 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -100.09 89.25 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.6 pttt -170.07 137.96 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -142.6 30.73 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.482 -179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -138.46 151.36 47.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.569 -0.707 . . . . 0.0 109.464 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 169.41 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.597 -0.689 . . . . 0.0 109.479 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 68.88 -69.59 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.524 -0.735 . . . . 0.0 109.683 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -110.29 128.8 55.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.762 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 160.39 44.45 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.48 52.47 2.79 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.397 2.731 . . . . 0.0 110.557 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -91.06 20.09 5.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.582 -0.699 . . . . 0.0 110.454 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.569 ' OE1' HD23 ' A' ' 11' ' ' LEU . 3.5 mt-10 -158.57 152.63 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 t -112.63 36.13 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.569 HD23 ' OE1' ' A' ' 9' ' ' GLU . 1.2 mm? -76.11 -168.74 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.601 -0.687 . . . . 0.0 109.284 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.873 ' HB3' HD12 ' A' ' 15' ' ' ILE . 30.3 m-80 -70.06 77.12 0.5 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.703 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.25 1.06 79.25 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -35.33 7.25 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 12' ' ' ASN . 6.7 mt -74.71 -57.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.858 -0.789 . . . . 0.0 108.957 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.2 t -56.19 -30.85 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.962 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -32.72 74.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' HD23 ' A' ' 22' ' ' LEU . 9.9 mmm -88.74 -17.67 29.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.741 -0.6 . . . . 0.0 109.944 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' CD1' HG22 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -87.34 -35.37 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.528 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' THR . 46.0 t -78.59 -30.82 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -69.97 -59.73 2.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.661 -0.649 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.994 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.3 pp -63.24 -33.73 76.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.16 -41.51 62.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.484 -0.76 . . . . 0.0 109.537 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -64.87 -37.53 87.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.7 t80 -63.49 -24.05 67.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -74.12 -62.99 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.669 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 21.9 tttt -62.1 -41.95 98.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.876 -0.515 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -57.76 -23.94 54.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.772 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' PHE . 48.9 t -89.81 165.11 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 29' ' ' VAL . 45.4 t -76.01 -70.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.459 -0.776 . . . . 0.0 111.107 -178.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -88.69 67.73 8.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.815 . . . . 0.0 110.675 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -151.1 38.95 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 109.666 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -88.69 -25.59 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.718 . . . . 0.0 109.589 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.472 ' CD2' ' CD ' ' A' ' 35' ' ' LYS . 5.5 p-80 -69.99 -51.82 29.32 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.02 -19.34 63.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.739 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.2 t80 -57.15 -57.67 11.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.216 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.44 -26.77 66.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.655 -0.653 . . . . 0.0 109.469 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.848 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -53.98 -64.79 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.378 -0.826 . . . . 0.0 110.215 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.994 ' CG ' HD11 ' A' ' 22' ' ' LEU . 70.5 m-85 -74.01 -25.44 59.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 110.13 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -63.4 -47.73 80.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.357 -0.839 . . . . 0.0 109.316 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.42 -49.94 50.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.595 -0.691 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.751 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -61.95 -27.35 68.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 109.808 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -72.69 -28.22 62.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.938 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 p -84.81 -46.56 11.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.873 HG11 HG23 ' A' ' 65' ' ' VAL . 8.1 p -64.2 -35.57 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 110.109 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.6 HG13 HG13 ' A' ' 45' ' ' VAL . 66.8 mt -84.22 -37.05 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.951 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 16' ' ' THR . . . -82.61 -19.99 37.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.402 -0.811 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -104.72 21.52 16.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.301 -0.875 . . . . 0.0 110.014 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.528 ' CE1' HD22 ' A' ' 62' ' ' LEU . 3.9 t80 -94.07 140.81 23.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -86.32 9.96 3.83 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.015 2.476 . . . . 0.0 111.071 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.1 m-70 -147.18 -176.61 5.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.76 162.64 12.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.714 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.601 HG23 ' HB3' ' A' ' 58' ' ' GLU . 50.7 mt -107.52 144.76 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.616 -0.677 . . . . 0.0 109.195 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -91.6 -63.72 1.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 109.673 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.8 p -124.42 -179.86 4.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.502 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.24 -29.87 72.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -30.36 70.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.991 . . . . 0.0 109.491 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.601 ' HB3' HG23 ' A' ' 53' ' ' ILE . 5.1 mt-10 -81.13 -25.74 36.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.581 -0.699 . . . . 0.0 109.724 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -83.89 -33.62 24.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.477 -0.765 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.526 -0.734 . . . . 0.0 109.974 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -59.68 -25.62 64.9 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.427 -0.796 . . . . 0.0 110.208 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 59' ' ' ALA . 10.9 mt -70.8 152.01 95.16 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.491 -0.756 . . . . 0.0 109.464 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -77.94 103.02 1.64 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.106 2.538 . . . . 0.0 110.297 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.13 -30.4 2.02 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.873 HG23 HG11 ' A' ' 45' ' ' VAL . 38.2 t -89.98 140.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.588 -0.948 . . . . 0.0 109.44 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 70' ' ' ALA . . . -105.06 -146.64 15.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -99.47 -36.16 9.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.968 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.05 -60.2 2.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.848 HD11 ' HB1' ' A' ' 38' ' ' ALA . 46.8 mm -61.74 -36.54 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.535 -0.728 . . . . 0.0 109.728 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -57.83 -39.59 78.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -61.72 -39.6 92.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.093 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -62.58 -30.23 71.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.621 -0.674 . . . . 0.0 109.312 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 59' ' ' ALA . 49.5 mm -62.84 -45.13 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.63 -41.79 74.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.42 -28.75 70.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.13 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -52.47 18.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.378 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.26 -25.75 61.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.972 -0.455 . . . . 0.0 110.086 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.23 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 109.543 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.9 m -107.55 -60.78 1.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.74 56.6 4.1 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -144.12 35.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.547 -0.972 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.73 104.93 8.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.499 -0.751 . . . . 0.0 109.459 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.3 mtm-85 -99.32 -41.75 7.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -73.32 151.87 41.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 mt -105.52 168.14 9.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -111.0 141.24 44.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.663 . . . . 0.0 109.53 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.489 -179.973 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt 60.12 36.27 21.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.559 -0.713 . . . . 0.0 109.734 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -108.86 -30.96 7.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.82 -81.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.731 -0.606 . . . . 0.0 109.721 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.24 148.06 98.18 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 0.0 109.441 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.03 -26.84 1.35 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.203 2.602 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -62.52 164.12 7.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.41 -0.806 . . . . 0.0 109.645 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.77 -166.21 0.64 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.697 -0.627 . . . . 0.0 109.319 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.582 -0.699 . . . . 0.0 109.407 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.25 -164.55 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.437 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.54 ' HB2' HD13 ' A' ' 15' ' ' ILE . 20.4 p30 -88.66 53.3 2.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 0.39 78.12 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.09 -39.6 5.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.792 HG22 HD12 ' A' ' 19' ' ' LEU . 2.9 mp -65.77 -41.87 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.874 -0.78 . . . . 0.0 109.202 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 4.6 t -59.65 -31.08 69.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.613 -0.679 . . . . 0.0 109.643 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -65.0 -33.53 76.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.603 ' O ' HD23 ' A' ' 22' ' ' LEU . 15.1 mmt -90.13 -15.22 32.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.667 -0.646 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.792 HD12 HG22 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -88.86 -35.18 16.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 108.519 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 16' ' ' THR . 43.4 t -81.07 -31.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.3 -57.34 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.993 HD11 ' CG ' ' A' ' 39' ' ' TYR . 2.5 pp -63.27 -34.65 78.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -51.7 -44.78 63.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.55 -0.719 . . . . 0.0 109.791 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.91 -35.07 79.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.7 t80 -63.56 -24.66 67.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.854 -0.529 . . . . 0.0 109.898 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 21.2 mm-40 -79.25 -56.63 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.851 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 18.0 ttpt -64.99 -41.37 95.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.497 -0.752 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -58.51 -26.69 63.74 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.823 . . . . 0.0 109.412 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 25' ' ' PHE . 56.9 t -89.55 164.77 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.2 t -78.63 -70.16 0.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.454 -0.779 . . . . 0.0 111.093 -178.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -81.01 57.85 3.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.511 -0.743 . . . . 0.0 110.905 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.88 62.01 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 179.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -109.56 -28.87 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.195 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.437 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -63.35 -49.1 75.24 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -70.8 -25.99 63.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.594 -0.691 . . . . 0.0 109.312 179.375 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 28.6 t80 -51.35 -59.01 4.69 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.291 -0.88 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -61.37 -27.84 68.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.531 -0.731 . . . . 0.0 109.318 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.034 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -56.68 -65.96 0.52 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.461 -0.774 . . . . 0.0 109.953 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.993 ' CG ' HD11 ' A' ' 22' ' ' LEU . 81.1 m-85 -71.27 -8.79 56.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 110.798 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -83.88 -54.41 4.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.119 -0.988 . . . . 0.0 109.3 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -61.07 -29.11 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.516 -0.74 . . . . 0.0 109.83 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.822 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -79.82 -47.17 15.61 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.529 -0.732 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -61.6 -26.24 67.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.879 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 -45.36 27.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.966 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 62' ' ' LEU . 12.6 p -75.51 -44.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -0.777 . . . . 0.0 110.086 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.48 ' N ' HG13 ' A' ' 45' ' ' VAL . 70.3 mt -67.6 -55.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 -179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -61.53 -20.01 62.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -116.02 28.11 8.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 109.575 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.482 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 2.4 t80 -89.7 141.77 28.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.7 Cg_endo -85.7 8.41 4.56 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.002 2.468 . . . . 0.0 110.998 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 63.7 m-70 -146.55 175.25 10.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 139.83 36.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.631 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.08 108.36 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.428 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -69.75 -40.34 76.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.821 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.3 m -148.55 -179.88 7.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.532 -0.73 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.33 -26.36 61.59 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.82 96.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.479 -1.012 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.58 -24.99 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.719 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -84.62 -27.67 27.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.415 -0.803 . . . . 0.0 109.733 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -75.9 -40.52 54.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -59.92 -22.4 62.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.788 ' HB3' HG21 ' A' ' 45' ' ' VAL . 86.5 mt -59.3 139.04 88.58 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 109.717 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -79.45 112.36 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.957 2.438 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.27 -28.52 5.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.78 138.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.932 . . . . 0.0 109.361 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.09 -139.52 10.17 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -99.22 -27.82 13.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.964 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.5 -65.51 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.402 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.034 HD11 ' HB1' ' A' ' 38' ' ' ALA . 50.5 mm -61.94 -42.13 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 109.717 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.74 82.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.534 -0.729 . . . . 0.0 109.673 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.7 -35.75 77.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.514 -0.741 . . . . 0.0 109.53 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -68.9 -28.94 67.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.619 -0.676 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.5 mm -63.17 -49.44 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 109.144 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.22 -40.61 74.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.454 -0.779 . . . . 0.0 109.694 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.01 -28.77 70.33 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.43 -51.65 27.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.64 -0.662 . . . . 0.0 109.294 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.65 -25.68 61.37 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.907 -0.496 . . . . 0.0 110.039 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.405 -0.809 . . . . 0.0 109.587 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -106.44 -54.75 2.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 109.407 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.56 3.19 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -170.17 155.01 5.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -1.016 . . . . 0.0 109.539 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 82' ' ' LEU . 9.5 mt -103.91 99.27 9.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.552 -0.717 . . . . 0.0 109.359 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -66.82 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.701 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 144.58 25.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.59 -0.694 . . . . 0.0 109.541 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -99.99 123.57 44.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.48 166.43 10.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.423 -179.95 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -85.14 155.26 21.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.622 -0.674 . . . . 0.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 59.92 92.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -85.59 -51.64 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.73 163.46 15.68 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.619 -0.676 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.54 177.68 4.21 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.34 2.693 . . . . 0.0 110.505 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -89.13 81.74 6.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.589 -0.695 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.95 105.07 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.738 . . . . 0.0 109.359 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -91.94 85.56 5.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.538 -0.727 . . . . 0.0 109.58 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mt -68.37 -69.74 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 109.286 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.69 ' HB2' HD12 ' A' ' 15' ' ' ILE . 24.1 p30 -83.8 57.83 4.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.609 -0.682 . . . . 0.0 109.496 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.29 0.51 78.28 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.87 -39.52 5.79 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.69 HD12 ' HB2' ' A' ' 12' ' ' ASN . 3.3 mt -68.21 -52.25 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.826 -0.808 . . . . 0.0 109.086 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -55.88 -33.98 65.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.737 -0.602 . . . . 0.0 110.175 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.36 -33.49 73.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.552 -0.718 . . . . 0.0 109.45 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt -86.88 -13.74 43.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.693 -0.629 . . . . 0.0 110.258 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -85.44 -35.71 21.09 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.495 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.54 -31.68 20.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.747 -0.595 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.97 HD11 ' CG ' ' A' ' 39' ' ' TYR . 3.6 pp -63.28 -33.05 74.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.08 -41.95 65.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -63.54 -37.77 88.58 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.5 t80 -62.69 -23.58 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.92 -0.487 . . . . 0.0 109.707 178.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.1 mm-40 -77.34 -57.58 3.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.067 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 13.6 tttt -66.47 -41.35 89.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -58.12 -25.27 61.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.732 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 25' ' ' PHE . 54.2 t -89.43 164.35 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.8 t -77.01 -70.25 0.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 110.925 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -84.54 61.7 6.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 110.638 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.79 52.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -98.98 -28.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.372 -0.83 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.9 p-80 -65.27 -49.26 70.26 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -69.15 -22.06 63.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.675 . . . . 0.0 109.569 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 26.8 t80 -56.9 -64.59 0.83 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -55.96 -25.02 41.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 109.772 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.09 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -54.71 -64.87 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.441 -0.787 . . . . 0.0 110.053 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.97 ' CG ' HD11 ' A' ' 22' ' ' LEU . 45.7 m-85 -81.7 -25.76 35.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.667 . . . . 0.0 110.282 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 tpt85 -62.11 -44.47 96.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.393 -0.817 . . . . 0.0 109.8 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -78.0 -42.58 32.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.796 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.795 ' CB ' HG21 ' A' ' 69' ' ' ILE . . . -62.97 -29.74 71.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 109.662 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -76.64 -31.71 57.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -75.49 -41.31 55.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 62' ' ' LEU . 11.4 p -70.88 -44.25 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.478 -0.764 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.548 HG13 HG13 ' A' ' 45' ' ' VAL . 69.9 mt -73.41 -27.95 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.471 -0.768 . . . . 0.0 109.853 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.41 -23.3 43.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -116.64 28.14 8.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.586 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 2.1 t80 -88.1 142.48 31.95 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 40.3 Cg_endo -85.63 6.78 5.41 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.063 2.509 . . . . 0.0 111.177 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.6 m-70 -145.67 170.77 15.81 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -98.26 135.95 39.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.551 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.789 HG23 ' HB3' ' A' ' 58' ' ' GLU . 55.9 mt -73.06 120.66 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.572 -0.705 . . . . 0.0 109.271 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -82.16 -49.64 9.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.543 -0.723 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.48 -179.81 5.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.607 -0.683 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.42 -27.72 71.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.01 96.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.589 -0.948 . . . . 0.0 109.681 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.789 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -61.36 -20.79 63.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.836 179.944 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -87.87 -26.4 22.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.397 -0.815 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -74.01 -39.92 63.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.504 -0.747 . . . . 0.0 109.71 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.19 -25.86 65.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.55 -0.719 . . . . 0.0 110.01 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HG21 ' A' ' 45' ' ' VAL . 84.3 mt -59.21 144.64 82.89 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.503 -0.748 . . . . 0.0 109.714 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -79.1 112.61 3.09 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.021 2.481 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.13 -28.57 6.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.7 139.6 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 109.343 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.43 -137.61 7.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 p -99.1 -29.34 12.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.601 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -65.92 -65.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.482 -0.761 . . . . 0.0 109.587 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.09 HD11 ' HB1' ' A' ' 38' ' ' ALA . 49.7 mm -61.78 -42.78 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.818 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.89 70.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.7 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.43 -43.22 99.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -62.22 -28.45 69.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.315 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.2 mm -63.48 -44.52 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.41 -41.3 76.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.474 -0.766 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.07 -27.54 69.47 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.549 ' CD2' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -71.46 -52.09 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 0.0 109.409 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -71.22 -26.68 63.03 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.949 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.367 -0.833 . . . . 0.0 109.527 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 -66.63 1.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.416 -0.803 . . . . 0.0 109.272 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.25 41.91 98.49 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.19 -52.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.692 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -108.6 123.51 49.05 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -65.84 143.24 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.676 . . . . 0.0 109.455 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.74 19.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 109.491 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.51 ' N ' HD22 ' A' ' 85' ' ' LEU . 4.3 mm? -71.14 -176.41 1.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.412 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.98 80.24 1.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.6 -0.687 . . . . 0.0 109.49 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.6 tptp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.386 -179.906 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -78.29 -35.45 47.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.12 -82.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -145.53 143.23 29.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.85 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.89 159.72 84.53 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.451 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.5 -168.94 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.412 2.741 . . . . 0.0 110.575 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -84.87 99.48 10.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.632 -0.668 . . . . 0.0 109.48 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -149.78 30.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.602 -0.686 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 p -86.15 145.25 27.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.685 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 52' ' ' LYS . 4.4 mt -83.15 -170.31 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.725 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.68 ' HB3' HG22 ' A' ' 46' ' ' ILE . 28.3 m120 58.37 29.84 18.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.493 -0.754 . . . . 0.0 109.921 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.16 -17.22 54.09 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -91.25 -38.43 5.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 12' ' ' ASN . 3.2 mt -69.08 -49.52 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.836 -0.802 . . . . 0.0 109.155 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 47' ' ' ALA . 5.0 t -57.48 -35.01 69.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.055 -179.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -59.74 -35.53 74.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.458 -0.776 . . . . 0.0 109.471 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.699 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.1 tpp -90.35 -11.88 39.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.163 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.667 ' CD1' HG22 ' A' ' 15' ' ' ILE . 3.9 mt -87.48 -32.62 19.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.702 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.3 t -85.57 -36.54 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HA ' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -67.04 -47.24 71.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.914 HD11 ' CG ' ' A' ' 39' ' ' TYR . 1.9 pp -73.82 -34.97 64.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 108.437 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -53.82 -49.9 67.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.675 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -62.4 -33.02 73.94 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 37.5 t80 -64.52 -21.33 66.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.714 -0.616 . . . . 0.0 109.609 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -78.47 -57.81 3.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.366 -0.834 . . . . 0.0 108.85 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 5.1 tmtt? -66.81 -39.79 87.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 109.426 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -58.7 -26.4 63.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.791 . . . . 0.0 109.603 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' PHE . 63.1 t -89.44 164.41 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -77.03 -70.01 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.768 . . . . 0.0 111.012 -178.617 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -84.64 60.34 6.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 110.687 -178.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 26' ' ' GLU . . . -150.91 63.96 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -110.12 -31.02 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.812 . . . . 0.0 109.008 179.777 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 4.3 p-80 -60.88 -48.8 80.15 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.426 -0.796 . . . . 0.0 108.904 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -69.92 -26.02 63.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.645 -0.659 . . . . 0.0 109.544 179.339 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 27.3 t80 -51.54 -65.56 0.54 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -57.61 -25.06 59.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.058 ' HB1' HD11 ' A' ' 69' ' ' ILE . . . -57.42 -67.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.337 -0.852 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.914 ' CG ' HD11 ' A' ' 22' ' ' LEU . 74.8 m-85 -72.32 -24.65 61.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.64 -0.663 . . . . 0.0 110.268 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 -62.54 -42.3 99.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -75.12 -44.53 46.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.504 -0.747 . . . . 0.0 109.801 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 69' ' ' ILE . . . -62.11 -41.26 98.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 19' ' ' LEU . . . -65.21 -29.45 70.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.793 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -70.78 -34.67 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.72 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.842 HG21 ' HB3' ' A' ' 62' ' ' LEU . 13.6 p -90.14 -45.35 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 110.121 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.68 HG22 ' HB3' ' A' ' 12' ' ' ASN . 69.7 mt -66.74 -55.64 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.0 109.723 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB2' ' OG1' ' A' ' 16' ' ' THR . . . -59.25 -19.92 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -118.05 28.08 8.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.763 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.614 ' CZ ' HD21 ' A' ' 62' ' ' LEU . 1.6 t80 -91.05 139.84 25.85 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 49' ' ' TYR . 41.7 Cg_endo -85.09 6.95 5.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.034 2.489 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.415 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 66.7 m-70 -147.14 172.52 13.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.168 -0.957 . . . . 0.0 109.536 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HB3' HD13 ' A' ' 11' ' ' LEU . 5.5 pttm -98.61 144.05 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.553 -0.717 . . . . 0.0 109.512 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.814 HG23 ' HB3' ' A' ' 58' ' ' GLU . 57.3 mt -75.28 108.85 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 109.36 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -71.18 -46.57 61.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.657 -0.652 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.9 173.43 11.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.08 -28.43 68.91 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.44 71.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.654 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.814 ' HB3' HG23 ' A' ' 53' ' ' ILE . 6.4 tt0 -74.36 -24.18 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.556 -0.715 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.755 ' HB2' HG21 ' A' ' 73' ' ' ILE . . . -85.38 -29.31 24.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.41 -0.806 . . . . 0.0 109.587 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -76.22 -38.82 55.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.543 -0.723 . . . . 0.0 109.629 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -60.32 -23.67 64.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 0.0 110.06 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.842 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.9 mt -60.94 141.29 93.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.515 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.54 107.91 2.22 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.939 2.426 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.9 -28.78 3.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 70' ' ' ALA . 28.3 t -89.79 138.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -1.02 . . . . 0.0 109.379 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.7 -137.38 8.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -98.91 -26.69 14.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.598 -0.943 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -69.93 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.058 HD11 ' HB1' ' A' ' 38' ' ' ALA . 48.3 mm -61.42 -45.08 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.733 . . . . 0.0 109.804 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -57.62 -34.11 68.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.469 -0.77 . . . . 0.0 109.831 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.95 -43.55 98.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.732 . . . . 0.0 109.312 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -63.43 -29.65 70.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.673 . . . . 0.0 109.266 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.755 HG21 ' HB2' ' A' ' 59' ' ' ALA . 47.8 mm -63.17 -46.42 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.67 -40.72 72.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.531 -0.731 . . . . 0.0 109.647 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.58 -28.72 70.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -52.31 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.56 -0.712 . . . . 0.0 109.36 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -72.68 -25.67 61.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.932 -0.48 . . . . 0.0 110.005 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.93 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -58.19 1.93 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.451 -0.781 . . . . 0.0 109.435 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.66 37.32 4.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -170.07 179.24 3.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.541 -0.976 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 mt -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 0.0 109.461 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.05 100.65 11.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.735 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -139.21 76.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 85' ' ' LEU . 4.5 mm? -70.87 161.47 30.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.422 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.54 35.73 2.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.517 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 tttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.442 -179.979 . . . . . . . . 0 0 . 1 stop_ save_